Sentence,class,file
"Core tip:  Athlete’s heart is a physiological condition  that in some cases can simulate pathological disease, Submit a Manuscript: http://www.f6publishing.com DOI: 10.4330/wjc.v9.i6.470World J Cardiol  2017 June 26; 9(6): 470-480 ISSN 1949-8462 (online)World Journal of  Cardiology WJC",Non-OADS,/arxiv_data1/oa_pdf/fe/99/WJC-9-470.PMC5491465.pdf
World J Cardiol  2017; 9(6): 470-480  Available from: URL:   http://www.wjgnet.com/ 1949-8462 /full/v9/i6/ 470.htm  DOI: http:// dx.doi.org/ 10.4330 /wjc.v9.i6.,Non-OADS,/arxiv_data1/oa_pdf/fe/99/WJC-9-470.PMC5491465.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/fe/99/WJC-9-470.PMC5491465.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Andrei D Mǎrgulescu, MD, PhD, Specia - list in Cardiology and Internal Medicine, Assistant Professor ,  Department of Cardiology, University and Emergency Hospital,  169 Splaiul Independentei, Sector 5, Bucharest 050098,  Romania.",Non-OADS,/arxiv_data1/oa_pdf/98/f7/WJC-9-481.PMC5491466.pdf
World J Cardiol  2017; 9(6): 481-495  Available  from: URL:  http://www.wjgnet.com/ 1949-8462 /full/v9/i6/ 481.Submit a Manuscript: http://www.f6publishing.com DOI: 10.4330/wjc.v9.i6.481World J Cardiol  2017 June 26; 9(6): 481-495 ISSN 1949-8462 (online)World Journal of  Cardiology WJC,Non-OADS,/arxiv_data1/oa_pdf/98/f7/WJC-9-481.PMC5491466.pdf
Assessment of aortic valve disease htm  DOI: http://dx.doi.org/ 10.4330 /wjc.v9.i6.,Non-OADS,/arxiv_data1/oa_pdf/98/f7/WJC-9-481.PMC5491466.pdf
"The EuroSCORE Ⅱ (http://www.euroscore.org/calc.html)  includes 12 predictors identified from a retrospective  population of 14799 patients who underwent different  cardiovascular surgical interventions (mainly coronary  artery bypass graft) in Europe, in 1995.",Non-OADS,/arxiv_data1/oa_pdf/98/f7/WJC-9-481.PMC5491466.pdf
"The STS score  (Society of Thoracic Surgeons, http://riskcalc.sts.or g)  includes 24 predictors identified from a population of  64292 patients who underwent surgical intervention only  for AS in the United States between 2002 and 2006.",Non-OADS,/arxiv_data1/oa_pdf/98/f7/WJC-9-481.PMC5491466.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/98/f7/WJC-9-481.PMC5491466.pdf
"See: http://creativecommons.org/licenses/ by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. S Lucy Roche, Staff Cardiologist,   Division of Cardiology, 5N-521 Toronto General Hospital, 585  University Avenue, Toronto, ON M5G 2N2,  Canada.",Non-OADS,/arxiv_data1/oa_pdf/09/d5/WJC-9-496.PMC5491467.pdf
Key words:  Congenital heart disease; Arrhythmia; Adult;  AblationSubmit a Manuscript: http://www.f6publishing.com DOI: 10.4330/wjc.v9.i6.496World J Cardiol  2017 June 26; 9(6): 496-507 ISSN 1949-8462 (online)World Journal of  Cardiology WJC,Non-OADS,/arxiv_data1/oa_pdf/09/d5/WJC-9-496.PMC5491467.pdf
World J Cardiol   2017; 9(6): 496-507  Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/09/d5/WJC-9-496.PMC5491467.pdf
com/ 1949-8462 /full/v9/i6/ 496.htm  DOI: http://dx.doi.org/ 10.4330 / wjc.v9.i6.,Non-OADS,/arxiv_data1/oa_pdf/09/d5/WJC-9-496.PMC5491467.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/09/d5/WJC-9-496.PMC5491467.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  John G Kingma, PhD,  Department of  Medicine, Faculty of Medicine, Laval University, 2725 chemin  Ste-Foy, Ste-Foy, Québec, QC G1V 4G5,  Canada.",Non-OADS,/arxiv_data1/oa_pdf/11/a0/WJC-9-508.PMC5491468.pdf
"Core tip:  Neural elements within the intrinsic cardiac  nervous system are known to transduce sensory inputs  from the heart, blood vessels and surrounding organs Submit a Manuscript: http://www.f6publishing.com DOI: 10.4330/wjc.v9.i6.508World J Cardiol  2017 June 26; 9(6): 508-520 ISSN 1949-8462 (online)World Journal of  Cardiology WJC",Non-OADS,/arxiv_data1/oa_pdf/11/a0/WJC-9-508.PMC5491468.pdf
wjgnet.com/ 1949-8462 /full/v9/i6/ 508.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/11/a0/WJC-9-508.PMC5491468.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/11/a0/WJC-9-508.PMC5491468.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Jackson J Liang, DO,  Cardiac Electro - physiology, Cardiovascular Division, Hospital of the University of  Pennsylvania, 3400 Spruce St., Philadelphia, PA 19104,  United States.",Non-OADS,/arxiv_data1/oa_pdf/86/96/WJC-9-521.PMC5491469.pdf
Submit a Manuscript: http://www.f6publishing.com DOI: 10.4330/wjc.v9.i6.521World J Cardiol  2017 June 26; 9(6): 521-530 ISSN 1949-8462 (online)World Journal of  Cardiology WJC,Non-OADS,/arxiv_data1/oa_pdf/86/96/WJC-9-521.PMC5491469.pdf
wjgnet.com/ 1949-8462 /full/v9/i6/ 521.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/96/WJC-9-521.PMC5491469.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/86/96/WJC-9-521.PMC5491469.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Jeremie Barraud, MD,  Department  of Cardiology, Aix-Marseille University, Assistance Publique -  Hôpitaux de Marseille, Nord Hospital, Chemin des Bourrelly,  13015 Marseille, France.",Non-OADS,/arxiv_data1/oa_pdf/0f/ae/WJC-9-531.PMC5491470.pdf
wjgnet.com/ 1949-8462 /full/v9/i6/ 531.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0f/ae/WJC-9-531.PMC5491470.pdf
531Submit a Manuscript: http://www.f6publishing.com DOI: 10.4330/wjc.v9.i6.531World J Cardiol  2017 June 26; 9(6): 531-538 ISSN 1949-8462 (online)World Journal of  Cardiology WJC,Non-OADS,/arxiv_data1/oa_pdf/0f/ae/WJC-9-531.PMC5491470.pdf
"Available from:  URL: https://clinicaltrials.gov/ct2/show/NCT02188147 48 Collins AJ , Foley RN, Chavers B, Gilbertson D, Herzog C,  Johansen K, Kasiske B, Kutner N, Liu J, St Peter W, Guo H,  Gustafson S, Heubner B, Lamb K, Li S, Li S, Peng Y, Qiu Y,  Roberts T, Skeans M, Snyder J, Solid C, Thompson B, Wang C,  Weinhandl E, Zaun D, Arko C, Chen SC, Daniels F, Ebben J,  Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B,  Constantini E, Everson S, Eggers P, Agodoa L. ‘United States  Renal Data System 2011 Annual Data Report: Atlas of chronic  kidney disease & amp; end-stage renal disease in the United States.",OADS,/arxiv_data1/oa_pdf/0f/ae/WJC-9-531.PMC5491470.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/0f/ae/WJC-9-531.PMC5491470.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Klaus Kettering, MD,  Department of Cardiology, University of Frankfurt, Theodor ­Stern ­Kai 7, 60590  Frankfurt, Germany.",Non-OADS,/arxiv_data1/oa_pdf/55/50/WJC-9-539.PMC5491471.pdf
RESULTS A 3D TEE could be performed successfully in all patients   prior to the ablation procedure and all four pulmonary Submit a Manuscript: http://www.f6publishing.com DOI: 10.4330/wjc.v9.i6.539World J Cardiol  2017 June 26; 9(6): 539-546 ISSN 1949-8462 (online)World Journal of  Cardiology WJC Clinical Trials Study,Non-OADS,/arxiv_data1/oa_pdf/55/50/WJC-9-539.PMC5491471.pdf
wjgnet.com/ 1949 ­8462 /full/v9/i6/ 539.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/50/WJC-9-539.PMC5491471.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/55/50/WJC-9-539.PMC5491471.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Manuscript source:  Invited manuscript Correspondence to:  Paolo Ferrero, MD,  Adult Congenital Heart  Disease, Bristol Heart Institute, University of Bristol, Marlborough  Street, Bristol BS2 8HW, United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/d6/03/WJC-9-547.PMC5491472.pdf
During Submit a Manuscript: http://www.f6publishing.com DOI: 10.4330/wjc.v9.i6.547World J Cardiol  2017 June 26; 9(6): 547-552 ISSN 1949-8462 (online)World Journal of  Cardiology WJC Observational Study,Non-OADS,/arxiv_data1/oa_pdf/d6/03/WJC-9-547.PMC5491472.pdf
World J Cardiol  2017; 9(6): 547-552  Available from: URL:   http://www.wjgnet.com/ 1949-8462 /full/v9/i6/ 547.htm  DOI: http:// dx.doi.org/ 10.4330 /wjc.v9.i6.,Non-OADS,/arxiv_data1/oa_pdf/d6/03/WJC-9-547.PMC5491472.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/d6/03/WJC-9-547.PMC5491472.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Kazuaki Nishio, MD,  Department of  Internal Medicine, Matsui Hospital, 1-7-10, Ikegami, Ota-ku, Tokyo  145-0082, Japan.",Non-OADS,/arxiv_data1/oa_pdf/3f/64/WJC-9-553.PMC5491473.pdf
Submit a Manuscript: http://www.f6publishing.com DOI: 10.4330/wjc.v9.i6.553World J Cardiol  2017 June 26; 9(6): 553-557 ISSN 1949-8462 (online)World Journal of  Cardiology WJC,Non-OADS,/arxiv_data1/oa_pdf/3f/64/WJC-9-553.PMC5491473.pdf
World J Cardiol  2017; 9(6): 553-557   Available from: URL:  http://www.wjgnet.com/ 1949-8462 /full/v9/ i6/553.htm  DOI: http://dx.doi.org/ 10.4330 /wjc.v9.i6.,Non-OADS,/arxiv_data1/oa_pdf/3f/64/WJC-9-553.PMC5491473.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/3f/64/WJC-9-553.PMC5491473.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Konstantinos Aznaouridis, PhD,  Cardio - logy Department, Castle Hill Hospital, Hull and East Yorkshire NHS  Trust, Castle Rd, Cottingham HU16 5JQ,  United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/7e/7a/WJC-9-558.PMC5491474.pdf
World J Cardiol  2017; 9(6): 558-561  Submit a Manuscript: http://www.f6publishing.com DOI: 10.4330/wjc.v9.i6.558World J Cardiol  2017 June 26; 9(6): 558-561 ISSN 1949-8462 (online)World Journal of  Cardiology WJC,Non-OADS,/arxiv_data1/oa_pdf/7e/7a/WJC-9-558.PMC5491474.pdf
Inadvertent cardiac phlebography Available from: URL:  http://www.wjgnet.com/ 1949-8462 /full/v9/ i6/558.htm  DOI: http://dx.doi.org/ 10.4330 /wjc.v9.i6.,Non-OADS,/arxiv_data1/oa_pdf/7e/7a/WJC-9-558.PMC5491474.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/7e/7a/WJC-9-558.PMC5491474.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. Maila Castro Lourenço Neves,   Department of Mental Health, Federal University of Minas Gerais,  Avenida Alfredo Balena, 190 - Sala 240, CEP 30130-100 Belo  Horizonte, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/fe/84/WJP-7-106.PMC5491475.pdf
"mailacln@ufmg.b r Telephone:  +55-31-34099786 Received:  January 21, 2017 Peer-review started:  January 21, 2017 First decision:  February 15, 2017 Revised:  March 30, 2017 Accepted:  April 23, 2017 Article in press:  April 24, 2017 Published online:  June 22, 2017 Abstract AIM To identify factors associated with depressive symptoms Submit a Manuscript: http://www.f6publishing.com DOI: 10.5498/wjp.v7.i2.106World J Psychiatr  2017 June 22; 7(2): 106-113 ISSN 2220-3206 (online)World Journal of  Psychiatry WJP Observational Study",Non-OADS,/arxiv_data1/oa_pdf/fe/84/WJP-7-106.PMC5491475.pdf
World J Psychiatr  2017; 7(2): 106-113  Available from:  URL:  http://www.wjgnet.com/2220-3206/full/v7/i2/ 106.htm   DOI: http://dx.doi.org/10.5498/wjp.v7.i2.,Non-OADS,/arxiv_data1/oa_pdf/fe/84/WJP-7-106.PMC5491475.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/fe/84/WJP-7-106.PMC5491475.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Hasan Belli, MD, Associate Professor,  Department of Psychiatry, Health Sciences University, Bagcilar  Education And Research Hospital, Merkez Mahallesi, Bagcılar,  34100 Istanbul, Turkey.",Non-OADS,/arxiv_data1/oa_pdf/2e/e1/WJP-7-114.PMC5491476.pdf
Submit a Manuscript: http://www.f6publishing.com DOI: 10.5498/wjp.v7.i2.114World J Psychiatr  2017 June 22; 7(2): 114-120 ISSN 2220-3206 (online)World Journal of  Psychiatry WJP Observational Study,Non-OADS,/arxiv_data1/oa_pdf/2e/e1/WJP-7-114.PMC5491476.pdf
World J Psychiatr  2017; 7(2): 114-120  Available  from: URL:  http://www.wjgnet.com/2220-3206/full/v7/i2/ 114. htm  DOI: http://dx.doi.org/10.5498/wjp.v7.i2.,Non-OADS,/arxiv_data1/oa_pdf/2e/e1/WJP-7-114.PMC5491476.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/2e/e1/WJP-7-114.PMC5491476.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Eiji Kirino, MD, PhD,  Department of  Psychiatry, Juntendo University Shizuoka Hospital, 1129 Nagaoka,  Izunokuni-shi, Shizuoka 410-2211, Japan.",Non-OADS,/arxiv_data1/oa_pdf/59/dc/WJP-7-121.PMC5491477.pdf
"Of these, Factor 1 could be  interpreted as favouring a tendency for AD, Factor 2 as  favouring a tendency for pseudo-dementia, and Factor 3  as favouring a depressive tendency.Submit a Manuscript: http://www.f6publishing.com DOI: 10.5498/wjp.v7.i2.121World J Psychiatr  2017 June 22; 7(2): 121-127 ISSN 2220-3206 (online)World Journal of  Psychiatry WJP Observational Study",Non-OADS,/arxiv_data1/oa_pdf/59/dc/WJP-7-121.PMC5491477.pdf
World J Psychiatr  2017; 7(2): 121-127  Available  from: URL:  http://www.wjgnet.com/2220-3206/full/v7/i2/ 121. htm  DOI: http://dx.doi.org/10.5498/wjp.v7.i2.,Non-OADS,/arxiv_data1/oa_pdf/59/dc/WJP-7-121.PMC5491477.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/59/dc/WJP-7-121.PMC5491477.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Silvia Grassi, MD,  Department of  Psychiatry, University of Milan, Fondazione IRCCS Ospedale  Maggiore Policlinico, Mangiagalli e Regina Elena, Via F. Sforza  35, 20122 Milan, Italy.",Non-OADS,/arxiv_data1/oa_pdf/f0/47/WJP-7-128.PMC5491478.pdf
This Submit a Manuscript: http://www.f6publishing.com DOI: 10.5498/wjp.v7.i2.128World J Psychiatr  2017 June 22; 7(2): 128-132 ISSN 2220-3206 (online)World Journal of  Psychiatry WJP,Non-OADS,/arxiv_data1/oa_pdf/f0/47/WJP-7-128.PMC5491478.pdf
World J Psychiatr  2017; 7(2): 128-132   Available from: URL:  http://www.wjgnet.com/2220-3206/full/v7/ i2/128.htm  DOI: http://dx.doi.org/10.5498/wjp.v7.i2.,Non-OADS,/arxiv_data1/oa_pdf/f0/47/WJP-7-128.PMC5491478.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/f0/47/WJP-7-128.PMC5491478.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. William Davies,  School of Psychology,  Cardiff University, Tower Building 70, Park Place, Cardiff CF10  3A T, United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/ab/64/WJP-7-77.PMC5491479.pdf
Identifying Submit a Manuscript: http://www.f6publishing.com DOI: 10.5498/wjp.v7.i2.77World J Psychiatr  2017 June 22; 7(2): 77-88 ISSN 2220-3206 (online)World Journal of  Psychiatry WJP,Non-OADS,/arxiv_data1/oa_pdf/ab/64/WJP-7-77.PMC5491479.pdf
World J Psychiatr   2017; 7(2): 77­88  Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/ab/64/WJP-7-77.PMC5491479.pdf
com/2220 ­3206/full/v7/i2/ 77.htm  DOI: http://dx.doi.org/10.5498/ wjp.v7.i2.,Non-OADS,/arxiv_data1/oa_pdf/ab/64/WJP-7-77.PMC5491479.pdf
"Available from: URL: https://www.ncbi.nlm.nih.gov/ unigene 41 Gratton AM , Ye L, Brownfoot FC, Hannan NJ, Whitehead C,  Cannon P, Deo M, Fuller PJ, Tong S, Kaitu’u ­Lino TJ.",Non-OADS,/arxiv_data1/oa_pdf/ab/64/WJP-7-77.PMC5491479.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/ab/64/WJP-7-77.PMC5491479.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. Adel Gabriel, Associate Clinical  Professor,  Departments of Psychiatry and Community Health  Sciences, University of Calgary, Suite 300, 5 Richard Way SW,  Calgary, AB T3E 7M8, Canada.",Non-OADS,/arxiv_data1/oa_pdf/58/34/WJP-7-89.PMC5491480.pdf
Submit a Manuscript: http://www.f6publishing.com DOI: 10.5498/wjp.v7.i2.89World J Psychiatr  2017 June 22; 7(2): 89-97 ISSN 2220-3206 (online)World Journal of  Psychiatry WJP Basic Study,Non-OADS,/arxiv_data1/oa_pdf/58/34/WJP-7-89.PMC5491480.pdf
World J Psychiatr   2017; 7(2): 89-97  Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/58/34/WJP-7-89.PMC5491480.pdf
com/2220-3206/full/v7/i2/ 89.htm  DOI: http://dx.doi.org/10.5498/ wjp.v7.i2.,Non-OADS,/arxiv_data1/oa_pdf/58/34/WJP-7-89.PMC5491480.pdf
"Available from:  URL: https://www.albertahealthservices.ca/assets/info/hp/mha/if- hp-mha-guide.pdf 17 Lachar D , Bailley SE, Rhoades HM, Varner RV .",Non-OADS,/arxiv_data1/oa_pdf/58/34/WJP-7-89.PMC5491480.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/58/34/WJP-7-89.PMC5491480.pdf
The study  is registered at https://clinicaltrials.gov/ct2/show/NCT01309516?,Non-OADS,/arxiv_data1/oa_pdf/a1/47/WJP-7-98.PMC5491481.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Nusrat Husain, MBBS, MCPS (Psych),  DPH, MPH, Dip (Psych), MD, Proffesor of Psychiatry, University  of Manchester, Honorary Consultant Psychiatrist Lancashire Care  NHS Trust, Jean McFarlane Building, Oxford Road, Manchester  M13 9PL, United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/a1/47/WJP-7-98.PMC5491481.pdf
"nusrat.husain@manchester.ac.u k Telephone:  +44-16-13067921 Received:  December 3, 2016  Peer-review started:  December 5, 2016  First decision:  April 17, 2017 Revised:  May 16, 2017  Accepted:  May 30, 2017   Article in press:  May 31, 2017Submit a Manuscript: http://www.f6publishing.com DOI: 10.5498/wjp.v7.i2.98World J Psychiatr  2017 June 22; 7(2): 98-105 ISSN 2220-3206 (online)World Journal of  Psychiatry WJP Randomized Controlled Trial",Non-OADS,/arxiv_data1/oa_pdf/a1/47/WJP-7-98.PMC5491481.pdf
World J Psychiatr  2017; 7(2): 98-105   Available from: URL:  http://www.wjgnet.com/2220-3206/full/v7/ i2/98.htm  DOI: http://dx.doi.org/10.5498/wjp.v7.i2.,Non-OADS,/arxiv_data1/oa_pdf/a1/47/WJP-7-98.PMC5491481.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/a1/47/WJP-7-98.PMC5491481.pdf
e00336 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
"For this reason, not only are many Article No~e00336 2 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Article No~e00336 3 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
"In turn, each of these layers are, depending on the context, made up of Article No~e00336 4 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Article No~e00336 5 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
"From poor to rich: 1) an online regular photo, 2) an Article No~e00336 6 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Article No~e00336 7 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
The results of the Article No~e00336 8 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
"Opinion on the physical shop: Since the presentation of a physical shopping experience via an online modality is central to this study, we will also study the level that seeing different online photos of the shop influences the consumer ’s Article No~e00336 9 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Article No~e00336 10 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Article No~e00336 11 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
"Also, the number of test subjects who were not familiar with Article No~e00336 12 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
"In contrast to experiment 1, it was timed how long the test subject looked at Article No~e00336 13 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Article No~e00336 14 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
By means of a Article No~e00336 15 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Test subjects from the VR Article No~e00336 16 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Article No~e00336 17 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Chi-square Article No~e00336 18 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Article No~e00336 19 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Article No~e00336 20 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Article No~e00336 21 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Article No~e00336 22 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Article No~e00336 23 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
"With the other variables, a difference was always found between the effect of the VR photo and the other two photos, but not between the Article No~e00336 24 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
"One important discussion point around the first experiment ’s methodology is related to how, due to practical reasons, not all test subjects could be randomly Article No~e00336 25 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Article No~e00336 26 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Retrieved on 16 December 2015 http://www.marketingfacts.nl/berichten/25-tips- voor-het-inrichten-van-de-winkelpaginas-in-je-webshop .,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Retrieved on 17 December 2015 http://www.digitaslbi.,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Retrieved on 23 August 2016 http://fashionretailfuture.com/hema-app-scan-in-store/ .,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Article No~e00336 27 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Retrieved on 12 September 2015 https://www.kennisnet.nl/artikel/6-dingen-die-je-moet-weten- over-virtual-reality/ .,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Retrieved on 21 December 2015 http://www.frankwatching.com/archive/2012/12/20/in-4-stappen- naar-een-omnichannelstrategie/ .,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Retrieved on 18 December 2015 http://www.hlntv.com/article/2014/03/05/haptic-touchsc- reen-texture-fujitsu-5-things-future .,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Retrieved on 12 September 2016 http://www.multiscope.nl/persberichten/ consument-heeft-hoge-verwachting-van- vr-brillen.html .,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Retrieved on 21 December 2015 http://www.nu.nl/breda/ 4030217/verandering-parkeertarieven-draagt-bij-shop .,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Article No~e00336 28 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Cor Molenaar: “Binnenstad moet nieuwe kansen krijgen ”.. Retrieved on 21 December 2015 http://www.retaildetail.nl/case-van-de-week/item/ 15681-cor-molenaar-binnenstad-moet-nieuwe-kansen-krijgen .,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Retrieved on 21 December 2015 http://www.retailnews.nl/nieuws/JTY7T4T7EeOSgiIACiAWJg-0/ consument-vindt-shopexperience-ondermaats.html .,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Retrieved on 21 December 2015 http://www.amsterdamcreativeindus- tries.com/news/eerste-virtuele-winkeltour-ter-wereld-met-google-cardboard .,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Retrieved on 21 December 2015 http://shoppermarketingupdate.nl/retailers- groeien-toe-naar-shopexperience-2-0/ .,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
retrieved on 5 September 2016 http://www.hva.nl/createit/lectoraten/lectoraten/lectoraten/con- tent/folder/lectoraat-crossmedia/publicaties?tools/item/online-goes-offline.html .,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Retrieved on 5 September 2016 http://www.tns-nipo.com/nieuws/nieuws- berichten/showrooming-met-smartphone-ramp-redding-voor-ret/ .,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Retrieved on 7 November 2016 http://www.emerce.nl/ achtergrond/virtuele-spiegel-als-oplossing-online-en-offline-winkelen .,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Article No~e00336 29 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
Article No~e00336 30 http://dx.doi.org/10.1016/j.heliyon.2017.e00336 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/b3/main.PMC5491482.pdf
New Microbe and New Infect 2017; 19:38–42 © 2017 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2017.05.005,Non-OADS,/arxiv_data1/oa_pdf/a1/c3/main.PMC5491483.pdf
"New species from undernourished African children 39 © 2017 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,19,3 8 –42 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/a1/c3/main.PMC5491483.pdf
"Scale bar indicates 0.5% nucleotide sequence divergence.40 New Microbes and New Infections , Volume 19 Number C, September 2017 NMNI © 2017 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,19,3 8 –42 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/a1/c3/main.PMC5491483.pdf
"New species from undernourished African children 41 © 2017 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,19,3 8 –42 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/a1/c3/main.PMC5491483.pdf
"Microbiol Today 2006;33:152 .42 New Microbes and New Infections , Volume 19 Number C, September 2017 NMNI © 2017 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,19,3 8 –42 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/a1/c3/main.PMC5491483.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/d1/main.PMC5491484.pdf
The  triceps http://dx.doi.org/10.1016/j.ijscr.2017.06.026 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/0f/d1/main.PMC5491484.pdf
"Muscle  Nerve  (2017),  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/0f/d1/main.PMC5491484.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d3/77/main.PMC5491485.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.06.016 2049-0801/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d3/77/main.PMC5491485.pdf
Available from: http://www.england.nhs.uk/statistics/statistical- work-areas/ae-waiting-times-and-activity/weekly-ae-sitreps-2014-15/ .,Non-OADS,/arxiv_data1/oa_pdf/d3/77/main.PMC5491485.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/f3/main.PMC5491486.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.06.058 2049-0801/ ©2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/ac/f3/main.PMC5491486.pdf
This  is  an  open  access  article  under the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/99/main.PMC5491487.pdf
"His  postoperative  course  was  unremarkable,  and http://dx.doi.org/10.1016/j.ijscr.2017.06.007 2210-2612/Published by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.",Non-OADS,/arxiv_data1/oa_pdf/95/99/main.PMC5491487.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/99/main.PMC5491487.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/52/7f/main.PMC5491488.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.06.059 2049-0801/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/7f/main.PMC5491488.pdf
"http://dx.doi.org/10.1016/j.nicl.2017.06.029 Received 28 March 2017; Received in revised form 9 June 2017; Accepted 22 June 2017⁎Corresponding author at: Department of Neurotrauma, Naval Medical Research Center, 503 Robert Grant Ave, Silver Spring, MD 20910, USA.",OADS,/arxiv_data1/oa_pdf/f9/b0/main.PMC5491489.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f9/b0/main.PMC5491489.pdf
Source reconstruction Each participant's cortical surface was determined using the FreeSurfer image analysis software ( http://surfer.nmr.mgh.harvard.,OADS,/arxiv_data1/oa_pdf/f9/b0/main.PMC5491489.pdf
"2, 255. http://dx.doi.org/10.3389/fpsyg.2011.00255 .",Non-OADS,/arxiv_data1/oa_pdf/f9/b0/main.PMC5491489.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8d/05/cia-12-971.PMC5491569.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 971–976Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  971OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CIA.S13799 3 social participation and perceived depression  among elderly population in south Africa gang hao1 ghose Bishwajit2 shangfeng Tang2 Changping nie1 lu Ji3 rui huang4 1Zunyi Medical and Pharmaceutical  College, Zunyi, 2school of Medicine  and health Management, Tongji  Medical College, huazhong University  of science and T echnology, Wuhan,   3Cancer Center, sun Yat- sen  University, guangzhou, guangdong,   4school of Pharmacy, Tongji Medical  College, huazhong University of  science and T echnology, Wuhan,   People’s republic of ChinaAbstract:  There is a growing consensus regarding the influence of various psychosocial  factors such as degree of social participation on health and disease outcomes, quality of life,  and general well-being.",Non-OADS,/arxiv_data1/oa_pdf/8d/05/cia-12-971.PMC5491569.pdf
"From the perspective of civil society organizations, social participation can indicate  the involvement of the general public in health decision-making as an essential ele - ment of democratic decision-making process health care.2,3 On the other hand, from  the social capital perspective it can refer to the interconnectivity and/or cohesiveness Correspondence: shangfeng Tang school of Medicine and health  Management, Tongji Medical College,  huazhong University of science and  Technology, 13 hangkong road, Wuhan,  hubei 430030, People’s republic of China Tel +86 133 4989 5639 email sftang@hust.edu.c n Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Hao et al Running head recto: Social participation and perceived depression among elderly population DOI: http://dx.doi.org/10.2147/CIA.S137993",Non-OADS,/arxiv_data1/oa_pdf/8d/05/cia-12-971.PMC5491569.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/8d/05/cia-12-971.PMC5491569.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/8d/05/cia-12-971.PMC5491569.pdf
"Available from: http://apps.who.int/healthinfo/systems/surveydata/ index.php/catalog/7/related_citation s. Accessed May 29, 2017.",OADS,/arxiv_data1/oa_pdf/8d/05/cia-12-971.PMC5491569.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/56/46/cmar-9-229.PMC5491570.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/56/46/cmar-9-229.PMC5491570.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Cancer Management and Research 2017:9 229–241Cancer Management and Research Dovepress submit your manuscript | www.dovepress.com Dovepress  229 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S95663Management of malignant pleural effusion:  challenges and solutions Erika Penz1 Kristina N Watt1 Christopher A Hergott2 Najib M Rahman3 Ioannis Psallidas3 1Division of Respirology,   Department of Medicine, University  of Saskatchewan, Saskatoon, SK,   2Division of Respirology, Department  of Medicine, University of Calgary,  Calgary, AB, Canada;  3Oxford  Centre for Respiratory Medicine,   Respiratory Trials Unit, Oxford University, Oxford, UKAbstract: Malignant pleural effusion (MPE) is a sign of advanced cancer and is associated  with significant symptom burden and mortality.",Non-OADS,/arxiv_data1/oa_pdf/56/46/cmar-9-229.PMC5491570.pdf
"Paramalignant effusion is defined as an effusion that is not a direct result of neoplastic involvement of the Correspondence: Erika Penz Room 537, Ellis Hall, Royal University Hospital, 103 Hospital Drive, Saskatoon, SK S7N 0W8, CanadaTel +1 306 844 1009 ext 4Fax +1 306 844 1532Email erika.penz@usask.caJournal name: Cancer Management and Research Article Designation: REVIEWY ear: 2017V olume: 9Running head verso: Penz et alRunning head recto: Malignant pleural effusion managementDOI: http://dx.doi.org/10.2147/CMAR.S95663",Non-OADS,/arxiv_data1/oa_pdf/56/46/cmar-9-229.PMC5491570.pdf
"Cancer Management and Research 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Cancer Management and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/cancer-management-and-research-journalCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/56/46/cmar-9-229.PMC5491570.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 241 Malignant pleural effusion management  64.,Non-OADS,/arxiv_data1/oa_pdf/56/46/cmar-9-229.PMC5491570.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0d/dd/copd-12-1867.PMC5491571.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1867–1876International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1867OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S13296 2 Double bronchodilation in chronic obstructive  pulmonary disease: a crude analysis from a   systematic review Jose luis lopez-Campos1,2 Carmen Calero-acuña1,2 eduardo Márquez-Martín1 esther Quintana gallego1,2 laura Carrasco-hernández1 Maria abad arranz1 Francisco Ortega ruiz1,2 1Virgen del rocio University hospital,   Biomedicine Institute of seville (IBis),   hospital Universitario Virgen del  rocío, Universidad de sevilla, sevilla,   spain; 2Centro de Investigación  Biomédica en red de enfermedades  respiratorias (CIBeres), Instituto de  salud Carlos III, Madrid, spainObjective:  The combination of a long-acting muscarinic antagonist (LAMA) and a long-acting  β2-agonist (LABA) in a single inhaler is a viable treatment option for patients with chronic  obstructive pulmonary disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/0d/dd/copd-12-1867.PMC5491571.pdf
"41013  seville, spain Tel/fax +34 95 501 3167 email lopezcampos@separ.e s Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Lopez-Campos et al Running head recto: Double bronchodilation in COPD DOI: http://dx.doi.org/10.2147/COPD.S132962",Non-OADS,/arxiv_data1/oa_pdf/0d/dd/copd-12-1867.PMC5491571.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/0d/dd/copd-12-1867.PMC5491571.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0d/dd/copd-12-1867.PMC5491571.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/03/22/copd-12-1857.PMC5491572.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1857–1865International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1857RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S13659 2 Th17 profile in COPD exacerbations Marco Antonio Ponce- Gallegos1–3 Alejandra Ramírez-v enegas4 Ramcés Falfán-v alencia1 1HLA Laboratory, Instituto Nacional  de enfermedades Respiratorias Ismael  Cosío Villegas, Mexico City, Mexico;   2Medicine Academic Unit, Universidad  Autónoma de Nayarit.",Non-OADS,/arxiv_data1/oa_pdf/03/22/copd-12-1857.PMC5491572.pdf
"People harboring AAT deficiency alleles have a greater susceptibility to presenting  the disease or presenting it at an earlier age.1,4 On the other hand, cytokines such as  TNF- α, IL-1 β, IL-6, CXCL8 (also called IL-8), IL-22, IL-23, IL-17A, IL-17F and  TGF- β among others are increased in samples from patients with COPD, suggesting  an important role in its pathophysiology and in the exacerbations that may occur due Correspondence: Ramcés Falfán-valencia Calzada de Tlalpan 4502, Sección XVI,  Código Postal 14080, Deleg, Tlalpan,  Mexico City, Mexico Tel +52 55 5487 1700 ext 5152 email rfalfanv@iner.gob.m x Journal name: International Journal of COPD Article Designation: Review Y ear: 2017 Volume: 12 Running head verso: Ponce-Gallegos et al Running head recto: Th17 profile in COPD exacerbations DOI: http://dx.doi.org/10.2147/COPD.S136592",Non-OADS,/arxiv_data1/oa_pdf/03/22/copd-12-1857.PMC5491572.pdf
Available from: http://www.who.int/ respiratory/copd/en/.,Non-OADS,/arxiv_data1/oa_pdf/03/22/copd-12-1857.PMC5491572.pdf
Available from: http://goldcopd.org/global-strategy-diagnosis- management-prevention-copd-2016/.,Non-OADS,/arxiv_data1/oa_pdf/03/22/copd-12-1857.PMC5491572.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/03/22/copd-12-1857.PMC5491572.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/03/22/copd-12-1857.PMC5491572.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d5/6b/amep-8-395.PMC5491574.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d5/6b/amep-8-395.PMC5491574.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2017:8 395–398Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 395 COMMENTARY open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S136664 Creating physicians of the 21st century:  assessment of the clinical years Allison A Vanderbilt1 Sara Q Perkins2 Moriah K Muscaro2 Thomas J Papadimos3 Reginald F Baugh4 1Department of Family Medicine,   2College of Medicine and Life  Sciences, University of T oledo,   3Department of Anesthesiology,   4Department of Surgery, College of  Medicine and Life Sciences, University  of T oledo, T oledo, OH, USAAbstract:  Medical education has been under a constant state of revision for the past several  years.",Non-OADS,/arxiv_data1/oa_pdf/d5/6b/amep-8-395.PMC5491574.pdf
"The National Board of Medical Examiners’ subject-specific exams are not sufficient on their own, as they primarily measures content knowledge and not clinical reasoning or the students’ ability to synthesize the information,  particularly  Correspondence: Allison A Vanderbilt Department of Family Medicine, College of Medicine and Life Sciences, University of Toledo, 3000 Arlington Ave, MS 1050, Toledo, OH 43626, USAEmail allison.vanderbilt@utoledo.eduJournal name: Advances in Medical Education and Practice Article Designation: COMMENTAR YY ear: 2017V olume: 8Running head verso: Vanderbilt et alRunning head recto: Creating physicians of the 21st centuryDOI: http://dx.doi.org/10.2147/AMEP .S136664",Non-OADS,/arxiv_data1/oa_pdf/d5/6b/amep-8-395.PMC5491574.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/d5/6b/amep-8-395.PMC5491574.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 398 Vanderbilt et al  7.,Non-OADS,/arxiv_data1/oa_pdf/d5/6b/amep-8-395.PMC5491574.pdf
Available  from: http://www.acgme.org.,Non-OADS,/arxiv_data1/oa_pdf/d5/6b/amep-8-395.PMC5491574.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ec/35/copd-12-1877.PMC5491575.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1877–1882International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1877RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S13800 6 Maintenance therapy in COPD: time to phase out  ICS and switch to the new LAMA/LABA inhalers?",Non-OADS,/arxiv_data1/oa_pdf/ec/35/copd-12-1877.PMC5491575.pdf
"However, this shift is warranted as  lung function often does not match severity of symptoms, functional limitation, and  exacerbation rates.4Correspondence: Syed Mohammad Tariq Department of Respiratory Medicine,  Luton and Dunstable University Hospital,  Lewsey Road, Luton LU4 0DZ, UK Tel +44 78 8602 5415 Fax +44 15 8249 7237 email syed.tariq@ldh.nhs.u k Journal name: International Journal of COPD Article Designation: Review Y ear: 2017 Volume: 12 Running head verso: Tariq and Thomas Running head recto: Switching from ICS to LAMA/LABA in COPD DOI: http://dx.doi.org/10.2147/COPD.S138006",Non-OADS,/arxiv_data1/oa_pdf/ec/35/copd-12-1877.PMC5491575.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/ec/35/copd-12-1877.PMC5491575.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/35/copd-12-1877.PMC5491575.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/83/dd/ceor-9-361.PMC5491576.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/83/dd/ceor-9-361.PMC5491576.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2017:9 361–371ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  361 ORiginal REsEaRCh open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S134130The economic and humanistic costs of chronic  lower back pain in Japan William Montgomery1 Masayo sato2 Yasuo nagasaka2 Jeffrey Vietri3 1global Patient Outcomes & Real  World Evidence, Eli lilly australia  Pty ltd., West Ryde, australia;   2Medical Development Unit Japan, Eli  lilly Japan K.K., Kobe, Japan; 3Kantar  health, horsham, P a, UsaBackground: Few data are available that provide estimates of the economic impact of chronic  lower back pain (CLBP) in Japan.",Non-OADS,/arxiv_data1/oa_pdf/83/dd/ceor-9-361.PMC5491576.pdf
"3 Another recent survey in Japan  found that LBP was the site of pain for approximately 31% of Japanese adults with Correspondence: Masayo sato Eli lilly Japan K.K., sannomiya Plaza Building, 7-1-5 isogamidori, Chuo-ku, Kobe 651-0086, JapanTel +81 078 242 9317Email sato_masayo@lilly.comJournal name: ClinicoEconomics and Outcomes Research Article Designation: Original ResearchY ear: 2017V olume: 9Running head verso: Montgomery et alRunning head recto: Cost of CLBP in JapanDOI: http://dx.doi.org/10.2147/CEOR.S134130",Non-OADS,/arxiv_data1/oa_pdf/83/dd/ceor-9-361.PMC5491576.pdf
Available from: http://www.who.int/choice/publications/p_2003_generalised_cea.pdf.,Non-OADS,/arxiv_data1/oa_pdf/83/dd/ceor-9-361.PMC5491576.pdf
Available from: http://www.imshealth.com/en/thought-leadership/quintilesims-institute/reports/global-medicines-use-in-2020.,Non-OADS,/arxiv_data1/oa_pdf/83/dd/ceor-9-361.PMC5491576.pdf
"ClinicoEconomics and Outcomes Research 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/83/dd/ceor-9-361.PMC5491576.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 371 Cost of ClBP in Japan  21.,Non-OADS,/arxiv_data1/oa_pdf/83/dd/ceor-9-361.PMC5491576.pdf
Available from: http://www.mhlw.go.jp/bunya/iryouhoken/database/zenpan/dl/h23_doukou_03.pdf.,OADS,/arxiv_data1/oa_pdf/83/dd/ceor-9-361.PMC5491576.pdf
Avail-able from: http://www.mhlw.go.jp/stf/shingi/2r9852000001wj9o-att/2r9852000001wje3.pdf [Japanese].,Non-OADS,/arxiv_data1/oa_pdf/83/dd/ceor-9-361.PMC5491576.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/af/bc/copd-12-1811.PMC5491577.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1811–1817International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1811OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S13061 6 Expression profiling of miRNA-145 and miRNA- 338 in serum and sputum of patients with COPD,  asthma, and asthma–COPD overlap syndrome  phenotype Donato lacedonia* grazia Pia Palladino* Maria Pia Foschino-Barbaro giulia scioscia giovanna elisiana  Carpagnano Department of Medical and Surgical  sciences, Institute of respiratory  Diseases, University of Foggia,   Foggia, Italy *These authors contributed equally  to this workBackground and objectives:  A new phenotype with overlapping characteristics between  asthma and chronic obstructive pulmonary disease (COPD) called asthma–COPD overlap  syndrome (ACOS) is emerging among inflammation diseases.",Non-OADS,/arxiv_data1/oa_pdf/af/bc/copd-12-1811.PMC5491577.pdf
"On the other hand, according to Global Initiative for Asthma (GINA) Correspondence: Donato lacedonia Department of Medical and Surgical  sciences, Institute of respiratory  Diseases, University of Foggia, Viale degli  Aviatori, 71100 Foggia, Italy Tel +39 881 73 3084 Fax +39 881 73 3040 email donato.lacedonia@unifg.i t Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Lacedonia et al Running head recto: miRNAs and inflammatory lung diseases DOI: http://dx.doi.org/10.2147/COPD.S130616",Non-OADS,/arxiv_data1/oa_pdf/af/bc/copd-12-1811.PMC5491577.pdf
"Available from: http://ginasthma.org/ wp-content/uploads/2016/01/GINA_Report_2015_Aug11-1.pd f.  Accessed June 5, 2017.",OADS,/arxiv_data1/oa_pdf/af/bc/copd-12-1811.PMC5491577.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/af/bc/copd-12-1811.PMC5491577.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/af/bc/copd-12-1811.PMC5491577.pdf
"However, the expression profile and the function of Best1 in the central nervous system (CNS) have been relatively less investi-gated.Distribution and Function of the Bestrophin-1  (Best1) Channel in the Brain Soo-Jin Oh1,2,3 and C. Justin Lee1,3* 1Center for Neuroscience, Korea Institute of Science and Technology (KIST), Seoul 02792, 2Convergence Research Center for  Diagnosis, Treatment and Care System of Dementia, Korea Institute of Science and Technology (KIST), Seoul 02792,   3Center for Glia-Neuron Interaction, Korea Institute of Science and Technology (KIST), Seoul 02792, Koreahttps://doi.org/10.5607/en.2017.26.3.113 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/1a/ef/en-26-113.PMC5491579.pdf
"TEL: 82-2-958-6421, FAX: 82-2-958-6919 e-mail: cjl@kist.re.kr Copyright © Experimental Neurobiology 2017. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1a/ef/en-26-113.PMC5491579.pdf
"114 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.113Soo-Jin Oh and C. Justin Lee In this review, we focus on the expression pattern and the func- tion of Best1 in the brain.",Non-OADS,/arxiv_data1/oa_pdf/1a/ef/en-26-113.PMC5491579.pdf
"Although mRNA of hBest1 was detected in various tissues, especially in the brain as described in Allen Brain Atlas with ISH and microarray (http://www.brain-map.org), the protein expression for hBest1 had been reported only in RPE.",OADS,/arxiv_data1/oa_pdf/1a/ef/en-26-113.PMC5491579.pdf
115 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.113Bestrophin-1 in the Brain blot or immunohistochemistry using mBest1 specific polyclonal  primary antibody raised against the C-terminus (A524-E541) of mBest1 as a target antigen [19].,Non-OADS,/arxiv_data1/oa_pdf/1a/ef/en-26-113.PMC5491579.pdf
"Despite those unequivocal lines of evidence on protein and  mRNA expression of mBest1 in the brain, many scientists have been led astray by the unexpected extremely low expression level of Best1 transcript in astrocytes and neurons in the popular tran-scriptome database available from the Brain RNA-Seq (http://web.stanford.edu/group/barres_lab/brain_rnaseq.html).",Non-OADS,/arxiv_data1/oa_pdf/1a/ef/en-26-113.PMC5491579.pdf
"116 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.113Soo-Jin Oh and C. Justin Lee Interestingly, the expression pattern of mBest1 in reactive astro- cytes showed a markedly different pattern from normal astrocytes.",OADS,/arxiv_data1/oa_pdf/1a/ef/en-26-113.PMC5491579.pdf
117 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.113Bestrophin-1 in the Brain protons (Fig.,Non-OADS,/arxiv_data1/oa_pdf/1a/ef/en-26-113.PMC5491579.pdf
118 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.113Soo-Jin Oh and C. Justin Lee in gene expression have been observed.,OADS,/arxiv_data1/oa_pdf/1a/ef/en-26-113.PMC5491579.pdf
119 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.113Bestrophin-1 in the Brain which originate from the channel’ s unique ability to permeate  important transmitters such as glutamate and GABA (Fig.,Non-OADS,/arxiv_data1/oa_pdf/1a/ef/en-26-113.PMC5491579.pdf
120 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.113Soo-Jin Oh and C. Justin Lee 19.,Non-OADS,/arxiv_data1/oa_pdf/1a/ef/en-26-113.PMC5491579.pdf
"121 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.113Bestrophin-1 in the Brain ant L, W anitchakool P , Zimmermann S, Reiff CM, Horling F ,  Schrewe H, Schreiber R, Kunzelmann K, W etzel CH, W eber BH (2015) Bestrophin 1 is indispensable for volume regula-tion in human retinal pigment epithelium cells.",Non-OADS,/arxiv_data1/oa_pdf/1a/ef/en-26-113.PMC5491579.pdf
"The aim of Altered GABAergic Signaling in Brain Disease at  Various Stages of Life Y oo Sung Kim and Bo-Eun Y oon * Department of Molecular Biology, Dankook University, Cheonan 31116, Koreahttps://doi.org/10.5607/en.2017.26.3.122 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/68/55/en-26-122.PMC5491580.pdf
"TEL: 82-41-550-3694, FAX: 82-41-559-7941 e-mail: boeunyoon@dankook.ac.kr Copyright © Experimental Neurobiology 2017. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/55/en-26-122.PMC5491580.pdf
123 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.122GABA and Brain Diseases the review is to establish the role of GABA in basic brain function  and identify GABA-related mechanisms of neural diseases that can have an impact from the cradle to the grave (Fig.,Non-OADS,/arxiv_data1/oa_pdf/68/55/en-26-122.PMC5491580.pdf
124 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.122Y oo Sung Kim and Bo-Eun Y oon creased in these animals suggests that the GABAB receptor affects  neurogenesis in adults [25].,Non-OADS,/arxiv_data1/oa_pdf/68/55/en-26-122.PMC5491580.pdf
"125 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.122GABA and Brain Diseases Although it has not yet been possible to definitively link this to  GABA, numerous studies to date have focused on the GABA re-ceptors, GABA A and GABAB.",Non-OADS,/arxiv_data1/oa_pdf/68/55/en-26-122.PMC5491580.pdf
126 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.122Y oo Sung Kim and Bo-Eun Y oon hanced activation of T rkB in mature neurons decreases surface ex- pression of the GABAA receptor [52].,OADS,/arxiv_data1/oa_pdf/68/55/en-26-122.PMC5491580.pdf
"127 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.122GABA and Brain Diseases neurodegenerative diseases, and diseases related to the brain are  increasing steadily.",Non-OADS,/arxiv_data1/oa_pdf/68/55/en-26-122.PMC5491580.pdf
"128 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.122Y oo Sung Kim and Bo-Eun Y oon limited to an investigation of the phenotypes associated with the  overexpression or inhibition/KO of GABA and/or GABA recep-tors [89, 90].",Non-OADS,/arxiv_data1/oa_pdf/68/55/en-26-122.PMC5491580.pdf
"129 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.122GABA and Brain Diseases tional League Against Epilepsy (UK Chapter), London.",Non-OADS,/arxiv_data1/oa_pdf/68/55/en-26-122.PMC5491580.pdf
130 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.122Y oo Sung Kim and Bo-Eun Y oon 39.,Non-OADS,/arxiv_data1/oa_pdf/68/55/en-26-122.PMC5491580.pdf
131 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.122GABA and Brain Diseases 79.,Non-OADS,/arxiv_data1/oa_pdf/68/55/en-26-122.PMC5491580.pdf
"TRP is metabolized into kynurenine (KYN) by tryptophan 2,3-dioxygenase (TDO) or indoleamine High-Fat Diet and Voluntary Chronic Aerobic  Exercise Recover Altered Levels of Aging-Related  Tryptophan Metabolites along the Kynurenine  Pathway Keon-Joo Lee1,2, Keun-Hwa Jung1,2*, Joo-Y oun Cho3, Soon-Tae Lee1,2, Hwa Suk Kim3,  Jun Hwa Shim3, Sang Kun Lee1,2, Manho Kim1,2 and Kon Chu1,2* 1Department of Neurology, Seoul National University Hospital, Seoul 03080, 2Program in Neuroscience, Neuroscience  Research Institute of SNUMRC, College of Medicine, Seoul National University, Seoul 03080, 3Department of Clinical  Pharmacology & Therapeutics, Seoul National University College of Medicine and Hospital, Seoul 03080, Koreahttps://doi.org/10.5607/en.2017.26.3.132 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/be/96/en-26-132.PMC5491581.pdf
"Keun-Hwa Jung, TEL: 82-2-2072-4901, FAX: 82-2-3672-7553 e-mail: jungkh@gmail.com Kon Chu, TEL: 82-2-2072-1878, FAX: 82-2-3672-4949e-mail: stemcell.snu@gmail.com Copyright © Experimental Neurobiology 2017. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/96/en-26-132.PMC5491581.pdf
"133 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.132Tryptophan Metabolite Pathway and Aging 2,3 dioxygenase (IDO) and then enters into the kynurenine path- way.",Non-OADS,/arxiv_data1/oa_pdf/be/96/en-26-132.PMC5491581.pdf
"134 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.132Keon-Joo Lee, et al.",OADS,/arxiv_data1/oa_pdf/be/96/en-26-132.PMC5491581.pdf
"135 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.132Tryptophan Metabolite Pathway and Aging 3-month-old group compared with controls (p=0.028), while  KYNA increased in the 6-month-old (p=0.021) and 8-month-old group (p=0.028) (Fig.",OADS,/arxiv_data1/oa_pdf/be/96/en-26-132.PMC5491581.pdf
"136 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.132Keon-Joo Lee, et al.",OADS,/arxiv_data1/oa_pdf/be/96/en-26-132.PMC5491581.pdf
"137 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.132Tryptophan Metabolite Pathway and Aging tylcholine receptors [24], as well as potent antioxidant properties  [25].",OADS,/arxiv_data1/oa_pdf/be/96/en-26-132.PMC5491581.pdf
"138 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.132Keon-Joo Lee, et al.",OADS,/arxiv_data1/oa_pdf/be/96/en-26-132.PMC5491581.pdf
139 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.132Tryptophan Metabolite Pathway and Aging NAD(+) activate Sirt1 to rescue premature aging in cockayne  syndrome.,Non-OADS,/arxiv_data1/oa_pdf/be/96/en-26-132.PMC5491581.pdf
"140 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.132Keon-Joo Lee, et al.",OADS,/arxiv_data1/oa_pdf/be/96/en-26-132.PMC5491581.pdf
"Tyrosine phosphorylated Gab1 provides The Scaffolding Protein, Grb2-associated Binder-1, in  Skeletal Muscles and Terminal Schwann Cells Regulates  Postnatal Neuromuscular Synapse Maturation So Y oung Park1, So Y oung Jang1, Y oon Kyoung Shin1, Dong Keun Jung1, Byeol A Y oon3,  Jong Kook Kim3, Y oung Rae Jo1, Hye Jeong Lee2 and Hwan Tae Park1* Departments of 1Physiology and 2Pharmacology, 3Peripheral Neuropath Research Center (PNRC), College of Medicine,  Dong-A University, Busan 49201, Koreahttps://doi.org/10.5607/en.2017.26.3.141 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/01/6b/en-26-141.PMC5491582.pdf
"TEL: 82-51-240-2636, FAX: 82-51-247-3318 e-mail: phwantae@dau.ac.kr Copyright © Experimental Neurobiology 2017. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/01/6b/en-26-141.PMC5491582.pdf
"142 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.141So Y oung Park, et al.",OADS,/arxiv_data1/oa_pdf/01/6b/en-26-141.PMC5491582.pdf
"143 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.141Gab1 in Neuromuscular Junction ticular, it was recently shown that axonal NRG1-type III signaling  regulates synaptic elimination in NMJ development by modulat-ing tSC activity [16, 17].",OADS,/arxiv_data1/oa_pdf/01/6b/en-26-141.PMC5491582.pdf
"144 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.141So Y oung Park, et al.",OADS,/arxiv_data1/oa_pdf/01/6b/en-26-141.PMC5491582.pdf
145 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.141Gab1 in Neuromuscular Junction even at P14 (Fig.,Non-OADS,/arxiv_data1/oa_pdf/01/6b/en-26-141.PMC5491582.pdf
"146 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.141So Y oung Park, et al.",OADS,/arxiv_data1/oa_pdf/01/6b/en-26-141.PMC5491582.pdf
"147 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.141Gab1 in Neuromuscular Junction plates of Gab1-SCKO mice at P10 after triple fluorescent staining  with an anti-S100 antibody, α-BX and Hoechst staining.",Non-OADS,/arxiv_data1/oa_pdf/01/6b/en-26-141.PMC5491582.pdf
"148 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.141So Y oung Park, et al.",OADS,/arxiv_data1/oa_pdf/01/6b/en-26-141.PMC5491582.pdf
"149 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.141Gab1 in Neuromuscular Junction HM, Kuang WJ, W ood WI, Goeddel DV , V andlen RL (1992)  Identification of heregulin, a specific activator of p185erbB2.",OADS,/arxiv_data1/oa_pdf/01/6b/en-26-141.PMC5491582.pdf
"150 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.141So Y oung Park, et al.",OADS,/arxiv_data1/oa_pdf/01/6b/en-26-141.PMC5491582.pdf
"The penumbra is at the peripheral zone of this core injury and can be salvageable if collateral arteries provide blood into this region Repeated Oral Administration of Human Serum  Albumin Protects from the Cerebral Ischemia   in Rat Brain Following MCAO Hyejin Park1,2, Minyoung Hong2, Gil-Ja Jhon3, Y oungmi Lee3 and Minah Suh1,4,5,6* 1Center for Neuroscience Imaging Research (CNIR), Institute for Basic Science (IBS), Suwon 16419,   2Department of Biological Science, Sungkyunkwan University, Suwon 16419,   3Department of Chemistry and Nano Science, Ewha Womans University, Seoul 03760,   4Department of Biomedical Engineering, Sungkyunkwan University, Suwon 16419,   5Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul 06351,   6Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University, Suwon 16219, Koreahttps://doi.org/10.5607/en.2017.26.3.151 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/9c/dd/en-26-151.PMC5491583.pdf
"TEL: 82-31-299-4496, FAX: 82-31-299-4506 e-mail: minahsuh@skku.edu Copyright © Experimental Neurobiology 2017. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/dd/en-26-151.PMC5491583.pdf
"152 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.151Hyejin Park, et al.",OADS,/arxiv_data1/oa_pdf/9c/dd/en-26-151.PMC5491583.pdf
153 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.151Oral Administration of Human Serum Albumin Protects Cerebral Ischemia with a hot pad to keep body temperature stable.,Non-OADS,/arxiv_data1/oa_pdf/9c/dd/en-26-151.PMC5491583.pdf
"154 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.151Hyejin Park, et al.",OADS,/arxiv_data1/oa_pdf/9c/dd/en-26-151.PMC5491583.pdf
"155 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.151Oral Administration of Human Serum Albumin Protects Cerebral Ischemia scavenge for radical oxygen and bind to free fatty acids and metal  ions, thus obstructing the oxidative process of lipid peroxidation.",Non-OADS,/arxiv_data1/oa_pdf/9c/dd/en-26-151.PMC5491583.pdf
"156 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.151Hyejin Park, et al.",OADS,/arxiv_data1/oa_pdf/9c/dd/en-26-151.PMC5491583.pdf
"157 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.151Oral Administration of Human Serum Albumin Protects Cerebral Ischemia Fiebig HH, Unger C (1997) Synthesis of new maleimide de- rivatives of daunorubicin and biological activity of acid labile transferrin conjugates.",Non-OADS,/arxiv_data1/oa_pdf/9c/dd/en-26-151.PMC5491583.pdf
"Functional Characterization of Resting and  Adenovirus-Induced Reactive Astrocytes in   Three-Dimensional Culture Junsung Woo1,2,3†, Sun-Kyoung Im4†, Heejung Chun1,2, Soon-Y oung Jung2,   Soo-Jin Oh1,2,3, Nakwon Choi5,6, C. Justin Lee1,2,3,7* and Eun-Mi Hur1,4,7* 1Center for Neuroscience, Korea Institute of Science and Technology (KIST), Seoul 02792, 2Functional Connectomics, Korea  Institute of Science and Technology (KIST), Seoul 02792, 3Center for Glia-Neuron Interaction, Korea Institute of Science and  Technology (KIST), Seoul 02792, 4Convergence Research Center for Diagnosis, Treatment and Care System of Dementia,  Korea Institute of Science and Technology (KIST), Seoul 02792, 5Center for BioMicrosystems, Brain Science Institute, Korea  Institute of Science and Technology (KIST), Seoul 02792, 6Division of Bio-Medical Science &Technology, KIST School,  Korea University of Science and Technology, Seoul 02792, 7Department of Neuroscience, Division of Bio-Medical Science  &Technology, KIST School, Korea University of Science and Technology, Seoul 02792, Koreahttps://doi.org/10.5607/en.2017.26.3.158 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/71/61/en-26-158.PMC5491584.pdf
"Copyright © Experimental Neurobiology 2017. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/71/61/en-26-158.PMC5491584.pdf
"159 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.1583D Cultured Reactive Astrocytes INTRODUCTION In vitro cell culture systems has been widely utilized as a simple,  fast, and cost-effective experimental tool in basic and applied sci- ences.",OADS,/arxiv_data1/oa_pdf/71/61/en-26-158.PMC5491584.pdf
"160 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.158Junsung Woo, et al.",OADS,/arxiv_data1/oa_pdf/71/61/en-26-158.PMC5491584.pdf
161 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.1583D Cultured Reactive Astrocytes vivo  [22].,Non-OADS,/arxiv_data1/oa_pdf/71/61/en-26-158.PMC5491584.pdf
"162 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.158Junsung Woo, et al.",OADS,/arxiv_data1/oa_pdf/71/61/en-26-158.PMC5491584.pdf
"163 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.1583D Cultured Reactive Astrocytes display this electrophysiological property, we measured the pas - sive conductance from individual astrocytes by whole-cell patch- clamping.",OADS,/arxiv_data1/oa_pdf/71/61/en-26-158.PMC5491584.pdf
"164 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.158Junsung Woo, et al.",OADS,/arxiv_data1/oa_pdf/71/61/en-26-158.PMC5491584.pdf
"165 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.1583D Cultured Reactive Astrocytes reduced morphological complexity and show biochemical signs of  undesired reactiveness, such as high levels of GFAP , vimentin, and nestin [6, 11, 18].",OADS,/arxiv_data1/oa_pdf/71/61/en-26-158.PMC5491584.pdf
"166 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.158Junsung Woo, et al.",OADS,/arxiv_data1/oa_pdf/71/61/en-26-158.PMC5491584.pdf
167 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.1583D Cultured Reactive Astrocytes 17.,Non-OADS,/arxiv_data1/oa_pdf/71/61/en-26-158.PMC5491584.pdf
"The peripheral nervous system Eosinophilic Granulomatosis with Polyangiitis  Presented as Acute Polyneuropathy and   Cerebral Vasculitis Il-Han Y oo1, Sang Tae Choi2, Seong-Ho Choi3, Jeong-Min Kim1 and Suk-Won Ahn1* 1Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul 06973,   2Division of Rheumatology, Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University   College of Medicine, Seoul 06973, 3Division of Infectious Diseases, Department of Internal Medicine,   Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul 06973, Koreahttps://doi.org/10.5607/en.2017.26.3.168 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/ac/e4/en-26-168.PMC5491585.pdf
"TEL: 82-2-6299-3153, FAX: 82-2-6299-3153 e-mail: icandr@hanmail.net Copyright © Experimental Neurobiology 2017. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/e4/en-26-168.PMC5491585.pdf
"169 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.168EGPA with Neurological Involvement involvement of the EGPA is commonly presented, however, cere - bral involvement such as stroke is rare, and furthermore a concur - rent neurological complication involving acute polyneuropathy  and cerebral infarction is extremely rare in the EGPA In this report, we describe a patient with EGPA who presented  with acute sensorimotor polyneuropathy mimicking a GBS and concurrent cerebral infarction.",Non-OADS,/arxiv_data1/oa_pdf/ac/e4/en-26-168.PMC5491585.pdf
"170 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.168Il-Han Y oo, et al.",OADS,/arxiv_data1/oa_pdf/ac/e4/en-26-168.PMC5491585.pdf
171 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.168EGPA with Neurological Involvement normalities progresses over 1 to 2 weeks and reaches a peak within  2 to 4 weeks [10].,Non-OADS,/arxiv_data1/oa_pdf/ac/e4/en-26-168.PMC5491585.pdf
"There has been a possibility of child and adolescent onset traumatic brain An Autopsy Proven Child Onset Chronic  Traumatic Encephalopathy Kyuho Lee1, Seong-Ik Kim1, Yujin Lee1, Jae Kyung Won1,2 and Sung-Hye Park1,2,3* 1Department of Pathology, Seoul National University Hospital, College of Medicine, Seoul 03080,   2Brain Bank, Seoul National University Hospital, College of Medicine, Seoul 03080,   3Neuroscience Research Institute, Seoul National University, Seoul 03080, Koreahttps://doi.org/10.5607/en.2017.26.3.172 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/90/db/en-26-172.PMC5491586.pdf
"TEL: 82-2-2072-3090, FAX: 82-2-765-5600 e-mail: shparknp@snu.ac.kr Copyright © Experimental Neurobiology 2017. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/db/en-26-172.PMC5491586.pdf
"173 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.172CTE, Autopsy injury or chronic recurrent concussion.",Non-OADS,/arxiv_data1/oa_pdf/90/db/en-26-172.PMC5491586.pdf
"174 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.172Kyuho Lee, et al.",OADS,/arxiv_data1/oa_pdf/90/db/en-26-172.PMC5491586.pdf
"175 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.172CTE, Autopsy the tau protein was discovered [8].",Non-OADS,/arxiv_data1/oa_pdf/90/db/en-26-172.PMC5491586.pdf
"176 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.172Kyuho Lee, et al.",OADS,/arxiv_data1/oa_pdf/90/db/en-26-172.PMC5491586.pdf
"177 www.enjournal.org https://doi.org/10.5607/en.2017.26.3.172CTE, Autopsy brain injury.",Non-OADS,/arxiv_data1/oa_pdf/90/db/en-26-172.PMC5491586.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c0/7a/cia-12-977.PMC5491613.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 977–983Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  977OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S13058 3 Assessment of renal function in geriatric palliative  care patients – comparison of creatinine-based  estimation equations ewa Deskur-smielecka1,2 Aleksandra Kotlinska- lemieszek1,2 Jerzy Chudek3,4 Katarzyna Wieczorowska- T obis1,2 1Department of Palliative Medicine,   Poznan University of Medical sciences,   2Palliative Medicine Unit, University  hospital of lord’s Transfiguration,   Poznan, 3Pathophysiology Unit,   Department of Pathophysiology,   4Department of Internal Medicine  and Oncological Chemotherapy,   Medical Faculty in Katowice, Medical  University of silesia, Katowice, PolandBackground:  Renal function impairment is common in geriatric palliative care patients.",Non-OADS,/arxiv_data1/oa_pdf/c0/7a/cia-12-977.PMC5491613.pdf
"rusa 55, 61-245  Poznan, Poland Tel/fax +48 61 8738 303 email edeskur@ump.edu.p l Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Deskur-Smielecka et al Running head recto: Kidney function in geriatric palliative care patients DOI: http://dx.doi.org/10.2147/CIA.S130583",Non-OADS,/arxiv_data1/oa_pdf/c0/7a/cia-12-977.PMC5491613.pdf
Available from:  http://www.who.int/childgrowth/publications/physical_status/en /.,Non-OADS,/arxiv_data1/oa_pdf/c0/7a/cia-12-977.PMC5491613.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/c0/7a/cia-12-977.PMC5491613.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/c0/7a/cia-12-977.PMC5491613.pdf
Available from: https://www.niddk.nih.gov/health-information/ health-communication-programs/nkdep/lab-evaluation/gfr/estimating /.,OADS,/arxiv_data1/oa_pdf/c0/7a/cia-12-977.PMC5491613.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/05/01/ceg-10-105.PMC5491618.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/05/01/ceg-10-105.PMC5491618.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical and Experimental Gastroenterology 2017:10 105–111Clinical and Experimental Gastroenterology Dovepress submit your manuscript | www.dovepress.com Dovepress  105 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S115518Secondary sclerosing cholangitis in critically   ill patients: current perspectives Hafsteinn O Gudnason1  Einar S Björnsson1,2 1Division of Gastroenterology and  Hepatology, Department of Internal  Medicine, Landspitali, University Hospital of Iceland,  2Faculty of  Medicine, University of Iceland,  Reykjavik, IcelandAbstract:  Secondary sclerosing cholangitis (SSC) is a term used for a group of chronic chole- static disease affecting the intra- and/or extrahepatic biliary tree with inflammation and progres- sive stricture formation, which can lead to biliary cirrhosis.",Non-OADS,/arxiv_data1/oa_pdf/05/01/ceg-10-105.PMC5491618.pdf
"14,15 In severe form of SSC-CIP , treatment options are limited to liver transplantations  (LT), although this is a rare indication for LT. SSC-CIP is a relatively newly described condition with one of the first cases reported in the year 1997 by Schmitt et al 16 and Correspondence: Einar S Björnsson   Faculty of Medicine, The National  University Hospital of Iceland, Hringbraut, 101 Reykjavik, IcelandTel +354 825 3747 Email einarsb@landspitali.isJournal name: Clinical and Experimental Gastroenterology Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: Gudnason and BjörnssonRunning head recto: Secondary sclerosing cholangitis in critically ill patientsDOI: http://dx.doi.org/10.2147/CEG.S115518",Non-OADS,/arxiv_data1/oa_pdf/05/01/ceg-10-105.PMC5491618.pdf
"Clinical and Experimental Gastroenterology 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-and-experimental-gastroenterology-journalClinical and Experimental Gastroenterology is an international, peer- reviewed, open access, online journal publishing original research, reports, editorials, reviews and commentaries on all aspects of   gastroenterology in the clinic and laboratory.",Non-OADS,/arxiv_data1/oa_pdf/05/01/ceg-10-105.PMC5491618.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 111 Secondary sclerosing cholangitis in critically ill patients,Non-OADS,/arxiv_data1/oa_pdf/05/01/ceg-10-105.PMC5491618.pdf
"FLYLEAFABOUT COVER EDITORS FOR  THIS ISSUEContents AIM AND SCOPE June 26, 2017 |Volume 9 |ssue 6| WJSC|www.wjgnet.comWorld Journal of Stem Cells Volume 9  Number 6  June 26, 2017 EDITORIAL 	OFFICE Xiu-Xia Song, Director World Journal of  Stem Cells Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-2238242 Fax: +1-925-2238243 E-mail: editorialoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.wjgnet.com PUBLISHER Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501,  Pleasanton, CA 94588, USA Telephone: +1-925-2238242 Fax: +1-925-2238243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.wjgnet.com PUBLICATION 	DATE June 26, 2017COPYRIGHT © 2017 Baishideng Publishing Group Inc.",Non-OADS,/arxiv_data1/oa_pdf/47/b2/WJSC-9-89.PMC5491631.pdf
"INSTRUCTIONS 	TO	AUTHORS http://www .wjgnet.com/bpg/gerinfo/204 ONLINE 	SUBMISSION 	 http://www.f6publishing.comNAME 	OF	JOURNAL 	 World Journal of  Stem Cells ISSN ISSN 1948-0210 (online) LAUNCH 	DATE December 31, 2009 FREQUENCY Monthly EDITORS-IN-CHIEF Tong Cao, BM BCh, DDS, PhD, Associate Profes - sor, Doctor, Department of Oral Sciences, National  University of Singapore, Singapore 119083, Singapore Oscar Kuang-Sheng Lee, MD, PhD, Professor,  Medical Research and Education of Veterans General  Hospital-Taipei, No.",Non-OADS,/arxiv_data1/oa_pdf/47/b2/WJSC-9-89.PMC5491631.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to:  Yuko Miyagoe-Suzuki, MD, PhD,  Section Chief, Department of Molecular Therapy, National  Institute of Neuroscience, National Center of Neurology and  Psychiatry, 4-1-1 Ogawa-higashi, Kodaira, Tokyo 187-8502,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/47/b2/WJSC-9-89.PMC5491631.pdf
"miyagoe@ncnp.go.jp Telephone:  +81-42-3461720 Fax: +81-42-3461750 Received:  January 29, 2017  Peer-review started:  February 13, 2017 First decision:  March 27, 2017  Revised:  May 9, 2017  Accepted:  May 18, 2017Submit a Manuscript: http://www.f6publishing.com DOI: 10.4252/wjsc.v9.i6.89World J Stem Cells  2017 June 26; 9(6): 89-97 ISSN 1948-0210 (online) Article in press:  May 19, 2017 Published online:  June 26, 2017 Abstra ct Human induced pluri potent stem cells (hiPS cells or  hiPSCs) can be derived from cells of patients with severe  muscle disease.",Non-OADS,/arxiv_data1/oa_pdf/47/b2/WJSC-9-89.PMC5491631.pdf
"On the other hand, hiPS stocks are under  construction for allogeneic transplantation of immune ­ compatible donor cells (https://www.cira.kyoto ­u.",Non-OADS,/arxiv_data1/oa_pdf/47/b2/WJSC-9-89.PMC5491631.pdf
"The Central Institute for  Experimental Animals in Japan established NOG  (NOD/ Shi­scid/IL-2Rγnull)­mdx mice, which have a different  mutation in the IL ­2 receptor gamma gene, and are also  expected to be good recipients of human iPSC ­derived  muscle progenitor cells (https://www.ciea.or .jp/about/ reports/pdf/report/59_report.pdf).",Non-OADS,/arxiv_data1/oa_pdf/47/b2/WJSC-9-89.PMC5491631.pdf
The measurement can be performed under  anesthesia at different tim e points (http://www.brck .,Non-OADS,/arxiv_data1/oa_pdf/47/b2/WJSC-9-89.PMC5491631.pdf
"Various muscle disease ­specific iPSCs have already  been generated and deposited in a cell bank ( e.g.,  http://cell.brc.riken.jp/en/; https://catalog.coriell.",Non-OADS,/arxiv_data1/oa_pdf/47/b2/WJSC-9-89.PMC5491631.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/47/b2/WJSC-9-89.PMC5491631.pdf
"Contents NAME	OF	JOURN AL	 World Journal of  Radiology ISSN ISSN 1949-8470 (online) LAUNCH	DATE January 31, 2009 FREQUENCY Monthly EDITORS-IN-CHIEF Kai U Juergens, MD, Associate Professor, MRT  und PET/CT, Nuklearmedizin Bremen Mitte, ZE - MODI - Zentrum fü r morphologische und moleku - lare Diagnostik, Bremen 28177, Germany Edwin JR van Beek, MD, PhD, Professor, Clinical  Research Imaging Centre and  Department of  Medi - cal Radiology, University of  Edinburgh, Edinburgh  EH16 4TJ, United Kingdom Thomas J Vogl, MD, Professor, Reader in Health  Technology Assessment,  Department of  Diagnos - tic and Interventional Radiology, Johann Wolfgang  Goethe University of  Frankfurt, Frankfurt 60590, FLYLEAF EDITORS FOR  THIS ISSUEResponsible Assistant Editor:  Xiang Li            Responsible Science Editor:  Fang-Fang Ji Responsible Electronic Editor: Huan-Liang Wu            Proofing Editorial Office Director:  Jin-Lei Wang Proofing Editor-in-Chief:  Lian-Sheng Ma Germany EDITORIAL	BOARD	MEMBERS All editorial board members resources online at http:// www .wjgnet.com/1949-8470/editorialboard.htm EDITORIAL 	OFFICE Xiu-Xia Song, Director World Journal of  Radiology Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-2238242 Fax: +1-925-2238243 E-mail: editorialoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.wjgnet.com PUBLISHER Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501,  Pleasanton, CA 94588, USA Telephone: +1-925-2238242 Fax: +1-925-2238243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.w jgnet.comPUBLICATION	DATE June 28, 2017 COPYRIGHT © 2017 Baishideng Publishing Group Inc.",Non-OADS,/arxiv_data1/oa_pdf/f7/7d/WJR-9-253.PMC5491653.pdf
"INSTRUCTIONS	TO	AUTHORS http://www.wjgnet.com/bpg/gerinfo/204 ONLINE	SUBMISSION	 http://www.f6publishing.comABOUT COVER Editorial 	Board 	Member 	of	World 	Journal 	of	Radiology ,	Giuseppe 	Malinverni, 	 MD,	Director, 	Radiation 	Oncology	 Department, 	Ospedali 	Riuniti 	Marche	 Nord, 	 13044 	Crescentino, 	Vercelli 	Province, 	Italy World Journal of  Radiology  (World J Radiol , WJR, online ISSN 1949-8470, DOI: 10.4329)  is a peer-reviewed open access academic journal that aims to guide clinical practice and  improve diagnostic and therapeutic skills of  clinicians.",Non-OADS,/arxiv_data1/oa_pdf/f7/7d/WJR-9-253.PMC5491653.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Dr. Abhishek Mahajan, MD, Radiodia - gnosis, Fellowship Cancer Imaging, MRes, Associate Pro- fessor ,  Department of Radiodiagnosis and Imaging, Tata Memorial  Hospital, Tata Memorial Centre, Room No.",Non-OADS,/arxiv_data1/oa_pdf/f7/7d/WJR-9-253.PMC5491653.pdf
Published by Baishideng Publishing  Group Inc. All rights reserved.World Journal of  Radiology WJR Submit a Manuscript: http://www.f6publishing.com DOI: 10.4329/wjr.v9.i6.253World J Radiol  2017 June 28; 9(6): 253-268 ISSN 1949-8470 (online),Non-OADS,/arxiv_data1/oa_pdf/f7/7d/WJR-9-253.PMC5491653.pdf
wjgnet.com/ 1949 ­8470 /full/v9/i6/253.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f7/7d/WJR-9-253.PMC5491653.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/f7/7d/WJR-9-253.PMC5491653.pdf
"Contents NAME	OF	JOURN AL	 World Journal of  Radiology ISSN ISSN 1949-8470 (online) LAUNCH	DATE January 31, 2009 FREQUENCY Monthly EDITORS-IN-CHIEF Kai U Juergens, MD, Associate Professor, MRT  und PET/CT, Nuklearmedizin Bremen Mitte, ZE - MODI - Zentrum fü r morphologische und moleku - lare Diagnostik, Bremen 28177, Germany Edwin JR van Beek, MD, PhD, Professor, Clinical  Research Imaging Centre and  Department of  Medi - cal Radiology, University of  Edinburgh, Edinburgh  EH16 4TJ, United Kingdom Thomas J Vogl, MD, Professor, Reader in Health  Technology Assessment,  Department of  Diagnos - tic and Interventional Radiology, Johann Wolfgang  Goethe University of  Frankfurt, Frankfurt 60590, FLYLEAF EDITORS FOR  THIS ISSUEResponsible Assistant Editor:  Xiang Li            Responsible Science Editor:  Fang-Fang Ji Responsible Electronic Editor: Huan-Liang Wu            Proofing Editorial Office Director:  Jin-Lei Wang Proofing Editor-in-Chief:  Lian-Sheng Ma Germany EDITORIAL	BOARD	MEMBERS All editorial board members resources online at http:// www .wjgnet.com/1949-8470/editorialboard.htm EDITORIAL 	OFFICE Xiu-Xia Song, Director World Journal of  Radiology Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-2238242 Fax: +1-925-2238243 E-mail: editorialoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.wjgnet.com PUBLISHER Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501,  Pleasanton, CA 94588, USA Telephone: +1-925-2238242 Fax: +1-925-2238243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.w jgnet.comPUBLICATION	DATE June 28, 2017 COPYRIGHT © 2017 Baishideng Publishing Group Inc.",Non-OADS,/arxiv_data1/oa_pdf/87/09/WJR-9-269.PMC5491654.pdf
"INSTRUCTIONS	TO	AUTHORS http://www.wjgnet.com/bpg/gerinfo/204 ONLINE	SUBMISSION	 http://www.f6publishing.comABOUT COVER Editorial 	Board 	Member 	of	World 	Journal 	of	Radiology ,	Giuseppe 	Malinverni, 	 MD,	Director, 	Radiation 	Oncology	 Department, 	Ospedali 	Riuniti 	Marche	 Nord, 	 13044 	Crescentino, 	Vercelli 	Province, 	Italy World Journal of  Radiology  (World J Radiol , WJR, online ISSN 1949-8470, DOI: 10.4329)  is a peer-reviewed open access academic journal that aims to guide clinical practice and  improve diagnostic and therapeutic skills of  clinicians.",Non-OADS,/arxiv_data1/oa_pdf/87/09/WJR-9-269.PMC5491654.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Prabhakar Rajiah, MBBS, MD, FRCR,  Associate Professor, Associate Director  of Cardiac CT and  MRI, Department of Radiology, Cardiothoracic Imaging, UT  Southwestern Medical Center, E6.120 B, Mail code 9316, 5323  Harry Hines Boulevard, Dallas, TX 75204,  United States.",Non-OADS,/arxiv_data1/oa_pdf/87/09/WJR-9-269.PMC5491654.pdf
World J Radiol  2017; 9(6): 269-279  Available from:  URL:  http://www.wjgnet.com/ 1949-8470 /full/v9/i6/269.htm  DOI:  http://dx.doi.org/10.4329/wjr.v9.i6.269 INTRODUCTION Lung cancer is the leading oncologic cause of mortality  in both men and women in the United States.,Non-OADS,/arxiv_data1/oa_pdf/87/09/WJR-9-269.PMC5491654.pdf
World­World Journal of  Radiology WJR Submit a Manuscript: http://www.f6publishing.com DOI: 10.4329/wjr.v9.i6.269World J Radiol  2017 June 28; 9(6): 269-279 ISSN 1949-8470 (online),Non-OADS,/arxiv_data1/oa_pdf/87/09/WJR-9-269.PMC5491654.pdf
Available from: URL: https://seer.cancer.gov/statfacts/html/lungb.,Non-OADS,/arxiv_data1/oa_pdf/87/09/WJR-9-269.PMC5491654.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/87/09/WJR-9-269.PMC5491654.pdf
"Contents NAME	OF	JOURN AL	 World Journal of  Radiology ISSN ISSN 1949-8470 (online) LAUNCH	DATE January 31, 2009 FREQUENCY Monthly EDITORS-IN-CHIEF Kai U Juergens, MD, Associate Professor, MRT  und PET/CT, Nuklearmedizin Bremen Mitte, ZE - MODI - Zentrum fü r morphologische und moleku - lare Diagnostik, Bremen 28177, Germany Edwin JR van Beek, MD, PhD, Professor, Clinical  Research Imaging Centre and  Department of  Medi - cal Radiology, University of  Edinburgh, Edinburgh  EH16 4TJ, United Kingdom Thomas J Vogl, MD, Professor, Reader in Health  Technology Assessment,  Department of  Diagnos - tic and Interventional Radiology, Johann Wolfgang  Goethe University of  Frankfurt, Frankfurt 60590, FLYLEAF EDITORS FOR  THIS ISSUEResponsible Assistant Editor:  Xiang Li            Responsible Science Editor:  Fang-Fang Ji Responsible Electronic Editor: Huan-Liang Wu            Proofing Editorial Office Director:  Jin-Lei Wang Proofing Editor-in-Chief:  Lian-Sheng Ma Germany EDITORIAL	BOARD	MEMBERS All editorial board members resources online at http:// www .wjgnet.com/1949-8470/editorialboard.htm EDITORIAL 	OFFICE Xiu-Xia Song, Director World Journal of  Radiology Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-2238242 Fax: +1-925-2238243 E-mail: editorialoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.wjgnet.com PUBLISHER Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501,  Pleasanton, CA 94588, USA Telephone: +1-925-2238242 Fax: +1-925-2238243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.w jgnet.comPUBLICATION	DATE June 28, 2017 COPYRIGHT © 2017 Baishideng Publishing Group Inc.",Non-OADS,/arxiv_data1/oa_pdf/26/02/WJR-9-280.PMC5491655.pdf
"INSTRUCTIONS	TO	AUTHORS http://www.wjgnet.com/bpg/gerinfo/204 ONLINE	SUBMISSION	 http://www.f6publishing.comABOUT COVER Editorial 	Board 	Member 	of	World 	Journal 	of	Radiology ,	Giuseppe 	Malinverni, 	 MD,	Director, 	Radiation 	Oncology	 Department, 	Ospedali 	Riuniti 	Marche	 Nord, 	 13044 	Crescentino, 	Vercelli 	Province, 	Italy World Journal of  Radiology  (World J Radiol , WJR, online ISSN 1949-8470, DOI: 10.4329)  is a peer-reviewed open access academic journal that aims to guide clinical practice and  improve diagnostic and therapeutic skills of  clinicians.",Non-OADS,/arxiv_data1/oa_pdf/26/02/WJR-9-280.PMC5491655.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Giovanni Salvatore Camastra, MD,  Department of Cardiology and of Radiology M.G.V annini Hospital,  via di acqua Bullicante 4, 00177 Roma, Italy.",Non-OADS,/arxiv_data1/oa_pdf/26/02/WJR-9-280.PMC5491655.pdf
Clinical and echocardiographic follow-ups were  performed at 12 ± 2 mo and no major adverse cardiac  events were revealed.World Journal of  Radiology WJR Submit a Manuscript: http://www.f6publishing.com DOI: 10.4329/wjr.v9.i6.280World J Radiol  2017 June 28; 9(6): 280-286 ISSN 1949-8470 (online) Retrospective Study,Non-OADS,/arxiv_data1/oa_pdf/26/02/WJR-9-280.PMC5491655.pdf
World J Radiol  2017; 9(6): 280 ­286  Available from:  URL:  http://www.wjgnet.com/ 1949 ­8470 /full/v9/i6/280.htm  DOI:  http://dx.doi.org/10.4329/wjr.v9.i6.280 INTRODUCTION Troponin can accurately predict the presence of acute  coronary syndrome (ACS) in patients with coronary  artery disease (CAD) and is usually used in the risk  assessment of patients presenting acute chest pain.,Non-OADS,/arxiv_data1/oa_pdf/26/02/WJR-9-280.PMC5491655.pdf
"The extension of contrast  enhancement and the left ventricular ejection fraction,  were measured using the freely available software  segment on the website ( http://segment.heiberg.se )[8].",OADS,/arxiv_data1/oa_pdf/26/02/WJR-9-280.PMC5491655.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/26/02/WJR-9-280.PMC5491655.pdf
"Contents NAME	OF	JOURN AL	 World Journal of  Radiology ISSN ISSN 1949-8470 (online) LAUNCH	DATE January 31, 2009 FREQUENCY Monthly EDITORS-IN-CHIEF Kai U Juergens, MD, Associate Professor, MRT  und PET/CT, Nuklearmedizin Bremen Mitte, ZE - MODI - Zentrum fü r morphologische und moleku - lare Diagnostik, Bremen 28177, Germany Edwin JR van Beek, MD, PhD, Professor, Clinical  Research Imaging Centre and  Department of  Medi - cal Radiology, University of  Edinburgh, Edinburgh  EH16 4TJ, United Kingdom Thomas J Vogl, MD, Professor, Reader in Health  Technology Assessment,  Department of  Diagnos - tic and Interventional Radiology, Johann Wolfgang  Goethe University of  Frankfurt, Frankfurt 60590, FLYLEAF EDITORS FOR  THIS ISSUEResponsible Assistant Editor:  Xiang Li            Responsible Science Editor:  Fang-Fang Ji Responsible Electronic Editor: Huan-Liang Wu            Proofing Editorial Office Director:  Jin-Lei Wang Proofing Editor-in-Chief:  Lian-Sheng Ma Germany EDITORIAL	BOARD	MEMBERS All editorial board members resources online at http:// www .wjgnet.com/1949-8470/editorialboard.htm EDITORIAL 	OFFICE Xiu-Xia Song, Director World Journal of  Radiology Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-2238242 Fax: +1-925-2238243 E-mail: editorialoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.wjgnet.com PUBLISHER Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501,  Pleasanton, CA 94588, USA Telephone: +1-925-2238242 Fax: +1-925-2238243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.w jgnet.comPUBLICATION	DATE June 28, 2017 COPYRIGHT © 2017 Baishideng Publishing Group Inc.",Non-OADS,/arxiv_data1/oa_pdf/72/21/WJR-9-287.PMC5491656.pdf
"INSTRUCTIONS	TO	AUTHORS http://www.wjgnet.com/bpg/gerinfo/204 ONLINE	SUBMISSION	 http://www.f6publishing.comABOUT COVER Editorial 	Board 	Member 	of	World 	Journal 	of	Radiology ,	Giuseppe 	Malinverni, 	 MD,	Director, 	Radiation 	Oncology	 Department, 	Ospedali 	Riuniti 	Marche	 Nord, 	 13044 	Crescentino, 	Vercelli 	Province, 	Italy World Journal of  Radiology  (World J Radiol , WJR, online ISSN 1949-8470, DOI: 10.4329)  is a peer-reviewed open access academic journal that aims to guide clinical practice and  improve diagnostic and therapeutic skills of  clinicians.",Non-OADS,/arxiv_data1/oa_pdf/72/21/WJR-9-287.PMC5491656.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Jacobus F A Jansen, PhD,  Departments of  Radiology and Nuclear Medicine, Maastricht University Medical  Center, PO Box 5800, 6202 AZ, Maastricht,  The Netherlands.",Non-OADS,/arxiv_data1/oa_pdf/72/21/WJR-9-287.PMC5491656.pdf
Three groups of World Journal of  Radiology WJR Submit a Manuscript: http://www.f6publishing.com DOI: 10.4329/wjr.v9.i6.287World J Radiol  2017 June 28; 9(6): 287-294 ISSN 1949-8470 (online) Observational Study,Non-OADS,/arxiv_data1/oa_pdf/72/21/WJR-9-287.PMC5491656.pdf
World J Radiol   2017; 9(6): 287 ­294  Available from: URL:  http://www.wjgnet.com/ 1949 ­8470 /full/v9/i6/287.htm  DOI: http://dx.doi.org/10.4329/ wjr.v9.i6.287 INTRODUCTION Epilepsy is generally treated with antiepileptic drugs  (AEDs).,Non-OADS,/arxiv_data1/oa_pdf/72/21/WJR-9-287.PMC5491656.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/72/21/WJR-9-287.PMC5491656.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Adiponectin, fear extinction and DG excitability D Zhang et al 1055 Molecular Psychiatry (2017), 1044 –1055",Non-OADS,/arxiv_data1/oa_pdf/d0/f5/mp201658a.PMC5491689.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f5/c3/ijgm-10-177.PMC5491699.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f5/c3/ijgm-10-177.PMC5491699.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine 2017:10 177–187International Journal of General Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 177 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S138583Health care provider experience with canagliflozin  in real-world clinical practice: favorability,  treatment patterns, and patient outcomes Susan C Bolge1 Natalia M Flores2 Shu Huang3 Jennifer Cai1 1Janssen Scientific Affairs, LLC,   Titusville, NJ, 2Kantar Health, Foster  City, CA, 3Kantar Health, New Y ork,   NY, USAPurpose: This study describes how health care providers approach canagliflozin for the treat- ment of patients with type 2 diabetes mellitus (T2DM) in the real world.",Non-OADS,/arxiv_data1/oa_pdf/f5/c3/ijgm-10-177.PMC5491699.pdf
"T2DM is highly prevalent in the USA with recent estimates of 9.3% of the population having the condition 1 and it  is associated with a substantial economic and humanistic burden on society.2 To pre- vent the progression of T2DM and related complications, the most recent consensus guidelines of the American Diabetes Association (ADA) indicate that a concentration of glycosylated hemoglobin (HbA1c) ≥7.0% should serve as a trigger to initiate or Correspondence: Shu Huang Marketing Insights, Kantar Health, 11 Madison Avenue, New York City, NY 10010, USATel +1 212 706 4263Email shu.huang@kantarhealth.comJournal name: International Journal of General Medicine Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Bolge et alRunning head recto: Health care provider experience with canagliflozinDOI: http://dx.doi.org/10.2147/IJGM.S138583",Non-OADS,/arxiv_data1/oa_pdf/f5/c3/ijgm-10-177.PMC5491699.pdf
"International Journal of General Medicine 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/f5/c3/ijgm-10-177.PMC5491699.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 187 Health care provider experience with canagliflozin Supplementary materials Table S1  Patient characteristics by provider type Patient characteristics Provider type One-way ANOVA   p-valueEndocrinologist   (N=101)PCP   (N=101)NP/PA   (N=100) Mean SD Mean SD Mean SD Age (% of patients, years) <18 2.46a4.27 2.98a5.29 3.00a4.38 0.644 18–44 21.83a,b9.29 20.03a12.2 23.60b11.03 0.069 45–64 35.62a11.89 35.93a13.84 37.19a12.28 0.652 65–74 25.01a8.94 26.30a12.75 24.81a13.3 0.625 ≥75 15.08a8.13 14.76a11.04 11.40b11.54 0.021 Ethnicity (% of patients) White 60.41a21.32 59.72a26.83 46.80b23.08 <0.001 Black or African American 16.93a11.81 17.61a14.82 24.17b16.73 0.001 Hispanic or Latino 12.89a10.45 13.75a15.35 18.79b15.81 0.006 Asian 7.01a7.72 6.96a11.38 5.91a5.93 0.597 Other (mixed racial background, native American, etc.",Non-OADS,/arxiv_data1/oa_pdf/f5/c3/ijgm-10-177.PMC5491699.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/98/48/dddt-11-1871.PMC5491700.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 1871–1879Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1871CliniC al Trial repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S13782 5 Efficacy and safety of retinol palmitate ophthalmic  solution in the treatment of dry eye: a Japanese  phase ii clinical trial Hiroshi T oshida1 T oshinari Funaki2 Koichi ono3 nobuhito Tabuchi4 Sota Watanabe4 Tamotsu Seki5 Hiroshi otake6 Takuji Kato7 nobuyuki ebihara8 akira Murakami2 1Department of ophthalmology,   Juntendo University Shizuoka  Hospital, Shizuoka, 2Department  of ophthalmology, Juntendo  University Graduate School  of Medicine, 3Department of  ophthalmology, Juntendo Tokyo  Koto Geriatric Medical Center,   T okyo, 4pharmaceutical research  laboratories, lion Corporation,   Kanagawa, 5Tamagawa eye Clinic,   T okyo, 6otake eye Clinic, Kanagawa,   7Kato eye Clinic, T okyo, 8Department  of ophthalmology, Juntendo  University Urayasu Hospital,   Chiba, JapanPurpose:  The purpose of this study was to investigate the efficacy and safety of the  administration of retinol palmitate (VApal) ophthalmic solution (500 IU/mL) for the treatment  of patients with dry eye.",Non-OADS,/arxiv_data1/oa_pdf/98/48/dddt-11-1871.PMC5491700.pdf
"Therefore, a reduction Correspondence: Hiroshi Toshida Department of ophthalmology, Juntendo  University Shizuoka Hospital, 1129,  nagaoka, izunokuni, Shizuoka 410-2295,  Japan Tel +81 55 948 3111 Fax +81 55 948 5088 email toshida@juntendo.ac.j p Journal name: Drug Design, Development and Therapy Article Designation: Clinical Trial Report Y ear: 2017 Volume: 11 Running head verso: Toshida et al Running head recto: Efficacy and safety of VApal ophthalmic solution in dry eye DOI: http://dx.doi.org/10.2147/DDDT.S137825",Non-OADS,/arxiv_data1/oa_pdf/98/48/dddt-11-1871.PMC5491700.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/98/48/dddt-11-1871.PMC5491700.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/98/48/dddt-11-1871.PMC5491700.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/37/e6/dddt-11-1891.PMC5491701.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 1891–1904Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1891Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S13175 3 synthesis and cytotoxic activities of novel  4-methoxy-substituted and 5-methyl-substituted  (3′S,4′S)-(-)-cis-khellactone derivatives that  induce apoptosis via the intrinsic pathway Jingrun chen1,* Junjie liu1,* Dongxiao cui1 chaoqun Yan1 liqiang Meng1 liqian sun1 shurong Ban1 rui ge1 Taigang liang1,2 Qingshan li1,2 1laboratory of Medicinal chemistry,   school of Pharmaceutical science,   shanxi Medical University, 2college  of Traditional chinese Medicine,   shanxi University of Traditional  chinese Medicine, Taiyuan, shanxi,   People’s  republic of china *These authors contributed equally  to this workAbstract:  This study deals with the design and synthesis of a series of novel 4-methoxy-substituted  and 5-methyl-substituted (3 ′S,4′S)-(-)-cis-khellactones.",Non-OADS,/arxiv_data1/oa_pdf/37/e6/dddt-11-1891.PMC5491701.pdf
"Keywords:  4-methoxy-substituted and 5-methyl-substituted (3 ′S,4′S)-(-)-cis-khellactones,  synthesis, cytotoxic activity, apoptosis Abbreviations AO, acridine orange; (DHQD)2-PYR, hydroquinidine-2,5-diphenyl-4,6-pyrimidinediyl  diether; DMEM, Dulbecco’s Modified Eagle’s Medium; DMSO,  dimethyl  sulfoxide; EB, ethidium bromide; ECL, enhanced chemiluminescence; ee, enantio - meric excess; ESI,  electrospray ionization; FBS, fetal bovine serum; FITC, fluorescein  isothiocyanate; HPLC, high-performance liquid chromatography; HRP, horseradish  peroxidase; IC50, 50% inhibitory concentration; JC-1, 5,5 ′,6,6′-tetrachloro-1,1 ′,3,3′- tetraethyl-imidacarbocyanine iodide; MMP, mitochondrial membrane potential; NMR,  nuclear magnetic resonance; PE, petroleum ether; PI, propidium iodide; ppm, parts per  million; RIPA, radio-immunoprecipitation assay; SDS-PAGE, sodium dodecyl sulfate  polyacrylamide gel electrophoresis; TBS-T, tris-buffered saline plus Tween-20; TLC,  thin-layer chromatography; TMS, tetramethylsilane.correspondence: Taigang liang;   Qingshan li laboratory of Medicinal chemistry,  school of Pharmaceutical science, shanxi  Medical University, no 56, Xinjian  nan road, Taiyuan 030001, shanxi,  People’s republic of china Tel/fax +86 351 469 0322 email ltaigang@163.co m;  sxlqs2012@163.co mJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Chen et al Running head recto: Synthesis and cytotoxic activities DOI: http://dx.doi.org/10.2147/DDDT.S131753",Non-OADS,/arxiv_data1/oa_pdf/37/e6/dddt-11-1891.PMC5491701.pdf
"Available from:  http://globocan.iarc.f r. Accessed December 18, 2013.",Non-OADS,/arxiv_data1/oa_pdf/37/e6/dddt-11-1891.PMC5491701.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/37/e6/dddt-11-1891.PMC5491701.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/37/e6/dddt-11-1891.PMC5491701.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4c/4b/ijn-12-4579.PMC5491702.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 4579–4591International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4579OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S13130 9 Antitumor HPV E7-specific CTL activity elicited  by in vivo engineered exosomes produced  through DNA inoculation Paola Di Bonito1 chiara chiozzini2 claudia arenaccio2 simona anticoli2 Francesco Manfredi2 eleonora Olivetta2 Flavia Ferrantelli2 emiliana Falcone3 Anna Ruggieri3 Maurizio Federico2 1Department of Infectious, Parasitic  and Immunomediated Diseases,   Istituto Superiore di Sanità, Rome,   Italy; 2National AIDS Center, Istituto  Superiore di Sanità, Rome, Italy;   3Department of Veterinary Public  Health and Food Safety, Istituto  Superiore di Sanità, Rome, ItalyAbstract:  We recently proved that exosomes engineered in vitro to deliver high amounts of  HPV E7 upon fusion with the Nefmut exosome-anchoring protein elicit an efficient anti-E7 cyto - toxic T lymphocyte immune response.",Non-OADS,/arxiv_data1/oa_pdf/4c/4b/ijn-12-4579.PMC5491702.pdf
"Nanovesicles showing both physical and biochemical  features resembling exosomes, but those generated through direct extrusion of plasma  membrane have also been described in muscle cells.2–4correspondence: Maurizio Federico National AIDS Center, Istituto  Superiore di Sanità, Viale Regina  Elena, 299, 00161 Rome, Italy Tel +39 06 4990 3605 Fax +39 06 4990 3002 email maurizio.federico@iss.i t Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Di Bonito et al Running head recto: Endogenously engineered exosomes as anti-HPV vaccine DOI: http://dx.doi.org/10.2147/IJN.S131309",Non-OADS,/arxiv_data1/oa_pdf/4c/4b/ijn-12-4579.PMC5491702.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/4c/4b/ijn-12-4579.PMC5491702.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/4b/ijn-12-4579.PMC5491702.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/34/50/dddt-11-1849.PMC5491703.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 1849–1857Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1849Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S13594 9 Differential effect of platelet-rich plasma fractions  on β1-integrin signaling, collagen biosynthesis, and  prolidase activity in human skin fibroblasts T omasz guszczyn1 Arkadiusz Surażyński2 Ilona Zaręba2 edyta rysiak2 Janusz Popko1 Jerzy Pałka2 1Department of Pediatric Orthopedics  and Traumatology, 2Department  of Medicinal chemistry, Medical  University of Białystok, Białystok,   PolandAbstract:  The study was conducted to evaluate the effects of platelet-rich plasma (PRP),  supernatant of PRP (SPRP) obtained by centrifugation, and supernatant of activated PRP (SActi- PRP) obtained by Ca2+ solution-treated PRP on collagen biosynthesis, prolidase activity, and  β1-integrin signaling in cultured human skin fibroblasts.",Non-OADS,/arxiv_data1/oa_pdf/34/50/dddt-11-1849.PMC5491703.pdf
"Waszyngtona 17, 15–274  Białystok, Poland Tel/fax +48 85 745 0895 email tombial@mp.p l Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Guszczyn et al Running head recto: Effects of PRP in human skin fibroblasts DOI: http://dx.doi.org/10.2147/DDDT.S135949",Non-OADS,/arxiv_data1/oa_pdf/34/50/dddt-11-1849.PMC5491703.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/34/50/dddt-11-1849.PMC5491703.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/50/dddt-11-1849.PMC5491703.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6d/7c/dddt-11-1881.PMC5491704.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 1881–1890Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1881Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S13980 4 T otal flavonoids from Rhizoma Drynariae  (Gusuibu) for treating osteoporotic fractures:  implication in clinical practice Yili Zhang1 Junjie Jiang1 Hao Shen1 Yan Chai2 Xu wei3 Yanming Xie1 1Institute of Basic Research in  Clinical Medicine, China Academy of  Chinese Medical Sciences, Beijing,   China; 2Department of Epidemiology,   University of California, Los Angeles,   CA, USA; 3Department of Scientific  Research, wangjing Hospital, China  Academy of Chinese Medical Sciences,   Beijing, ChinaAbstract:  This systematic review was performed to determine the clinical efficacy and safety  of total flavonoids from Rhizoma Drynariae (TFRD) for osteoporotic fractures and to provide  clear evidence for clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/6d/7c/dddt-11-1881.PMC5491704.pdf
"Over the next  30 years, osteoporotic fractures will account for more than half of all fractures.14 The  projected cost of osteoporotic hip fractures alone may reach US $131 billion worldwide  by 2050.15 In addition, the risk of osteoporotic fractures in women is higher than that  of breast cancer, endometrial cancer, and ovarian cancer, while in men it is higher than  prostate cancer.15 Therefore, enhancing treatment for osteoporotic fractures to promote  healing and prevent recurrence is an important public health issue.16,17Correspondence: Xu wei Department of Scientific Research,  Wangjing Hospital, China Academy of  Chinese Medical Sciences, Huajiadi Street,  Chaoyang District, Beijing 100102, China Tel +86 134 8871 6557 email weixu.007@163.co m  Yanming Xie Institute of Basic Research in Clinical  Medicine, China Academy of Chinese  Medical Sciences, No 16 Nanxiao Street,  Dongzhimennei, Dongcheng District,  Beijing 100700, China Tel +86 6409 3302 email datamining5288@163.co mJournal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2017 Volume: 11 Running head verso: Zhang et al Running head recto: TFRD for osteoporotic fractures DOI: http://dx.doi.org/10.2147/DDDT.S139804",Non-OADS,/arxiv_data1/oa_pdf/6d/7c/dddt-11-1881.PMC5491704.pdf
"Methods  The protocol of this systematic review has been registered  on PROSPERO (registration number: CRD42017052797),  available from https://www.crd.york.ac.uk/PROSPERO/ display_record.asp?ID =CRD4201705279 7. eligibility criteria This systematic review was carried out and reported in  accordance with Preferred Reporting Items for Systematic  Reviews and Meta-Analysis (PRISMA).36 Also, all included  trials were appraised by using Consolidated Standards  for Reporting Trials for Traditional Chinese Medicine  (CONSORT for TCM).37 Types of studies All prospective RCTs without the restriction of language  were included.",Non-OADS,/arxiv_data1/oa_pdf/6d/7c/dddt-11-1881.PMC5491704.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/6d/7c/dddt-11-1881.PMC5491704.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6d/7c/dddt-11-1881.PMC5491704.pdf
Available from: http://d.dxy.cn/preview/601851 5.,Non-OADS,/arxiv_data1/oa_pdf/6d/7c/dddt-11-1881.PMC5491704.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/88/0a/dddt-11-1859.PMC5491705.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 1859–1870Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1859Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S13060 1 Molecular docking, Qsar and aDMeT studies of  withanolide analogs against breast cancer Dharmendra K Yadav1 surendra Kumar2 saloni1 harpreet singh3 Mi-hyun Kim1 Praveen sharma4 sanjeev Misra4 Feroz Khan5 1Department of Pharmacy, college  of Pharmacy, gachon University,   Yeonsu-gu, incheon, republic of Korea;   2Faculty of Pharmacy, Department  of Pharmaceutical chemistry, Babu  Banarasi Das northern india institute  of T echnology, lucknow, 3Department  of Bioinformatics, indian council  of Medical research, new Delhi,   4Department of Biochemistry, all india  institute of Medical sciences, Jodhpur,   5Metabolic & structural Biology  Department, csir– central institute  of Medicinal & aromatic Plant,   lucknow, indiaAbstract:  Withanolides are a group of pharmacologically active compounds present in most  prodigal amounts in roots and leaves of Withania somnifera  (Indian ginseng), one of the most  important medicinal plants of Indian traditional practice of medicine.",Non-OADS,/arxiv_data1/oa_pdf/88/0a/dddt-11-1859.PMC5491705.pdf
"Historically, phytomolecules have played a key role in the  discovery and development of novel anticancer agents.1,2 Withania somnifera  (com - monly known as ashwagandha or Indian winter cherry) is one such medicinal plant,  whose all parts are used as ayurvedic remedies for healing various diseases, including  inflammation, arthritis, asthma and hypertension.3–5 The root extract of W. somnifera   is known as withanolide, which is composed of 14 bioactive compounds.6,7 Preclinical  experimental data indicates that W. somnifera  leaf and root extracts have anticancer  potential.8,9 For example, chemically induced tumorigenesis in the stomach and skin correspondence: Dharmendra K Yadav college of Pharmacy, gachon University,  hambakmoeiro 191, Yeonsu-gu,  incheon city, 406-799, Korea Tel +82 32 820 4947 email dharmendra30oct@gmail.co m  Feroz Khan Metabolic & structural Biology  Department, csir-central institute of  Medicinal and aromatic Plants, P.O.- ciMaP, Kukrail Picnic spot road,  lucknow, 226015, india Tel +91 522 271 8668 email f.khan@cimap.res.i n Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Y adav et al Running head recto: Withanolide analogs against breast cancer DOI: http://dx.doi.org/10.2147/DDDT.S130601",Non-OADS,/arxiv_data1/oa_pdf/88/0a/dddt-11-1859.PMC5491705.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/88/0a/dddt-11-1859.PMC5491705.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/88/0a/dddt-11-1859.PMC5491705.pdf
Case report A 50-year old woman with past medical history of congestive heart http://dx.doi.org/10.1016/j.gore.2017.06.009 Received 5 May 2017; Received in revised form 7 June 2017; Accepted 10 June 2017⁎*Corresponding author.E-mail address: ankit.mangla.md@gmail.com (A. Mangla).,Non-OADS,/arxiv_data1/oa_pdf/61/07/main.PMC5491753.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/61/07/main.PMC5491753.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/99/main.PMC5491754.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.06.004 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/09/99/main.PMC5491754.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 22 (2017) 67 e69,Non-OADS,/arxiv_data1/oa_pdf/09/99/main.PMC5491754.pdf
"[4–6]Thus, prosthesis sizing can prevent complications such as occlusion of the coronary ostia, annular http://dx.doi.org/10.1016/j.ejro.2017.06.001 Received 2 April 2017; Received in revised form 4 June 2017; Accepted 18 June 2017⁎Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/2e/4b/main.PMC5491755.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2e/4b/main.PMC5491755.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/da/b7/main.PMC5491756.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.06.008 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/da/b7/main.PMC5491756.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 22 (2017) 74 e76,Non-OADS,/arxiv_data1/oa_pdf/da/b7/main.PMC5491756.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/8c/main.PMC5491757.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.06.007 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/8c/main.PMC5491757.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 22 (2017) 60 e63,Non-OADS,/arxiv_data1/oa_pdf/bc/8c/main.PMC5491757.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/bc/8c/main.PMC5491757.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/e7/main.PMC5491758.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.06.012 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/e7/main.PMC5491758.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 22 (2017) 70 e73,Non-OADS,/arxiv_data1/oa_pdf/b9/e7/main.PMC5491758.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.04.019 2213-0071/ ©2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/4a/df/main.PMC5491759.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 22 (2017) 57 e59,Non-OADS,/arxiv_data1/oa_pdf/4a/df/main.PMC5491759.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5c/1d/main.PMC5491760.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.06.013 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/1d/main.PMC5491760.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 22 (2017) 64 e66,Non-OADS,/arxiv_data1/oa_pdf/5c/1d/main.PMC5491760.pdf
Received 14 February 2017; accepted 8 June 2017; http://dx.doi.org/10.1016/j.omtn.2017.06.004 .,Non-OADS,/arxiv_data1/oa_pdf/aa/f5/main.PMC5491761.pdf
77 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/f5/main.PMC5491761.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/4e/rjx120.PMC5491798.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/8d/rjx112.PMC5491799.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fd/8b/rjx110.PMC5491801.pdf
Available at: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm393576.htm.,Non-OADS,/arxiv_data1/oa_pdf/2b/94/e2017.00009.PMC5491802.pdf
Available at:http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm424443.htm.,Non-OADS,/arxiv_data1/oa_pdf/2b/94/e2017.00009.PMC5491802.pdf
Available at: http://citeseerx.ist.psu.edu/viewdoc/download;jsessionid /H110050B 68F165EE5273797EFF9ED85D00C905?doi /H1100510.1.1.501.7332& rep/H11005rep1&type /H11005pdf.,OADS,/arxiv_data1/oa_pdf/24/c6/e2017.00021.PMC5491803.pdf
Available at: https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/hospital-value-based-purchasing/index.html?redirect /H11005/hospital-value-based-purchasing.,Non-OADS,/arxiv_data1/oa_pdf/24/c6/e2017.00021.PMC5491803.pdf
Available at: http://hcahpsonline.org/home.aspx.,Non-OADS,/arxiv_data1/oa_pdf/24/c6/e2017.00021.PMC5491803.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/6b/8e/1349-7235-56-1129.PMC5491804.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/6b/8e/1349-7235-56-1129.PMC5491804.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/61/1e/1349-7235-56-1131.PMC5491805.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/61/1e/1349-7235-56-1131.PMC5491805.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/50/43/1349-7235-56-1141.PMC5491806.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/50/43/1349-7235-56-1141.PMC5491806.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/97/6b/1349-7235-56-1147.PMC5491807.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/97/6b/1349-7235-56-1147.PMC5491807.pdf
"To view the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/6f/d4/1349-7235-56-1153.PMC5491808.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/6f/d4/1349-7235-56-1153.PMC5491808.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/47/70/1349-7235-56-1157.PMC5491809.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/47/70/1349-7235-56-1157.PMC5491809.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/68/a4/1349-7235-56-1163.PMC5491810.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/68/a4/1349-7235-56-1163.PMC5491810.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/c1/bb/1349-7235-56-1169.PMC5491811.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/c1/bb/1349-7235-56-1169.PMC5491811.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/72/ca/1349-7235-56-1175.PMC5491812.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/72/ca/1349-7235-56-1175.PMC5491812.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/e9/da/1349-7235-56-1179.PMC5491813.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/e9/da/1349-7235-56-1179.PMC5491813.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/0e/28/1349-7235-56-1185.PMC5491814.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/0e/28/1349-7235-56-1185.PMC5491814.pdf
"Availablefrom: http://www.nccn.org/professi onals/physician_gls/pdf/nhl.pdf 9.Teshima T, Akashi K, Shibuya T, et al.",OADS,/arxiv_data1/oa_pdf/73/ed/1349-7235-56-1193.PMC5491815.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/73/ed/1349-7235-56-1193.PMC5491815.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/73/ed/1349-7235-56-1193.PMC5491815.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/9e/da/1349-7235-56-1199.PMC5491816.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/9e/da/1349-7235-56-1199.PMC5491816.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/a5/ac/1349-7235-56-1203.PMC5491817.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/a5/ac/1349-7235-56-1203.PMC5491817.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/a7/56/1349-7235-56-1207.PMC5491818.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/a7/56/1349-7235-56-1207.PMC5491818.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/66/37/1349-7235-56-1213.PMC5491819.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/66/37/1349-7235-56-1213.PMC5491819.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/a8/46/1349-7235-56-1219.PMC5491820.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/a8/46/1349-7235-56-1219.PMC5491820.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/6e/2f/1349-7235-56-1225.PMC5491821.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/6e/2f/1349-7235-56-1225.PMC5491821.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/85/56/1349-7235-56-1231.PMC5491822.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/85/56/1349-7235-56-1231.PMC5491822.pdf
"To view the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/bb/d9/1349-7235-56-1235.PMC5491823.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/bb/d9/1349-7235-56-1235.PMC5491823.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/41/4e/1349-7235-56-1239.PMC5491824.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/41/4e/1349-7235-56-1239.PMC5491824.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/4f/1b/1349-7235-56-1243.PMC5491825.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/4f/1b/1349-7235-56-1243.PMC5491825.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/c3/96/1349-7235-56-1247.PMC5491826.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/c3/96/1349-7235-56-1247.PMC5491826.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/54/2b/1349-7235-56-1253.PMC5491827.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/54/2b/1349-7235-56-1253.PMC5491827.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/ef/a3/1349-7235-56-1259.PMC5491828.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/ef/a3/1349-7235-56-1259.PMC5491828.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/2e/84/1349-7235-56-1265.PMC5491829.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/2e/84/1349-7235-56-1265.PMC5491829.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/02/b0/1349-7235-56-1267.PMC5491830.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/02/b0/1349-7235-56-1267.PMC5491830.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/58/6d/1349-7235-56-1269.PMC5491831.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/58/6d/1349-7235-56-1269.PMC5491831.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/20/39/1349-7235-56-1271.PMC5491832.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/20/39/1349-7235-56-1271.PMC5491832.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/a5/9b/1349-7235-56-1273.PMC5491833.pdf
"Department of Pathology, Microbiology and Immunol ogy, Vanderbilt University Medical Center, USA Received for publication August 20, 2016; Accepted for publication September 7, 2016Correspondence to Dr. Takashi Shi nha, shinha_takashi@yahoo.co.jp ⡥2017 The Japanese Society of Internal Medicine Journal W ebsite: http://www.naika.or.jp/imonline/index.html",Non-OADS,/arxiv_data1/oa_pdf/a5/9b/1349-7235-56-1273.PMC5491833.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/9a/06/1349-7235-56-1275.PMC5491834.pdf
"̍Department of Internal Medicine, Ima ri Arita Kyoritsu Hospital, Japan,̎Department of Neurology, Imari Arita Kyoritsu Hospital, Japan and ̏Department of Radiology, Imari Arita Kyoritsu Hospital, Japan Received for publication August 29, 2016; Accepted for publication September 4, 2016Correspondence to Dr. Toshihiko Mizuta, mizuta1221@gmail.com⡥2017 The Japanese Society of Internal Medicine Journal W ebsite: http://www.naika.or.jp/imonline/index.html",Non-OADS,/arxiv_data1/oa_pdf/9a/06/1349-7235-56-1275.PMC5491834.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e2/36/evw278.PMC5491842.pdf
2 http://www.ismni.orgL-N. Veilleux et al.,Non-OADS,/arxiv_data1/oa_pdf/69/f8/JMNI-17-001.PMC5492314.pdf
3 http://www.ismni.orgL-N. Veilleux et al.,Non-OADS,/arxiv_data1/oa_pdf/69/f8/JMNI-17-001.PMC5492314.pdf
4 http://www.ismni.orgL-N. Veilleux et al.,Non-OADS,/arxiv_data1/oa_pdf/69/f8/JMNI-17-001.PMC5492314.pdf
5 http://www.ismni.orgL-N. Veilleux et al.,Non-OADS,/arxiv_data1/oa_pdf/69/f8/JMNI-17-001.PMC5492314.pdf
6 http://www.ismni.orgL-N. Veilleux et al.,Non-OADS,/arxiv_data1/oa_pdf/69/f8/JMNI-17-001.PMC5492314.pdf
7 http://www.ismni.orgL-N. Veilleux et al.,Non-OADS,/arxiv_data1/oa_pdf/69/f8/JMNI-17-001.PMC5492314.pdf
20 http://www.ismni.orgS.,Non-OADS,/arxiv_data1/oa_pdf/72/5a/JMNI-17-019.PMC5492316.pdf
21 http://www.ismni.orgS.,Non-OADS,/arxiv_data1/oa_pdf/72/5a/JMNI-17-019.PMC5492316.pdf
22 http://www.ismni.orgS.,Non-OADS,/arxiv_data1/oa_pdf/72/5a/JMNI-17-019.PMC5492316.pdf
23 http://www.ismni.orgS.,Non-OADS,/arxiv_data1/oa_pdf/72/5a/JMNI-17-019.PMC5492316.pdf
24 http://www.ismni.orgS.,Non-OADS,/arxiv_data1/oa_pdf/72/5a/JMNI-17-019.PMC5492316.pdf
25 http://www.ismni.orgS.,Non-OADS,/arxiv_data1/oa_pdf/72/5a/JMNI-17-019.PMC5492316.pdf
26 http://www.ismni.orgS.,Non-OADS,/arxiv_data1/oa_pdf/72/5a/JMNI-17-019.PMC5492316.pdf
28 http://www.ismni.orgH.M.,Non-OADS,/arxiv_data1/oa_pdf/19/fc/JMNI-17-027.PMC5492317.pdf
29 http://www.ismni.orgH.M.,Non-OADS,/arxiv_data1/oa_pdf/19/fc/JMNI-17-027.PMC5492317.pdf
30 http://www.ismni.orgH.M.,Non-OADS,/arxiv_data1/oa_pdf/19/fc/JMNI-17-027.PMC5492317.pdf
31 http://www.ismni.orgH.M.,Non-OADS,/arxiv_data1/oa_pdf/19/fc/JMNI-17-027.PMC5492317.pdf
32 http://www.ismni.orgH.M.,Non-OADS,/arxiv_data1/oa_pdf/19/fc/JMNI-17-027.PMC5492317.pdf
33 http://www.ismni.orgH.M.,Non-OADS,/arxiv_data1/oa_pdf/19/fc/JMNI-17-027.PMC5492317.pdf
34 http://www.ismni.orgH.M.,Non-OADS,/arxiv_data1/oa_pdf/19/fc/JMNI-17-027.PMC5492317.pdf
35 http://www.ismni.orgH.M.,Non-OADS,/arxiv_data1/oa_pdf/19/fc/JMNI-17-027.PMC5492317.pdf
36 http://www.ismni.orgH.M.,Non-OADS,/arxiv_data1/oa_pdf/19/fc/JMNI-17-027.PMC5492317.pdf
37 http://www.ismni.orgH.M.,Non-OADS,/arxiv_data1/oa_pdf/19/fc/JMNI-17-027.PMC5492317.pdf
Available from: http://www.nationalacademies.org/hmd/Reports/2010/Dietary-Reference-Intakes-for-Calcium-and-Vitamin-D.aspx 33.,Non-OADS,/arxiv_data1/oa_pdf/19/fc/JMNI-17-027.PMC5492317.pdf
39 http://www.ismni.orgA.,Non-OADS,/arxiv_data1/oa_pdf/5a/6e/JMNI-17-038.PMC5492318.pdf
40 http://www.ismni.orgA.,Non-OADS,/arxiv_data1/oa_pdf/5a/6e/JMNI-17-038.PMC5492318.pdf
41 http://www.ismni.orgA.,Non-OADS,/arxiv_data1/oa_pdf/5a/6e/JMNI-17-038.PMC5492318.pdf
42 http://www.ismni.orgA.,Non-OADS,/arxiv_data1/oa_pdf/5a/6e/JMNI-17-038.PMC5492318.pdf
43 http://www.ismni.orgA.,Non-OADS,/arxiv_data1/oa_pdf/5a/6e/JMNI-17-038.PMC5492318.pdf
44 http://www.ismni.orgA.,Non-OADS,/arxiv_data1/oa_pdf/5a/6e/JMNI-17-038.PMC5492318.pdf
45 http://www.ismni.orgA.,Non-OADS,/arxiv_data1/oa_pdf/5a/6e/JMNI-17-038.PMC5492318.pdf
46 http://www.ismni.orgA.,Non-OADS,/arxiv_data1/oa_pdf/5a/6e/JMNI-17-038.PMC5492318.pdf
47 http://www.ismni.orgA.,Non-OADS,/arxiv_data1/oa_pdf/5a/6e/JMNI-17-038.PMC5492318.pdf
48 http://www.ismni.orgA.,Non-OADS,/arxiv_data1/oa_pdf/5a/6e/JMNI-17-038.PMC5492318.pdf
49 http://www.ismni.orgA.,Non-OADS,/arxiv_data1/oa_pdf/5a/6e/JMNI-17-038.PMC5492318.pdf
60 http://www.ismni.orgW.R.D.,Non-OADS,/arxiv_data1/oa_pdf/22/6e/JMNI-17-059.PMC5492320.pdf
61 http://www.ismni.orgW.R.D.,Non-OADS,/arxiv_data1/oa_pdf/22/6e/JMNI-17-059.PMC5492320.pdf
62 http://www.ismni.orgW.R.D.,Non-OADS,/arxiv_data1/oa_pdf/22/6e/JMNI-17-059.PMC5492320.pdf
63 http://www.ismni.orgW.R.D.,Non-OADS,/arxiv_data1/oa_pdf/22/6e/JMNI-17-059.PMC5492320.pdf
: pQCT precision in children 64 http://www.ismni.orgTable 2.,Non-OADS,/arxiv_data1/oa_pdf/22/6e/JMNI-17-059.PMC5492320.pdf
65 http://www.ismni.orgW.R.D.,Non-OADS,/arxiv_data1/oa_pdf/22/6e/JMNI-17-059.PMC5492320.pdf
66 http://www.ismni.orgW.R.D.,Non-OADS,/arxiv_data1/oa_pdf/22/6e/JMNI-17-059.PMC5492320.pdf
67 http://www.ismni.orgW.R.D.,Non-OADS,/arxiv_data1/oa_pdf/22/6e/JMNI-17-059.PMC5492320.pdf
68 http://www.ismni.orgW.R.D.,Non-OADS,/arxiv_data1/oa_pdf/22/6e/JMNI-17-059.PMC5492320.pdf
70 http://www.ismni.orgI.,Non-OADS,/arxiv_data1/oa_pdf/c4/7a/JMNI-17-069.PMC5492321.pdf
71 http://www.ismni.orgI.,Non-OADS,/arxiv_data1/oa_pdf/c4/7a/JMNI-17-069.PMC5492321.pdf
72 http://www.ismni.orgI.,Non-OADS,/arxiv_data1/oa_pdf/c4/7a/JMNI-17-069.PMC5492321.pdf
73 http://www.ismni.orgI.,Non-OADS,/arxiv_data1/oa_pdf/c4/7a/JMNI-17-069.PMC5492321.pdf
74 http://www.ismni.orgI.,Non-OADS,/arxiv_data1/oa_pdf/c4/7a/JMNI-17-069.PMC5492321.pdf
75 http://www.ismni.orgI.,Non-OADS,/arxiv_data1/oa_pdf/c4/7a/JMNI-17-069.PMC5492321.pdf
76 http://www.ismni.orgI.,Non-OADS,/arxiv_data1/oa_pdf/c4/7a/JMNI-17-069.PMC5492321.pdf
77 http://www.ismni.orgI.,Non-OADS,/arxiv_data1/oa_pdf/c4/7a/JMNI-17-069.PMC5492321.pdf
79 http://www.ismni.orgF.,Non-OADS,/arxiv_data1/oa_pdf/48/02/JMNI-17-078.PMC5492322.pdf
80 http://www.ismni.orgF.,Non-OADS,/arxiv_data1/oa_pdf/48/02/JMNI-17-078.PMC5492322.pdf
81 http://www.ismni.orgF.,Non-OADS,/arxiv_data1/oa_pdf/48/02/JMNI-17-078.PMC5492322.pdf
82 http://www.ismni.orgF.,Non-OADS,/arxiv_data1/oa_pdf/48/02/JMNI-17-078.PMC5492322.pdf
83 http://www.ismni.orgF.,Non-OADS,/arxiv_data1/oa_pdf/48/02/JMNI-17-078.PMC5492322.pdf
84 http://www.ismni.orgF.,Non-OADS,/arxiv_data1/oa_pdf/48/02/JMNI-17-078.PMC5492322.pdf
85 http://www.ismni.orgF.,Non-OADS,/arxiv_data1/oa_pdf/48/02/JMNI-17-078.PMC5492322.pdf
87 http://www.ismni.orgU.,Non-OADS,/arxiv_data1/oa_pdf/68/0e/JMNI-17-086.PMC5492323.pdf
88 http://www.ismni.orgU.,Non-OADS,/arxiv_data1/oa_pdf/68/0e/JMNI-17-086.PMC5492323.pdf
89 http://www.ismni.orgU.,Non-OADS,/arxiv_data1/oa_pdf/68/0e/JMNI-17-086.PMC5492323.pdf
90 http://www.ismni.orgU.,Non-OADS,/arxiv_data1/oa_pdf/68/0e/JMNI-17-086.PMC5492323.pdf
91 http://www.ismni.orgU.,Non-OADS,/arxiv_data1/oa_pdf/68/0e/JMNI-17-086.PMC5492323.pdf
92 http://www.ismni.orgU.,Non-OADS,/arxiv_data1/oa_pdf/68/0e/JMNI-17-086.PMC5492323.pdf
93 http://www.ismni.orgU.,Non-OADS,/arxiv_data1/oa_pdf/68/0e/JMNI-17-086.PMC5492323.pdf
94 http://www.ismni.orgU.,Non-OADS,/arxiv_data1/oa_pdf/68/0e/JMNI-17-086.PMC5492323.pdf
95 http://www.ismni.orgU.,Non-OADS,/arxiv_data1/oa_pdf/68/0e/JMNI-17-086.PMC5492323.pdf
96 http://www.ismni.orgU.,Non-OADS,/arxiv_data1/oa_pdf/68/0e/JMNI-17-086.PMC5492323.pdf
105 http://www.ismni.orgH.,Non-OADS,/arxiv_data1/oa_pdf/09/fb/JMNI-17-104.PMC5492325.pdf
106 http://www.ismni.orgH.,Non-OADS,/arxiv_data1/oa_pdf/09/fb/JMNI-17-104.PMC5492325.pdf
107 http://www.ismni.orgH.,Non-OADS,/arxiv_data1/oa_pdf/09/fb/JMNI-17-104.PMC5492325.pdf
109 http://www.ismni.orgJ.,Non-OADS,/arxiv_data1/oa_pdf/ea/fa/JMNI-17-108.PMC5492326.pdf
110 http://www.ismni.orgJ.,Non-OADS,/arxiv_data1/oa_pdf/ea/fa/JMNI-17-108.PMC5492326.pdf
111 http://www.ismni.orgJ.,Non-OADS,/arxiv_data1/oa_pdf/ea/fa/JMNI-17-108.PMC5492326.pdf
112 http://www.ismni.orgJ.,Non-OADS,/arxiv_data1/oa_pdf/ea/fa/JMNI-17-108.PMC5492326.pdf
113 http://www.ismni.orgJ.,Non-OADS,/arxiv_data1/oa_pdf/ea/fa/JMNI-17-108.PMC5492326.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b6/7c/bmjquality.2017.000064.PMC5492467.pdf
Available from: http://www.nrls.npsa.nhs.uk/resources/patient-safety- topics/medication-safety/?entryid45=66720&p=2 4.,Non-OADS,/arxiv_data1/oa_pdf/b6/7c/bmjquality.2017.000064.PMC5492467.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/81/52/bmjquality.2017.000043.PMC5492475.pdf
"See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode 6 Flores CJ, et al.BMJ Quality Improvement Reports 2017; 6:e000009.",Non-OADS,/arxiv_data1/oa_pdf/6d/b5/bmjquality.2017.000009.PMC5492477.pdf
https://www.blood.gov.au/pbm-guidelines (accessed 20 December2016).,Non-OADS,/arxiv_data1/oa_pdf/6d/b5/bmjquality.2017.000009.PMC5492477.pdf
https://www.blood.gov.au/national-product-list (accessed 16 November 2016).,Non-OADS,/arxiv_data1/oa_pdf/6d/b5/bmjquality.2017.000009.PMC5492477.pdf
http://www.pbs.gov.au/ medicine/item/10104T.,Non-OADS,/arxiv_data1/oa_pdf/6d/b5/bmjquality.2017.000009.PMC5492477.pdf
https://www.thermofisher.,Non-OADS,/arxiv_data1/oa_pdf/7a/8e/br-07-01-0017.PMC5492560.pdf
"Envigo RMS Division, i ndianapolis, i N,  2016. http://www.envigo.com/resources/data-sheets/envigo -5193 -131-leaflets -2016 -nude -mouse -combination -a4-refs.pdf.",Non-OADS,/arxiv_data1/oa_pdf/9d/0d/or-38-01-0089.PMC5492638.pdf
DOI: http://dx.doi.org/10.1590/1518-8345.1537.2897.,Non-OADS,/arxiv_data1/oa_pdf/ab/9e/0104-1169-rlae-25-e2897.PMC5492649.pdf
Available from: https://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/ab/9e/0104-1169-rlae-25-e2897.PMC5492649.pdf
Available from:  http://academic-eb-britannica.ez18.periodicos.capes.,Non-OADS,/arxiv_data1/oa_pdf/ab/9e/0104-1169-rlae-25-e2897.PMC5492649.pdf
Available from: https://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/ab/9e/0104-1169-rlae-25-e2897.PMC5492649.pdf
Available from:  http://www.scielo.br/scielo.php?script=sci_arttext&pid =S0034-72802014000100028 5.,Non-OADS,/arxiv_data1/oa_pdf/ab/9e/0104-1169-rlae-25-e2897.PMC5492649.pdf
Available from: https://www.ncbi.nlm.nih.gov/pmc/ articles/PMC4859424/ 6.,Non-OADS,/arxiv_data1/oa_pdf/ab/9e/0104-1169-rlae-25-e2897.PMC5492649.pdf
Available from:  https://www.ncbi.nlm.nih.gov/pubmed/26633035 7.,Non-OADS,/arxiv_data1/oa_pdf/ab/9e/0104-1169-rlae-25-e2897.PMC5492649.pdf
Available from: https://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/ab/9e/0104-1169-rlae-25-e2897.PMC5492649.pdf
Available from:  https://www.ncbi.nlm.nih.gov/pubmed/26266438 9.,Non-OADS,/arxiv_data1/oa_pdf/ab/9e/0104-1169-rlae-25-e2897.PMC5492649.pdf
Available  at:http://www.who.int/mediacentre/factsheets/fs282/en/ 10.,Non-OADS,/arxiv_data1/oa_pdf/ab/9e/0104-1169-rlae-25-e2897.PMC5492649.pdf
Available from: https://www.ncbi.nlm.nih.gov/ pubmed/27413493 13.,Non-OADS,/arxiv_data1/oa_pdf/ab/9e/0104-1169-rlae-25-e2897.PMC5492649.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/ab/9e/0104-1169-rlae-25-e2897.PMC5492649.pdf
Available from: https://www.ncbi.nlm.nih.gov/ pubmed/27635063 15.,Non-OADS,/arxiv_data1/oa_pdf/ab/9e/0104-1169-rlae-25-e2897.PMC5492649.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/ab/9e/0104-1169-rlae-25-e2897.PMC5492649.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/ab/9e/0104-1169-rlae-25-e2897.PMC5492649.pdf
Available from:  http://www.ncbi.nlm.nih.gov/pubmed/25134494 18.,Non-OADS,/arxiv_data1/oa_pdf/ab/9e/0104-1169-rlae-25-e2897.PMC5492649.pdf
Available from: https://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/ab/9e/0104-1169-rlae-25-e2897.PMC5492649.pdf
Available from:  https://www.ncbi.nlm.nih.gov/pubmed/25287818 22.,Non-OADS,/arxiv_data1/oa_pdf/ab/9e/0104-1169-rlae-25-e2897.PMC5492649.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/ab/9e/0104-1169-rlae-25-e2897.PMC5492649.pdf
DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/af/9a/0104-1169-rlae-25-e2903.PMC5492650.pdf
Disponible en: http://www.seom.,Non-OADS,/arxiv_data1/oa_pdf/af/9a/0104-1169-rlae-25-e2903.PMC5492650.pdf
Available from: http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC4366417/pdf/nihms662731.pdf 6.,Non-OADS,/arxiv_data1/oa_pdf/af/9a/0104-1169-rlae-25-e2903.PMC5492650.pdf
Available from: http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC4219945/pdf/kjped-57-434.pdf 7.,Non-OADS,/arxiv_data1/oa_pdf/af/9a/0104-1169-rlae-25-e2903.PMC5492650.pdf
Available from: http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC3168862/pdf/NURSING2011-929868.pdf 11.,Non-OADS,/arxiv_data1/oa_pdf/af/9a/0104-1169-rlae-25-e2903.PMC5492650.pdf
Available from: http://www.jpsmjournal.com/ article/S0885-3924(08)00561-7/fulltext,Non-OADS,/arxiv_data1/oa_pdf/af/9a/0104-1169-rlae-25-e2903.PMC5492650.pdf
Disponible en:  http://www.pedro.org.au/spanish/ downloads/pedro-scale/ 13.,Non-OADS,/arxiv_data1/oa_pdf/af/9a/0104-1169-rlae-25-e2903.PMC5492650.pdf
Available from:  https://www.researchgate.net/profile/Kay_Savik/ publication/23655253_Massage_Therapy_for_Children_ With_Cancer/links/0912f510fe9561c023000000.pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/af/9a/0104-1169-rlae-25-e2903.PMC5492650.pdf
Available from:   http://www.sciencedirect.com/science/article/pii/ S1360859201902281 17.,Non-OADS,/arxiv_data1/oa_pdf/af/9a/0104-1169-rlae-25-e2903.PMC5492650.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/af/9a/0104-1169-rlae-25-e2903.PMC5492650.pdf
Available  from:  http://ac.els-cdn.com/S0021755713001654/1- s2.0-S0021755713001654-main.pdf?_tid=1e3b6362- 54f4-11e6-904d-00000aab0f27&acdnat=1469731993_ b339159ff86ca7340e15330bd8950ac1 19.,Non-OADS,/arxiv_data1/oa_pdf/af/9a/0104-1169-rlae-25-e2903.PMC5492650.pdf
Available from:  http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/af/9a/0104-1169-rlae-25-e2903.PMC5492650.pdf
Available from:  http://www.ctcpjournal.,Non-OADS,/arxiv_data1/oa_pdf/af/9a/0104-1169-rlae-25-e2903.PMC5492650.pdf
Available  from:  http://www.ncbi.nlm.nih.gov/pubmed/20308209 22.,Non-OADS,/arxiv_data1/oa_pdf/af/9a/0104-1169-rlae-25-e2903.PMC5492650.pdf
Available from:  http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC4318475/pdf/main.pdf 23.,Non-OADS,/arxiv_data1/oa_pdf/af/9a/0104-1169-rlae-25-e2903.PMC5492650.pdf
Available from: http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC4109717/pdf/nihms577633.pdf 28.,Non-OADS,/arxiv_data1/oa_pdf/af/9a/0104-1169-rlae-25-e2903.PMC5492650.pdf
Available from: http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC4266937/pdf/nihms597751.pdf 29.,Non-OADS,/arxiv_data1/oa_pdf/af/9a/0104-1169-rlae-25-e2903.PMC5492650.pdf
Available from: http://www.ncbi.nlm.nih.gov/ pmc/articles/PMC3696961 30.,Non-OADS,/arxiv_data1/oa_pdf/af/9a/0104-1169-rlae-25-e2903.PMC5492650.pdf
Available from:  https://www.ncbi.nlm.nih.gov/pubmed/24689780,Non-OADS,/arxiv_data1/oa_pdf/af/9a/0104-1169-rlae-25-e2903.PMC5492650.pdf
DOI: http://dx.doi.org/10.1590/1518-8345.1775.2904.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available from:  http://journals.lww.com/jbisrir/Abstract/2017/01000/ Effectiveness_of_patient_centered_interventions_ on.9.aspx 2.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available from: http://onlinelibrary.wiley.com/ doi/10.1111/psyg.12217/epdf 3.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available  from: http://onlinelibrary.wiley.com/doi/10.1111/ jocn.12278/pdf 4.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available from: http://www.sciencedirect.com/science/ article/pii/S135730391200299X 5.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available from: http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC4461128/ 6.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Disponível em: http://www20.anvisa.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available from: https://www.ncbi.nlm.nih.gov/pmc/ articles/PMC5220428/pdf/BMRI20168612143.pdf 10.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available from:  http://www.sciencedirect.com/science/article/pii/ S0828282X16309801 12.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available from: http://www.scielo.br/ pdf/reben/v68n3/0034-7167-reben-68-03-0445.pdf 14.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Disponível em:  http://www.scielo.br/pdf/anp/v52n1/01.pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available from: http://www.scielo.br/pdf/ rlae/v16n4/16.pdf 16.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available from: http://www.scielo.br/pdf/ape/v29n3/ en_1982-0194-ape-29-03-0253.pdf 18.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available from:  https://www.cambridge.org/ core/journals/canadian-journal-on-aging-la-revue- canadienne-du-vieillissement/article/development- of-a-scale-to-identify-the-fall-prone-patient/ A0CDFA5381DEC8DA4D7E7A1B1A74692E 20.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available from:  https://academic.oup.com/bja/article/84/1/11/266065/ Validity-and-reliability-of-a-postoperative 21.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available from: http://www.aornjournal.org/article/ S0001-2092(10)01307-4/pdf 23.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available from:  http://www.scielo.br/pdf/rgenf/v35n4/1983-1447- rgenf-35-04-00028.pdf 24.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available from:  http://www.sciencedirect.com/science/article/pii/ S1089947216000411,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available from: http://www.scielo.br/pdf/rba/ v66n4/0034-7094-rba-66-04-0369.pdf 27.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available from: http://www.sciencedirect.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available  from: http://onlinelibrary.wiley.com/doi/10.1111/ jocn.13743/epdf 29.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available from: http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC4394325/ 30.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available  from: http://www.ncbi.nlm.nih.gov/pubmed/23769987 31.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available from: http://www.sciencedirect.com/science/ article/pii/S1879406815000995 33.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available from: http://www.scielo.br/ pdf/medical/v1n6/2318-8111-medical-01-06-0291.pdf 34.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available from: http://www.rbmastologia.com.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available  from: http://www.archives-pmr.org/article/S0003- 9993(13)00892-7/pdf 37.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available from: http://onlinelibrary.wiley.com/ doi/10.1002/ejp.917/epdf 38.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available from: http://www.journals.usp.br/rlae/article/ view/85061/87906 39.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Disponível em: http://www.scielo.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available from: http://www.scielo.br/pdf/reeusp/ v44n1/a19v44n1.pdf 42.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Disponível em:  http://www.scielo.br/pdf/rgenf/v33n2/17.pdf,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
Available from: http://www.sciencedirect.com/science/ article/pii/S1543594611001784 45.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/0104-1169-rlae-25-e2904.PMC5492651.pdf
DOI: http://dx.doi.org/10.1590/1518-8345.1516.2909.,Non-OADS,/arxiv_data1/oa_pdf/bc/93/0104-1169-rlae-25-e2909.PMC5492652.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/bc/93/0104-1169-rlae-25-e2909.PMC5492652.pdf
Available from:  http://www.un-documents.net/our-common-future.pdf 4.,Non-OADS,/arxiv_data1/oa_pdf/bc/93/0104-1169-rlae-25-e2909.PMC5492652.pdf
Available from: http://journals.lww.com/ajnonline/ Abstract/2013/04000/Greening_the__Proclamation_ for_Change____Healing.32.aspx.,Non-OADS,/arxiv_data1/oa_pdf/bc/93/0104-1169-rlae-25-e2909.PMC5492652.pdf
Available from:  http://www.scielo.br/scielo.php?script=sci_arttext&pid =S1983-14472011000200018 6.,Non-OADS,/arxiv_data1/oa_pdf/bc/93/0104-1169-rlae-25-e2909.PMC5492652.pdf
Available from:  http://www.sciencedirect.com/science/article/pii/ S0956053X08000238 7.,Non-OADS,/arxiv_data1/oa_pdf/bc/93/0104-1169-rlae-25-e2909.PMC5492652.pdf
Available from: http://www.scielo.br/scielo.php?script=sci_ arttext&pid=S0104-530X2011000400002 Portuguese 12.,Non-OADS,/arxiv_data1/oa_pdf/bc/93/0104-1169-rlae-25-e2909.PMC5492652.pdf
Available from: http://www.scielo.br/scielo.,Non-OADS,/arxiv_data1/oa_pdf/bc/93/0104-1169-rlae-25-e2909.PMC5492652.pdf
Available from: http://jehse.biomedcentral.com/ articles/10.1186/2052-336X-11-20 20.,Non-OADS,/arxiv_data1/oa_pdf/bc/93/0104-1169-rlae-25-e2909.PMC5492652.pdf
DOI: http://dx.doi.org/10.1590/1518-8345.1714.2911.URLday month year,Non-OADS,/arxiv_data1/oa_pdf/43/be/0104-1169-rlae-25-e2911.PMC5492653.pdf
2012; 11:11.  doi:  http://dx.doi.org/10.1186/1472-6955-11-11  2.,Non-OADS,/arxiv_data1/oa_pdf/43/be/0104-1169-rlae-25-e2911.PMC5492653.pdf
2015; 6(1): 879-81. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/be/0104-1169-rlae-25-e2911.PMC5492653.pdf
2014; 32(2): 634-45. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/be/0104-1169-rlae-25-e2911.PMC5492653.pdf
Available from: http://scielo.sld.cu/scielo.php?script=sci_ arttext&pid=S0864-34662015000500008&lng=es.,OADS,/arxiv_data1/oa_pdf/43/be/0104-1169-rlae-25-e2911.PMC5492653.pdf
Available  from: http://www.revista.ufpe.br/revistaenfermagem/ index.php/revista/article/view/7461/pdf_8623  6.,Non-OADS,/arxiv_data1/oa_pdf/43/be/0104-1169-rlae-25-e2911.PMC5492653.pdf
2016; 69(2):307-15. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/be/0104-1169-rlae-25-e2911.PMC5492653.pdf
2016 Jun; 72 (6):  1273-86. doi: http://dx.doi.org/10.1111/jan.12913 8.,OADS,/arxiv_data1/oa_pdf/43/be/0104-1169-rlae-25-e2911.PMC5492653.pdf
doi: http://dx.doi.org/10.1016/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/be/0104-1169-rlae-25-e2911.PMC5492653.pdf
2008; 1(1): 34-9. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/be/0104-1169-rlae-25-e2911.PMC5492653.pdf
2013 Jan  10; 144 (1-2): 94-100. doi: http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/be/0104-1169-rlae-25-e2911.PMC5492653.pdf
2013;22(1-2):60-4. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/be/0104-1169-rlae-25-e2911.PMC5492653.pdf
2016; 5(1): 37-45. doi:  http://dx.doi.org/10.4321/S1699-695X2012000100007 15.,Non-OADS,/arxiv_data1/oa_pdf/43/be/0104-1169-rlae-25-e2911.PMC5492653.pdf
Available from: http://revistas.um.es/ eglobal/article/view/16071  17.,Non-OADS,/arxiv_data1/oa_pdf/43/be/0104-1169-rlae-25-e2911.PMC5492653.pdf
Available from:  http://ene-enfermeria.org/ojs/index.php/ENE/article/ viewFile/156/139  18.,Non-OADS,/arxiv_data1/oa_pdf/43/be/0104-1169-rlae-25-e2911.PMC5492653.pdf
Available from: http://revistas.ufps.edu.co/ojs/ index.php/cienciaycuidado/article/view/246/267  19.,Non-OADS,/arxiv_data1/oa_pdf/43/be/0104-1169-rlae-25-e2911.PMC5492653.pdf
2014;  32(2): 225-35. doi: https://www.ncbi.nlm.nih.gov/ pubmed/25230033 22.,Non-OADS,/arxiv_data1/oa_pdf/43/be/0104-1169-rlae-25-e2911.PMC5492653.pdf
Available  from: http://www.objnursing.uff.br/index.php/nursing/ article/view/5299  23.,Non-OADS,/arxiv_data1/oa_pdf/43/be/0104-1169-rlae-25-e2911.PMC5492653.pdf
Available from: http://www.scielo.,Non-OADS,/arxiv_data1/oa_pdf/43/be/0104-1169-rlae-25-e2911.PMC5492653.pdf
2015; 16(4):461-9. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/be/0104-1169-rlae-25-e2911.PMC5492653.pdf
"2013 Sept/Oct [cited Oct 5, 2016];10(65): Available from:  http://web2014.fuden.es/FICHEROS_ADMINISTRADOR/ ORIGINAL/NURE66_original_gacela.pdf",Non-OADS,/arxiv_data1/oa_pdf/43/be/0104-1169-rlae-25-e2911.PMC5492653.pdf
Guidelines NCCNN: Breast Cancer Version 2.2011 Journal 2015.  https://www.nccn.org/professionals/physician_gls/f_guidelines.asp.,Non-OADS,/arxiv_data1/oa_pdf/78/b0/mco-07-01-0003.PMC5492732.pdf
"For the knockout of PinX1 , three sgRNAs were  designed according to the Feng Zhang Lab at http://crispr.mit.",Non-OADS,/arxiv_data1/oa_pdf/fc/aa/or-38-01-0109.PMC5492774.pdf
"[Epub ahead of print] This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/97/pyx020.PMC5492779.pdf
http://mhlw-grants.niph.go.jp/niph/ search/NIDD00.do?resarchNum=201027094A.,Non-OADS,/arxiv_data1/oa_pdf/7f/97/pyx020.PMC5492779.pdf
"Am J Psychiatry:1–52, http://psychiatryonline.org/guidelines.",Non-OADS,/arxiv_data1/oa_pdf/0e/75/pyx022.PMC5492785.pdf
"In: MicroRNA Cancer Regulation Springer, pp1-20, 2013. http://dx.doi.org/10.1007/978-94-007-5590-1_1.",Non-OADS,/arxiv_data1/oa_pdf/45/8c/or-38-01-0082.PMC5492799.pdf
Available at http://publicationethics.org/files/retrac- tion%20guidelines.pdf.,Non-OADS,/arxiv_data1/oa_pdf/32/6d/pyx013.PMC5492806.pdf
Available at http://mhlw-grants.niph.go.jp/niph/search/NIDD00.do?resrchNum=201027094A.,Non-OADS,/arxiv_data1/oa_pdf/32/6d/pyx013.PMC5492806.pdf
http://legismex.mty.itesm.,Non-OADS,/arxiv_data1/oa_pdf/35/03/br-07-01-0021.PMC5492814.pdf
https://evs.nci.nih.gov/ftp1/CTCAE/Archive/CTCAE_4.02  _2009 -09-15_QuickRef erence_5x7_Locked.pdf.,OADS,/arxiv_data1/oa_pdf/f9/f1/mco-07-01-0024.PMC5492816.pdf
"The qualified clean  reads were mapped and analysed with the ‘small RNA ’ bioin - formatics pipeline from the Thermo Fisher LifeScope version 2.5.1 software (https://www.thermofisher.com/it/en/home/technical-resources/software-downloads/lifescope-genomic-analysis-software.html), using as a target the human genome GRCh38/hg38 and the dataset of mature and precursor miRNA sequences (miRBase, release 21.0) (25).",OADS,/arxiv_data1/oa_pdf/8e/95/or-38-01-0003.PMC5492854.pdf
"For each differentially expressed miRNA, a list of experimentally validated targets was extracted from miRTarBase release 6 (http://mirtarbase.mbc.nctu.edu.tw/) (28).",OADS,/arxiv_data1/oa_pdf/8e/95/or-38-01-0003.PMC5492854.pdf
Promoter regions of the differentially expressed miRNAs in the comparison MNA vs. MNnA were scanned for motifs by FIMO 4.10.2 software (http://meme-suite.org/tools/fimo) (33).,OADS,/arxiv_data1/oa_pdf/8e/95/or-38-01-0003.PMC5492854.pdf
"The 3'UTR  region of the human MYCN gene (3HSAR055440 derived from http://utrdb.ba.itb.cnr.it/) was amplified from genomic DNA using a proof reading Phusion High-Fidelity PCR M aster  Mix (Finnzymes, Espoo, Finland) with the following primers:",Non-OADS,/arxiv_data1/oa_pdf/8e/95/or-38-01-0003.PMC5492854.pdf
"Creative Commons At- tribution Non-Commercial No Derivatives 4.0 License: https://creativecommons.org/licenses/by-nc-nd/4.0/ INTRODUCTION Urothelial carcinoma of the bladder is a leading cause of cancer deaths worldwide, with an esti- mated 429,800 new cases reported in 2012.1Pa- tients with metastatic urothelial carcinoma are typically treated with cisplatin-based combina- tion chemotherapy in the ﬁrst-line setting, with a median overall survival (OS) of 14 to 15 months.2,3 Prognostic factors associated with shorter OSinclude poor performance status, visceral metas- tasis, and low albumin or hemoglobin level.4 Second-line chemotherapies, such as paclitaxel, pemetrexed, docetaxel, and vin ﬂunine, have lim- ited ef ﬁcacy, with median survival of approxi- mately 7 months.5-8 Immunotherapy with immune checkpoint inhibitors, particularly agents targeting the pro-grammed death-ligand 1/programmed death-1(PD-L1/PD-1) axis, has improved treatment out-comes in several tumor types.",Non-OADS,/arxiv_data1/oa_pdf/86/56/JCO.2016.71.6795.PMC5493051.pdf
=$ 0732-183X/17/3519w-2117w/$20.00 ASSOCIATED CONTENT See accompanying Oncology Grand Rounds on page 2109 Data Supplement DOI: https://doi.org/10.1200/JCO.,Non-OADS,/arxiv_data1/oa_pdf/86/56/JCO.2016.71.6795.PMC5493051.pdf
2016.71.6795 DOI: https://doi.org/10.1200/JCO.2016.,OADS,/arxiv_data1/oa_pdf/86/56/JCO.2016.71.6795.PMC5493051.pdf
"Lyon, France: International Agency for Research onCancer, 2016. http://gco.iarc.fr/today 2.Kaufman D, Raghavan D, Carducci M, et al: Phase II trial of gemcitabine plus cisplatin in patientswith metastatic urothelial cancer.",Non-OADS,/arxiv_data1/oa_pdf/86/56/JCO.2016.71.6795.PMC5493051.pdf
"MeSH Keywords:  Breast • Neoplastic Cells, Circulating • Triple Negative Breast Neoplasms  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/902637Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection GDepartment of Breast Surgery, The Third Affiliated Hospital of Zhengzhou  University, Zhengzhou, Henan, P.R.",Non-OADS,/arxiv_data1/oa_pdf/57/31/medscimonit-23-3071.PMC5493060.pdf
"MeSH Keywords:  Acupuncture • Depressive Disorder • Excitatory Amino Acid Transporter 2  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/902549Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 The Second Clinical College, Guangzhou University of Traditional Chinese  Medicine, Guangzhou, Guangdong, P.R.",Non-OADS,/arxiv_data1/oa_pdf/f9/cb/medscimonit-23-3080.PMC5493061.pdf
"MeSH Keywords:  Diarrhea, Infantile • Intestinal Obstruction • Polyhydramnios  Full-text PDF: http://www.amjcaserep.com/abstract/index/idArt/903433Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection GShizuoka Children’s Hospital, Perinatal Medical Center, Shizuoka, JapanISSN 1941-5923 © Am J Case Rep, 2017; 18: 707-713 DOI: 10.12659/AJCR.903433 707 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/e9/42/amjcaserep-18-707.PMC5493062.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creative - commons.org/licenses/by/4.0/) which permits users to read, download, copy, distribute, print, search, or link to the full texts of these articles in any medium or format and to remix, transform and build upon  the material, provided the original work is properly cited and any changes properly indicated  .Biochemia Medica 2017;27(2):430–3  https://doi.org/10.11613/BM.2017.047  430Abstract We report on a preanalytical issue we encountered during routine clinical chemistry analyses, potentially leading to deviated analysis results and  believe that it might help other laboratories to overcome similar problems.",Non-OADS,/arxiv_data1/oa_pdf/f2/aa/bm-27-430.PMC5493160.pdf
https://doi.org/10.11613/BM.2017.047 Biochemia Medica 2017;27(2):430–3    431 Cadamuro J. et al.,OADS,/arxiv_data1/oa_pdf/f2/aa/bm-27-430.PMC5493160.pdf
Biochemia Medica 2017;27(2): 430–3  https://doi.org/10.11613/BM.2017.047  432 Cadamuro J. et al.,OADS,/arxiv_data1/oa_pdf/f2/aa/bm-27-430.PMC5493160.pdf
https://doi.org/10.11613/BM.2017.047 Biochemia Medica 2017;27(2):430–3    433 Cadamuro J. et al.,OADS,/arxiv_data1/oa_pdf/f2/aa/bm-27-430.PMC5493160.pdf
Tran-sfusion 2004;44:977-83. https://doi.org/10.1111/j.1537-2995.2004.04036.x.,Non-OADS,/arxiv_data1/oa_pdf/f2/aa/bm-27-430.PMC5493160.pdf
Transfusion 2004;44:967-72. https://doi.org/10.1111/j.1537-2995.2004.03319.x.,Non-OADS,/arxiv_data1/oa_pdf/f2/aa/bm-27-430.PMC5493160.pdf
Transfusion 2004;44:1112-8. https://doi.org/10.1111/j.1537-2995.2004.04098.x.,Non-OADS,/arxiv_data1/oa_pdf/f2/aa/bm-27-430.PMC5493160.pdf
Tran-sfusion 2004;44:959-66. https://doi.org/10.1111/j.1537-2995.2004.03398.x.,Non-OADS,/arxiv_data1/oa_pdf/f2/aa/bm-27-430.PMC5493160.pdf
Asian J Transfus Sci 2011;5:175-6. https://doi.org/10.4103/0973-6247.83247.,Non-OADS,/arxiv_data1/oa_pdf/f2/aa/bm-27-430.PMC5493160.pdf
Clin Chem 2004;50:2391-2. https://doi.org/10.1373/clinchem.2004.039248.,Non-OADS,/arxiv_data1/oa_pdf/f2/aa/bm-27-430.PMC5493160.pdf
Transfusion 2005;45:1127-32. https://doi.org/10.1111/j.1537-2995.2005.04351.x.,Non-OADS,/arxiv_data1/oa_pdf/f2/aa/bm-27-430.PMC5493160.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creative - commons.org/licenses/by/4.0/) which permits users to read, download, copy, distribute, print, search, or link to the full texts of these articles in any medium or format and to remix, transform and build upon  the material, provided the original work is properly cited and any changes properly indicated  .Biochemia Medica 2017;27(2):342–9  https://doi.org/10.11613/BM.2017.037  342Abstract Background : For a quicker delivery of laboratory test results to the hospital emergency department (ED), we implemented an autoverification  system based on the reference change value (RCV).",Non-OADS,/arxiv_data1/oa_pdf/02/6c/bm-27-342.PMC5493162.pdf
https://doi.org/10.11613/BM.2017.037 Biochemia Medica 2017;27(2):342–9    343 Fernández-Grande E. et al.,Non-OADS,/arxiv_data1/oa_pdf/02/6c/bm-27-342.PMC5493162.pdf
Biochemia Medica 2017;27(2): 342–9  https://doi.org/10.11613/BM.2017.037  344 Fernández-Grande E. et al.,Non-OADS,/arxiv_data1/oa_pdf/02/6c/bm-27-342.PMC5493162.pdf
https://doi.org/10.11613/BM.2017.037 Biochemia Medica 2017;27(2):342–9    345 Fernández-Grande E. et al.,Non-OADS,/arxiv_data1/oa_pdf/02/6c/bm-27-342.PMC5493162.pdf
Biochemia Medica 2017;27(2): 342–9  https://doi.org/10.11613/BM.2017.037  346 Fernández-Grande E. et al.,Non-OADS,/arxiv_data1/oa_pdf/02/6c/bm-27-342.PMC5493162.pdf
https://doi.org/10.11613/BM.2017.037 Biochemia Medica 2017;27(2):342–9    347 Fernández-Grande E. et al.,Non-OADS,/arxiv_data1/oa_pdf/02/6c/bm-27-342.PMC5493162.pdf
Biochemia Medica 2017;27(2): 342–9  https://doi.org/10.11613/BM.2017.037  348 Fernández-Grande E. et al.,Non-OADS,/arxiv_data1/oa_pdf/02/6c/bm-27-342.PMC5493162.pdf
https://doi.org/10.11613/BM.2017.037 Biochemia Medica 2017;27(2):342–9    349 Fernández-Grande E. et al.,Non-OADS,/arxiv_data1/oa_pdf/02/6c/bm-27-342.PMC5493162.pdf
Ann Emerg  Med 2008;52(2):126-36. https://doi.org/10.1016/j.anne - mergmed.2008.03.014  2.,Non-OADS,/arxiv_data1/oa_pdf/02/6c/bm-27-342.PMC5493162.pdf
Emerg  Med J 2012;29:437-43. https://doi.org/10.1136/emer - med-2011-200532  3.,Non-OADS,/arxiv_data1/oa_pdf/02/6c/bm-27-342.PMC5493162.pdf
(in Spanish) https://doi.org/10.1016/S0025-7753(01)71734-4  5.,Non-OADS,/arxiv_data1/oa_pdf/02/6c/bm-27-342.PMC5493162.pdf
https://doi.org/10.1016/j.annemergmed.2005.06.013  6.,OADS,/arxiv_data1/oa_pdf/02/6c/bm-27-342.PMC5493162.pdf
Ann Emerg Med  2002;39:430-2. https://doi.org/10.1067/mem.2002.122707  8.,Non-OADS,/arxiv_data1/oa_pdf/02/6c/bm-27-342.PMC5493162.pdf
Am J Clin Pathol 2006;125:765-70. https://doi.org/10.1309/3J5P9VJRUP4U5RU5 11.,Non-OADS,/arxiv_data1/oa_pdf/02/6c/bm-27-342.PMC5493162.pdf
Clin Chem 2005;51:2406-8. https://doi.org/10.1373/clinchem.2005.054395 12.,Non-OADS,/arxiv_data1/oa_pdf/02/6c/bm-27-342.PMC5493162.pdf
J Pathol Inform 2014;5:13. https://doi.org/10.4103/2153-3539.129450 13.,Non-OADS,/arxiv_data1/oa_pdf/02/6c/bm-27-342.PMC5493162.pdf
Clin Chem Lab Med 2012;50:961. https://doi.org/10.1515/cclm.2011.82715.,Non-OADS,/arxiv_data1/oa_pdf/02/6c/bm-27-342.PMC5493162.pdf
Clin Biochem 2008;41:1265.  https://doi.org/10.1016/j.clinbiochem.2008.08.009.,OADS,/arxiv_data1/oa_pdf/02/6c/bm-27-342.PMC5493162.pdf
Clin Lab 2014;60:143-50. https://doi.org/10.7754/Clin.Lab.2013.130109.,Non-OADS,/arxiv_data1/oa_pdf/02/6c/bm-27-342.PMC5493162.pdf
http://www.we - stgard.com/biodatabase-2012-update.htm.,OADS,/arxiv_data1/oa_pdf/02/6c/bm-27-342.PMC5493162.pdf
Am J Clin Pathol 2013;140:193-202. https://doi.org/10.1309/ AJCPNUTIPQTRRG0D 23.,Non-OADS,/arxiv_data1/oa_pdf/02/6c/bm-27-342.PMC5493162.pdf
Scand J Clin Lab Invest 2016;76:500-502. https://doi.org/10.1080/00365513.2016.1200135 24.,Non-OADS,/arxiv_data1/oa_pdf/02/6c/bm-27-342.PMC5493162.pdf
Clin Chem Lab Med 2009;47:1355-60. https://doi.org/10.1515/CCLM.2009.316 26.,Non-OADS,/arxiv_data1/oa_pdf/02/6c/bm-27-342.PMC5493162.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creative - commons.org/licenses/by/4.0/) which permits users to read, download, copy, distribute, print, search, or link to the full texts of these articles in any medium or format and to remix, transform and build upon  the material, provided the original work is properly cited and any changes properly indicated  .Biochemia Medica 2017;27(2):292–9  https://doi.org/10.11613/BM.2017.032  292Abstract Introduction : We approach the problem of ""predatory"" journals and publishers from the perspective of small scientific communities and small  journals that may sometimes be perceived as ""predatory"".",Non-OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
"https://doi.org/10.11613/BM.2017.032 Biochemia Medica 2017;27(2):292–9    293 Stojanovski J, Marusic A.",OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
"Biochemia Medica 2017;27(2): 292–9  https://doi.org/10.11613/BM.2017.032  294 Stojanovski J, Marusic A.",Non-OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
"The most popular blacklist of alleg - edly “predatory” publishers and journals, main - tained by Jeffrey Beall at http://scholarlyoa.org, was closed recently (18).",Non-OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
"https://doi.org/10.11613/BM.2017.032 Biochemia Medica 2017;27(2):292–9    295 Stojanovski J, Marusic A.",OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
Methods To investigate the transparency of editorial poli - cies in Croatian open access journals we first iden - tified 444 journals on the Croatian Repository of Open Access journals Hrčak  (http://hrcak.srce.hr ).,Non-OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
The data on government financial support were taken from the Ministry of Science and Education web site ( http://public.mzos.hr/De - fault.aspx?art=15180&sec=3804 ) and all other data  were collected from the Hrčak  repository.,OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
"Biochemia Medica 2017;27(2): 292–9  https://doi.org/10.11613/BM.2017.032  296 Stojanovski J, Marusic A.",OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
"https://doi.org/10.11613/BM.2017.032 Biochemia Medica 2017;27(2):292–9    297 Stojanovski J, Marusic A.",OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
"Biochemia Medica 2017;27(2): 292–9  https://doi.org/10.11613/BM.2017.032  298 Stojanovski J, Marusic A.",Non-OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
https://doi.org/10.1087/20100308  3.,Non-OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
Ava- ilable at: http://digitalcommons.unl.edu/cgi/viewcontent.,Non-OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
https://doi.org/10.1371/journal.pone.0127502  5.,Non-OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
Nature 2016;533:452-4. https://doi.org/10.1038/533452a  6.,Non-OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
Frontiers in Neuroscience 2015;9:1-18. https://doi.org/10.3389/fnins.2015.00169  7.,Non-OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
F1000Re - search 2016;5:632. https://doi.org/10.12688/f1000resear - ch.8460.3  8.,Non-OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
Available at: https://www.fosteropens - cience.eu/.,Non-OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
BMC Medicine 2013;10:73. https://doi.org/10.1186/1741-7015-10-73 11.,Non-OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
J Assoc Inf Sci Tech-nol 2012;63:1496-1504. https://doi.org/10.1002/asi.22709 12.,Non-OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
"BMC Medicine 2015,13:230. https://doi.org/10.1186/s12916-015-0469-2 14.",Non-OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
Nature 2012;489:179. https://doi.org/10.1038/489179a 15.,Non-OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
J Libr Sch Commun 2014;2:1-11. https://doi.org/10.7710/2162-3309.1133 16.,Non-OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
"https://doi.org/10.11613/BM.2017.032 Biochemia Medica 2017;27(2):292–9    299 Stojanovski J, Marusic A.",Non-OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
Available at: http://www.editage.com/insights/bealls-list-of-predatory-publishers-and-journals-no-longer- available.,Non-OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
Available at: https://doaj.org/.,Non-OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
Learned Publishing 2009;22:263-73. https://doi.org/10.1087/20090402 24.,Non-OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
Available at: http://hrcak.srce.hr.,Non-OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
Available at: http://oaspa.org/principles-of-transparency-and-best-practice-in-scholarly-publishing/.,Non-OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
Wien Klin Wochenschr 2009;121:256-61. https://doi.org/10.1007/s00508-009-1148-0 28.,Non-OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
Biochem Med (Zagreb) 2015;25:12-21. https://doi.org/10.11613/BM.2015.002 29.,Non-OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
Front Comput Neurosci 2012;6:1-18. https://doi.org/10.3389/fncom.2012.00079 31.,Non-OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
Available at: https://zenodo.org/re - cord/19739#.WOpuL4iGMdV.,Non-OADS,/arxiv_data1/oa_pdf/60/7b/bm-27-292.PMC5493163.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creative - commons.org/licenses/by/4.0/) which permits users to read, download, copy, distribute, print, search, or link to the full texts of these articles in any medium or format and to remix, transform and build upon  the material, provided the original work is properly cited and any changes properly indicated  .Biochemia Medica 2017;27(2):426–9  https://doi.org/10.11613/BM.2017.046  426Abstract The case presented highlights a common pre-analytical problem identified in the laboratory that was initially missed.",Non-OADS,/arxiv_data1/oa_pdf/46/b5/bm-27-426.PMC5493164.pdf
"https://doi.org/10.11613/BM.2017.046 Biochemia Medica 2017;27(2):426–9    427 Cornes M. Unexpected hypocalcaemia in a haemolysed sampleience associated with coming to have repeat tests  performed to confirm, or disprove the original re - sult.",Non-OADS,/arxiv_data1/oa_pdf/46/b5/bm-27-426.PMC5493164.pdf
Biochemia Medica 2017;27(2): 426–9  https://doi.org/10.11613/BM.2017.046  428 Cornes M. Unexpected hypocalcaemia in a haemolysed sample•	the cost of bringing a patient in to be re-bled  was unnecessary and a waste of resources •	other patients were made to wait while this pa - tient was seen unnecessarily.,Non-OADS,/arxiv_data1/oa_pdf/46/b5/bm-27-426.PMC5493164.pdf
https://doi.org/10.11613/BM.2017.046 Biochemia Medica 2017;27(2):426–9    429 Cornes M. Unexpected hypocalcaemia in a haemolysed sample•	Contamination (or other interferences) should  always be considered if a result does not fit with the clinical picture.,Non-OADS,/arxiv_data1/oa_pdf/46/b5/bm-27-426.PMC5493164.pdf
Clin Chem Lab Med 2015;53:1321-31.  https://doi.org/10.1515/cclm-2014-1053  2.,Non-OADS,/arxiv_data1/oa_pdf/46/b5/bm-27-426.PMC5493164.pdf
Scand J Clin Lab Invest 2017;77:153-63. https://doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/46/b5/bm-27-426.PMC5493164.pdf
J Clin Pathol 2011;64:1019-20. https://doi.org/10.1136/jclin-path-2011-200206  5.,Non-OADS,/arxiv_data1/oa_pdf/46/b5/bm-27-426.PMC5493164.pdf
Clin Chem Lab Med 2013;51:2281-5. https://doi.org/10.1515/cclm-2013-0412  6.,Non-OADS,/arxiv_data1/oa_pdf/46/b5/bm-27-426.PMC5493164.pdf
Clin Chem Lab Med 2017;55:27-31. https://doi.org/10.1515/cclm-2016-0426  7.,Non-OADS,/arxiv_data1/oa_pdf/46/b5/bm-27-426.PMC5493164.pdf
https://doi.org/10.1111/j.1742- 1241.2008.01981.x 9.,Non-OADS,/arxiv_data1/oa_pdf/46/b5/bm-27-426.PMC5493164.pdf
2014;24(3):359-67.  https://doi.org/10.11613/BM.2014.038 11.,Non-OADS,/arxiv_data1/oa_pdf/46/b5/bm-27-426.PMC5493164.pdf
Int J Lab Hematol 2015;37:403-9. https://doi.org/10.1111/ijlh.12301 13.,Non-OADS,/arxiv_data1/oa_pdf/46/b5/bm-27-426.PMC5493164.pdf
Clin Biochem 2016;49:1340-1345. https://doi.org/10.1016/j.clinbiochem.2016.09.014 14.,OADS,/arxiv_data1/oa_pdf/46/b5/bm-27-426.PMC5493164.pdf
Ann Clin Biochem 2007;44:294-6. https://doi.org/10.1258/000456307780480846 16.,Non-OADS,/arxiv_data1/oa_pdf/46/b5/bm-27-426.PMC5493164.pdf
Clin Chim Acta  2011;412:1-6. https://doi.org/10.1016/j.cca.2010.08.028 17.,OADS,/arxiv_data1/oa_pdf/46/b5/bm-27-426.PMC5493164.pdf
https://doi.org/10.1016/j.clinbiochem.2017.02.001.,OADS,/arxiv_data1/oa_pdf/46/b5/bm-27-426.PMC5493164.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creative - commons.org/licenses/by/4.0/) which permits users to read, download, copy, distribute, print, search, or link to the full texts of these articles in any medium or format and to remix, transform and build upon  the material, provided the original work is properly cited and any changes properly indicated  .https://doi.org/10.11613/BM.2017.027 Biochemia Medica 2017;27(2):259–69    259Abstract Introduction : Despite increased visibility of clinical trials through international trial registries, patients often remain uninformed of their existence,  especially if they do not have access to adequate information about clinical research, including the language of the information.",Non-OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
Biochemia Medica 2017;27(2):259–69  https://doi.org/10.11613/BM.2017.027  260 Šolić I. et.,Non-OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
"Materials and methods Study design Data sources  To identify the availability of information on clini - cal trials in Croatia, we searched the web-sites of  the Ministry of Health ( https://zdravlje.gov.hr/ ),  which is a regulatory competent authority for the approval of clinical trials, and the Agency for Me - dicinal Products and Medical Devices ( http://www.",OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
https://doi.org/10.11613/BM.2017.027 Biochemia Medica 2017;27(2):259–69    261 Šolić I. et.,OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
"Transparency of clinical trialsister of the European Medicines Agency ( https:// www.clinicaltrialsregister.eu/ctr-search/search ),  which registers interventional clinical trials on  medicines conducted in the European Union (EU) and the European Economic Area (EEA) since 2004, and ClinicalTrials.gov ( https://clinicaltrials.gov/ct2/ home ), which is a registry and results database of  clinical studies and is hosted by the National Li - brary of Medicine.",Non-OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
Biochemia Medica 2017;27(2):259–69  https://doi.org/10.11613/BM.2017.027  262 Šolić I. et.,Non-OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
https://doi.org/10.11613/BM.2017.027 Biochemia Medica 2017;27(2):259–69    263 Šolić I. et.,OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
Biochemia Medica 2017;27(2):259–69  https://doi.org/10.11613/BM.2017.027  264 Šolić I. et.,Non-OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
https://doi.org/10.11613/BM.2017.027 Biochemia Medica 2017;27(2):259–69    265 Šolić I. et.,OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
Biochemia Medica 2017;27(2):259–69  https://doi.org/10.11613/BM.2017.027  266 Šolić I. et.,Non-OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
https://doi.org/10.11613/BM.2017.027 Biochemia Medica 2017;27(2):259–69    267 Šolić I. et.,OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
Biochemia Medica 2017;27(2):259–69  https://doi.org/10.11613/BM.2017.027  268 Šolić I. et.,Non-OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
Biochem Med (Zagreb)  2013;23:12-5. https://doi.org/10.11613/BM.2013.003  2.,Non-OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
N Engl J Med 2004;351:1250-1. https://doi.org/10.1056/NEJMe048225  4. International Committee of Medical Journal Editors.,Non-OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
Available at: http://www.icmje.org/news-and-editorials/M15-2928-PAP .pdf.,Non-OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
N Engl J Med 2016;375:1998-2004. https://doi.org/10.1056/NEJMsr1611785  6.,Non-OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
Available at: http://www.ema.europa.eu/ema/in-dex.jsp?curl=pages/special_topics/general/general_con-tent_000555.jsp&mid=WC0b01ac05809f363e.,Non-OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
J Cancer Educ 2015;30:655-9. https://doi.org/10.1007/s13187-015-0797-0  8.,Non-OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
Available at: https://www.nap.edu/catalog/23530/strategies-for-ensuring-diversity-inclu-sion-and-meaningful-participation-in-clinical-trials.,Non-OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
Available at: http://cro.rbhs.ru-tgers.edu/documents/clinical_trials_recruitment_and_en-rollment.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
Cli-nics (Sao Paulo) 2012;67:603-8. https://doi.org/10.6061/cli-nics/2012(06)10 12.,Non-OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
https://doi.org/10.1097/ JTO.0b013e318031cdb6 13.,Non-OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
JAMA 2004;292:1593-601. https://doi.org/10.1001/jama.292.13.1593 14.,Non-OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
https://doi.org/10.11613/BM.2017.027 Biochemia Medica 2017;27(2):259–69    269 Šolić I. et.,Non-OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
https://doi.org/10.1097/NCC.0b013e31820254db 16.,Non-OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
Available at: http://www.hcjz.hr/index.php/hcjz/ar - ticle/view/807/773.,Non-OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
Biochem Med (Zagreb) 2013;23:316-20. https://doi.org/10.11613/BM.2013.038 18.,Non-OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
Available at:  http://www.who.int/ictrp/network/primary/en/.,OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
Available at: http://www.efgcp.eu/EFGCPReports.asp?L1=5&L2=1 Acce - ssed January 16th 2017.,Non-OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
Available at: http://narodne-novine.nn.hr/clanci/sluzbe - ni/2015_03_25_534.html.,Non-OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
Available at: https://zdravlje.gov.hr/o-ministarstvu/djelokrug-1297/lijekovi-i-medicinski-proizvodi-1349/1349.,Non-OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
https://doi.org/10.2196/jmir.4127 25.,Non-OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
Available at: https://clinicaltrials.gov/ct2/about-site/history.,Non-OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
Available at: http://www.who.int/ictrp/network/trds/en/.,OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
BMC Med Res Methodol 2015;15:18. https://doi.org/10.1186/s12874-015-0012-3,Non-OADS,/arxiv_data1/oa_pdf/c1/3e/bm-27-259.PMC5493165.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creative - commons.org/licenses/by/4.0/) which permits users to read, download, copy, distribute, print, search, or link to the full texts of these articles in any medium or format and to remix, transform and build upon  the material, provided the original work is properly cited and any changes properly indicated  .https://doi.org/10.11613/BM.2017.035 Biochemia Medica 2017;27(2):325–31    325Abstract Introduction : Scuba diving represents a combination of exercise and changes in environmental conditions.",Non-OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
Biochemia Medica 2017;27(2): 325–31  https://doi.org/10.11613/BM.2017.035  326 Perovic A. et al.,Non-OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
https://doi.org/10.11613/BM.2017.035 Biochemia Medica 2017;27(2):325–31    327 Perovic A. et al.,OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
Biochemia Medica 2017;27(2): 325–31  https://doi.org/10.11613/BM.2017.035  328 Perovic A. et al.,Non-OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
https://doi.org/10.11613/BM.2017.035 Biochemia Medica 2017;27(2):325–31    329 Perovic A. et al.,OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
Biochemia Medica 2017;27(2): 325–31  https://doi.org/10.11613/BM.2017.035  330 Perovic A. et al.,Non-OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
https://doi.org/10.11613/BM.2017.035 Biochemia Medica 2017;27(2):325–31    331 Perovic A. et al.,OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
Available at:  http://history.cmas.org/the-history-of-cmas.,Non-OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
Clin Lab Hae - matol 2002;24:197-204. https://doi.org/10.1046/j.1365-2257.2002.00455.x  5.,Non-OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
Clin  Chem Lab Med 2006;44:358-65. https://doi.org/10.1515/ CCLM.2006.073  6.,Non-OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
Sports Med 1988;5:41- 56. https://doi.org/10.2165/00007256-198805010-00004   7.,Non-OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
Biochem Med (Zagreb) 2014;24:68- 79. https://doi.org/10.11613/BM.2014.009  8.,Non-OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
Exp Biol Med 2008;233:1181-8. https://doi.org/10.3181/0801-RM-28  9.,Non-OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
Int J Sports Med 2012;33:531-6. https://doi.org/10.1055/s-0031-1297957 10.,Non-OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
Free Radic Res 2007;41:274-81. https://doi.org/10.1080/10715760601080371 11.,Non-OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
Med  Sci Sports Exerc 2009;41:1271-6. https://doi.org/10.1249/ MSS.0b013e3181951069 12.,Non-OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
Biochem Med (Zagreb) 2013;23:242-54. https://doi.org/10.11613/BM.2013.031 13.,Non-OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
Available at: https://www.westgard.com/biodatabase-2014-update.htm.,OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
Biochem Med (Zagreb) 2012;22:15-23. https://doi.org/10.11613/BM.2012.003  15.,Non-OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
Life Sci 2002;70:2721-34. https://doi.org/10.1016/S0024-3205(02)01537-0 16.,OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
Biochem Med (Zagreb) 2011;21:71-8. https://doi.org/10.11613/BM.2011.014 19.,Non-OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
Immunol Cell Biol 2000;78:496-501. https://doi.org/10.1111/j.1440-1711.2000.t01-5-.x 21.,Non-OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
Free Radic Res 2005;39:1317-24. https://doi.org/10.1080/10715760500177500 22.,Non-OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
Sao Paulo Med J 2003;121:9-14. https://doi.org/10.1590/S1516-31802003000100003 23.,Non-OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
Clin Physi-ol Funct Imaging 2010;30:432-8. https://doi.org/10.1111/j.1475-097X.2010.00962.x 24.,Non-OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
Eur J Appl Physiol 2012;112:2131-7. https://doi.org/10.1007/s00421-011-2187-6 25.,Non-OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
Eur J Appl  Physiol 2013;113:2637-45. https://doi.org/10.1007/s00421- 013-2676-x 26.,Non-OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
Physiol Geno - mics 2014;46:647-54. https://doi.org/10.1152/physiolgeno - mics.00028.2014 27.,Non-OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
Clin Chim Acta 2001;306:119-26. https://doi.org/10.1016/S0009-8981(01)00406-5 28.,Non-OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
Clin Biochem 2015;48:85-8. https://doi.org/10.1016/j.clinbiochem.2014.10.005,OADS,/arxiv_data1/oa_pdf/68/ce/bm-27-325.PMC5493166.pdf
"Key words : analysis of variance; biostatistics; measurement comparisons Received: October 28, 2016 Accepted: April 4, 2017Resolution of Students t-tests, ANOVA and analysis of variance components  from intermediary data Kallner Anders* Department of Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden *Corresponding author: Anders.Kallner@ki.se https://doi.org/10.11613/BM.2017.026 Biochemia Medica 2017;27(2):253–8    253Lessons in biostatistics Introduction Comparison of results from different experimental  designs, between instruments and between meth - ods is an everyday task in analytical chemistry and its applied sciences, e.g.",OADS,/arxiv_data1/oa_pdf/76/f7/bm-27-253.PMC5493167.pdf
Biochemia Medica 2017;27(2):253–8  https://doi.org/10.11613/BM.2017.026  254 Kallner A.,Non-OADS,/arxiv_data1/oa_pdf/76/f7/bm-27-253.PMC5493167.pdf
https://doi.org/10.11613/BM.2017.026 Biochemia Medica 2017;27(2):253–8    255 Kallner A.,Non-OADS,/arxiv_data1/oa_pdf/76/f7/bm-27-253.PMC5493167.pdf
Biochemia Medica 2017;27(2):253–8  https://doi.org/10.11613/BM.2017.026  256 Kallner A.,Non-OADS,/arxiv_data1/oa_pdf/76/f7/bm-27-253.PMC5493167.pdf
https://doi.org/10.11613/BM.2017.026 Biochemia Medica 2017;27(2):253–8    257 Kallner A.,Non-OADS,/arxiv_data1/oa_pdf/76/f7/bm-27-253.PMC5493167.pdf
Biochemia Medica 2017;27(2):253–8  https://doi.org/10.11613/BM.2017.026  258 Kallner A.,Non-OADS,/arxiv_data1/oa_pdf/76/f7/bm-27-253.PMC5493167.pdf
NIST/SEMATECH e-Handbook of Statistical Methods Availa- ble at: http://www.itl.nist.gov/div898/handbook/prc/secti-on4/prc44.htm.,Non-OADS,/arxiv_data1/oa_pdf/76/f7/bm-27-253.PMC5493167.pdf
Available at https://egret.psychol.cam.ac.uk/psychology/graduate/Guide_to_ANOVA.pdf.,Non-OADS,/arxiv_data1/oa_pdf/76/f7/bm-27-253.PMC5493167.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creative - commons.org/licenses/by/4.0/) which permits users to read, download, copy, distribute, print, search, or link to the full texts of these articles in any medium or format and to remix, transform and build upon  the material, provided the original work is properly cited and any changes properly indicated  .https://doi.org/10.11613/BM.2017.040 Biochemia Medica 2017;27(2):387–97    387Abstract Introduction : Thalassemia screening program has been implemented for years in Southeast Asia, but no external quality assessment program has  been established.",Non-OADS,/arxiv_data1/oa_pdf/e6/2f/bm-27-387.PMC5493168.pdf
Biochemia Medica 2017;27(2): 387–97  https://doi.org/10.11613/BM.2017.040  388 Prommetta S. et al.,Non-OADS,/arxiv_data1/oa_pdf/e6/2f/bm-27-387.PMC5493168.pdf
https://doi.org/10.11613/BM.2017.040 Biochemia Medica 2017;27(2):387–97    389 Prommetta S. et al.,Non-OADS,/arxiv_data1/oa_pdf/e6/2f/bm-27-387.PMC5493168.pdf
Biochemia Medica 2017;27(2): 387–97  https://doi.org/10.11613/BM.2017.040  390 Prommetta S. et al.,OADS,/arxiv_data1/oa_pdf/e6/2f/bm-27-387.PMC5493168.pdf
https://doi.org/10.11613/BM.2017.040 Biochemia Medica 2017;27(2):387–97    391 Prommetta S. et al.,Non-OADS,/arxiv_data1/oa_pdf/e6/2f/bm-27-387.PMC5493168.pdf
Biochemia Medica 2017;27(2): 387–97  https://doi.org/10.11613/BM.2017.040  392 Prommetta S. et al.,Non-OADS,/arxiv_data1/oa_pdf/e6/2f/bm-27-387.PMC5493168.pdf
https://doi.org/10.11613/BM.2017.040 Biochemia Medica 2017;27(2):387–97    393 Prommetta S. et al.,Non-OADS,/arxiv_data1/oa_pdf/e6/2f/bm-27-387.PMC5493168.pdf
Biochemia Medica 2017;27(2): 387–97  https://doi.org/10.11613/BM.2017.040  394 Prommetta S. et al.,Non-OADS,/arxiv_data1/oa_pdf/e6/2f/bm-27-387.PMC5493168.pdf
https://doi.org/10.11613/BM.2017.040 Biochemia Medica 2017;27(2):387–97    395 Prommetta S. et al.,Non-OADS,/arxiv_data1/oa_pdf/e6/2f/bm-27-387.PMC5493168.pdf
Biochemia Medica 2017;27(2): 387–97  https://doi.org/10.11613/BM.2017.040  396 Prommetta S. et al.,Non-OADS,/arxiv_data1/oa_pdf/e6/2f/bm-27-387.PMC5493168.pdf
https://doi.org/10.1101/cshperspect.a011692  2.,Non-OADS,/arxiv_data1/oa_pdf/e6/2f/bm-27-387.PMC5493168.pdf
Hematol Oncol  Clin North Am 2016;30:359-71. https://doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/e6/2f/bm-27-387.PMC5493168.pdf
Prenat Diagn 2010;30:540-6. https://doi.org/10.1002/pd.2514  5.,Non-OADS,/arxiv_data1/oa_pdf/e6/2f/bm-27-387.PMC5493168.pdf
Vox Sang 2008;95:280-7. https://doi.org/10.1111/j.1423-0410.2008.01097.x  8. International Organizational for Standardization (ISO).,Non-OADS,/arxiv_data1/oa_pdf/e6/2f/bm-27-387.PMC5493168.pdf
https://doi.org/10.11613/BM.2017.040 Biochemia Medica 2017;27(2):387–97    397 Prommetta S. et al.,Non-OADS,/arxiv_data1/oa_pdf/e6/2f/bm-27-387.PMC5493168.pdf
Int J Lab Hematol 2011;33:424-33. https://doi.org/10.1111/j.1751-553X.2011.01301.x 12.,Non-OADS,/arxiv_data1/oa_pdf/e6/2f/bm-27-387.PMC5493168.pdf
"Chapple L, Harris A, Phelan L, Bain B. Reassessment of a simple chemical method using DCIP for screening for haemoglobin E. J Clin Pathol 2006;59:74-6. https://doi.org/10.1136/jcp.2005.027961 16.",Non-OADS,/arxiv_data1/oa_pdf/e6/2f/bm-27-387.PMC5493168.pdf
J Commun Genet 2010;1:11-7. https://doi.org/10.1007/s12687-010-0009-x 18.,Non-OADS,/arxiv_data1/oa_pdf/e6/2f/bm-27-387.PMC5493168.pdf
Clin Chem Lab Med 2013;51:1265-71. https://doi.org/10.1515/cclm-2012-0588 19.,Non-OADS,/arxiv_data1/oa_pdf/e6/2f/bm-27-387.PMC5493168.pdf
Am J Clin Pathol 1997;107:567-75. https://doi.org/10.1093/ajcp/107.5.567 20.,Non-OADS,/arxiv_data1/oa_pdf/e6/2f/bm-27-387.PMC5493168.pdf
Clin Chem Lab Med 2007;45:88-92. https://doi.org/10.1515/CCLM.2007.002 21.,Non-OADS,/arxiv_data1/oa_pdf/e6/2f/bm-27-387.PMC5493168.pdf
Genet Test Mol Biomar - kers 2009;13:31-6. https://doi.org/10.1089/gtmb.2008.0072 22.,OADS,/arxiv_data1/oa_pdf/e6/2f/bm-27-387.PMC5493168.pdf
Availa- ble at: https://www.skml.nl/en/rondzendingen/overzicht/rondzending?id=147.,Non-OADS,/arxiv_data1/oa_pdf/e6/2f/bm-27-387.PMC5493168.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creative - commons.org/licenses/by/4.0/) which permits users to read, download, copy, distribute, print, search, or link to the full texts of these articles in any medium or format and to remix, transform and build upon  the material, provided the original work is properly cited and any changes properly indicated  .Biochemia Medica 2017;27(2):332–41  https://doi.org/10.11613/BM.2017.036  332Abstract Introduction : The aim of this study was to assess the analytical performances of the newly developed Access2 25-hydroxyvitamin D (25(OH)D) total  immunoassay on two analysers, DxI800 and Access2 (Beckman Coulter, Brea, CA, USA), and compare these two and a recalibrated Modular E 170  25(OH)D assay (Roche Diagnostics, Penzberg, Germany) with reference liquid chromatography tandem-mass spectrometry (LC -MS/MS) with special emphasis on clinical diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
https://doi.org/10.11613/BM.2017.036 Biochemia Medica 2017;27(2):332–41    333 Madenci ÖÇ.,Non-OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
Biochemia Medica 2017;27(2): 332–41  https://doi.org/10.11613/BM.2017.036  334 Madenci ÖÇ.,Non-OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
https://doi.org/10.11613/BM.2017.036 Biochemia Medica 2017;27(2):332–41    335 Madenci ÖÇ.,Non-OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
Biochemia Medica 2017;27(2): 332–41  https://doi.org/10.11613/BM.2017.036  336 Madenci ÖÇ.,Non-OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
https://doi.org/10.11613/BM.2017.036 Biochemia Medica 2017;27(2):332–41    337 Madenci ÖÇ.,Non-OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
Biochemia Medica 2017;27(2): 332–41  https://doi.org/10.11613/BM.2017.036  338 Madenci ÖÇ.,Non-OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
https://doi.org/10.11613/BM.2017.036 Biochemia Medica 2017;27(2):332–41    339 Madenci ÖÇ.,Non-OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
Biochemia Medica 2017;27(2): 332–41  https://doi.org/10.11613/BM.2017.036  340 Madenci ÖÇ.,Non-OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
Endocr Rev 2012;33:456-92. https://doi.org/10.1210/er.2012-1000  2.,Non-OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
N Engl J Med 2007;357:266– 81. https://doi.org/10.1056/NEJMra070553  3.,Non-OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
https://doi.org/10.1016/j.annepidem.2007.12.001  4.,OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
Clin Biochem 2016;49:486-91. https://doi.org/10.1016/j.clinbiochem.2015.11.022   5.,OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
Intern Med J 2012;42:43-50. https://doi.org/10.1111/j.1445-5994.2011.02471.x  6.,Non-OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
Clin Biochem 2012;45:811-5. https://doi.org/10.1016/j.clinbiochem.2012.02.016                    12.,OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
Clin Biochem 2009;42:484-90. https://doi.org/10.1016/j.clinbiochem.2008.11.009 13.,OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
Biochem Med (Zagreb) 2012;22:276-82. https://doi.org/10.11613/BM.2012.031 15.,Non-OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
Steroids 2012;77:1366-72. https://doi.org/10.1016/j.stero - ids.2012.07.013  16.,OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
Clin Chem 2012;58:531-42. https://doi.org/10.1373/clinchem.2011.172155 17.,Non-OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
J Clin Endocrinol Metab 2004;89:3152-7. https://doi.org/10.1210/jc.2003-031979 18.,Non-OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
Clin Lab 2014;60:1541-50. https://doi.org/10.7754/Clin.Lab.2014.131114  19.,Non-OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
Biochem Med (Zagreb) 2015;25:203-12.  https://doi.org/10.11613/BM.2015.020,Non-OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
https://doi.org/10.11613/BM.2017.036 Biochemia Medica 2017;27(2):332–41    341 Madenci ÖÇ.,Non-OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
J Steroid Biochem Mol Biol 2015;148:41-6. https://doi.org/10.1016/j.jsbmb.2014.09.013  21.,OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInfor - mation/Guidances/UCM368107.pdf.,Non-OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
J Clin Lab Anal 2011;25:130-3. https://doi.org/10.1002/jcla.20446 24.,Non-OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
Clin Chim Acta 2009;408:8-25. https://doi.org/10.1016/j.cca.2009.06.02725.,OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
Clin Biochem 2015;48:1089-96. https://doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
"Binkley &, Krueger DC, Morgan S, Wiebe D. Current sta- tus of clinical 25-hydroxyvitamin D measurement: An  assessment of between-laboratory agreement Clin  Chim Acta 2010;411:1976-82. https://doi.org/10.1016/j.cca.2010.08.018 27.",OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
Curr Drug Targets 2011;12:19-28. https://doi.org/10.2174/138945011793591608 28.,Non-OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
Am J Clin Pathol 2010;134:148-56. https://doi.org/10.1309/ AJCPPIA7DFBT4GKS  29.,Non-OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
J Clin En- docrinol Metab 2006;91:3055-61. https://doi.org/10.1210/ jc.2006-0710,Non-OADS,/arxiv_data1/oa_pdf/04/f7/bm-27-332.PMC5493169.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creative - commons.org/licenses/by/4.0/) which permits users to read, download, copy, distribute, print, search, or link to the full texts of these articles in any medium or format and to remix, transform and build upon  the material, provided the original work is properly cited and any changes properly indicated  .Biochemia Medica 2017;27(2):300–7  https://doi.org/10.11613/BM.2017.033  300Review Background The relationship between the two biologically ac - tive thyroid hormones, free thyroxine (fT4) and free  triiodothyronine (fT3), and thyroid stimulating hor - mone (TSH), the pituitary hormone that controls  them, is tightly preserved in many diverse physio - logical and pathological conditions.",Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
https://doi.org/10.11613/BM.2017.033 Biochemia Medica 2017;27(2):300–7    301 Premawardhana LD.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
Biochemia Medica 2017;27(2): 300–7  https://doi.org/10.11613/BM.2017.033  302 Premawardhana LD.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
https://doi.org/10.11613/BM.2017.033 Biochemia Medica 2017;27(2):300–7    303 Premawardhana LD.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
Biochemia Medica 2017;27(2): 300–7  https://doi.org/10.11613/BM.2017.033  304 Premawardhana LD.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
https://doi.org/10.11613/BM.2017.033 Biochemia Medica 2017;27(2):300–7    305 Premawardhana LD.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
Biochemia Medica 2017;27(2): 300–7  https://doi.org/10.11613/BM.2017.033  306 Premawardhana LD.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
Eur J Endocrinol 2014;171:197-208. https://doi.org/10.1530/EJE-14-0285  2.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
https://doi.org/10.1210/jcem.87.3.8165   3.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
Acta Endocrinol 2016;12:125-129. https://doi.org/10.4183/aeb.2016.125  4.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
Clin Phar - macol Ther 2012;91:577-579. https://doi.org/10.1038/clpt.2012.10  5.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
https://doi.org/10.1002/cphy.c150027  6.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
Horm Metab Res 2015;4:702-710. https://doi.org/10.1055/s-0035-1548832 7.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
Clin Chem Lab Med 2006;44;750-759. https://doi.org/10.1515/CCLM.2006.123  8.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
Clin Endocrinol (Oxf) 2003;58:20-21. https://doi.org/10.1046/j.1365-2265.2003.01690.x  9.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
Available at: http://www.btf-thyroid.org/images/stories/pdf/tft_guideline_final_versi - on_july_2006.pdf.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
https://doi.org/10.11613/BM.2017.033 Biochemia Medica 2017;27(2):300–7    307 Premawardhana LD.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
JAMA Intern Med 2014;174:32-39. https://doi.org/10.1001/jama-internmed.2013.11312 14.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
J Emerg Med 2015;49:481-487. https://doi.org/10.1016/j.je - mermed.2015.05.003 15.,OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
J Clin Pathol 2003;56:243-8. https://doi.org/10.1136/jcp.56.4.243 16.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
Diagnosis  2014;1:269-27. https://doi.org/10.1515/dx-2014-0045 17.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
https://doi.org/10.1016/j.beem.2013.10.003 18.,OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
https://doi.org/10.1530/EJE-14-0285 19.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
J Clin Invest 2006;116:2571-9. https://doi.org/10.1172/JCI29812  20.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
"Mol Endocrinol 2011;25:1-14. https://doi.org/10.1210/me.2010-0095 21. de Vries EM, Fliers E, Boelen.",Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
https://doi.org/10.1530/JOE-15-0133 22.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
Lancet Diabetes Endocri-nol 2015;3:816-25. https://doi.org/10.1016/S2213-8587(15)00225-9.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
https://doi.org/10.1016/j.beem.2009.08.003 24. van den Berghe G. Non-Thyroidal Illness in the ICU: A Syn-drome with Different Faces.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
https://doi.org/10.1089/thy.2014.0201 25.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
Eur J Clin  Invest 2011;41:212-20. https://doi.org/10.1111/j.1365- 2362.2010.02395.x 26.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
J Endocrinol 2010;205:1- 13. https://doi.org/10.1677/JOE-09-0412 27.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
Front Endocrinol 2012;3:1-7.  https://doi.org/10.3389/fendo.2012.0000828.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
https://doi.org/10.1111/j.1365-2265.1990.tb00854.x 30.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
Circulation 2003;107:708-13.  https://doi.org/10.1161/01.CIR.0000048124.64204.3F 31.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
Clin  Endocrinol (Oxf) 2009;70:961-7. https://doi.org/10.1111/ j.1365-2265.2008.03421.x 32.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
Thyr Res Pract 2016;13:19-24. https://doi.org/10.4103/0973-0354.159531 33.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
Eur J Clin Invest 2007;37:651-7. https://doi.org/10.1111/j.1365-2362.2007.01839.x 34.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
JAMA 1998;280:2020-24. https://doi.org/10.1001/jama.280.23.2020  36.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
Ann Clin Biochem 2013;50:166-8. https://doi.org/10.1258/acb.2012.012100 39.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
West J Emerg Med 2015;16:195-202. https://doi.org/10.5811/westjem.2014.11.23490 40.,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
Sci Rep 2016;6:22271. https://doi.org/10.1038/srep22271,Non-OADS,/arxiv_data1/oa_pdf/71/93/bm-27-300.PMC5493170.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creative - commons.org/licenses/by/4.0/) which permits users to read, download, copy, distribute, print, search, or link to the full texts of these articles in any medium or format and to remix, transform and build upon  the material, provided the original work is properly cited and any changes properly indicated  .https://doi.org/10.11613/BM.2017.043 Biochemia Medica 2017;27(2):411–7    411Abstract Introduction : Urinary microRNAs (miRNAs) are emerging as a clinically useful tool for early and non-invasive detection of various types of cancer.",Non-OADS,/arxiv_data1/oa_pdf/a6/3a/bm-27-411.PMC5493171.pdf
Biochemia Medica 2017;27(2): 411–7  https://doi.org/10.11613/BM.2017.043  412 Fedorko M. et al.,OADS,/arxiv_data1/oa_pdf/a6/3a/bm-27-411.PMC5493171.pdf
https://doi.org/10.11613/BM.2017.043 Biochemia Medica 2017;27(2):411–7    413 Fedorko M. et al.,OADS,/arxiv_data1/oa_pdf/a6/3a/bm-27-411.PMC5493171.pdf
Biochemia Medica 2017;27(2): 411–7  https://doi.org/10.11613/BM.2017.043  414 Fedorko M. et al.,OADS,/arxiv_data1/oa_pdf/a6/3a/bm-27-411.PMC5493171.pdf
https://doi.org/10.11613/BM.2017.043 Biochemia Medica 2017;27(2):411–7    415 Fedorko M. et al.,OADS,/arxiv_data1/oa_pdf/a6/3a/bm-27-411.PMC5493171.pdf
Biochemia Medica 2017;27(2): 411–7  https://doi.org/10.11613/BM.2017.043  416 Fedorko M. et al.,OADS,/arxiv_data1/oa_pdf/a6/3a/bm-27-411.PMC5493171.pdf
https://doi.org/10.11613/BM.2017.043 Biochemia Medica 2017;27(2):411–7    417 Fedorko M. et al.,OADS,/arxiv_data1/oa_pdf/a6/3a/bm-27-411.PMC5493171.pdf
Available at:  http://seer.cancer.gov/csr/1975_2012.,Non-OADS,/arxiv_data1/oa_pdf/a6/3a/bm-27-411.PMC5493171.pdf
https://doi.org/10.1016/j.uro - lonc.2013.04.011  4.,OADS,/arxiv_data1/oa_pdf/a6/3a/bm-27-411.PMC5493171.pdf
Curr Oncol 2010;17:70-80. https://doi.org/10.3747/co.v17i1.356  5.,Non-OADS,/arxiv_data1/oa_pdf/a6/3a/bm-27-411.PMC5493171.pdf
Biochem Biophys Res Comm 2012;417:371-5. https://doi.org/10.1016/j.bbrc.2011.11.119  6.,OADS,/arxiv_data1/oa_pdf/a6/3a/bm-27-411.PMC5493171.pdf
https://doi.org/10.1677/ERC-09-0184 7.,Non-OADS,/arxiv_data1/oa_pdf/a6/3a/bm-27-411.PMC5493171.pdf
"Sci Rep 2016;6:24229. https://doi.org/10.1038/ srep24229 10. von Brandenstein M, Pandarakalam JJ, Kroon L, Loeser H,  Herden J, Braun G, et al.",OADS,/arxiv_data1/oa_pdf/a6/3a/bm-27-411.PMC5493171.pdf
Am J Pathol 2012;180:1787-97. https://doi.org/10.1016/j.ajpath.2012.01.014 11.,Non-OADS,/arxiv_data1/oa_pdf/a6/3a/bm-27-411.PMC5493171.pdf
Urol Oncol 2017;35:294-99. https://doi.org/10.1016/j.urolonc.2016.12.007,Non-OADS,/arxiv_data1/oa_pdf/a6/3a/bm-27-411.PMC5493171.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creative - commons.org/licenses/by/4.0/) which permits users to read, download, copy, distribute, print, search, or link to the full texts of these articles in any medium or format and to remix, transform and build upon  the material, provided the original work is properly cited and any changes properly indicated  .https://doi.org/10.11613/BM.2017.045 Biochemia Medica 2017;27(2):421–5    421Abstract We describe the case of a 55-year old women admitted at night to the emergency department (ED), complaining for acute abdominal pain lasting for  nearly 5 hours.",Non-OADS,/arxiv_data1/oa_pdf/6b/e7/bm-27-421.PMC5493172.pdf
"Biochemia Medica 2017;27(2): 421–5  https://doi.org/10.11613/BM.2017.045  422 Lippi G, Cervellin G. Acutely developing spurious anemiaMethods A 55-year old women, with a medical history of ir - ritable bowel syndrome, was admitted at 1:00 am  to the emergency department (ED) of the Univer - sity Hospital of Parma, complaining for acute ab - dominal pain lasting for nearly 5 hours.",Non-OADS,/arxiv_data1/oa_pdf/6b/e7/bm-27-421.PMC5493172.pdf
"https://doi.org/10.11613/BM.2017.045 Biochemia Medica 2017;27(2):421–5    423 Lippi G, Cervellin G. Acutely developing spurious anemiaInterventions and further investigations In the lack of signs and symptoms of internal or ex - ternal haemorrhage, the emergency physicians  called the laboratory, to discuss the possible rea - sons underlying the acutely developing anaemia or for troubleshooting potential preanalytical and analytical errors.",Non-OADS,/arxiv_data1/oa_pdf/6b/e7/bm-27-421.PMC5493172.pdf
"Biochemia Medica 2017;27(2): 421–5  https://doi.org/10.11613/BM.2017.045  424 Lippi G, Cervellin G. Acutely developing spurious anemiaable explanation to the data observed in our case  report, with blood cells and large molecules ( i.e.,  haemoglobin, C reactive protein and creatinine) displaying decreased values and filterable ele - ments ( i.e., ions) remaining virtually unchanged  from upright to supine patient posture.",Non-OADS,/arxiv_data1/oa_pdf/6b/e7/bm-27-421.PMC5493172.pdf
Biochem Med (Za-greb) 2012;22:145-9. https://doi.org/10.11613/BM.2012.017  2.,Non-OADS,/arxiv_data1/oa_pdf/6b/e7/bm-27-421.PMC5493172.pdf
Clin Chim Acta 2014;432:33-7. https://doi.org/10.1016/j.cca.2013.11.008 3.,OADS,/arxiv_data1/oa_pdf/6b/e7/bm-27-421.PMC5493172.pdf
"Biochem Med (Zagreb) 2014;24:68-79. https://doi.org/10.11613/BM.2014.009  4. van Kerkhof LW, Van Dycke KC, Jansen EH, Beekhof PK, van Oostrom CT, Ruskovska T, et al.",Non-OADS,/arxiv_data1/oa_pdf/6b/e7/bm-27-421.PMC5493172.pdf
https://doi.org/10.1371/journal.pone.0135652,Non-OADS,/arxiv_data1/oa_pdf/6b/e7/bm-27-421.PMC5493172.pdf
"https://doi.org/10.11613/BM.2017.045 Biochemia Medica 2017;27(2):421–5    425 Lippi G, Cervellin G. Acutely developing spurious anemia 5.",Non-OADS,/arxiv_data1/oa_pdf/6b/e7/bm-27-421.PMC5493172.pdf
Scand J Clin Lab Invest 1999;59:491-500. https://doi.org/10.1080/00365519950185229  6.,Non-OADS,/arxiv_data1/oa_pdf/6b/e7/bm-27-421.PMC5493172.pdf
Biochem Med (Zagreb) 2016;26:17-33. https://doi.org/10.11613/BM.2016.002  7.,Non-OADS,/arxiv_data1/oa_pdf/6b/e7/bm-27-421.PMC5493172.pdf
Clin Chem Lab Med 2013;51:1585-93. https://doi.org/10.1515/cclm-2013-0283  8.,Non-OADS,/arxiv_data1/oa_pdf/6b/e7/bm-27-421.PMC5493172.pdf
Clin Chem Lab Med 2015;53:1321-31.  https://doi.org/10.1515/cclm-2014-1053  9.,Non-OADS,/arxiv_data1/oa_pdf/6b/e7/bm-27-421.PMC5493172.pdf
Clin Chim Acta 2015;440:164-8. https://doi.org/10.1016/j.cca.2014.11.02413.,OADS,/arxiv_data1/oa_pdf/6b/e7/bm-27-421.PMC5493172.pdf
Available at: http://emedicine.medscape.com/article/780334-overview.,Non-OADS,/arxiv_data1/oa_pdf/6b/e7/bm-27-421.PMC5493172.pdf
Biochem Med (Zagreb) 2013;23:242-54. https://doi.org/10.11613/BM.2013.031 19.,Non-OADS,/arxiv_data1/oa_pdf/6b/e7/bm-27-421.PMC5493172.pdf
Clin Chim Acta 2015;450:104-9. https://doi.org/10.1016/j.cca.2015.08.001 20.,OADS,/arxiv_data1/oa_pdf/6b/e7/bm-27-421.PMC5493172.pdf
Clin Chem Lab Med 2015;53:357-70. https://doi.org/10.1515/cclm-2014-1051,Non-OADS,/arxiv_data1/oa_pdf/6b/e7/bm-27-421.PMC5493172.pdf
"Key words : predatory journals; publication ethics; medical publishing Received: March 12, 2017 Accepted: May 11, 2017 https://doi.org/10.11613/BM.2017.030 Biochemia Medica 2017;27(2):279–84    279Ethical issues in publishing in predatory journals Lorraine E. Ferris*1, Margaret A Winker2 1Dalla Lana School of Public Health, University of Toronto, Toronto, Canada 2Secretary, World Association of Medical Editors (WAME)  *Corresponding author: Lorraine.ferris@utoronto.caResearch integrity corner: Special issue on predatory journals Review Introduction Predatory journals, or journals that charge an arti - cle processing charge (APC) to authors, yet do not  have the hallmarks of legitimate scholarly journals such as peer review and editing, Editorial Boards, editorial offices, and other editorial standards,  pose a new challenge for authors, editors, and  readers.",Non-OADS,/arxiv_data1/oa_pdf/b1/f8/bm-27-279.PMC5493173.pdf
"Biochemia Medica 2017;27(2): 279–84  https://doi.org/10.11613/BM.2017.030  280 Ferris LE, Winker MA.",Non-OADS,/arxiv_data1/oa_pdf/b1/f8/bm-27-279.PMC5493173.pdf
"https://doi.org/10.11613/BM.2017.030 Biochemia Medica 2017;27(2):279–84    281 Ferris LE, Winker MA.",Non-OADS,/arxiv_data1/oa_pdf/b1/f8/bm-27-279.PMC5493173.pdf
"Biochemia Medica 2017;27(2): 279–84  https://doi.org/10.11613/BM.2017.030  282 Ferris LE, Winker MA.",Non-OADS,/arxiv_data1/oa_pdf/b1/f8/bm-27-279.PMC5493173.pdf
"https://doi.org/10.11613/BM.2017.030 Biochemia Medica 2017;27(2):279–84    283 Ferris LE, Winker MA.",Non-OADS,/arxiv_data1/oa_pdf/b1/f8/bm-27-279.PMC5493173.pdf
"Biochemia Medica 2017;27(2): 279–84  https://doi.org/10.11613/BM.2017.030  284 Ferris LE, Winker MA.",Non-OADS,/arxiv_data1/oa_pdf/b1/f8/bm-27-279.PMC5493173.pdf
BMC Med  2015;13:230. https://doi.org/10.1186/s12916-015-0469-2  4.,Non-OADS,/arxiv_data1/oa_pdf/b1/f8/bm-27-279.PMC5493173.pdf
Available at: http://www.wame.org/identifying-pre - datory-or-pseudo-journals.,Non-OADS,/arxiv_data1/oa_pdf/b1/f8/bm-27-279.PMC5493173.pdf
Available at: https://www.researchga-te.net/publication/312623188_Predatory_Journals_Do_Not_Enter.,Non-OADS,/arxiv_data1/oa_pdf/b1/f8/bm-27-279.PMC5493173.pdf
https://doi.org/10.1007/s11019-016-9740-3  7.,Non-OADS,/arxiv_data1/oa_pdf/b1/f8/bm-27-279.PMC5493173.pdf
Availa- ble at: http://www.wame.org/about/principles-of-transpa- rency-and-best-practice.,Non-OADS,/arxiv_data1/oa_pdf/b1/f8/bm-27-279.PMC5493173.pdf
Curr Sci 2016;111:1759-1764. https://doi.org/10.18520/cs/v111/i11/1759-1764 10.,Non-OADS,/arxiv_data1/oa_pdf/b1/f8/bm-27-279.PMC5493173.pdf
Available at: http://www.the-scientist.com/?articles.view/articleNo/27383/title/Elsevier-publis - hed-6-fake-journals/.,Non-OADS,/arxiv_data1/oa_pdf/b1/f8/bm-27-279.PMC5493173.pdf
Available at: http://www.wame.org/wame-professionalism-code-of-conduct.,Non-OADS,/arxiv_data1/oa_pdf/b1/f8/bm-27-279.PMC5493173.pdf
Ava-ilable at: http://publicationethics.org/resources/code-con-duct.,Non-OADS,/arxiv_data1/oa_pdf/b1/f8/bm-27-279.PMC5493173.pdf
Available at: http://www.sciencemag.org/news/2016/12/predatory-publishers-gain-foothold-indian-academia-s-upper-eche - lon.,Non-OADS,/arxiv_data1/oa_pdf/b1/f8/bm-27-279.PMC5493173.pdf
Natl Med J India 2016;29:1-5. https://doi.org/10.4103/0970-258X.186900 18.,Non-OADS,/arxiv_data1/oa_pdf/b1/f8/bm-27-279.PMC5493173.pdf
Available at: https://journosdiary.com/2017/01/16/india-ugc-predatory-journals/.,Non-OADS,/arxiv_data1/oa_pdf/b1/f8/bm-27-279.PMC5493173.pdf
Science 2013;342:60-5. https://doi.org/10.1126/science.342.6154.60 20.,Non-OADS,/arxiv_data1/oa_pdf/b1/f8/bm-27-279.PMC5493173.pdf
Ava- ilable at: http://retractionwatch.com/2016/11/30/surprise- paper-retracted-author-tells-journal-pile-dung/.,Non-OADS,/arxiv_data1/oa_pdf/b1/f8/bm-27-279.PMC5493173.pdf
Available at: https://publica-tionethics.org/case/withdrawal-accepted-manuscript-pre - datory-journal.,Non-OADS,/arxiv_data1/oa_pdf/b1/f8/bm-27-279.PMC5493173.pdf
Available at: https://www.ftc.gov/news-events/press-releases/2016/08/ftc-charges-academic-jour - nal-publisher-omics-group-deceived.,Non-OADS,/arxiv_data1/oa_pdf/b1/f8/bm-27-279.PMC5493173.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creative - commons.org/licenses/by/4.0/) which permits users to read, download, copy, distribute, print, search, or link to the full texts of these articles in any medium or format and to remix, transform and build upon  the material, provided the original work is properly cited and any changes properly indicated  .Biochemia Medica 2017;27(2):378–86   https://doi.org/10.11613/BM.2017.039  378Abstract Introduction : Haemoglobin A1c (HbA1c) is a key analyte for the monitoring of glycemic balance in diabetic patients and is used for diabetes diagno - sis in many countries.",Non-OADS,/arxiv_data1/oa_pdf/1a/60/bm-27-378.PMC5493174.pdf
https://doi.org/10.11613/BM.2017.039 Biochemia Medica 2017;27(2):378–86    379 Desmons A. et al.,Non-OADS,/arxiv_data1/oa_pdf/1a/60/bm-27-378.PMC5493174.pdf
Biochemia Medica 2017;27(2): 378–86  https://doi.org/10.11613/BM.2017.039  380 Desmons A. et al.,Non-OADS,/arxiv_data1/oa_pdf/1a/60/bm-27-378.PMC5493174.pdf
https://doi.org/10.11613/BM.2017.039 Biochemia Medica 2017;27(2):378–86    381 Desmons A. et al.,Non-OADS,/arxiv_data1/oa_pdf/1a/60/bm-27-378.PMC5493174.pdf
Biochemia Medica 2017;27(2): 378–86  https://doi.org/10.11613/BM.2017.039  382 Desmons A. et al.,Non-OADS,/arxiv_data1/oa_pdf/1a/60/bm-27-378.PMC5493174.pdf
https://doi.org/10.11613/BM.2017.039 Biochemia Medica 2017;27(2):378–86    383 Desmons A. et al.,Non-OADS,/arxiv_data1/oa_pdf/1a/60/bm-27-378.PMC5493174.pdf
Biochemia Medica 2017;27(2): 378–86  https://doi.org/10.11613/BM.2017.039  384 Desmons A. et al.,Non-OADS,/arxiv_data1/oa_pdf/1a/60/bm-27-378.PMC5493174.pdf
https://doi.org/10.11613/BM.2017.039 Biochemia Medica 2017;27(2):378–86    385 Desmons A. et al.,Non-OADS,/arxiv_data1/oa_pdf/1a/60/bm-27-378.PMC5493174.pdf
https://doi.org/10.1515/cclm-2012-0548  2.,Non-OADS,/arxiv_data1/oa_pdf/1a/60/bm-27-378.PMC5493174.pdf
https://doi.org/10.1373/clinchem.2010.161596 3.,Non-OADS,/arxiv_data1/oa_pdf/1a/60/bm-27-378.PMC5493174.pdf
https://doi.org/10.2174/1573399811666150701143112  4.,Non-OADS,/arxiv_data1/oa_pdf/1a/60/bm-27-378.PMC5493174.pdf
Biochemia Medica 2017;27(2): 378–86  https://doi.org/10.11613/BM.2017.039  386 Desmons A. et al.,Non-OADS,/arxiv_data1/oa_pdf/1a/60/bm-27-378.PMC5493174.pdf
https://doi.org/10.1056/NEJM199309303291401  5.,Non-OADS,/arxiv_data1/oa_pdf/1a/60/bm-27-378.PMC5493174.pdf
Diabetes Care 2017;40:405-11. https://doi.org/10.2337/dc16-1889  6.,Non-OADS,/arxiv_data1/oa_pdf/1a/60/bm-27-378.PMC5493174.pdf
https://doi.org/10.1515/cclm-2012- 0017  7.,Non-OADS,/arxiv_data1/oa_pdf/1a/60/bm-27-378.PMC5493174.pdf
https://doi.org/10.1515/CCLM.2009.136  8.,Non-OADS,/arxiv_data1/oa_pdf/1a/60/bm-27-378.PMC5493174.pdf
https://doi.org/10.1016/j.diabres.2015.01.034  9.,OADS,/arxiv_data1/oa_pdf/1a/60/bm-27-378.PMC5493174.pdf
https://doi.org/10.11613/BM.2016.03910.,Non-OADS,/arxiv_data1/oa_pdf/1a/60/bm-27-378.PMC5493174.pdf
https://doi.org/10.1016/S0009-9120(03)00013-4 11.,OADS,/arxiv_data1/oa_pdf/1a/60/bm-27-378.PMC5493174.pdf
Clin Chem Lab Med  2016;54:73-9. https://doi.org/10.1515/cclm-2015-0398 13.,Non-OADS,/arxiv_data1/oa_pdf/1a/60/bm-27-378.PMC5493174.pdf
https://doi.org/10.1016/j.clinbio - chem.2013.12.005 15.,OADS,/arxiv_data1/oa_pdf/1a/60/bm-27-378.PMC5493174.pdf
https://doi.org/10.1515/cclm-2015-0067 16.,Non-OADS,/arxiv_data1/oa_pdf/1a/60/bm-27-378.PMC5493174.pdf
"February 15th 2017.  http://www.wame.org https://doi.org/10.11613/BM.2017.031 Biochemia Medica 2017;27(2):285–91    285Identifying predatory or pseudo-journals Christine Laine1, Margaret A. Winker*2 1Vice President, World Association of Medical Editors (WAME)  2 Secretary, World Association of Medical Editors (WAME) *Corresponding author: margaret.winker@wame.org.Research integrity corner: Special issue on predatory journals Review This World Association of Medical Editors (WAME)  document aims to provide guidance to help edi - tors, researchers, funders, academic institutions and other stakeholders distinguish predatory jour - nals from legitimate journals.",Non-OADS,/arxiv_data1/oa_pdf/0d/8f/bm-27-285.PMC5493175.pdf
"Biochemia Medica 2017;27(2): 285–91  https://doi.org/10.11613/BM.2017.031  286 Laine C, Winker MA.",Non-OADS,/arxiv_data1/oa_pdf/0d/8f/bm-27-285.PMC5493175.pdf
"https://doi.org/10.11613/BM.2017.031 Biochemia Medica 2017;27(2):285–91    287 Laine C, Winker MA.",Non-OADS,/arxiv_data1/oa_pdf/0d/8f/bm-27-285.PMC5493175.pdf
*Formerly available at https://scholarlyoa.files.wordpress.com/2015/01/criteria-2015.pdf; no longer accessible.,Non-OADS,/arxiv_data1/oa_pdf/0d/8f/bm-27-285.PMC5493175.pdf
"Biochemia Medica 2017;27(2): 285–91  https://doi.org/10.11613/BM.2017.031  288 Laine C, Winker MA.",Non-OADS,/arxiv_data1/oa_pdf/0d/8f/bm-27-285.PMC5493175.pdf
* Available at: https://doaj.org/publishers#seal.Table  2.,Non-OADS,/arxiv_data1/oa_pdf/0d/8f/bm-27-285.PMC5493175.pdf
*Available at: http://thinkchecksubmit.org/check/.Table  3.,Non-OADS,/arxiv_data1/oa_pdf/0d/8f/bm-27-285.PMC5493175.pdf
"https://doi.org/10.11613/BM.2017.031 Biochemia Medica 2017;27(2):285–91    289 Laine C, Winker MA.",Non-OADS,/arxiv_data1/oa_pdf/0d/8f/bm-27-285.PMC5493175.pdf
"Biochemia Medica 2017;27(2): 285–91  https://doi.org/10.11613/BM.2017.031  290 Laine C, Winker MA.",Non-OADS,/arxiv_data1/oa_pdf/0d/8f/bm-27-285.PMC5493175.pdf
Available at: https://mpra.ub.uni-muenchen.de/73075/1/MPRA_paper_73075.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/8f/bm-27-285.PMC5493175.pdf
"https://doi.org/10.11613/BM.2017.031 Biochemia Medica 2017;27(2):285–91    291 Laine C, Winker MA.",Non-OADS,/arxiv_data1/oa_pdf/0d/8f/bm-27-285.PMC5493175.pdf
Available at: http://www.currentscien-ce.ac.in/Volumes/111/11/1759.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/8f/bm-27-285.PMC5493175.pdf
Accessed February 7th 2017. https://doi.org/10.18520/cs/v111/i11/1759-1764  4.,Non-OADS,/arxiv_data1/oa_pdf/0d/8f/bm-27-285.PMC5493175.pdf
Available at:  http://www.the-scientist.com/?articles.view/articleNo/27383/title/Else - vier-published-6-fake-journals/.,Non-OADS,/arxiv_data1/oa_pdf/0d/8f/bm-27-285.PMC5493175.pdf
Science 2013;342:60-65. https://doi.org/10.1126/science.342.6154.60  6.,Non-OADS,/arxiv_data1/oa_pdf/0d/8f/bm-27-285.PMC5493175.pdf
Med Health Care and Phi-los 2016. https://doi.org/10.1007/s11019-016-9740-3   8.,Non-OADS,/arxiv_data1/oa_pdf/0d/8f/bm-27-285.PMC5493175.pdf
BMC Med 2015;13:230. https://doi.org/10.1186/s12916-015-0469-2  9.,Non-OADS,/arxiv_data1/oa_pdf/0d/8f/bm-27-285.PMC5493175.pdf
Available at https://web.archi-ve.org/web/20170113114519/https://scholarlyoa.com/2016/01/05/bealls-list-of-predatory-publishers-2016/.,Non-OADS,/arxiv_data1/oa_pdf/0d/8f/bm-27-285.PMC5493175.pdf
Available at: http://www.sciencemag.org/news/2017/01/mystery-controversial-list-predatory-publis - hers-disappears.,Non-OADS,/arxiv_data1/oa_pdf/0d/8f/bm-27-285.PMC5493175.pdf
Available at: http://www.wame.org/about/princi-ples-of-transparency-and-best-practice.,Non-OADS,/arxiv_data1/oa_pdf/0d/8f/bm-27-285.PMC5493175.pdf
Available at: http://walt.lishost.org/2016/01/trust-me-the-other-problem-with-87-of-bealls-lists/.,Non-OADS,/arxiv_data1/oa_pdf/0d/8f/bm-27-285.PMC5493175.pdf
Availa- ble at: http://blog.scielo.org/en/2015/08/02/motion-to-re - pudiate-mr-jeffrey-bealls-classist-attack-on-scielo/.,Non-OADS,/arxiv_data1/oa_pdf/0d/8f/bm-27-285.PMC5493175.pdf
https://doi.org/10.5260/chara.15.2.67 17.,Non-OADS,/arxiv_data1/oa_pdf/0d/8f/bm-27-285.PMC5493175.pdf
Available at: https://doaj.org/faq#whatis.,Non-OADS,/arxiv_data1/oa_pdf/0d/8f/bm-27-285.PMC5493175.pdf
Available at: http://thinkchecksubmit.org.,Non-OADS,/arxiv_data1/oa_pdf/0d/8f/bm-27-285.PMC5493175.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creative - commons.org/licenses/by/4.0/) which permits users to read, download, copy, distribute, print, search, or link to the full texts of these articles in any medium or format and to remix, transform and build upon  the material, provided the original work is properly cited and any changes properly indicated  .Biochemia Medica 2017;27(2):270–2  https://doi.org/10.11613/BM.2017.028  270Received: May 2, 2017 Accepted: May 9, 2017Predatory journals and their effects on scientific research community Farrokh Habibzadeh*1, Ana-Maria Simundic2,3 1World Association of Medical Editors (WAME), Past President 2Department of Medical Laboratory Diagnostics, University Hospital “Sveti Duh” , Zagreb, Croatia 3Editor-in-chief, Biochemia Medica, Zagreb, Croatia *Corresponding author: Farrokh.Habibzadeh@theijoem.com Biochemia Medica  is an Open Access Journal dedi - cated to promote science and its values.",Non-OADS,/arxiv_data1/oa_pdf/88/dc/bm-27-270.PMC5493176.pdf
"https://doi.org/10.11613/BM.2017.028 Biochemia Medica 2017;27(2):270–2    271 Habibzadeh F, Simundic AM.",Non-OADS,/arxiv_data1/oa_pdf/88/dc/bm-27-270.PMC5493176.pdf
"Biochemia Medica 2017;27(2): 270–2  https://doi.org/10.11613/BM.2017.028  272 Habibzadeh F, Simundic AM.",Non-OADS,/arxiv_data1/oa_pdf/88/dc/bm-27-270.PMC5493176.pdf
Bi- ochem Med (Zagreb) 2013;23:5-6. https://doi.org/10.11613/ BM.2013.001  3.,Non-OADS,/arxiv_data1/oa_pdf/88/dc/bm-27-270.PMC5493176.pdf
Biochem Med (Zagreb) 2015;25:324-34.  https://doi.org/10.11613/BM.2015.033  4.,Non-OADS,/arxiv_data1/oa_pdf/88/dc/bm-27-270.PMC5493176.pdf
Biochem Med (Zagreb) 2013;23:16-8. https://doi.org/10.11613/BM.2013.004  5.,Non-OADS,/arxiv_data1/oa_pdf/88/dc/bm-27-270.PMC5493176.pdf
Biochem Med (Za-greb) 2014;24:321-8. https://doi.org/10.11613/BM.2014.034  6.,Non-OADS,/arxiv_data1/oa_pdf/88/dc/bm-27-270.PMC5493176.pdf
Biochem Med (Zagreb) 2015;25:12-21. https://doi.org/10.11613/BM.2015.002 7.,Non-OADS,/arxiv_data1/oa_pdf/88/dc/bm-27-270.PMC5493176.pdf
Biochem  Med (Zagreb) 2017;27:273-8. https://dx.doi.org/10.11613/ BM.2017.029  8.,Non-OADS,/arxiv_data1/oa_pdf/88/dc/bm-27-270.PMC5493176.pdf
Biochem Med (Zagreb) 2017;27:292-9. https://dx.doi.org/10.11613/BM.2017.032 10.,Non-OADS,/arxiv_data1/oa_pdf/88/dc/bm-27-270.PMC5493176.pdf
Biochem Med (Zagreb) 2017;27:285-91. https://dx.doi.org/10.11613/BM.2017.031,Non-OADS,/arxiv_data1/oa_pdf/88/dc/bm-27-270.PMC5493176.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creative - commons.org/licenses/by/4.0/) which permits users to read, download, copy, distribute, print, search, or link to the full texts of these articles in any medium or format and to remix, transform and build upon  the material, provided the original work is properly cited and any changes properly indicated  .https://doi.org/10.11613/BM.2017.029 Biochemia Medica 2017;27(2):273–8    273Abstract This article is a first-hand account of the author’s work identifying and listing predatory publishers from 2012 to 2017 .",Non-OADS,/arxiv_data1/oa_pdf/6e/73/bm-27-273.PMC5493177.pdf
Biochemia Medica 2017;27(2): 273–8  https://doi.org/10.11613/BM.2017.029  274 Beall J.,Non-OADS,/arxiv_data1/oa_pdf/6e/73/bm-27-273.PMC5493177.pdf
https://doi.org/10.11613/BM.2017.029 Biochemia Medica 2017;27(2):273–8    275 Beall J.,Non-OADS,/arxiv_data1/oa_pdf/6e/73/bm-27-273.PMC5493177.pdf
Biochemia Medica 2017;27(2): 273–8  https://doi.org/10.11613/BM.2017.029  276 Beall J.,Non-OADS,/arxiv_data1/oa_pdf/6e/73/bm-27-273.PMC5493177.pdf
https://doi.org/10.11613/BM.2017.029 Biochemia Medica 2017;27(2):273–8    277 Beall J.,Non-OADS,/arxiv_data1/oa_pdf/6e/73/bm-27-273.PMC5493177.pdf
Biochemia Medica 2017;27(2): 273–8  https://doi.org/10.11613/BM.2017.029  278 Beall J.,Non-OADS,/arxiv_data1/oa_pdf/6e/73/bm-27-273.PMC5493177.pdf
J Korean Med Sci 2016;31:1511-3. https://doi.org/10.3346/jkms.2016.31.10.1511  3.,Non-OADS,/arxiv_data1/oa_pdf/6e/73/bm-27-273.PMC5493177.pdf
Available at: https://en.wikipedia.org/wiki/Posterous.,Non-OADS,/arxiv_data1/oa_pdf/6e/73/bm-27-273.PMC5493177.pdf
https://doi.org/10.1111/1475-4932.12258  5.,Non-OADS,/arxiv_data1/oa_pdf/6e/73/bm-27-273.PMC5493177.pdf
Am Sociol Rev 1983;48:781-95. https://doi.org/10.2307/2095325  6.,Non-OADS,/arxiv_data1/oa_pdf/6e/73/bm-27-273.PMC5493177.pdf
https://doi.org/10.2983/035.035.0101,Non-OADS,/arxiv_data1/oa_pdf/6e/73/bm-27-273.PMC5493177.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creative - commons.org/licenses/by/4.0/) which permits users to read, download, copy, distribute, print, search, or link to the full texts of these articles in any medium or format and to remix, transform and build upon  the material, provided the original work is properly cited and any changes properly indicated  .Biochemia Medica 2017;27(2):418–20  https://doi.org/10.11613/BM.2017.044  418Received: May 10, 2017 Accepted: May 16, 2017Biochemia Medica introduces new section: Pre-analytical mysteries Ana-Maria Simundic*1,2, Janne Cadamuro3,4, Michael Cornes3,5 1Editor-in-chief, Biochemia Medica, Zagreb, Croatia;  2Department of Medical Laboratory Diagnostics, University Hospital “Sveti Duh” , Zagreb, Croatia 3Case report Editor, Pre-analytical mysteries, Biochemia Medica, Zagreb, Croatia  4Department of Laboratory Medicine, Paracelsus Medical University, Salzburg, Austria 5Worcestershire Acute Hospitals NHS Trust, Worcester, United Kingdom *Corresponding author: am.simundic@gmail.comPre-analytical mysteries Among the many things which journal editors  need to focus on in order for a journal to become an internationally recognized, is to identify its niche,  i.e.",Non-OADS,/arxiv_data1/oa_pdf/24/10/bm-27-418.PMC5493178.pdf
https://doi.org/10.11613/BM.2017.044 Biochemia Medica 2017;27(2):418–20    419 Simundic  AM.,Non-OADS,/arxiv_data1/oa_pdf/24/10/bm-27-418.PMC5493178.pdf
"For templates, see  http://www.care-statement.org/downloads ).",Non-OADS,/arxiv_data1/oa_pdf/24/10/bm-27-418.PMC5493178.pdf
Biochemia Medica 2017;27(2): 418–20  https://doi.org/10.11613/BM.2017.044  420 Simundic  AM.,Non-OADS,/arxiv_data1/oa_pdf/24/10/bm-27-418.PMC5493178.pdf
Biochem Med (Zagreb) 2006;16:5-7. https://doi.org/10.11613/BM.2006.002  2.,Non-OADS,/arxiv_data1/oa_pdf/24/10/bm-27-418.PMC5493178.pdf
Biochem Med (Zagreb) 2017;27:421-5. https://dx.doi.org/10.11613/BM.2017.045 3.,Non-OADS,/arxiv_data1/oa_pdf/24/10/bm-27-418.PMC5493178.pdf
Biochem Med (Zagreb) 2017;27:426-9. https://dx.doi.org/10.11613/BM.2017.046  4.,Non-OADS,/arxiv_data1/oa_pdf/24/10/bm-27-418.PMC5493178.pdf
Biochem Med (Zagreb) 2017;27:430-3. https://dx.doi.org/10.11613/BM.2017.047,Non-OADS,/arxiv_data1/oa_pdf/24/10/bm-27-418.PMC5493178.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creative - commons.org/licenses/by/4.0/) which permits users to read, download, copy, distribute, print, search, or link to the full texts of these articles in any medium or format and to remix, transform and build upon  the material, provided the original work is properly cited and any changes properly indicated  .Biochemia Medica 2017;27(2):404–10  http://doi.org/10.11613/BM.2017.042  404Abstract Introduction : The aim of this study is to present a case of 44 years old woman with topiramate induced metabolic acidosis and kidney stones.",Non-OADS,/arxiv_data1/oa_pdf/83/97/bm-27-404.PMC5493179.pdf
https://doi.org/10.11613/BM.2017.042 Biochemia Medica 2017;27(2):404–10    405 Salek T. et al.,Non-OADS,/arxiv_data1/oa_pdf/83/97/bm-27-404.PMC5493179.pdf
Biochemia Medica 2017;27(2): 404–10  https://doi.org/10.11613/BM.2017.042  406 Salek T. et al.,Non-OADS,/arxiv_data1/oa_pdf/83/97/bm-27-404.PMC5493179.pdf
https://doi.org/10.11613/BM.2017.042 Biochemia Medica 2017;27(2):404–10    407 Salek T. et al.,Non-OADS,/arxiv_data1/oa_pdf/83/97/bm-27-404.PMC5493179.pdf
Biochemia Medica 2017;27(2): 404–10  https://doi.org/10.11613/BM.2017.042  408 Salek T. et al.,Non-OADS,/arxiv_data1/oa_pdf/83/97/bm-27-404.PMC5493179.pdf
https://doi.org/10.11613/BM.2017.042 Biochemia Medica 2017;27(2):404–10    409 Salek T. et al.,Non-OADS,/arxiv_data1/oa_pdf/83/97/bm-27-404.PMC5493179.pdf
Biochemia Medica 2017;27(2): 404–10  https://doi.org/10.11613/BM.2017.042  410 Salek T. et al.,Non-OADS,/arxiv_data1/oa_pdf/83/97/bm-27-404.PMC5493179.pdf
Available at: http://uroweb.org/guideline/urolithiasis/.,Non-OADS,/arxiv_data1/oa_pdf/83/97/bm-27-404.PMC5493179.pdf
https://doi.org/10.1111/bcp.12283  3.,Non-OADS,/arxiv_data1/oa_pdf/83/97/bm-27-404.PMC5493179.pdf
https://doi.org/10.1111/j.1365-2125.2009.03521.x  4.,Non-OADS,/arxiv_data1/oa_pdf/83/97/bm-27-404.PMC5493179.pdf
https://doi.org/10.1053/j.ajkd.2006.07.003  5.,Non-OADS,/arxiv_data1/oa_pdf/83/97/bm-27-404.PMC5493179.pdf
https://doi.org/10.1093/ ndt/gfu350  6.,Non-OADS,/arxiv_data1/oa_pdf/83/97/bm-27-404.PMC5493179.pdf
https://doi.org/10.1590/S0004-282X2005000300032  8.,Non-OADS,/arxiv_data1/oa_pdf/83/97/bm-27-404.PMC5493179.pdf
Urol Res 2011;39:303– 307. https://doi.org/10.1007/s00240-010-0347-5  9.,Non-OADS,/arxiv_data1/oa_pdf/83/97/bm-27-404.PMC5493179.pdf
https://doi.org/10.1111/bcp.12751 11.,Non-OADS,/arxiv_data1/oa_pdf/83/97/bm-27-404.PMC5493179.pdf
BMC Nephrol 2014;15:55. https://doi.org/10.1186/1471-2369-15-55 12.,Non-OADS,/arxiv_data1/oa_pdf/83/97/bm-27-404.PMC5493179.pdf
https://doi.org/10.4103/2230-8210.93745,Non-OADS,/arxiv_data1/oa_pdf/83/97/bm-27-404.PMC5493179.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creative - commons.org/licenses/by/4.0/) which permits users to read, download, copy, distribute, print, search, or link to the full texts of these articles in any medium or format and to remix, transform and build upon  the material, provided the original work is properly cited and any changes properly indicated  .Biochemia Medica 2017;27(2):350–77  https://doi.org/10.11613/BM.2017.038  350Abstract Introduction : A nationwide multicentre study was conducted to establish well-defined reference intervals (RIs) of haematological parameters for  the Turkish population in consideration of sources of variation in reference values (RVs).",Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.11613/BM.2017.038 Biochemia Medica 2017;27(2):350–77    351 Ozarda Y .,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
Biochemia Medica 2017;27(2): 350–77  https://doi.org/10.11613/BM.2017.038  352 Ozarda Y .,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.11613/BM.2017.038 Biochemia Medica 2017;27(2):350–77    353 Ozarda Y .,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
"Reference intervals of haematology parameters in TurkeyCVA, % Analytical system Centre Control WBC RBC Hb Hct MCV MCH MCHC RDW PLT MPV Fe Fer CBC Fe Fer Bursa C1 1.98 0.62 0.88 0.84 0.65 0.65 0.47 1.40 2.84 1.19 3.69 3.95 Cell  Dyne (A)Arcitect  16000 (A)Architect  i2000 (A) C2 1.67 0.54 0.69 1.01 0.51 0.69 0.45 1.53 2.38 0.79 2.41 3.21 İzmir C1 1.95 0.83 0.86 0.80 0.67 0.60 0.42 1.71 2.76 1.22 3.55 3.37LH780  (BC)AU 5800 (BC)Unicell  DXI 800  (BC)C2 1.80 0.52 0.62 0.92 0.55 0.68 0.44 1.62 2.69 0.96 2.72 3.64 Manisa C1 2.44 0.86 1.04 1.25 0.70 0.64 0.50 1.62 3.42 1.75 3.81 4.78LH780  (BC)ADVIA 1800  (S)ADVIA  Centaur  (S)C2 2.16 0.94 0.74 1.00 0.63 0.70 0.52 1.63 2.78 1.14 2.86 4.02 Antalya C1 1.93 0.76 1.11 0.93 0.59 0.61 0.48 1.69 3.12 1.32 3.05 3.24 2000i (S)Cobas  Integra800(S)Cobas  E601(S) C2 2.01 0.60 0.78 0.98 0.65 0.67 0.49 1.64 2.95 0.99 2.93 3.55 Mersin C1 1.79 0.74 0.94 1.22 0.69 0.62 0.65 1.45 3.15 0.98 3.44 4.04 2000i (S)Arcitect 8000  (A)ADVIA  Centaur  (S)C2 1.90 0.88 0.70 1.18 0.64 0.64 0.59 1.68 3.40 1.14 3.79 3.77 Diyarbakır C1 1.84 0.92 0.85 0.97 0.61 0.54 0.42 1.36 2.87 1.01 2.57 3.29 Rubi (A)Arcitect  16000 (A)Cobas  E601(R) C2 1.61 0.90 0.87 1.11 0.58 0.59 0.54 1.67 2.65 1.17 2.89 3.76 Urfa C1 1.82 0.83 1.15 0,95 0.60 0.59 0.39 1.55 3.26 1.73 3.05 3.91 Cell  Dyne (A)Arcitect  16000 (A)Architect  i2000 (A) C2 1.76 0.74 0.81 1.26 0.50 0.64 0.48 1.71 2.93 1.60 3.39 3.88 Ankara C1 2.42 0.81 0.73 0.82 0,62 0.67 0.51 1.64 2.77 1.45 4.13 3.76LH 780  (BC)AU 680 (BC)Unicell  DXI 800  (BC)C2 1.95 0.53 0.69 1.10 0.57 0.69 0.47 1.55 2.90 1.22 3.92 3.50 Konya C1 1.99 0.93 1.20 0.84 0.69 0.61 0.44 1.28 2.65 1.14 3.60 4.19 Cell  Dyne (A)Arcitect  16000 (A)Cobas  E601(S) C2 1.78 0.77 0.92 0,98 0.61 0.68 0.49 1.49 2.47 0.85 3.01 3.90 Erzurum C1 1.79 0.71 1.14 0.88 0.59 0.67 0.40 1.54 2.82 1.27 3.76 3.79LH 780  (BC)AU 5800 (BC)Unicell  DXI 800  (BC)C2 2.15 0.50 0.77 1.00 0.51 0.63 0.41 1.40 2.65 0.78 3.11 3.35 Ordu C1 2.03 0.89 1.09 0.99 0.68 0.59 0.49 1.19 3.33 0.96 2.95 4.41 Cell  Dyne (A)Arcitect 8000  (A)Architect  i2000 (A) C2 1.96 0.75 0.82 1.00 0.64 0.62 0.45 1.49 3.27 1.09 2.87 3.63 Trabzon C1 1.64 0.80 0.93 1.29 0.63 0.60 0.53 1.30 2.93 1.02 3.16 3.84LH 780  (BC)AU 5800 (BC)Unicell  DXI 800  (BC)C2 2.06 0.54 0.70 1.34 0.51 0.61 0.52 1.74 2.42 0.94 2.88 3.52 The desirable limits for CVAs were set as half of within-individual within-subject biologic variation (CVI) as reported on the Westgard website; https://www.westgard.",Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
Biochemia Medica 2017;27(2): 350–77  https://doi.org/10.11613/BM.2017.038  354 Ozarda Y .,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.11613/BM.2017.038 Biochemia Medica 2017;27(2):350–77    355 Ozarda Y .,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
Biochemia Medica 2017;27(2): 350–77  https://doi.org/10.11613/BM.2017.038  356 Ozarda Y .,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.11613/BM.2017.038 Biochemia Medica 2017;27(2):350–77    357 Ozarda Y .,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
Biochemia Medica 2017;27(2): 350–77  https://doi.org/10.11613/BM.2017.038  358 Ozarda Y .,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.11613/BM.2017.038 Biochemia Medica 2017;27(2):350–77    359 Ozarda Y .,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
Biochemia Medica 2017;27(2): 350–77  https://doi.org/10.11613/BM.2017.038  360 Ozarda Y .,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.11613/BM.2017.038 Biochemia Medica 2017;27(2):350–77    361 Ozarda Y .,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
Biochemia Medica 2017;27(2): 350–77  https://doi.org/10.11613/BM.2017.038  362 Ozarda Y .,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.11613/BM.2017.038 Biochemia Medica 2017;27(2):350–77    363 Ozarda Y .,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
Biochemia Medica 2017;27(2): 350–77  https://doi.org/10.11613/BM.2017.038  364 Ozarda Y .,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.11613/BM.2017.038 Biochemia Medica 2017;27(2):350–77    365 Ozarda Y .,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
Biochemia Medica 2017;27(2): 350–77  https://doi.org/10.11613/BM.2017.038  366 Ozarda Y .,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.11613/BM.2017.038 Biochemia Medica 2017;27(2):350–77    367 Ozarda Y .,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
Biochemia Medica 2017;27(2): 350–77  https://doi.org/10.11613/BM.2017.038  368 Ozarda Y .,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.11613/BM.2017.038 Biochemia Medica 2017;27(2):350–77    369 Ozarda Y .,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
Biochemia Medica 2017;27(2): 350–77  https://doi.org/10.11613/BM.2017.038  370 Ozarda Y .,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.11613/BM.2017.038 Biochemia Medica 2017;27(2):350–77    371 Ozarda Y .,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
Biochemia Medica 2017;27(2): 350–77  https://doi.org/10.11613/BM.2017.038  372 Ozarda Y .,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.11613/BM.2017.038 Biochemia Medica 2017;27(2):350–77    373 Ozarda Y .,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
Biochemia Medica 2017;27(2): 350–77  https://doi.org/10.11613/BM.2017.038  374 Ozarda Y .,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.11613/BM.2017.038 Biochemia Medica 2017;27(2):350–77    375 Ozarda Y .,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
Biochemia Medica 2017;27(2): 350–77  https://doi.org/10.11613/BM.2017.038  376 Ozarda Y .,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.1515/CCLM.2010.315  2.,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.1515/cclm-2013-0249  3.,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.1515/cclm-2013-0248 4.,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
Clin Chim Acta 2017;467:70-82. https://doi.org/10.1016/j.cca.2016.09.016  5.,OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.1515/cclm-2014-0228  6.,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.1373/clinchem.2015.240531  7. International Organization for Standardization.,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.11613/BM.2017.038 Biochemia Medica 2017;27(2):350–77    377 Ozarda Y .,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.11613/BM.2016.001  9.,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.1080/00365510410002797 10.,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.1097/PAT.0000000000000148 11.,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
Available at: http://sbu.saglik.gov.tr/Ekutupha-ne/kitaplar/EN%20YILLIK.pdf.,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.3109/00365519609088595 13.,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
Available at: http://www.westgard.com/biodatabase1.htm#11.,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.1016/j.cca.2014.01.025 16.,OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.1373/clinchem.2007.091843 17.,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.1515/cclm-2015-0490 18.,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
Clin Chem Lab Med 2015;5:371-6. https://doi.org/10.1515/cclm-2014-0927 19. International Council for Standardization in Haematology (ICSH).,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.1093/ajcp/100.4.37120.,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.1007/BF02598003 24.,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.1515/CCLM.2006.139 25.,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.1080/00365510410006324 26.,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.1002/ajh.10011 27.,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
https://doi.org/10.5505/tjb.2013.68077 30.,Non-OADS,/arxiv_data1/oa_pdf/58/75/bm-27-350.PMC5493180.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creative - commons.org/licenses/by/4.0/) which permits users to read, download, copy, distribute, print, search, or link to the full texts of these articles in any medium or format and to remix, transform and build upon  the material, provided the original work is properly cited and any changes properly indicated  .Biochemia Medica 2017;27(2):398–403   https://doi.org/10.11613/BM.2017.041  398Abstract Introduction : This study aimed to establish whether an alcoholic antiseptic, wiped or not before venipuncture, may jeopardize alcohol testing with  a commercial enzymatic assay and a reference head-space gas chromatography (GC) technique.",Non-OADS,/arxiv_data1/oa_pdf/c0/5b/bm-27-398.PMC5493181.pdf
https://doi.org/10.11613/BM.2017.041 Biochemia Medica 2017;27(2):398–403    399 Lippi G. et al.,Non-OADS,/arxiv_data1/oa_pdf/c0/5b/bm-27-398.PMC5493181.pdf
Biochemia Medica 2017;27(2): 398–403  https://doi.org/10.11613/BM.2017.041  400 Lippi G. et al.,Non-OADS,/arxiv_data1/oa_pdf/c0/5b/bm-27-398.PMC5493181.pdf
https://doi.org/10.11613/BM.2017.041 Biochemia Medica 2017;27(2):398–403    401 Lippi G. et al.,Non-OADS,/arxiv_data1/oa_pdf/c0/5b/bm-27-398.PMC5493181.pdf
Biochemia Medica 2017;27(2): 398–403  https://doi.org/10.11613/BM.2017.041  402 Lippi G. et al.,Non-OADS,/arxiv_data1/oa_pdf/c0/5b/bm-27-398.PMC5493181.pdf
https://doi.org/10.11613/BM.2017.041 Biochemia Medica 2017;27(2):398–403    403 Lippi G. et al.,Non-OADS,/arxiv_data1/oa_pdf/c0/5b/bm-27-398.PMC5493181.pdf
Nurs Stand  2005;19:55-65. https://doi.org/10.7748/ns2005.08.19.49.55.c3936  2.,Non-OADS,/arxiv_data1/oa_pdf/c0/5b/bm-27-398.PMC5493181.pdf
Biochem Med (Zagreb) 2016;26:17-33. https://doi.org/10.11613/BM.2016.002  3.,Non-OADS,/arxiv_data1/oa_pdf/c0/5b/bm-27-398.PMC5493181.pdf
Biochem Med (Zagreb) 2013;23:242-54. https://doi.org/10.11613/BM.2013.031  8.,Non-OADS,/arxiv_data1/oa_pdf/c0/5b/bm-27-398.PMC5493181.pdf
Clin Chem Lab Med 2011;49:9-11. https://doi.org/10.1515/CCLM.2011.025 10.,Non-OADS,/arxiv_data1/oa_pdf/c0/5b/bm-27-398.PMC5493181.pdf
J  Emerg Med 1997;15:687-92. https://doi.org/10.1016/S0736- 4679(97)00150-9 11.,Non-OADS,/arxiv_data1/oa_pdf/c0/5b/bm-27-398.PMC5493181.pdf
J Chro - matogr 1992;580:161-90. https://doi.org/10.1016/0378- 4347(92)80534-W 12.,Non-OADS,/arxiv_data1/oa_pdf/c0/5b/bm-27-398.PMC5493181.pdf
J Anal Toxicol 2013;37:552-8. https://doi.org/10.1093/jat/bkt059 13.,Non-OADS,/arxiv_data1/oa_pdf/c0/5b/bm-27-398.PMC5493181.pdf
Biochem Med (Zagreb) 2013;23:201-5. https://doi.org/10.11613/BM.2013.023 14.,Non-OADS,/arxiv_data1/oa_pdf/c0/5b/bm-27-398.PMC5493181.pdf
https://doi.org/10.7860/jcdr/2016/15967.7245 15.,Non-OADS,/arxiv_data1/oa_pdf/c0/5b/bm-27-398.PMC5493181.pdf
J Hosp Infect 2004;56:287-90. https://doi.org/10.1016/j.jhin.2004.01.00517.,OADS,/arxiv_data1/oa_pdf/c0/5b/bm-27-398.PMC5493181.pdf
Biochem Med (Zagreb)  2013;23:308-15. https://doi.org/10.11613/BM.2013.037 18.,Non-OADS,/arxiv_data1/oa_pdf/c0/5b/bm-27-398.PMC5493181.pdf
Available at: http://etsc.eu/blood-alcohol-content-bac-drink-driving-li-mits-across-europe.,Non-OADS,/arxiv_data1/oa_pdf/c0/5b/bm-27-398.PMC5493181.pdf
Leg Med (Tokyo) 2005;7:299-305. https://doi.org/10.1016/j.legalmed.2005.05.003 21.,OADS,/arxiv_data1/oa_pdf/c0/5b/bm-27-398.PMC5493181.pdf
Clin Chem Lab Med 2016;54:755-60. https://doi.org/10.1515/cclm-2015-1274 22.,Non-OADS,/arxiv_data1/oa_pdf/c0/5b/bm-27-398.PMC5493181.pdf
Biochem Med (Zagreb) 2015;25:57-63. https://doi.org/10.11613/BM.2015.006 24.,Non-OADS,/arxiv_data1/oa_pdf/c0/5b/bm-27-398.PMC5493181.pdf
Ann Emerg Med 1982;11:665-7. https://doi.org/10.1016/S0196-0644(82)80260-6 25.,OADS,/arxiv_data1/oa_pdf/c0/5b/bm-27-398.PMC5493181.pdf
Ther Drug Monit 2005;27:403-4. https://doi.org/10.1097/01.ftd.0000158868.74618.dd 28.,Non-OADS,/arxiv_data1/oa_pdf/c0/5b/bm-27-398.PMC5493181.pdf
J Emerg Med 2007;33:9-10. https://doi.org/10.1016/j.jemermed.2006.10.005 29.,OADS,/arxiv_data1/oa_pdf/c0/5b/bm-27-398.PMC5493181.pdf
Emerg Med Australas 2010;22:9-12. https://doi.org/10.1111/j.1742-6723.2009.01248.x 30.,Non-OADS,/arxiv_data1/oa_pdf/c0/5b/bm-27-398.PMC5493181.pdf
J Emerg Med 2012;43:718-9. https://doi.org/10.1016/j.jemermed.2011.07.025,OADS,/arxiv_data1/oa_pdf/c0/5b/bm-27-398.PMC5493181.pdf
"Key Words:  Children, Aortic aneurysm, Renovascular hypertension, Portal  hypertension, Thrombectomy, Autotransplantation Copyright © 2017, The Korean Society for Vascular Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/15/vsi-33-047.PMC5493186.pdf
Vasc Spec Int 2017;33(2):47-54  • https://doi.org/10.5758/vsi.2017.33.2.47Review,Non-OADS,/arxiv_data1/oa_pdf/1f/15/vsi-33-047.PMC5493186.pdf
https://doi.org/10.5758/vsi.2017.33.2.47 Pediatric Vascular Surgery Review 49necessary.,Non-OADS,/arxiv_data1/oa_pdf/1f/15/vsi-33-047.PMC5493186.pdf
https://doi.org/10.5758/vsi.2017.33.2.47 Pediatric Vascular Surgery Review 51held Doppler.,Non-OADS,/arxiv_data1/oa_pdf/1f/15/vsi-33-047.PMC5493186.pdf
"https://doi.org/10.5758/vsi.2017.33.2.47 Pediatric Vascular Surgery Review 53VASCULAR ACCESS FOR HEMODIALYSIS In the pediatric population, vascular access for hemo - dialysis is a challenge to vascular surgeons.",Non-OADS,/arxiv_data1/oa_pdf/1f/15/vsi-33-047.PMC5493186.pdf
"Key Words:  Femorofemoral, Bypass, Iliac artery, Vascular patency Copyright © 2017, The Korean Society for Vascular Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/51/vsi-33-055.PMC5493187.pdf
Vasc Spec Int 2017;33(2):55-58  • https://doi.org/10.5758/vsi.2017.33.2.55,Non-OADS,/arxiv_data1/oa_pdf/2f/51/vsi-33-055.PMC5493187.pdf
https://doi.org/10.5758/vsi.2017.33.2.55 Femorofemoral Bypass Graft 57months).,Non-OADS,/arxiv_data1/oa_pdf/2f/51/vsi-33-055.PMC5493187.pdf
"Key Words:  Aortic aneurysm, abdominal, Endovascular procedures, Stents, Endoleak Copyright © 2017, The Korean Society for Vascular Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/53/vsi-33-059.PMC5493188.pdf
Vasc Spec Int 2017;33(2):59-64  • https://doi.org/10.5758/vsi.2017.33.2.59,Non-OADS,/arxiv_data1/oa_pdf/1f/53/vsi-33-059.PMC5493188.pdf
"https://doi.org/10.5758/vsi.2017.33.2.59 Endovascular Repair of Aneurysm with Conical Neck Anatomy 61migration, and patency of the stent graft.",Non-OADS,/arxiv_data1/oa_pdf/1f/53/vsi-33-059.PMC5493188.pdf
https://doi.org/10.5758/vsi.2017.33.2.59 Endovascular Repair of Aneurysm with Conical Neck Anatomy 63distal and largest neck diameter.,Non-OADS,/arxiv_data1/oa_pdf/1f/53/vsi-33-059.PMC5493188.pdf
"Key Words:  Infrainguinal, Bypass, Composite graft  Copyright © 2017, The Korean Society for Vascular Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/08/vsi-33-065.PMC5493189.pdf
Vasc Spec Int 2017;33(2):65-71  • https://doi.org/10.5758/vsi.2017.33.2.65,Non-OADS,/arxiv_data1/oa_pdf/cc/08/vsi-33-065.PMC5493189.pdf
https://doi.org/10.5758/vsi.2017.33.2.65 Results of Infrainguinal Composite Graft 67with a composite graft.,Non-OADS,/arxiv_data1/oa_pdf/cc/08/vsi-33-065.PMC5493189.pdf
https://doi.org/10.5758/vsi.2017.33.2.65 Results of Infrainguinal Composite Graft 69makes the distal anastomosis feasible and redundant.,Non-OADS,/arxiv_data1/oa_pdf/cc/08/vsi-33-065.PMC5493189.pdf
"https://doi.org/10.5758/vsi.2017.33.2.65 Results of Infrainguinal Composite Graft 7119) Quiñones-Baldrich WJ, Prego AA,  Ucelay-Gomez R, Freischlag JA, Ahn  SS, Baker JD, et al.",OADS,/arxiv_data1/oa_pdf/cc/08/vsi-33-065.PMC5493189.pdf
"Key Words:  Aortic aneurysm, Endovascular, Double barrel, Sandwich, Endovascular  aneurysm repair Copyright © 2017, The Korean Society for Vascular Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/be/vsi-33-072.PMC5493190.pdf
Vasc Spec Int 2017;33(2):72-80  • https://doi.org/10.5758/vsi.2017.33.2.72,Non-OADS,/arxiv_data1/oa_pdf/8e/be/vsi-33-072.PMC5493190.pdf
"https://doi.org/10.5758/vsi.2017.33.2.72 Experiences of ST during EVAR 73(CIA) aneurysms is found in 55% to 65% of AAA patients in  Asia [2,3], and requires a more demanding procedure due  to potential difficulties in obtaining adequate distal landing  zones for stent-graft limb fixation.",Non-OADS,/arxiv_data1/oa_pdf/8e/be/vsi-33-072.PMC5493190.pdf
"https://doi.org/10.5758/vsi.2017.33.2.72 Experiences of ST during EVAR 75type of devices used to treat each of the three types of  aneurysmal diseases (AIA, AAA plus short healthy CIA, AAA  plus unilateral CIA) are summarized in Table 2 and Table 3 .",OADS,/arxiv_data1/oa_pdf/8e/be/vsi-33-072.PMC5493190.pdf
https://doi.org/10.5758/vsi.2017.33.2.72 Experiences of ST during EVAR 77Only one gutter endoleak were detected on completion  angiography.,Non-OADS,/arxiv_data1/oa_pdf/8e/be/vsi-33-072.PMC5493190.pdf
"https://doi.org/10.5758/vsi.2017.33.2.72 Experiences of ST during EVAR 79was observed in final angiography, additional stents were  used.",Non-OADS,/arxiv_data1/oa_pdf/8e/be/vsi-33-072.PMC5493190.pdf
"Key Words:  Endoleak, Aortic aneurysm, Endovascular procedures Copyright © 2017, The Korean Society for Vascular Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/50/vsi-33-081.PMC5493191.pdf
Vasc Spec Int 2017;33(2):81-83  • https://doi.org/10.5758/vsi.2017.33.2.81,Non-OADS,/arxiv_data1/oa_pdf/0a/50/vsi-33-081.PMC5493191.pdf
"https://doi.org/10.5758/vsi.2017.33.2.81 Late Type 3b Endoleak Mimicking Type 2 Endoleak 83During the operation, multiple leaks from the suture holes  on endograft were found (Fig.",Non-OADS,/arxiv_data1/oa_pdf/0a/50/vsi-33-081.PMC5493191.pdf
"Key Words:  Renal artery aneurysm, Auto-transplantation, Hand-assisted  laparoscopy Copyright © 2017, The Korean Society for Vascular Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/42/89/vsi-33-084.PMC5493192.pdf
Vasc Spec Int 2017;33(2):84-87  • https://doi.org/10.5758/vsi.2017.33.2.84,Non-OADS,/arxiv_data1/oa_pdf/42/89/vsi-33-084.PMC5493192.pdf
https://doi.org/10.5758/vsi.2017.33.2.84 Surgery for Hilar RAA 85ography did not reveal any atherosclerotic changes in the  iliac arteries.,Non-OADS,/arxiv_data1/oa_pdf/42/89/vsi-33-084.PMC5493192.pdf
"https://doi.org/10.5758/vsi.2017.33.2.84 Surgery for Hilar RAA 876) Desai CS, Maybury R, Cummings LS,  Johnson LB, Fishbein TM, Neville R,  et al.",Non-OADS,/arxiv_data1/oa_pdf/42/89/vsi-33-084.PMC5493192.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/af/a0/tcrm-13-647.PMC5493201.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 647–653Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  647ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/TCRM.S11222 7 effect of treatment with single total-dose  intravenous iron versus daily oral iron(iii)- hydroxide polymaltose on moderate puerperal  iron-deficiency anemia Chukwuemeka anthony  iyoke1 Fausta Chioma emegoakor1 euzebus Chinonye ezugwu1 lucky Osaheni lawani2 leonard Ogbonna ajah1 Jude anazoeze Madu3 hyginus Uzo ezegwui1 Frank Okechukwu ezugwu4 1Department of Obstetrics and  gynaecology, University of nigeria,    enugu Campus, 2Department  of Obstetrics and gynaecology,   Federal T eaching hospital, abakaliki,   3Department of haematology,   University of nigeria, nsukka,   4Department of Obstetrics and  gynaecology, College of Medicine,   enugu state University, enugu, nigeriaBackground:  Iron-deficiency anemia is the most common nutritional cause of anemia in  pregnancy and is often responsible for puerperal anemia.",Non-OADS,/arxiv_data1/oa_pdf/af/a0/tcrm-13-647.PMC5493201.pdf
"Keywords:  effect, intravenous, iron, puerperal, anemia Introduction Postpartum anemia is a major contributor to puerperal complications with the risk  being greatest among those women who were anemic in pregnancy.1,2 Anemia (occur - ring in pregnancy or postpartum) has been implicated as a significant cause of direct  and indirect maternal and perinatal morbidity and mortality.3–8 The associations  between anemia and reduced work performance/productivity,9,10 impaired cognition8 Correspondence: Chukwuemeka  anthony iyoke Department of Obstetrics and  gynaecology, University of nigeria,  enugu Campus, PO Box 4994, enugu  headquarters, enugu 400001, nigeria Tel +234 42 80 8583 1167 email chukwuemeka.iyoke@unn.edu.n g Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Iyoke et al Running head recto: Use of total-dose intravenous iron for treatment of moderate puerperal anemia DOI: http://dx.doi.org/10.2147/TCRM.S112227",Non-OADS,/arxiv_data1/oa_pdf/af/a0/tcrm-13-647.PMC5493201.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/af/a0/tcrm-13-647.PMC5493201.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/af/a0/tcrm-13-647.PMC5493201.pdf
"DOI: https://doi.org/10.1200/JGO.2016.003392 Published online on jgo.org on July 20, 2016.",OADS,/arxiv_data1/oa_pdf/ee/06/JGO.2016.003392.PMC5493216.pdf
"mechanism for real-time, daily or more frequent, monitoring of levels of symptoms.DOI: https://doi.org/10.1200/JGO.2016.004119 Published online on jgo.org on July 27, 2016.",Non-OADS,/arxiv_data1/oa_pdf/94/cd/JGO.2016.004119.PMC5493217.pdf
http://www.painpolicy.wisc.edu/countryprofiles 7.The Economist Intelligence Unit: The 2015 Quality of Death Index.,Non-OADS,/arxiv_data1/oa_pdf/94/cd/JGO.2016.004119.PMC5493217.pdf
"DOI: https://doi.org/10.1200/JGO.2016.005579 Published online on jgo.org on August 24, 2016.",OADS,/arxiv_data1/oa_pdf/6a/49/JGO.2016.005579.PMC5493222.pdf
http://www.msp.,Non-OADS,/arxiv_data1/oa_pdf/6a/49/JGO.2016.005579.PMC5493222.pdf
http://www.dof.gob.mx/nota_detalle.php?,Non-OADS,/arxiv_data1/oa_pdf/6a/49/JGO.2016.005579.PMC5493222.pdf
1733. http://wsp.presidencia.gov.co/ Normativa/Leyes/Documents/LEY%201733%20DEL%2008%20DE%20SEPTIEMBRE%20DE%202014.pdf 16.,Non-OADS,/arxiv_data1/oa_pdf/6a/49/JGO.2016.005579.PMC5493222.pdf
Ley 68 de 20 de Noviembre del a~no 2003. http://www.css.gob.pa/Ley% 2068%20del%2020%20de%20noviembre%20de%202003.pdf 18.,Non-OADS,/arxiv_data1/oa_pdf/6a/49/JGO.2016.005579.PMC5493222.pdf
http://www.aldf.gob.mx/archivo-077346ece61525438e126242a37d313e.pdf 19.,Non-OADS,/arxiv_data1/oa_pdf/6a/49/JGO.2016.005579.PMC5493222.pdf
Ley N° 18.473. https://sip21-webext.parlamento.gub.uy/temporales/leytemp9746455.htm 20.,Non-OADS,/arxiv_data1/oa_pdf/6a/49/JGO.2016.005579.PMC5493222.pdf
Ley 26.742. http://www.infoleg.gov.ar/ infolegInternet/anexos/195000-199999/197859/norma.htm 21.,Non-OADS,/arxiv_data1/oa_pdf/6a/49/JGO.2016.005579.PMC5493222.pdf
http://www.portalmedico.org.br/resolucoes/CFM/2012/1995_2012.pdf 22.,Non-OADS,/arxiv_data1/oa_pdf/6a/49/JGO.2016.005579.PMC5493222.pdf
http://www.eiuperspectives.economist.com/healthcare/2015-quality-death-index 24.,Non-OADS,/arxiv_data1/oa_pdf/6a/49/JGO.2016.005579.PMC5493222.pdf
http://www.lawreform.ie/_fileupload/ reports/rbioethics.pdf 25.,Non-OADS,/arxiv_data1/oa_pdf/6a/49/JGO.2016.005579.PMC5493222.pdf
https://www.congress.gov/bill/101st- congress/house-bill/4449 27.,Non-OADS,/arxiv_data1/oa_pdf/6a/49/JGO.2016.005579.PMC5493222.pdf
https://rm.coe.,Non-OADS,/arxiv_data1/oa_pdf/6a/49/JGO.2016.005579.PMC5493222.pdf
http://www.salud.gob.mx/unidades/cdi/nom/compi/rlgsmpsam.html 29.,Non-OADS,/arxiv_data1/oa_pdf/6a/49/JGO.2016.005579.PMC5493222.pdf
"Ley 26.529. http://www.infoleg.gov.ar/infolegInternet/anexos/160000-164999/160432/norma.htm 269 Volume 3, Issue 3, June 2017 jgo.org JGO –J o u r n a lo fG l o b a lO n c o l o g y",Non-OADS,/arxiv_data1/oa_pdf/6a/49/JGO.2016.005579.PMC5493222.pdf
http://conbioetica-mexico.salud.gob.mx/descargas/pdf/voluntades_anticipadas.pdf 31.,Non-OADS,/arxiv_data1/oa_pdf/6a/49/JGO.2016.005579.PMC5493222.pdf
http://www.notariadomexicano.org.,Non-OADS,/arxiv_data1/oa_pdf/6a/49/JGO.2016.005579.PMC5493222.pdf
http://www.excelsior.com.mx/comunidad/2015/01/ 08/1001508 33.,Non-OADS,/arxiv_data1/oa_pdf/6a/49/JGO.2016.005579.PMC5493222.pdf
http://www.incb.org/documents/Publications/AnnualReports/AR2015/English/ Supplement-AR15_availability_English.pdf 41.,Non-OADS,/arxiv_data1/oa_pdf/6a/49/JGO.2016.005579.PMC5493222.pdf
http://www.painpolicy.wisc.,Non-OADS,/arxiv_data1/oa_pdf/6a/49/JGO.2016.005579.PMC5493222.pdf
http://hospicecare.com/resources/ projects/opioid-price-watch/ 44.,Non-OADS,/arxiv_data1/oa_pdf/6a/49/JGO.2016.005579.PMC5493222.pdf
"DOI: https://doi.org/10.1200/JGO.2016.006148 Published online on jgo.org on September 21, 2016.",OADS,/arxiv_data1/oa_pdf/2e/c0/JGO.2016.006148.PMC5493225.pdf
Available at: http://www.planalto.gov.br/ccivil_03/constituicao/Consituicao.htm 2.,Non-OADS,/arxiv_data1/oa_pdf/2e/c0/JGO.2016.006148.PMC5493225.pdf
Di ´ario Oficial da Uni~ao.http://bvsms.saude.gov.br/bvs/saudelegis/gm/2013/prt0874_16_05_2013.html 7.,Non-OADS,/arxiv_data1/oa_pdf/2e/c0/JGO.2016.006148.PMC5493225.pdf
"Tanzania Ministry of Health and Social Welfare: Tanzania HIV Rapid Test Algorithm, 2007. http://ihi.eprints.org/823/1/ MoHSW.pdf_%2853%29.pdf 7.",Non-OADS,/arxiv_data1/oa_pdf/d6/f6/JGO.2015.002964.PMC5493231.pdf
Gastrointestinal Carcinoid Tumours Treatment (PDQ®).http://www.cancer.gov/types/gi-carcinoid-tumors/patient/ gi-carcinoid-treatment-pdq 11.,Non-OADS,/arxiv_data1/oa_pdf/9f/36/JGO.2015.002980.PMC5493232.pdf
http://www.ihi.org/Engage/Initiatives/TripleAim/Pages/ default.aspx 18.,Non-OADS,/arxiv_data1/oa_pdf/9f/36/JGO.2015.002980.PMC5493232.pdf
http://www.psqh.com/marapr08/ahrq.html 23.,Non-OADS,/arxiv_data1/oa_pdf/9f/36/JGO.2015.002980.PMC5493232.pdf
"1-360, 2015. https://www.nationalacademies.org/hmd/ ~/media/Files/Report%20Files/2001/ Crossing-the-Quality-Chasm/Quality%20Chasm%202001%20%20report%20brief.pdf 24.",Non-OADS,/arxiv_data1/oa_pdf/9f/36/JGO.2015.002980.PMC5493232.pdf
http://data.worldbank.org/country/lebanon 20.,Non-OADS,/arxiv_data1/oa_pdf/45/11/JGO.2016.003103.PMC5493233.pdf
http://www.who.int/countries/lbn/en/ 21.,Non-OADS,/arxiv_data1/oa_pdf/45/11/JGO.2016.003103.PMC5493233.pdf
http://www.moph.gov.lb/prevention/Surveillance/ Pages/Cancer.aspx 22.,Non-OADS,/arxiv_data1/oa_pdf/45/11/JGO.2016.003103.PMC5493233.pdf
"American Cancer Society: Cancer facts and figures 2014. http://www.cancer.org/research/cancerfactsstatistics/ cancerfactsfigures2014/ 30Volume 3, Issue 1, February 2017 jgo.org JGO –J o u r n a lo fG l o b a lO n c o l o g y",Non-OADS,/arxiv_data1/oa_pdf/45/11/JGO.2016.003103.PMC5493233.pdf
http://www2.inca.gov.br/wps/wcm/connect/ tiposdecancer/site/home/pancreas 3.,Non-OADS,/arxiv_data1/oa_pdf/db/69/JGO.2016.003269.PMC5493234.pdf
http://sigtap.datasus.gov.br/tabela-unificada/app/sec/inicio.jsp 11.,OADS,/arxiv_data1/oa_pdf/db/69/JGO.2016.003269.PMC5493234.pdf
Instituto Brasileiro de Geografia e Estat ´ıstica: (Pnad) de 2008. http://www.ibge.gov.br/home/estatistica/populacao/ trabalhoerendimento/pnad2008 15.,Non-OADS,/arxiv_data1/oa_pdf/db/69/JGO.2016.003269.PMC5493234.pdf
http://globocan.iarc.fr 2.,Non-OADS,/arxiv_data1/oa_pdf/16/9b/JGO.2015.002469.PMC5493244.pdf
http://screening.iarc.fr/ doc/SAcervical-cancer.pdf 16.,Non-OADS,/arxiv_data1/oa_pdf/16/9b/JGO.2015.002469.PMC5493244.pdf
http://www.unaids.org/sites/default/files/media_asset/ UNAIDS_Gap_report_en.pdf 27.,OADS,/arxiv_data1/oa_pdf/16/9b/JGO.2015.002469.PMC5493244.pdf
"National Cancer Institute: SEER cancer statistics review (CSR), 1975-2011. http://seer.cancer.gov/csr/1975_2012/ 41.",Non-OADS,/arxiv_data1/oa_pdf/16/9b/JGO.2015.002469.PMC5493244.pdf
"JAMA Oncol 1:505-527, 2015 [Erratum: JAMA Oncol 1:690, 2015] 7. International Agency for Research on Cancer: GLOBOCAN 2012: Estimated cancer incidence, mortality and prev- alence worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx 8.",Non-OADS,/arxiv_data1/oa_pdf/76/c7/JGO.2016.005397.PMC5493252.pdf
http://www.cen.scot.nhs.uk/files/ 4z-scope_right_from_th e_start_template.pdf 4.,Non-OADS,/arxiv_data1/oa_pdf/d8/02/JGO.2015.001925.PMC5493260.pdf
http://www.gmc-uk.org/guidance/good_medical_practice.asp 5.,Non-OADS,/arxiv_data1/oa_pdf/d8/02/JGO.2015.001925.PMC5493260.pdf
http://seer.cancer.gov/statfacts/html/ lungb.html 14.,Non-OADS,/arxiv_data1/oa_pdf/60/5f/JGO.2015.002105.PMC5493261.pdf
"REFERENCES references 1. International Agency for Research on Cancer: GLOBOCAN 2012 Cervical Cancer: Estimated Incidence, Mortality and Prevalence Worldwide in 2012. http://globocan.iarc.fr/old/FactSheets/cancers/cervix-new.asp 2.",Non-OADS,/arxiv_data1/oa_pdf/cf/f6/JGO.2016.003954.PMC5493265.pdf
"Howlader N, Noone AM, Krapcho M, et al: SEER Cancer Statistics Review, 1975-2012. http://seer.cancer.gov/csr/ 1975_2012/ 3.",OADS,/arxiv_data1/oa_pdf/cf/f6/JGO.2016.003954.PMC5493265.pdf
Catholic Campaign for Human Development: Interrelationships of three-year average state poverty rates: 2011-2013. http://www.povertyusa.org/the-state-of-poverty/poverty-map-state/# 4.,Non-OADS,/arxiv_data1/oa_pdf/cf/f6/JGO.2016.003954.PMC5493265.pdf
https://www.cancercare.on.ca/common/pages/ UserFile.aspx?fileId 5340742 6.,Non-OADS,/arxiv_data1/oa_pdf/cf/f6/JGO.2016.003954.PMC5493265.pdf
http://www.who.int/cancer/publications/nccp2002/en/ 11.,Non-OADS,/arxiv_data1/oa_pdf/cf/f6/JGO.2016.003954.PMC5493265.pdf
http://www.g-i-n.net/document-store/ working-groups-documents/adaptation/adapte-resource-toolkit-guideline-adaptation-2-0.pdf 14.,Non-OADS,/arxiv_data1/oa_pdf/cf/f6/JGO.2016.003954.PMC5493265.pdf
http://www.cancer.gov/types/ cervical/hp/cervical-treatment-pdq 39.,Non-OADS,/arxiv_data1/oa_pdf/cf/f6/JGO.2016.003954.PMC5493265.pdf
http://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_R19-en.pdf 56.,Non-OADS,/arxiv_data1/oa_pdf/cf/f6/JGO.2016.003954.PMC5493265.pdf
http://data.worldbank.org/indicator/NY.GNP.PCAP.CD?,Non-OADS,/arxiv_data1/oa_pdf/cf/f6/JGO.2016.003954.PMC5493265.pdf
"Data adapted ( http://apps.who.int/iris/bitstream/10665/94830/1/9789241548694_eng.pdf ).11,12Table A1 –Guidelines Considered in ADAPTE Process Guideline Link Colombo6(ESMO) http://annonc.oxfordjournals.org/content/23/suppl_7/vii27.full Koh18(NCCN) http://www.nccn.org/profe ssionals/physi cian_gls/pdf/cer vical_basic.pdf Koh16(NCCN) http://www.nccn.org/profe ssionals/physici an_gls/pdf/cervi cal_limited.pdf Koh17(NCCN) http://www.nccn.org/profe ssionals/physici an_gls/pdf/cervi cal_enhanced.pdf Koh8(NCCN) http://www.nccn.org/professionals /physician_gls/ pdf/cervical.pdf Hirte4(CCO) https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId 534224 Elit5(CCO) https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId 514090 Ebina7(JSGO) http://link.springer.com/article/10.1007/s10147-015-0806-7 WHO9http://www.who.int/reproductivehealth/publications/cancers/cervical-cancer-guide/en/ Abbreviations: CCO, Cancer Care Ontario; ESMO, European Society of Medical Oncology; JSGO, Japan Society of Gynecologic Oncology; NCCN, National Comprehensive Cancer Network.",Non-OADS,/arxiv_data1/oa_pdf/cf/f6/JGO.2016.003954.PMC5493265.pdf
http://medical-dictionary.thefreedictionary.com/breast 1cancer 2. WHO: Cancer fact sheet.,Non-OADS,/arxiv_data1/oa_pdf/98/68/JGO.2016.003509.PMC5493274.pdf
http://www.who.int/mediacentre/factsheets/fs297/en/ 3.,Non-OADS,/arxiv_data1/oa_pdf/98/68/JGO.2016.003509.PMC5493274.pdf
http://globocan.iarc.fr/old/su mmary_table_site-html.asp?,Non-OADS,/arxiv_data1/oa_pdf/98/68/JGO.2016.003509.PMC5493274.pdf
http://globocan.iarc.fr/ old/burden.asp?selection_pop=143 566&Text-p=Nigeria&selection_ca ncer=3152&Text-c=Breast&pYear=23& type=0&window=1&submit=%C2%A0Execute%C2%A0 5.,Non-OADS,/arxiv_data1/oa_pdf/98/68/JGO.2016.003509.PMC5493274.pdf
http://www.courier-journal.com/story/prime/ 2013/10/24/breast-cancer-inspires-breaking-guinness-world-records-record/3177439/ 8.,Non-OADS,/arxiv_data1/oa_pdf/98/68/JGO.2016.003509.PMC5493274.pdf
http://www.guinnessworldrecords.,Non-OADS,/arxiv_data1/oa_pdf/98/68/JGO.2016.003509.PMC5493274.pdf
"The Economic Times, India Times, May 17, 2016. http://economictimes.indiatimes.com/industry/ healthcare/biotech/pharmaceuticals/roche-moves-court-to-block-copies-of-cancer-drug-avastin-a-la-herceptin/articleshow/52289691.cms 15.",Non-OADS,/arxiv_data1/oa_pdf/28/67/JGO.2016.004895.PMC5493276.pdf
http://www.gavi.org/support/nvs/ human-papillomavirus-vaccine-support/ 22.,Non-OADS,/arxiv_data1/oa_pdf/28/67/JGO.2016.004895.PMC5493276.pdf
"The determination of which images were poor used a previously published criterion outlined in Maul et al.13 Using ImageJ software (http://imagej.nih.gov/ij/; provided in the public domain by the National Institutes of Health, Bethesda, MD, USA), the manually outlined choroid was isolated from the background OCT (Fig.",OADS,/arxiv_data1/oa_pdf/57/be/i1552-5783-58-7-3278.PMC5493330.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/6/e1700580/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/bc/b4/1700580.PMC5493412.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/6/e1700345/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/2e/2d/1700345.PMC5493413.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/6/e1602738/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/f2/8f/1602738.PMC5493414.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/6/e1700071/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/be/0a/1700071.PMC5493415.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/6/e1602363/DC1 Data Outliers removalVisualization of the SEFsModified Thompson tau testDiscrepancy measures between SEFs of small and large unitstable S1.,Non-OADS,/arxiv_data1/oa_pdf/6b/f2/1602363.PMC5493417.pdf
"“Key facts in Canada ’s robocalls controversy ”, CBC News, 14 August 2014, http://www.cbc.",Non-OADS,/arxiv_data1/oa_pdf/6b/f2/1602363.PMC5493417.pdf
"“Film of Zimbabwe ‘vote-rigging ’”, BBC News, 5 July 2008, http://news.bbc.co.uk/2/hi/ africa/7491077.stm.",Non-OADS,/arxiv_data1/oa_pdf/6b/f2/1602363.PMC5493417.pdf
"“Zim voter ‘rigging ’captured on camera ”, news24, 1 August 2013, http://www.news24.",Non-OADS,/arxiv_data1/oa_pdf/6b/f2/1602363.PMC5493417.pdf
"“Russians vote in national parliamentary elections ”, The Guardian, 4 December 2011, https://www.theguardian.com/world/2011/dec/04/russians-vote-national-parliamentary-elections.",Non-OADS,/arxiv_data1/oa_pdf/6b/f2/1602363.PMC5493417.pdf
"“Abusos con voto asistido empañan resultados del 14-A ”, El Nacional, 21 April 2013, http://redobservacionelectoral.info/abusos-con -voto-asistido-empanan-resultados-del-14-a/.",Non-OADS,/arxiv_data1/oa_pdf/6b/f2/1602363.PMC5493417.pdf
"“Observadores electorales atacados en las elecciones del pasado 14 de abril ”, Dailymotion, 6 May 2013, http://www.dailymotion.com/video/xzn7kc_observadores-electorales-atacados-en-las-elecciones-del-pasado-14-de-abril_news.",Non-OADS,/arxiv_data1/oa_pdf/6b/f2/1602363.PMC5493417.pdf
"“INFORME FINAL OBSERVACIÓN ELECCIONES PRESIDENCIALES 14 DE ABRIL DE 2013 ”, Observatorio Electoral Venezolano, Caracas, Venezuela, May 2013, http://www.oevenezolano.",Non-OADS,/arxiv_data1/oa_pdf/6b/f2/1602363.PMC5493417.pdf
"“RECURSO CONTENCIOSO ELECTORAL ”, Sala Electoral del Tribunal Supremo de Justicia REPÚBLICA BOLIVARIANA DE VENEZUELA, Caracas, Venezuela, 2 May 2013, http://esdata.info/pdf/201304-RecursoContenciosoElectoral.pdf.",Non-OADS,/arxiv_data1/oa_pdf/6b/f2/1602363.PMC5493417.pdf
"Elecciones Asamblea Nacional 2015 Venezuela ”, Instituto Interamericano de Derechos Humanos, 2016, https://www.iidh.ed.cr/IIDH/media/3651/informe-final-capel-2015.pdf.",Non-OADS,/arxiv_data1/oa_pdf/6b/f2/1602363.PMC5493417.pdf
"27 January 2014, Warsaw, Poland, http://www.osce.org/o dihr/elections/russia/21482?download=true.",Non-OADS,/arxiv_data1/oa_pdf/6b/f2/1602363.PMC5493417.pdf
"L. Van den Brande, “Observation of the parliamentary elections in the Russian Federation (2 December 2007) ”, Ad hoc Committee of the Bureau of the Assembly, 20 December 2007, Belgium, http://assembly.coe.int/nw/xml/XRef/X2H-Xref-ViewHTML.asp?",Non-OADS,/arxiv_data1/oa_pdf/6b/f2/1602363.PMC5493417.pdf
"“GOLOS Preliminary Report: The 2012 Presidential Election ”, GOLOS, 5 March 2012, Moscow, Russia, http://www.gndem.org/sites/default/files/5645-presidential-elections- preliminary-report-5-march-2012.pdf.42.",Non-OADS,/arxiv_data1/oa_pdf/6b/f2/1602363.PMC5493417.pdf
"“Uganda Presidential and Parliamentary Elections ”, Commonwealth Observer Group, 24 February 2011, London, United Kingdom, http://thecommonwealth.org/sites/default/files/news-items/documents/Uganda-COG-Final-Report.pdf.",Non-OADS,/arxiv_data1/oa_pdf/6b/f2/1602363.PMC5493417.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/6/e1700414/DC1 section S1.,Non-OADS,/arxiv_data1/oa_pdf/4c/37/1700414.PMC5493418.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/6/e1700589/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/6d/b1/1700589.PMC5493419.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/6/e1700288/DC1 table S1.,Non-OADS,/arxiv_data1/oa_pdf/1a/69/1700288.PMC5493420.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/17/35/ima-8-1.PMC5493528.pdf
http://www.zbi.ee/fungal-genomesize .,Non-OADS,/arxiv_data1/oa_pdf/17/35/ima-8-1.PMC5493528.pdf
Plant Disease : http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/17/35/ima-8-1.PMC5493528.pdf
Cambridge MA: Whitehead Institute; http://www.broadinstitute.org/annotation/fungi/fgi/FGI_02_whitepaper_2003.pdf .,Non-OADS,/arxiv_data1/oa_pdf/17/35/ima-8-1.PMC5493528.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/cb/22/ima-8-107.PMC5493529.pdf
"(including Bauhinus and Haradaea ) species (Fungal Records  Database for Britian and Ireland, FRDBI; http://www.fieldmycology.net/frdbi/frdbi.asp) have been reported so far, of which 11 are anther smuts on Caryophyllaceae .",Non-OADS,/arxiv_data1/oa_pdf/cb/22/ima-8-107.PMC5493529.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/8d/98/ima-8-117.PMC5493530.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/e9/03/ima-8-153.PMC5493532.pdf
"The initial species concept of Diaporthe  based on the  assumption of host-specificity, resulted in the introduction of more than 1000 names (http://www.indexfungorum.org/ Names/Names.asp ); (Gomes et al.",OADS,/arxiv_data1/oa_pdf/e9/03/ima-8-153.PMC5493532.pdf
About 991 names of Diaporthe  and 979 of Phomopsis   have been established to date (http://www.indexfungorum.org/Names/Names.asp).,OADS,/arxiv_data1/oa_pdf/e9/03/ima-8-153.PMC5493532.pdf
Trees  were visualized in FigTree v. 1.1.2 (http://tree.bio.ed.ac.uk/ software/).,OADS,/arxiv_data1/oa_pdf/e9/03/ima-8-153.PMC5493532.pdf
2013; https://nt.ars-grin.gov/fungaldatabases/).,OADS,/arxiv_data1/oa_pdf/e9/03/ima-8-153.PMC5493532.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/7e/fb/ima-8-17.PMC5493533.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/ea/13/ima-8-189.PMC5493534.pdf
are  currently accepted as belonging in five other genera (Species Fungorum [http://www.speciesfungorum.org]).,Non-OADS,/arxiv_data1/oa_pdf/ea/13/ima-8-189.PMC5493534.pdf
"Nor does the update to the entry in the on-line Appendices to the Code  (http://botany.si.edu/ references/codes/props/) that lists Nylander (Flora 43: 66, 7  Feb 1860) as the place of publication of Stictina, because  in this work Nylander also includes Sticta sylvatica under  Stictina.",Non-OADS,/arxiv_data1/oa_pdf/ea/13/ima-8-189.PMC5493534.pdf
"Despite the  lack of any supporting information about this usage, the  Committee agreed that conservation is warranted for this  widespread family of three genera and several dozen species (Species Fungorum [http://www.speciesfungorum.org]; Index  Fungorum [http://www.indexfungorum.org/]; Cannon &  Kirk, Fungal Families of the World, 2007).",Non-OADS,/arxiv_data1/oa_pdf/ea/13/ima-8-189.PMC5493534.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/d9/e3/ima-8-205.PMC5493535.pdf
The appropriate international body to consult is  clearly the International Commission on the Taxonomy of Fungi (ICTF; http://www.fungaltaxonomy.org/).,Non-OADS,/arxiv_data1/oa_pdf/d9/e3/ima-8-205.PMC5493535.pdf
"The ICTF has set up 21 international working groups  (http://www.fungaltaxonomy.org/subcommissions/), formally  approved at their meetings of 23 April 2015, 28 January  2016 and 6 March 2017.",Non-OADS,/arxiv_data1/oa_pdf/d9/e3/ima-8-205.PMC5493535.pdf
Full membership of each group is indicated on the ICTF website (http://www.fungaltaxonomy.,Non-OADS,/arxiv_data1/oa_pdf/d9/e3/ima-8-205.PMC5493535.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/08/03/ima-8-27.PMC5493536.pdf
"Literature on Tulasnella  from Australia was  reviewed, and this literature along with GenBank and culture  collection databases: CBS (CBS-KNAW Fungal Biodiversity  Centre culture collection) and MAFF (culture collection,  Ministry of Agriculture, Forestry and Fisheries, Tsukuba, Ibaraki, Japan, searched via NIAS [National Institute of Agro- Environmental Sciences] Genebank - http://www.gene.affrc.",OADS,/arxiv_data1/oa_pdf/08/03/ima-8-27.PMC5493536.pdf
Alignments were performed in Geneious  v. 8 (http://www.geneious.com; Kearse et al.,OADS,/arxiv_data1/oa_pdf/08/03/ima-8-27.PMC5493536.pdf
Trees were visualised  using FigTree v. 1.4.3 (http://tree.bio.ed.ac.uk/software/ figtree/) and rooted to Tulasnella eichleriana  sequences.,OADS,/arxiv_data1/oa_pdf/08/03/ima-8-27.PMC5493536.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/37/da/ima-8-49.PMC5493537.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/1f/11/ima-8-65.PMC5493538.pdf
The ML analysis was made with RAxML (randomized  axelerated [sic] maximum likelihood for high performance computing; Stamatakis 2014) through the CIPRES website  (http://www.phylo.org) to obtain a second measure of branch  support.,OADS,/arxiv_data1/oa_pdf/1f/11/ima-8-65.PMC5493538.pdf
http://www.plantzafrica.com/plantqrs/strelitzregmzimvu.htm.,Non-OADS,/arxiv_data1/oa_pdf/1f/11/ima-8-65.PMC5493538.pdf
http://www.plantzafrica.com/ plantqrs/strelitziareginae.htm.,Non-OADS,/arxiv_data1/oa_pdf/1f/11/ima-8-65.PMC5493538.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/67/86/ima-8-77.PMC5493539.pdf
All resulting trees were plotted using  FigTree v. 1.4.2 (http://tree.bio.ed.ac.uk/software/figtree/).,OADS,/arxiv_data1/oa_pdf/67/86/ima-8-77.PMC5493539.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/19/51/ima-8-99.PMC5493540.pdf
"2011, http://www.speciesfungorum.",Non-OADS,/arxiv_data1/oa_pdf/19/51/ima-8-99.PMC5493540.pdf
"Consensus trees were  visualized in FigTree 1.4.2 (available at http://tree.bio.ed.ac.uk/software/figtree/) and exported as SVG vector graphics  for assembly in Adobe Illustrator v10 (Adobe Systems, San  Jose, CA).",OADS,/arxiv_data1/oa_pdf/19/51/ima-8-99.PMC5493540.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by- nc-nd/4.0/ rThe Author(s) 2017Diagnostic autoantibodies for autoimmune liver diseases B-H Toh 5 Clinical & Translational Immunology",Non-OADS,/arxiv_data1/oa_pdf/3d/66/cti201714a.PMC5493583.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ rThe Author(s) 2017Editorial 3 Clinical & Translational Immunology",Non-OADS,/arxiv_data1/oa_pdf/8d/8a/cti201715a.PMC5493584.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ rThe Author(s) 2017Editorial 3 Clinical & Translational Immunology",Non-OADS,/arxiv_data1/oa_pdf/be/bc/cti201716a.PMC5493585.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by- nc-nd/4.0/ rThe Author(s) 2017Clinical & Translational Immunology (2017) 6, e145; doi:10.1038/cti.2017.26 Australasian Society for Immunology Inc. www.nature.com/cti",Non-OADS,/arxiv_data1/oa_pdf/4f/93/cti201726a.PMC5493590.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by- nc-sa/4.0/ rThe Author(s) 2017Clinical & Translational Immunology (2017) 6, e146; doi:10.1038/cti.2017.27 Australasian Society for Immunology Inc. www.nature.com/cti",Non-OADS,/arxiv_data1/oa_pdf/3d/b3/cti201727a.PMC5493591.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/6c/main.PMC5493811.pdf
"Finally,  surgery  and  chemotherapy  realized  the  stable  cure http://dx.doi.org/10.1016/j.ijscr.2017.05.007 2210-2612/© 2017  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/bf/6c/main.PMC5493811.pdf
"59  (1) (2015)  26–36,  http://dx.doi.org/10.1159/000369443 ,  Epub  2014  Dec  17.",Non-OADS,/arxiv_data1/oa_pdf/bf/6c/main.PMC5493811.pdf
"66  (1)  (2015)  73–78,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/bf/6c/main.PMC5493811.pdf
This  is  an  open access article under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/88/aa/main.PMC5493812.pdf
"The  symptoms of a  metastatic  tumor  in  the  mandible  include pain,  swelling,  loosening  of  teeth,  paresthesia,  cervical  lym- http://dx.doi.org/10.1016/j.ijscr.2017.05.001 2210-2612/© 2017  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/88/aa/main.PMC5493812.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/77/main.PMC5493813.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.05.002 2210-2612/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/77/main.PMC5493813.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/33/main.PMC5493814.pdf
"Incorporation  of  biologically  active  molecules,  particularly growth  factors  with  platelets  as  the  source  has  yielded  promising http://dx.doi.org/10.1016/j.ijscr.2017.06.009 2210-2612/© 2017  The  Authors.",OADS,/arxiv_data1/oa_pdf/c7/33/main.PMC5493814.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/b4/main.PMC5493815.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.06.019 2049-0801/ ©2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/15/b4/main.PMC5493815.pdf
"Moreover, http://dx.doi.org/10.1016/j.gore.2017.06.011 Received 27 January 2017; Received in revised form 20 June 2017; Accepted 22 June 2017⁎Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/74/7d/main.PMC5493816.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7d/main.PMC5493816.pdf
"http://dx.doi.org/10.1016/j.redox.2017.05.013 Received 23 May 2017; Accepted 23 May 2017⁎Corresponding author at: Division of Molecular Medicine, Department of Anesthesiology, Division of Cardiology, Department of Medicine, Cardiovascular Research Laboratories, David Ge ﬀen School of Medicine at University of California Los Angeles (UCLA), Los Angeles, CA 90095, United States.",Non-OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
"In the US, the Food and Drug Administration (FDA) established new rules on e-ci-garette regulations in 2016, with a series of timelines starting in August2016 ( http://fdaregs.info/fda-deeming-regulations/timeline/ ).",Non-OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
"Med 4 (2016) 856 –858, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
"Kim, K. Sudini, N. Consolini, S.A. Cormier, S. Lomnicki, F. Hasan, A. Pekosz, S. Biswal, Exposure to electronic cigarettes impairs pulmonary anti-bacterial and anti-viral defenses in a mouse model, PLoS One 10 (2015) e0116861, http://dx.doi.org/10.1371/journal.",Non-OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
"4(2016) 116 –128, http://dx.doi.org/10.1016/S2213-2600(15)00521-4 (Epub 2016 Jan 14).",OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
"12 (2015) 787 –788, http://dx.doi.org/10.1513/AnnalsATS.",Non-OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
"190 (2014) 611 –618, http://dx.doi.org/10.1164/rccm.201407-1198PP .",Non-OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
"Robertson, T. McAuley, D. Go ﬀ, N. Benowitz, Electronic cigarettes: a policy statement from the American Heart Association, Circulation 130 (2014) 1418 –1436, http://dx.doi.org/10.1161/CIR.0000000000000107 (Epub2014 Aug 24).",Non-OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
"(2014) 23, http://dx.doi.org/10.1136/tobaccocontrol-2014-051670 .",Non-OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
"10 (2014)S122 –S145, http://dx.doi.org/10.1016/j.jalz.2014.04.009 .",OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
"Yan, Nicotine delivery, tolerability and reduction of smoking urge in smokers following short-term use of one brand of electronic ci- garettes, BMC Public Health 15 (2015) 991, http://dx.doi.org/10.1186/s12889- 015-2349-2 .",Non-OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
"1259 (2012) 39 –46,http://dx.doi.org/10.1111/j.1749-6632.2012.06531.x .",Non-OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
"152 (2017) 221 –225, http://dx.doi.org/10.1016/j.envres.2016.09.026 (Epub 2016 Oct 28).",OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
"52 (2016) 58 –65,http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
"88(2014) 1295 –1308, http://dx.doi.org/10.1007/s00204-014-1294-7 (Epub2014 Jun 11).",Non-OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
"34 (2012) 529 –537, http://dx.doi.org/10.1016/j.reprotox.2012.08.001 (Epub2012 Aug 20).",OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
"Control 25 (2016) e10 –e15, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
"Public Health 12 (2015) 3915 –3925, http://dx.doi.org/10.3390/ ijerph120403915 .",Non-OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
"Ossip, S. McIntosh, R. Robinson, I. Rahman, Vapors produced by electronic cigarettes and e-juices with ﬂavorings induce toxicity, oxidative stress, and in ﬂammatory response in lung epithelial cells and in mouse lung, PLoS One 10 (2015) e0116732, http://dx.doi.org/10.1371/ journal.pone.0116732 (eCollection2015).",Non-OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
"309 (2015) L175 –87,http://dx.doi.org/10.1152/ajplung.00411.2014 (Epub2015 May 15).",Non-OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
"[25] R. Putzhammer, C. Doppler, T. Jakschitz, K. Heinz, J. Forste, K. Danzl, B. Messner, D. Bernhard, Vapours of US and EU market leader electronic cigarette brands and liquids are cytotoxic for human vascular endothelial cells, PLoS One 11 (2016) e0157337, http://dx.doi.org/10.1371/journal.pone.0157337 (eCollection2016).",Non-OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
"67 (2015) 652 –660, http://dx.doi.org/10.1016/j.molimm.2015.05.020 (Epub2015 Jun 11).",OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
"97 (2016) 441 –453, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
"477 (2016) 620 –625, http://dx.doi.org/10.1016/j.bbrc.2016.06.109 (Epub2016 Jun 23).",OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
"[29] R. Carnevale, S. Sciarretta, F. Violi, C. Nocella, L. Lo ﬀredo, L. Perri, M. Peruzzi, A.G. Marullo, E. De Falco, I. Chimenti, V. Valenti, G. Biondi-Zoccai, G. Frati, Acuteimpact of tobacco vs electronic cigarette smoking on oxidative stress and vascular function, Chest 150 (2016) 606 –612, http://dx.doi.org/10.1016/j.chest.2016.04.",Non-OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
"2 (2017) 278 –284, http://dx.doi.org/10.1001/jamacardio.2016.5303 .",Non-OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
"49 (2010) 1937 –1946, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
"17 (2016) 84, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/23/3c/main.PMC5493817.pdf
RESULTS Experimental System The objective of this study was to determine the potential of the longhomology arms in HDAds for introducing modi ﬁcations along their Received 10 May 2017; accepted 1 June 2017; http://dx.doi.org/10.1016/j.omtn.2017.06.001 .,OADS,/arxiv_data1/oa_pdf/a5/01/main.PMC5493818.pdf
101 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a5/01/main.PMC5493818.pdf
miRNAs comprise a class of small non-coding RNAs that negatively regulate the expression of target genes at the post-transcriptionallevel through interaction with the 3 0UTRs of the target genes.22 Recent studies have shown that hyperactivation of the Notch or Received 1 November 2016; accepted 12 June 2017; http://dx.doi.org/10.1016/j.omtn.2017.06.008 .,Non-OADS,/arxiv_data1/oa_pdf/3c/f4/main.PMC5493819.pdf
111 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/f4/main.PMC5493819.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes ﬁveﬁgures and three tables and can be found with this article online at http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/3c/f4/main.PMC5493819.pdf
"14–16Both A20 and PPAR acould inhibit NF- kB activation, Received 18 October 2016; accepted 14 June 2017; http://dx.doi.org/10.1016/j.omtn.2017.06.010 .",OADS,/arxiv_data1/oa_pdf/7d/d8/main.PMC5493820.pdf
123 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7d/d8/main.PMC5493820.pdf
"Physiol.,Published online January 18, 2017. http://dx.doi.org/10.1002/jcp.25804 .",OADS,/arxiv_data1/oa_pdf/7d/d8/main.PMC5493820.pdf
"RESULTS IL-6-STAT3 Signaling Promotes the Tube Formation of Tumor Cells To evaluate the effect of IL-6 signaling on VM formation, we ﬁrst em- ployed a well-established three-dimensional tube formation assay to Received 21 May 2017; accepted 13 June 2017; http://dx.doi.org/10.1016/j.omtn.2017.06.009 .",OADS,/arxiv_data1/oa_pdf/73/79/main.PMC5493821.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/73/79/main.PMC5493821.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Materials andMethods, eight ﬁgures, and one table and can be found with this article online at http://dx.doi.org/10.1016/j.omtn.2017.06.009 .",Non-OADS,/arxiv_data1/oa_pdf/73/79/main.PMC5493821.pdf
Thus we Received 1 December 2016; accepted 13 June 2017; http://dx.doi.org/10.1016/j.omtm.2017.06.001 .,Non-OADS,/arxiv_data1/oa_pdf/9d/60/main.PMC5493822.pdf
6 September 2017 ª2017 79 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/60/main.PMC5493822.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes four ﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.omtm.2017.,Non-OADS,/arxiv_data1/oa_pdf/9d/60/main.PMC5493822.pdf
"Protoc., Published online May 1, 2011. http://dx.doi.org/10.1101/pdb.",OADS,/arxiv_data1/oa_pdf/9d/60/main.PMC5493822.pdf
"The intrahepatic branches of the portal vein, hepatic artery, along with the bile duct run together within the portal http://dx.doi.org/10.1016/j.redox.2017.06.008 Received 19 March 2017; Received in revised form 18 June 2017; Accepted 20 June 2017⁎Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/95/f4/main.PMC5493836.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/95/f4/main.PMC5493836.pdf
"The further investigation of this concept has been envisioned as a possible “motor way ”to close the gap between the basic neuroscience approach and clinical practice http://dx.doi.org/10.1016/j.nicl.2017.06.021 Received 3 March 2017; Received in revised form 24 May 2017; Accepted 16 June 2017⁎Corresponding author at: Department of Neurology, University Hospital Frankfurt, Schleusenweg 2-16, 60528 Frankfurt am Main, Germany.",Non-OADS,/arxiv_data1/oa_pdf/ae/c7/main.PMC5493837.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ae/c7/main.PMC5493837.pdf
The randomization order and the determination of jitter length values were obtained by using the Optseq2 software ( http://surfer.nmr.,OADS,/arxiv_data1/oa_pdf/ae/c7/main.PMC5493837.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/77/ofx104.PMC5493936.pdf
Available at: http://www.cdc.gov/ibd/ibd-   epidemiology.htm.,Non-OADS,/arxiv_data1/oa_pdf/c4/77/ofx104.PMC5493936.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/0a/ofx102.PMC5493937.pdf
Available at:  http://www.samhsa.gov/data/.,OADS,/arxiv_data1/oa_pdf/7a/0a/ofx102.PMC5493937.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/14/ofx101.PMC5493938.pdf
"MULTIPLE SCLEROSIS MSJJOURNAL 262 journals.sagepub.com/home/msjhttps://doi.org/10.1177/1352458516687404 https://doi.org/10.1177/1352458516687404Multiple Sclerosis Journal 2018, Vol.",Non-OADS,/arxiv_data1/oa_pdf/f8/64/10.1177_1352458516687404.PMC5494005.pdf
Reprints and permissions:  http://www.sagepub.co.uk/ journalsPermissions.nav There is increasing interest in wellness and approaches  for its optimization among people with multiple sclero-sis (MS).,Non-OADS,/arxiv_data1/oa_pdf/f8/64/10.1177_1352458516687404.PMC5494005.pdf
"1 Wellness is “an active process through which  people become aware of, and make choices toward, a more successful existence” (http://www.nationalwell-ness.org/?page=AboutWellness).",Non-OADS,/arxiv_data1/oa_pdf/f8/64/10.1177_1352458516687404.PMC5494005.pdf
The obtained sequences underwent bioinformatics analysis using the ‘Nucleotide Blast ’Alignment Program at http://blast.ncbi.nlm.nih.gov/Blast.cgi.,OADS,/arxiv_data1/oa_pdf/85/48/hgv201723.PMC5494187.pdf
"Outcome of mutation analyzer web-based tools Computational pathogenicity predictions Prediction Score Score description Coding consequences (A) http://genetics.bwh.harvard.edu/ pph2/ (HumVar Prediction)7P: possibly damaging0.714 Frameshift (B) http://genetics.bwh.harvard.edu/ pph2/ (HumDiv Prediction)8D: probably damaging0.981 (C) http://www.mutationtaster.org/8D 1.83 A: disease Causing automatic, D: disease causing, N: polymorphism, P: polymorphism automaticFrameshift (D) http://Mutationtassessor Low High or medium: predicted functional, low or neutral: predicted non-functional (E) http://sift.jcvi.org/9Damaging 0.03 SIFT score.",Non-OADS,/arxiv_data1/oa_pdf/85/48/hgv201723.PMC5494187.pdf
"(F) http://www.ensembl.org10Coding sequence variant: 100%Frameshift (A) Predicted as possibly damaging to the pyrin protein with a score =0.714, (B) predicted as probably damaging to the pyrin protein with a score =0.981, (C) predicted as disease causing with a score =1.83, (D) predicted non-functional protein, (E) SIFT score =0.03, the amino acid substitution is predicted as damaging, (F) predicted as a coding sequence variant at 100%.Detection of a novel insertion mutation in exon 2 of the MEFV gene T Mejtoute et al 3 Ofﬁcial journal of the Japan Society of Human Genetics Human Genome Variation (2017) 17023",Non-OADS,/arxiv_data1/oa_pdf/85/48/hgv201723.PMC5494187.pdf
Available at: http://fmf.igh.cnrs.fr/ISSAID/infevers/.,Non-OADS,/arxiv_data1/oa_pdf/85/48/hgv201723.PMC5494187.pdf
Available at: http://www.els.net [doi: 10.1002/9780470015902.a0021442].,Non-OADS,/arxiv_data1/oa_pdf/85/48/hgv201723.PMC5494187.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017Detection of a novel insertion mutation in exon 2 of the MEFV gene T Mejtoute et al 4 Human Genome Variation (2017) 17023 Of ﬁcial journal of the Japan Society of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/85/48/hgv201723.PMC5494187.pdf
The delivery system is based on microparticles of PolyActive™ hydrogel  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/b6/nihms864135.PMC5494198.pdf
Supplementary data: Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.jconrel.,OADS,/arxiv_data1/oa_pdf/13/b6/nihms864135.PMC5494198.pdf
[PubMed: 24935282]  7. http://www.mddionline.com/article/genentech-betting-device-approach-block-buster-12-10-15 .,Non-OADS,/arxiv_data1/oa_pdf/13/b6/nihms864135.PMC5494198.pdf
8. http://www.neurotechusa.com/VEGF-Antagonist.html .,Non-OADS,/arxiv_data1/oa_pdf/13/b6/nihms864135.PMC5494198.pdf
2014 http://crstodayeurope.com/2014/04/ online April 2014 30.,Non-OADS,/arxiv_data1/oa_pdf/13/b6/nihms864135.PMC5494198.pdf
[PubMed: 24657808]  39. http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/ HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/ ucm092772.pdf .,Non-OADS,/arxiv_data1/oa_pdf/13/b6/nihms864135.PMC5494198.pdf
"2017 Jun;47(3):133 https://doi.org/10.5051/jpis.2017.47.3.133 pISSN 2093-2278·eISSN 2093-2286 Editorial Received:  Jun 27, 2017 Accepted:  Jun 27, 2017 *Correspondence: Tae-Il Kim (Editor-in-Chief) Department of Periodontology, Seoul National  University School of Dentistry, 101 Daehak-ro,  Jongno-gu, Seoul 03080, Korea.",Non-OADS,/arxiv_data1/oa_pdf/70/10/jpis-47-133.PMC5494307.pdf
"ORCID iDs Tae-Il Kim  https://orcid.org/0000-0003-4087-8021Tae-Il Kim   Department of Periodontology, Seoul National University School of Dentistry, Seoul, KoreaIntroducing our new online  manuscript-processing portal:   an upgrade much needed 133 https://jpis.org",Non-OADS,/arxiv_data1/oa_pdf/70/10/jpis-47-133.PMC5494307.pdf
"2017 Jun;47(3):134-142 https://doi.org/10.5051/jpis.2017.47.3.134 pISSN 2093-2278·eISSN 2093-2286 Research Article Received:  Feb 14, 2017 Accepted:  May 18, 2017 *Correspondence: Yong-Gun Kim Department of Periodontology, Kyungpook  National University School of Dentistry, 2177  Dalgubeol-daero, Jung-gu, Daegu 41940,  Korea.",Non-OADS,/arxiv_data1/oa_pdf/85/7b/jpis-47-134.PMC5494308.pdf
"ORCID iDs Ji-Eun Lee  https://orcid.org/0000-0002-8405-0480 Jae-Mok Lee  https://orcid.org/0000-0002-0291-6114 Youngkyun Lee  https://orcid.org/0000-0001-9049-6908 Jin-Woo Park  https://orcid.org/0000-0002-6632-023X Jo-Young Suh  https://orcid.org/0000-0002-3515-3854 Heung-Sik Um  https://orcid.org/0000-0002-7986-1019 Yong-Gun Kim  https://orcid.org/0000-0002-2793-7667Ji-Eun Lee  1,†, Jae-Mok Lee  1,†, Youngkyun Lee  2, Jin-Woo Park  1,   Jo-Young Suh  1, Heung-Sik Um  3, Yong-Gun Kim  1,* 1Department of Periodontology, Kyungpook National University School of Dentistry, Daegu, Korea 2Department of Biochemistry, Kyungpook National University School of Dentistry, Daegu, Korea 3 Department of Periodontology, Research Institute for Oral Sciences, Gangneung-Wonju National University  College of Dentistry, Gangneung, KoreaThe antiplaque and bleeding control  effects of a cetylpyridinium chloride  and tranexamic acid mouth rinse in  patients with gingivitis 134 https://jpis.org",Non-OADS,/arxiv_data1/oa_pdf/85/7b/jpis-47-134.PMC5494308.pdf
https://doi.org/10.5051/jpis.2017.47.3.134Effectiveness of TXA and CPC mouth rinse against gingivitis 135 https://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/85/7b/jpis-47-134.PMC5494308.pdf
The scoring system was as follows: 0=no dental plaque; 1=the presence of a discontinuous line of dental plaque at the gingival margin; 2=a continuous line of dental plaque at the gingival margin that does not extend further than 1 mm  from the margin; https://doi.org/10.5051/jpis.2017.47.3.134Effectiveness of TXA and CPC mouth rinse against gingivitis 136 https://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/85/7b/jpis-47-134.PMC5494308.pdf
https://doi.org/10.5051/jpis.2017.47.3.134Effectiveness of TXA and CPC mouth rinse against gingivitis 137 https://jpis.orgTable 1.,Non-OADS,/arxiv_data1/oa_pdf/85/7b/jpis-47-134.PMC5494308.pdf
"Between 3 and  6 weeks, the mean QHI value decreased in both groups, but this result was not statistically  https://doi.org/10.5051/jpis.2017.47.3.134Effectiveness of TXA and CPC mouth rinse against gingivitis 138 https://jpis.orgTable 2.",Non-OADS,/arxiv_data1/oa_pdf/85/7b/jpis-47-134.PMC5494308.pdf
https://doi.org/10.5051/jpis.2017.47.3.134Effectiveness of TXA and CPC mouth rinse against gingivitis 139 https://jpis.orgBaselinea)b)a)a) a) /three.LP wk /six.LP wk1.6 1.2 0.0QHI2.4 2.0 0.8 0.42.2 1.4 1.01.8 0.6 0.2Placebo CPC+TXA Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/85/7b/jpis-47-134.PMC5494308.pdf
"Moreover, there was a statistically significant difference between the experimental group  https://doi.org/10.5051/jpis.2017.47.3.134Effectiveness of TXA and CPC mouth rinse against gingivitis 140 https://jpis.orgBaselinea) a) /three.LP wk /six.LP wk0.6 0.4 0.3 0.0BOMP0.70.8 0.5 0.2 0.1Placebo CPC+TXA Figure 4.",OADS,/arxiv_data1/oa_pdf/85/7b/jpis-47-134.PMC5494308.pdf
PUBMED  | CROSSREF https://doi.org/10.5051/jpis.2017.47.3.134Effectiveness of TXA and CPC mouth rinse against gingivitis 141 https://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/85/7b/jpis-47-134.PMC5494308.pdf
PUBMED  | CROSSREF https://doi.org/10.5051/jpis.2017.47.3.134Effectiveness of TXA and CPC mouth rinse against gingivitis 142 https://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/85/7b/jpis-47-134.PMC5494308.pdf
"2017 Jun;47(3):143-153 https://doi.org/10.5051/jpis.2017.47.3.143 pISSN 2093-2278·eISSN 2093-2286 Research Article Received:  Apr 2, 2017 Accepted:  May 21, 2017 *Correspondence: Ki-Tae Koo Department of Periodontology and Dental  Research Institute, Seoul National University  School of Dentistry, 101 Daehak-ro, Jongno-gu,  Seoul 03080, Korea.",Non-OADS,/arxiv_data1/oa_pdf/20/f2/jpis-47-143.PMC5494309.pdf
"ORCID iDs Jung-Hoon Kim  https://orcid.org/0000-0001-9875-297X Ki-Tae Koo  https://orcid.org/0000-0002-9809-2630 Joseph Capetillo  https://orcid.org/0000-0002-4671-8398 Jung-Ju Kim  https://orcid.org/0000-0002-8819-6858 Jung-Min Yoo  https://orcid.org/0000-0003-2275-7656 Heithem Ben Amara  https://orcid.org/0000-0002-7927-9838Jung-Hoon Kim  1, Ki-Tae Koo  1,*, Joseph Capetillo  2, Jung-Ju Kim  1,  Jung-Min Yoo  1, Heithem Ben Amara  1, Jung-Chul Park  3,   Frank Schwarz  4, Ulf M.E.",Non-OADS,/arxiv_data1/oa_pdf/20/f2/jpis-47-143.PMC5494309.pdf
"Wikesjö  5 1 Department of Periodontology and Dental Research Institute, Seoul National University School of  Dentistry, Seoul, Korea 2US Army Advanced Education Program in Periodontics, Ft. Gordon, GA, USA 3Department of Periodontology, Dankook University College of Dentistry, Cheonan, Korea 4Department of Oral Surgery, Universitätsklinikum Düsseldorf, Düsseldorf, Germany 5 Laboratory for Applied Periodontal & Craniofacial Regeneration (LAPCR), Augusta University Dental  College of Georgia, Augusta, GA, USAPeriodontal and endodontic pathology  delays extraction socket healing in a  canine model 143 https://jpis.org",Non-OADS,/arxiv_data1/oa_pdf/20/f2/jpis-47-143.PMC5494309.pdf
Jung-Chul Park  https://orcid.org/0000-0002-2041-8047 Frank Schwarz  https://orcid.org/0000-0002-5873-9903 Ulf M.E.,Non-OADS,/arxiv_data1/oa_pdf/20/f2/jpis-47-143.PMC5494309.pdf
"Wikesjö  https://orcid.org/0000-0003-1607-0583 Funding This research was supported by the Basic  Science Research Program through the  National Research Foundation of Korea (NRF)  funded by the Ministry of Education, Science  and Technology (2012R1A1A1042670).",OADS,/arxiv_data1/oa_pdf/20/f2/jpis-47-143.PMC5494309.pdf
"Surgical protocol The animals were anesthetized using an intravenous injection of Zoletil® (0.1 mg/kg, Virbac,  Carros, France), Rompun® (2.3 mg/kg, Bayer Korea, Ansan, Korea), and atropine sulfate  https://doi.org/10.5051/jpis.2017.47.3.143Healing of diseased extraction socket 144 https://jpis.org",Non-OADS,/arxiv_data1/oa_pdf/20/f2/jpis-47-143.PMC5494309.pdf
"Next,  https://doi.org/10.5051/jpis.2017.47.3.143Healing of diseased extraction socket 145 https://jpis.org/zero.LP Oral hygiene Oral hygienePlaque accumulationmonths Diseased extraction socket Fresh extraction socketLesion induce Ligature removalExtraction Sacriﬁce & biopsies /one.LP /two.LP /three.LP /four.LP /five.LP /six.LP Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/20/f2/jpis-47-143.PMC5494309.pdf
"The  split extraction sockets were mounted on aluminum stubs, and sputter-coated with a 30-nm  https://doi.org/10.5051/jpis.2017.47.3.143Healing of diseased extraction socket 146 https://jpis.org",Non-OADS,/arxiv_data1/oa_pdf/20/f2/jpis-47-143.PMC5494309.pdf
"In the fresh extraction sites, a  well-organized fibrin clot constituted 37.5% of the overall content, whereas an artifactual  https://doi.org/10.5051/jpis.2017.47.3.143Healing of diseased extraction socket 147 https://jpis.org",Non-OADS,/arxiv_data1/oa_pdf/20/f2/jpis-47-143.PMC5494309.pdf
Trabecular bone  https://doi.org/10.5051/jpis.2017.47.3.143Healing of diseased extraction socket 148 https://jpis.orgTable 1.,Non-OADS,/arxiv_data1/oa_pdf/20/f2/jpis-47-143.PMC5494309.pdf
https://doi.org/10.5051/jpis.2017.47.3.143Healing of diseased extraction socket 149 https://jpis.org A B C DBB BBPDL PDLCLOT CLOTI-cells Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/20/f2/jpis-47-143.PMC5494309.pdf
The prevalence of periodontal  https://doi.org/10.5051/jpis.2017.47.3.143Healing of diseased extraction socket 150 https://jpis.org A B C D Figure 6.,Non-OADS,/arxiv_data1/oa_pdf/20/f2/jpis-47-143.PMC5494309.pdf
"This delay appeared more evident in the late  healing phase of the study, on days 60 and 90. https://doi.org/10.5051/jpis.2017.47.3.143Healing of diseased extraction socket 151 https://jpis.org A B C D Figure 7.",Non-OADS,/arxiv_data1/oa_pdf/20/f2/jpis-47-143.PMC5494309.pdf
PUBMED  | CROSSREF https://doi.org/10.5051/jpis.2017.47.3.143Healing of diseased extraction socket 152 https://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/20/f2/jpis-47-143.PMC5494309.pdf
PUBMED  | CROSSREF https://doi.org/10.5051/jpis.2017.47.3.143Healing of diseased extraction socket 153 https://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/20/f2/jpis-47-143.PMC5494309.pdf
"2017 Jun;47(3):154-164 https://doi.org/10.5051/jpis.2017.47.3.154 pISSN 2093-2278·eISSN 2093-2286 Research Article Received:  Apr 28, 2017 Accepted:  May 30, 2017 *Correspondence: Jong-Tae Park Department of Oral Anatomy, Dankook  University College of Dentistry, 119 Dandae-ro,  Dongnam-gu, Cheonan 31116, Korea.",Non-OADS,/arxiv_data1/oa_pdf/b7/6f/jpis-47-154.PMC5494310.pdf
ORCID iDs Sa-Beom Park  https://orcid.org/0000-0001-5686-6047 So-Youn An  https://orcid.org/0000-0002-8395-7881 Won-Jeong Han  https://orcid.org/0000-0003-0866-9887 Jong-Tae Park  https://orcid.org/0000-0003-1870-2740 Funding This work was supported by a National  Research Foundation of Korea Grant  funded by the Korean Government (NRF- 2016R1D1A1B01008853).,Non-OADS,/arxiv_data1/oa_pdf/b7/6f/jpis-47-154.PMC5494310.pdf
"Author Contributions Conceptualization: Jong-Tae Park; Formal  analysis: Sa-Beom Park, So-Youn An;  Investigation: Sa-Beom Park, So-Youn An, Sa-Beom Park  1,†, So-Youn An  2,†, Won-Jeong Han  3, Jong-Tae Park  1,* 1Department of Oral Anatomy, Dankook University College of Dentistry, Cheonan, Korea 2Department of Pediatric Dentistry, Wonkwang University, Daejeon, Korea 3Department of Dentomaxillofacial Radiology, Dankook University College of Dentistry, Cheonan, KoreaThree-dimensional measurement  of periodontal surface area for  quantifying inflammatory burden 154 https://jpis.org",Non-OADS,/arxiv_data1/oa_pdf/b7/6f/jpis-47-154.PMC5494310.pdf
"This study used CBCT to obtain 3D data of the teeth of 33 patients in order to measure  the inflamed RSA, as well as to obtain measurements of the surface area between the  https://doi.org/10.5051/jpis.2017.47.3.1543D measurement of periodontal surface area 155 https://jpis.org",Non-OADS,/arxiv_data1/oa_pdf/b7/6f/jpis-47-154.PMC5494310.pdf
"Due to limited CBCT resolution, it was difficult to clearly identify the CEJ in this  https://doi.org/10.5051/jpis.2017.47.3.1543D measurement of periodontal surface area 156 https://jpis.org",Non-OADS,/arxiv_data1/oa_pdf/b7/6f/jpis-47-154.PMC5494310.pdf
https://doi.org/10.5051/jpis.2017.47.3.1543D measurement of periodontal surface area 157 https://jpis.org A B C Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/b7/6f/jpis-47-154.PMC5494310.pdf
https://doi.org/10.5051/jpis.2017.47.3.1543D measurement of periodontal surface area 158 https://jpis.org SevereModerateMild/two.LP mm /four.LP mm /six.LP mmGingival marginSulcus CEJ CAL Attachment level BonePPDNormal Periodontitis Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/b7/6f/jpis-47-154.PMC5494310.pdf
The surface area appeared to be largest for the first molar  in both the maxilla (right: 242.31±31.91 mm2 in men and 212.40±24.67 mm2 in women; left:  https://doi.org/10.5051/jpis.2017.47.3.1543D measurement of periodontal surface area 159 https://jpis.orgTable 1.,Non-OADS,/arxiv_data1/oa_pdf/b7/6f/jpis-47-154.PMC5494310.pdf
"Classifying periodontal infections, which can be a risk factor for other  diseases, requires measuring the inflammatory burden, and hence quantifying the inflamed  https://doi.org/10.5051/jpis.2017.47.3.1543D measurement of periodontal surface area 160 https://jpis.orgTable 2.",Non-OADS,/arxiv_data1/oa_pdf/b7/6f/jpis-47-154.PMC5494310.pdf
"However, it is not appropriate for clinical  https://doi.org/10.5051/jpis.2017.47.3.1543D measurement of periodontal surface area 161 https://jpis.org",Non-OADS,/arxiv_data1/oa_pdf/b7/6f/jpis-47-154.PMC5494310.pdf
PUBMED  | CROSSREF https://doi.org/10.5051/jpis.2017.47.3.1543D measurement of periodontal surface area 162 https://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/b7/6f/jpis-47-154.PMC5494310.pdf
PUBMED  | CROSSREF https://doi.org/10.5051/jpis.2017.47.3.1543D measurement of periodontal surface area 163 https://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/b7/6f/jpis-47-154.PMC5494310.pdf
PUBMED  | CROSSREF https://doi.org/10.5051/jpis.2017.47.3.1543D measurement of periodontal surface area 164 https://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/b7/6f/jpis-47-154.PMC5494310.pdf
"2017 Jun;47(3):165-173 https://doi.org/10.5051/jpis.2017.47.3.165 pISSN 2093-2278·eISSN 2093-2286 Research Article Hyeyoon Chang  1, Sulhee Kim  1, Jin wook Hwang  2, Sungtae Kim  1,*,  Ki-Tae Koo  1, Tae-Il Kim  1, Yang-Jo Seol  1, Yong-Moo Lee  1, Young Ku  1,  Jong-Ho Lee  3,*, In-Chul Rhyu  1 1Department of Periodontology, Seoul National University School of Dentistry, Seoul, Korea 2ESTeam Paris Sud, INSERM UMR-S 935, Paris-Sud University, Paris-Saclay University, Villejuif, France 3Department of Oral and Maxillofacial Surgery, Seoul National University School of Dentistry, Seoul, KoreaComparative, randomized, double- blind clinical study of alveolar ridge  preservation using an extracellular  matrix-based dental resorbable  membrane in the extraction socket Received:  May 8, 2017 Accepted:  Jun 1, 2017 *Correspondence: Sungtae Kim Department of Periodontology, Dental  Research Institute, Seoul National University  School of Dentistry, 101 Daehak-ro, Jongno-gu,  Seoul 03080, Korea.",Non-OADS,/arxiv_data1/oa_pdf/6b/bf/jpis-47-165.PMC5494311.pdf
ORCID iDs Hyeyoon Chang  https://orcid.org/0000-0003-2900-9255 Sulhee Kim  https://orcid.org/0000-0001-8475-881X Jin wook Hwang  https://orcid.org/0000-0002-9342-3461 Sungtae Kim  https://orcid.org/0000-0001-6361-4104 Ki-Tae Koo  https://orcid.org/0000-0002-9809-2630 165 https://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/6b/bf/jpis-47-165.PMC5494311.pdf
"Tae-Il Kim  https://orcid.org/0000-0003-4087-8021 Yang-Jo Seol  https://orcid.org/0000-0002-2076-5452 Yong-Moo Lee  https://orcid.org/0000-0002-5619-3847 Young Ku  https://orcid.org/0000-0001-5682-0604 Jong-Ho Lee  https://orcid.org/0000-0002-8843-545X In-Chul Rhyu  https://orcid.org/0000-0003-4110-6381 Funding This research was supported by a grant  from the Korea Health Technology R&D  Project through the Korea Health Industry  Development Institute, funded by the Ministry  of Health and Welfare, Republic of Korea  (Grant number: HI14C0710).",Non-OADS,/arxiv_data1/oa_pdf/6b/bf/jpis-47-165.PMC5494311.pdf
https://doi.org/10.5051/jpis.2017.47.3.165Comparison of ECM membranes in ridge preservation 166 https://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/6b/bf/jpis-47-165.PMC5494311.pdf
"CGE14001) and registered as a clinical trial ( http://cris.nih.go.kr , approval No.",Non-OADS,/arxiv_data1/oa_pdf/6b/bf/jpis-47-165.PMC5494311.pdf
"Their general  https://doi.org/10.5051/jpis.2017.47.3.165Comparison of ECM membranes in ridge preservation 167 https://jpis.org /two.LP/two.LP patients: treatment group /two.LP/two.LP paients: control group /six.LP/six.LP patients screened (visit /one.LP) Day of surgery (visit /two.LP) : CBCT, clinical photo, VAS scale /one.LP month later (visit /four.LP) : clinical photo /three.LP months later (visit /five.LP) : clinical photo /six.LP months later (visit /six.LP) : CBCT, clinical photo, impression /seven.LP to /one.LP/zero.LP days later (visit /three.LP) : impression, clinical photo /two.LP/two.LP patients excluded by screening /two.LP patients dropped out /one.LP patient was lost to follow-up /one.LP patient re-entered dut to  retained root Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/6b/bf/jpis-47-165.PMC5494311.pdf
A region  of interest (ROI) was set in the scan of the 1-week cast from the upper-middle region of the  https://doi.org/10.5051/jpis.2017.47.3.165Comparison of ECM membranes in ridge preservation 168 https://jpis.orgTable 1.,Non-OADS,/arxiv_data1/oa_pdf/6b/bf/jpis-47-165.PMC5494311.pdf
https://doi.org/10.5051/jpis.2017.47.3.165Comparison of ECM membranes in ridge preservation 169 https://jpis.org A B Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/6b/bf/jpis-47-165.PMC5494311.pdf
https://doi.org/10.5051/jpis.2017.47.3.165Comparison of ECM membranes in ridge preservation 170 https://jpis.org A B /five.LP./five.LP/six.LP mm /seven.LP./three.LP/three.LP mm Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/6b/bf/jpis-47-165.PMC5494311.pdf
https://doi.org/10.5051/jpis.2017.47.3.165Comparison of ECM membranes in ridge preservation 171 https://jpis.orgTable 2.,Non-OADS,/arxiv_data1/oa_pdf/6b/bf/jpis-47-165.PMC5494311.pdf
PUBMED  | CROSSREF https://doi.org/10.5051/jpis.2017.47.3.165Comparison of ECM membranes in ridge preservation 172 https://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/6b/bf/jpis-47-165.PMC5494311.pdf
PUBMED  | CROSSREF https://doi.org/10.5051/jpis.2017.47.3.165Comparison of ECM membranes in ridge preservation 173 https://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/6b/bf/jpis-47-165.PMC5494311.pdf
"2017 Jun;47(3):174-181 https://doi.org/10.5051/jpis.2017.47.3.174 pISSN 2093-2278·eISSN 2093-2286 Research Article Received:  May 1, 2017 Accepted:  Jun 3, 2017 *Correspondence: Jeomil Choi Department of Periodontology, Pusan National  University School of Dentistry, 20 Geumo-ro,  Mulgeum-eup, Yangsan 50612, Korea.",Non-OADS,/arxiv_data1/oa_pdf/bc/0a/jpis-47-174.PMC5494312.pdf
ORCID iDs Eun-Young Kwon  https://orcid.org/0000-0001-9555-0360 Gil Sun Cha  https://orcid.org/0000-0001-5804-0337 Ji-Young Joo  https://orcid.org/0000-0002-4050-5797 Ju-Youn Lee  https://orcid.org/0000-0002-0772-033X Jeomil Choi  https://orcid.org/0000-0002-7491-6711 Funding This work was supported by a 2-year research  grant from Pusan National University (2017).,Non-OADS,/arxiv_data1/oa_pdf/bc/0a/jpis-47-174.PMC5494312.pdf
"Author Contributions Conceptualization: Eun-Young Kwon, Jeomil  Choi; Data curation: Eun-Young Kwon, Jeomil  Choi; Formal analysis: Ji-Young Joo, Ju-Youn  Lee, Jeomil Choi; Funding acquisition: Ju-Youn  Lee, Jeomil Choi; Investigation: Eun-Young  Kwon, Gil Sun Cha, Ji-Young Joo, Ju-Youn Eun-Young Kwon  1,2, Gil Sun Cha  1, Ji-Young Joo  1, Ju-Youn Lee  1,   Jeomil Choi  1,* 1Department of Periodontology, Pusan National University School of Dentistry, Yangsan, Korea 2Biomedical Research Institute, Pusan National University Hospital, Busan, KoreaRobust immunoreactivity of teenager  sera against peptide 19 from  Porphyromonas gingivalis  HSP60 174 https://jpis.org",Non-OADS,/arxiv_data1/oa_pdf/bc/0a/jpis-47-174.PMC5494312.pdf
https://doi.org/10.5051/jpis.2017.47.3.174Pep19 in teenagers 175 https://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/bc/0a/jpis-47-174.PMC5494312.pdf
The highest serum  https://doi.org/10.5051/jpis.2017.47.3.174Pep19 in teenagers 176 https://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/bc/0a/jpis-47-174.PMC5494312.pdf
PgHSP60 and oxLDL consistently  https://doi.org/10.5051/jpis.2017.47.3.174Pep19 in teenagers 177 https://jpis.orgTable 1.,Non-OADS,/arxiv_data1/oa_pdf/bc/0a/jpis-47-174.PMC5494312.pdf
https://doi.org/10.5051/jpis.2017.47.3.174Pep19 in teenagers 178 https://jpis.org B  AH/one.LP/zero.LP/endash.cap/one.LP/nine.LP PgHSP/six.LP/zero.LP Pep/nine.LP Pep/one.LP/four.LP Pep/one.LP/nine.LP /one.LP /two.LP /three.LP /four.LP /five.LP /six.LP /seven.LP /eight.LP/one.LP /two.LP /three.LP /four.LP /five.LP /six.LP /seven.LP /eight.LPHu/nine.LP Hu/one.LP/four.LP Hu/one.LP/nine.LP oxLDLDM/one.LP/zero.LP/endash.cap/one.LP/nine.LP PgHSP/six.LP/zero.LP Pep/nine.LP Pep/one.LP/four.LP Pep/one.LP/nine.LP Hu/nine.LP Hu/one.LP/four.LP Hu/one.LP/nine.LP oxLDL C/one.LP /two.LP /three.LP /four.LP /five.LP /six.LP /seven.LP /eight.LPPgHSP/six.LP/zero.LP Pep/nine.LP Pep/one.LP/four.LP Pep/one.LP/nine.LP Hu/nine.LP Hu/one.LP/four.LP Hu/one.LP/nine.LP oxLDLH/two.LP/zero.LP/endash.cap/two.LP/nine.LP Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/bc/0a/jpis-47-174.PMC5494312.pdf
https://doi.org/10.5051/jpis.2017.47.3.174Pep19 in teenagers 179 https://jpis.orgTable 3.,Non-OADS,/arxiv_data1/oa_pdf/bc/0a/jpis-47-174.PMC5494312.pdf
PUBMED  | CROSSREF https://doi.org/10.5051/jpis.2017.47.3.174Pep19 in teenagers 180 https://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/bc/0a/jpis-47-174.PMC5494312.pdf
PUBMED  | CROSSREF https://doi.org/10.5051/jpis.2017.47.3.174Pep19 in teenagers 181 https://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/bc/0a/jpis-47-174.PMC5494312.pdf
"2017 Jun;47(3):182-192 https://doi.org/10.5051/jpis.2017.47.3.182 pISSN 2093-2278·eISSN 2093-2286 Research Article Received:  May 10, 2017 Accepted:  Jun 7, 2017 *Correspondence: In-Sung Luke Yeo Department of Prosthodontics and Dental  Research Institute, Seoul National University  School of Dentistry, 101 Daehak-ro, Jongno-gu,  Seoul 03080, Korea.",Non-OADS,/arxiv_data1/oa_pdf/4d/4b/jpis-47-182.PMC5494313.pdf
ORCID iDs Jung-Yoo Choi  https://orcid.org/0000-0002-7534-5498 Jae-Hyuk Sim  https://orcid.org/0000-0003-0771-3268 In-Sung Luke Yeo  https://orcid.org/0000-0002-6780-2601 Funding This work was supported by a National  Research Foundation of Korea (NRF) grant  funded by the Korean Government (MSIP) (No.,Non-OADS,/arxiv_data1/oa_pdf/4d/4b/jpis-47-182.PMC5494313.pdf
"Author Contributions Conceptualization: Jung-Yoo Choi, Jae-Hyuk  Shim, In-Sung Luke Yeo; Data curation: Jung- Yoo Choi; Formal analysis: Jung-Yoo Choi,  In-Sung Luke Yeo; Funding acquisition: In-Sung  Luke Yeo; Investigation: Jung-Yoo Choi,  Jae-Hyuk Sim; Methodology: Jung-Yoo Choi,  Jae-Hyuk Shim, In-Sung Luke Yeo; Project Jung-Yoo Choi  1, Jae-Hyuk Sim  2, In-Sung Luke Yeo  1,2,* 1Dental Research Institute, Seoul National University School of Dentistry, Seoul, Korea 2Department of Prosthodontics, Seoul National University School of Dentistry, Seoul, KoreaCharacteristics of contact and  distance osteogenesis around modified  implant surfaces in rabbit tibiae 182 https://jpis.org",Non-OADS,/arxiv_data1/oa_pdf/4d/4b/jpis-47-182.PMC5494313.pdf
All animal experiments were conducted in accordance with the guidelines of  the Institute of Laboratory Animal Resources at Seoul National University (approval number:  https://doi.org/10.5051/jpis.2017.47.3.182Characteristics of contact and distance osteogenesis 183 https://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/4d/4b/jpis-47-182.PMC5494313.pdf
https://doi.org/10.5051/jpis.2017.47.3.182Characteristics of contact and distance osteogenesis 184 https://jpis.org /one.LP mm/four.LP./zero.LP mm /three.LP./three.LP mm B /four.LP./zero.LP mm/six.LP./zero.LP mm/zero.LP./two.LP mm A Left Right modSLA SLA Proximal Distal Implant with Ti tube Implant without Ti tube D /four.LP./zero.LP mm /three.LP./three.LP mm Cortical bone Right tibia Left tibiaTi tube Implant C /two.LP./zero.LP mm Cortical bone New boneTi tubeImplant E Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/4d/4b/jpis-47-182.PMC5494313.pdf
"Thus, sections were deparaffinized and rehydrated in a graded alcohol  series, followed by antigen retrieval in 10 mM Tris/1 mM ethylene diamine tetra-acetic acid  https://doi.org/10.5051/jpis.2017.47.3.182Characteristics of contact and distance osteogenesis 185 https://jpis.org",Non-OADS,/arxiv_data1/oa_pdf/4d/4b/jpis-47-182.PMC5494313.pdf
"Moreover, the implants within  https://doi.org/10.5051/jpis.2017.47.3.182Characteristics of contact and distance osteogenesis 186 https://jpis.org",Non-OADS,/arxiv_data1/oa_pdf/4d/4b/jpis-47-182.PMC5494313.pdf
https://doi.org/10.5051/jpis.2017.47.3.182Characteristics of contact and distance osteogenesis 187 https://jpis.org A B C D Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/4d/4b/jpis-47-182.PMC5494313.pdf
"While further studies verifying and extending these observations  https://doi.org/10.5051/jpis.2017.47.3.182Characteristics of contact and distance osteogenesis 189 https://jpis.org A  BTi tube /five.LP/zero.LP/zero.LP µm /five.LP/zero.LP µm /one.LP,/zero.LP/zero.LP/zero.LP µm/multiply.cap/one.LP/two.LP./five.LP /multiply.cap/four.LP/zero.LP /multiply.cap/two.LP/zero.LP/zero.LP/five.LP/zero.LP/zero.LP µm /five.LP/zero.LP µm /one.LP,/zero.LP/zero.LP/zero.LP µm/multiply.cap/one.LP/two.LP./five.LP /multiply.cap/four.LP/zero.LP /multiply.cap/two.LP/zero.LP/zero.LP C  DBone Bone BoneBone Implant ImplantImplantImplant Ti tubeTi tube /five.LP/zero.LP/zero.LP µm /five.LP/zero.LP µm /one.LP,/zero.LP/zero.LP/zero.LP µm/multiply.cap/one.LP/two.LP./five.LP /multiply.cap/four.LP/zero.LP /multiply.cap/two.LP/zero.LP/zero.LP/five.LP/zero.LP/zero.LP µm /five.LP/zero.LP µm /one.LP,/zero.LP/zero.LP/zero.LP µm/multiply.cap/one.LP/two.LP./five.LP /multiply.cap/four.LP/zero.LP /multiply.cap/two.LP/zero.LP/zero.LP Figure 3.",Non-OADS,/arxiv_data1/oa_pdf/4d/4b/jpis-47-182.PMC5494313.pdf
https://doi.org/10.5051/jpis.2017.47.3.182Characteristics of contact and distance osteogenesis 190 https://jpis.orgWith Ti tube Without Ti tubemodSLA SLA SLA modSLABIC ratio 0.00.20.40.61.0 0.8a)a)b) Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/4d/4b/jpis-47-182.PMC5494313.pdf
PUBMED  | CROSSREF https://doi.org/10.5051/jpis.2017.47.3.182Characteristics of contact and distance osteogenesis 191 https://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/4d/4b/jpis-47-182.PMC5494313.pdf
PUBMED  | CROSSREF https://doi.org/10.5051/jpis.2017.47.3.182Characteristics of contact and distance osteogenesis 192 https://jpis.org,Non-OADS,/arxiv_data1/oa_pdf/4d/4b/jpis-47-182.PMC5494313.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357https://doi.org/10.3346/jkms.2017.32.8.1215  • J Korean Med Sci 2017; 32: 1215-1216 Nontuberculous mycobacteria (NTM) are diverse microorgan - isms of genus Mycobacterium other than M. tuberculosis  com - plex and M. leprae , which are ubiquitous in the environment  such as tap water, swimming pools, natural water, room dust,  and soil (1).",Non-OADS,/arxiv_data1/oa_pdf/1d/86/jkms-32-1215.PMC5494316.pdf
• Increasing Burden of Nontuberculous Mycobacteria 1216  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1215DISCLOSURE The authors have no potential conflicts of interest to disclose.,Non-OADS,/arxiv_data1/oa_pdf/1d/86/jkms-32-1215.PMC5494316.pdf
ORCID Seung-Jung Kee https://orcid.org/0000-0001-9708-5837 Soon-Pal Suh https://orcid.org/0000-0002-1707-1898 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/1d/86/jkms-32-1215.PMC5494316.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Dysphagia due to Upper Esophageal Sphincter Disorder after  Suicide Attemptshttps://doi.org/10.3346/jkms.2017.32.8.1217  • J Korean Med Sci 2017; 32: 1217-1219IMAGES IN THIS ISSUE Otorhinolaryngology1/ 1 CROSSMARK_logo_3_Test 2017-03-16 https://crossmar k-cdn.crossref.org/widget/v2.0/logos /CROSSMARK_Color_square.sv g Fig.",Non-OADS,/arxiv_data1/oa_pdf/10/06/jkms-32-1217.PMC5494317.pdf
"• Cricopharyngeal Myotomy and Balloon Dilatation 1218  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1217with left vocal cord paralysis due to left vagus nerve injury and  cricopharyngeal dysfunction, endoscopic CO 2 laser cricopha - ryngeal myotomy using CO 2 laser 3.0 watt, super-pulse continu - ous mode and injection laryngoplasty of left vocal cord using  RestyleneTM (Q-Med, Uppsala, Sweden) were performed under  general anesthesia (Fig.",Non-OADS,/arxiv_data1/oa_pdf/10/06/jkms-32-1217.PMC5494317.pdf
ORCID Myung Jin Park https://orcid.org/0000-0002-5388-5522 Ah Ra Jung https://orcid.org/0000-0001-5647-1184 Young Gyu Eun https://orcid.org/0000-0003-4081-5207 Dae Hyun Kim https://orcid.org/0000-0002-8434-7380 Sung-Hoon Chung https://orcid.org/0000-0002-0352-9722 Young Chan Lee https://orcid.org/0000-0001-5577-7288 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/10/06/jkms-32-1217.PMC5494317.pdf
"• Cricopharyngeal Myotomy and Balloon Dilatation http://jkms.org   1219 https://doi.org/10.3346/jkms.2017.32.8.1217Address for Correspondence: Young Chan Lee, MD, PhD Department of Otolaryngology-Head and Neck Surgery, Kyung Hee University School of  Medicine, Kyung Hee University Hospital at Gangdong, 892 Dongnam-ro, Gangdong-gu,  Seoul 05278, Korea E-mail: medchan@hanmail.netReceived: 19 December 2016 / Accepted: 20 May 2017 Funding:  This work was supported by the National Research Foundation of Korea (NRF)   grant funded by the Korea government (MSIP) (NRF-2017R1C1B5017244).",Non-OADS,/arxiv_data1/oa_pdf/10/06/jkms-32-1217.PMC5494317.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Plagiarism in the Context of Education and Evolving Detection  Strategies Plagiarism may take place in any scientific journals despite currently employed anti- plagiarism tools.",Non-OADS,/arxiv_data1/oa_pdf/4e/0e/jkms-32-1220.PMC5494318.pdf
"Keywords:  Plagiarism; Information Retrieval; Similarity Detection; Research Activity;  Retraction of Publication as Topic; Research and Development; Publication EthicsArmen Yuri Gasparyan,1   Bekaidar Nurmashev,2   Bakhytzhan Seksenbayev,2   Vladimir I. Trukhachev,3   Elena I. Kostyukova,4   and George D. Kitas1,5 1Departments of Rheumatology and Research and  Development, Dudley Group NHS Foundation Trust  (Teaching Trust of the University of Birmingham,  UK), Russells Hall Hospital, Dudley, West Midlands,  UK; 2South Kazakhstan State Pharmaceutical  Academy, Shymkent, Kazakhstan; 3Stavropol State  Agrarian University, Stavropol, Russian Federation; 4Department of Accounting Management, Stavropol  State Agrarian University, Stavropol, Russian  Federation; 5Arthritis Research UK Epidemiology  Unit, University of Manchester, Manchester, UK Received: 18 May 2017 Accepted: 31 May 2017 Address for Correspondence: Armen Yuri Gasparyan, MD Departments of Rheumatology and Research and Development,  Dudley Group NHS Foundation Trust (Teaching Trust of the  University of Birmingham, UK), Russells Hall Hospital, Pensnett  Road, Dudley DY1 2HQ, West Midlands, UK E-mail: a.gasparyan@gmail.comhttps://doi.org/10.3346/jkms.2017.32.8.1220  • J Korean Med Sci 2017; 32: 1220-1227 INTRODUCTION Scholarly publications are the essence of scientific research, net - working, and exploration of new areas of knowledge.",Non-OADS,/arxiv_data1/oa_pdf/4e/0e/jkms-32-1220.PMC5494318.pdf
• Plagiarism http://jkms.org   1221 https://doi.org/10.3346/jkms.2017.32.8.1220is viewed by some authors as an acceptable form of reusing own  words and writings.,Non-OADS,/arxiv_data1/oa_pdf/4e/0e/jkms-32-1220.PMC5494318.pdf
"• Plagiarism 1222  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1220article covers the issue of plagiarism of ideas, which can be traced  by semantic analysis (22).",Non-OADS,/arxiv_data1/oa_pdf/4e/0e/jkms-32-1220.PMC5494318.pdf
"• Plagiarism http://jkms.org   1223 https://doi.org/10.3346/jkms.2017.32.8.1220DETECTION OF PLAGIARISM A large proportion of Scopus-indexed items on plagiarism re - lates to computer science (26.2%), reflecting the focus of spe - cialists on digital systems for tracking overlaps in scholarly arti - cles.",Non-OADS,/arxiv_data1/oa_pdf/4e/0e/jkms-32-1220.PMC5494318.pdf
• Plagiarism 1224  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1220text in such cases is critical for preventing misconduct in the fu - ture.,Non-OADS,/arxiv_data1/oa_pdf/4e/0e/jkms-32-1220.PMC5494318.pdf
• Plagiarism http://jkms.org   1225 https://doi.org/10.3346/jkms.2017.32.8.1220duct (83).,Non-OADS,/arxiv_data1/oa_pdf/4e/0e/jkms-32-1220.PMC5494318.pdf
ORCID Armen Yuri Gasparyan https://orcid.org/0000-0001-8749-6018 Vladimir I. Trukhachev https://orcid.org/0000-0003-4676-5407 Elena I. Kostyukova https://orcid.org/0000-0002-8393-6001 George D. Kitas https://orcid.org/0000-0002-0828-6176 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4e/0e/jkms-32-1220.PMC5494318.pdf
Available at  http://cseditors.wpengine.com/wp-content/uploads/entire_whitepaper.,Non-OADS,/arxiv_data1/oa_pdf/4e/0e/jkms-32-1220.PMC5494318.pdf
Available at https://ori.hhs.,Non-OADS,/arxiv_data1/oa_pdf/4e/0e/jkms-32-1220.PMC5494318.pdf
Avail - able at https://ori.hhs.gov/plagiarism-18 [accessed on 31 March 2017].,Non-OADS,/arxiv_data1/oa_pdf/4e/0e/jkms-32-1220.PMC5494318.pdf
• Plagiarism 1226  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1220lated to plagiarism?,Non-OADS,/arxiv_data1/oa_pdf/4e/0e/jkms-32-1220.PMC5494318.pdf
Available at https://www.theguardian.com/high - er-education-network/blog/2014/apr/09/international-students-proof - reading-academic-writing-support [accessed on 31 March 2017].,Non-OADS,/arxiv_data1/oa_pdf/4e/0e/jkms-32-1220.PMC5494318.pdf
Available at http://www.ithenticate.com/products/crosscheck [ac - cessed on 31 March 2017].,Non-OADS,/arxiv_data1/oa_pdf/4e/0e/jkms-32-1220.PMC5494318.pdf
Avail - able at http://blogs.discovermagazine.com/neuroskeptic/2015/02/07/ plagiarism-thesaurus/#.WQXZlBFOXcs [accessed on 31 March 2017].,Non-OADS,/arxiv_data1/oa_pdf/4e/0e/jkms-32-1220.PMC5494318.pdf
Avalable at http://www.nature.com/news/ publisher-pulls-58-articles-by-iranian-scientists-over-authorship-manip - ulation-1.20916 [accessed on 31 March 2017].,Non-OADS,/arxiv_data1/oa_pdf/4e/0e/jkms-32-1220.PMC5494318.pdf
• Plagiarism http://jkms.org   1227 https://doi.org/10.3346/jkms.2017.32.8.1220tory publishing is a threat to non-mainstream science.,Non-OADS,/arxiv_data1/oa_pdf/4e/0e/jkms-32-1220.PMC5494318.pdf
Available at http://icmje.org/icmje-recom - mendations.pdf [accessed on 17 May 2017].,Non-OADS,/arxiv_data1/oa_pdf/4e/0e/jkms-32-1220.PMC5494318.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Improvement in the Survival Rates of Very Low Birth Weight  Infants after the Establishment of the Korean Neonatal Network:  Comparison between the 2000s and 2010s  The survival rate (SR) of very low birth weight infants (VLBWIs) and extremely low birth  weight infants (ELBWIs) is a health indicator of neonatal intensive care unit (NICU)  outcomes.",Non-OADS,/arxiv_data1/oa_pdf/ec/51/jkms-32-1228.PMC5494319.pdf
"Keywords:  Infant, Very Low Birth Weight; Infant, Extremely Low Birth Weight; Survival  Rates; Intensive Care; Neonatal National Survey; Korean Neonatal NetworkSung-Hoon Chung and Chong-Woo Bae Department of Pediatrics, Kyung Hee University  Hospital at Gangdong, Kyung Hee University School  of Medicine, Seoul, Korea Received: 20 March 2017 Accepted: 22 April 2017 Address for Correspondence: Chong-Woo Bae, MD Department of Pediatrics, Kyung Hee University Hospital at  Gangdong, Kyung Hee University School of Medicine, 892  Dongnam-ro, Gangdong-gu, Seoul 05278, Korea E-mail: baecw@khnmc.or.kr Funding:  This work was supported by the Research Program  funded by the Korea Centers for Disease Control and Prevention  (2016-ER6307-00#).https://doi.org/10.3346/jkms.2017.32.8.1228  • J Korean Med Sci 2017; 32: 1228-1234 INTRODUCTION According to the World Health Organization classification of  newborn infants by weight, an infant with a birth weight < 1,500  g is classified as a very low birth weight infant (VLBWI), and  among them, an infant with a birth weight < 1,000 g is classified  as an extremely low birth weight infant (ELBWI).",Non-OADS,/arxiv_data1/oa_pdf/ec/51/jkms-32-1228.PMC5494319.pdf
• Survival Rates of Very Low Birth Weight Infants in Korea http://jkms.org   1229 https://doi.org/10.3346/jkms.2017.32.8.1228Europe) in 2003 (3).,Non-OADS,/arxiv_data1/oa_pdf/ec/51/jkms-32-1228.PMC5494319.pdf
"• Survival Rates of Very Low Birth Weight Infants in Korea 1230  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1228these annual reports, we collect the data of VLBWIs reported in  the corresponding year from the registered NICUs in Korea and  publish the report.",Non-OADS,/arxiv_data1/oa_pdf/ec/51/jkms-32-1228.PMC5494319.pdf
• Survival Rates of Very Low Birth Weight Infants in Korea http://jkms.org   1231 https://doi.org/10.3346/jkms.2017.32.8.1228Table 4.  International comparison of the neonatal outcomes of the VLBWIs by the iNeo Database Country Year No.,Non-OADS,/arxiv_data1/oa_pdf/ec/51/jkms-32-1228.PMC5494319.pdf
"• Survival Rates of Very Low Birth Weight Infants in Korea 1232  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1228Canada, and Europe in the future.",Non-OADS,/arxiv_data1/oa_pdf/ec/51/jkms-32-1228.PMC5494319.pdf
"• Survival Rates of Very Low Birth Weight Infants in Korea http://jkms.org   1233 https://doi.org/10.3346/jkms.2017.32.8.1228ther improvements, according to Kim (30).",Non-OADS,/arxiv_data1/oa_pdf/ec/51/jkms-32-1228.PMC5494319.pdf
ORCID Sung-Hoon Chung https://orcid.org/0000-0002-0352-9722 Chong-Woo Bae https://orcid.org/0000-0002-0965-5674 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ec/51/jkms-32-1228.PMC5494319.pdf
Available at http://www.knn.or.kr/index.jsp [accessed on  10 March 2017].,Non-OADS,/arxiv_data1/oa_pdf/ec/51/jkms-32-1228.PMC5494319.pdf
"• Survival Rates of Very Low Birth Weight Infants in Korea 1234  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1228trol and Prevention, 2015.",Non-OADS,/arxiv_data1/oa_pdf/ec/51/jkms-32-1228.PMC5494319.pdf
Available at http://nrn.shiga-med.ac.jp/English - default.htm [accessed on 20 April 2015].,Non-OADS,/arxiv_data1/oa_pdf/ec/51/jkms-32-1228.PMC5494319.pdf
Available at http://www.canadianneonatalnet - work.org/portal/ [accessed on 20 April 2015].,Non-OADS,/arxiv_data1/oa_pdf/ec/51/jkms-32-1228.PMC5494319.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Publication Delay of Korean Medical Journals Publication lag is a determinant to journal efficiency that was not yet studied concerning  Korean medical journals.",Non-OADS,/arxiv_data1/oa_pdf/4f/8f/jkms-32-1235.PMC5494320.pdf
"Keywords:  Bibliometrics; Peer Review; Publication DelayYounsuk Lee, KyoungOk Kim,   and Yujin Lee Department of Anesthesiology, Dongguk University  Ilsan Hospital, Goyang, Korea Received: 31 January 2017 Accepted: 7 May 2017 Address for Correspondence: Younsuk Lee, MD, PhD Department of Anesthesiology, Dongguk University Ilsan  Hospital, 27 Dongguk-ro, Ilsandong-gu, Goyang 10326,   Republic of Korea E-mail: ylee@dongguk.edu Funding:  This research was supported by Dongguk University  Research Fund.https://doi.org/10.3346/jkms.2017.32.8.1235  • J Korean Med Sci 2017; 32: 1235-1242 INTRODUCTION Publication delay of scientific papers is a well -known problem.",Non-OADS,/arxiv_data1/oa_pdf/4f/8f/jkms-32-1235.PMC5494320.pdf
"From ‘Satoshi Village, ’ a famous blog on  science general, we could also refer to the exact measurement  of publication lag in 3,475 articles published by PLOS (2), and  in 3 million or more PubMed (http://www.pubmed.gov/; Na - tional Library of Medicine.",Non-OADS,/arxiv_data1/oa_pdf/4f/8f/jkms-32-1235.PMC5494320.pdf
• Publication Lag = Acceptance Lag + Lead Lag 1236  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1235Table 1.,Non-OADS,/arxiv_data1/oa_pdf/4f/8f/jkms-32-1235.PMC5494320.pdf
"• Publication Lag = Acceptance Lag + Lead Lag http://jkms.org   1237 https://doi.org/10.3346/jkms.2017.32.8.1235articles possessing all 3 timestamps (‘received date, ’ ‘accepted  date, ’ and ‘epublished date’) per article (Fig.",Non-OADS,/arxiv_data1/oa_pdf/4f/8f/jkms-32-1235.PMC5494320.pdf
• Publication Lag = Acceptance Lag + Lead Lag 1238  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1235Fig.,Non-OADS,/arxiv_data1/oa_pdf/4f/8f/jkms-32-1235.PMC5494320.pdf
• Publication Lag = Acceptance Lag + Lead Lag http://jkms.org   1239 https://doi.org/10.3346/jkms.2017.32.8.1235Table 2.,Non-OADS,/arxiv_data1/oa_pdf/4f/8f/jkms-32-1235.PMC5494320.pdf
"• Publication Lag = Acceptance Lag + Lead Lag 1240  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1235and for the lead lag: ICC [lead ] = 12,231/(12,231 + 6,915) = 0.64  The individual coefficients for journals suggested that 4 out  of 10 journals have failed to shorten the acceptance lag (Table 2)  and 2 out of 10 journals have failed to shorten the lead lag (Ta - ble 3).",OADS,/arxiv_data1/oa_pdf/4f/8f/jkms-32-1235.PMC5494320.pdf
• Publication Lag = Acceptance Lag + Lead Lag http://jkms.org   1241 https://doi.org/10.3346/jkms.2017.32.8.1235research.,Non-OADS,/arxiv_data1/oa_pdf/4f/8f/jkms-32-1235.PMC5494320.pdf
"Writing - review &  editing: Lee Y, Kim K, Lee Y. ORCID Younsuk Lee https://orcid.org/0000-0003-2488-5926 KyoungOk Kim https://orcid.org/0000-0001-7509-3668 Yujin Lee https://orcid.org/0000-0003-1043-6214 REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/4f/8f/jkms-32-1235.PMC5494320.pdf
Available at http://blog.dhimmel.com/plos-and-publishing-de - lays/ [accessed on 31 December 2016].,Non-OADS,/arxiv_data1/oa_pdf/4f/8f/jkms-32-1235.PMC5494320.pdf
Available at  http://blog.dhimmel.com/history-of-delays/ [accessed on 31 December  2016].,Non-OADS,/arxiv_data1/oa_pdf/4f/8f/jkms-32-1235.PMC5494320.pdf
Available at https://www.insidehighered.com/news/  2016/12/02/scholar-complains-how-long-it-can-take-publish-interdisci - plinary-science/ [accessed on 17 January 2017].,Non-OADS,/arxiv_data1/oa_pdf/4f/8f/jkms-32-1235.PMC5494320.pdf
Avail - able at https://www.ncbi.nlm.nih.gov/pmc/tools/id-converter-api/ [ac - cessed on 6 January 2017].,OADS,/arxiv_data1/oa_pdf/4f/8f/jkms-32-1235.PMC5494320.pdf
Available at http://tdmsupport.crossref.org/researchers/ [ac - cessed on 6 January 2017].,OADS,/arxiv_data1/oa_pdf/4f/8f/jkms-32-1235.PMC5494320.pdf
Available at https://figshare.com/articles/Peer_Review_state - ments_from_2014_Author_survey/1362178 [accessed on 21 December  2016].,Non-OADS,/arxiv_data1/oa_pdf/4f/8f/jkms-32-1235.PMC5494320.pdf
• Publication Lag = Acceptance Lag + Lead Lag 1242  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1235that make a big difference .,Non-OADS,/arxiv_data1/oa_pdf/4f/8f/jkms-32-1235.PMC5494320.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Decoding Saccadic Directions Using Epidural ECoG in   Non-Human Primates A brain-computer interface (BCI) can be used to restore some communication as an  alternative interface for patients suffering from locked-in syndrome.",Non-OADS,/arxiv_data1/oa_pdf/e7/2a/jkms-32-1243.PMC5494321.pdf
"Received: 7 September 2016 Accepted: 24 April 2017 Address for Correspondence: Dong-Pyo Jang, PhD Department of Biomedical Engineering, Hanyang University,  222-1 Wangsimni-ro, Seongdong-gu, Seoul 04763, Korea E-mail: dongpjang@gmail.com Funding:  This research was supported by the Brain Research  Program through the National Research Foundation of Korea  (NRF) funded by the Ministry of Science, ICT & Future Planning  (2016M3C7A1904987) and supported by a grant of the Korea  Health Technology R & D Project through the Korea Health  Industry Development Institute (KHIDI), funded by the Ministry  of Health and Welfare, Republic of Korea (grant number:  HI14C3229).https://doi.org/10.3346/jkms.2017.32.8.1243  • J Korean Med Sci 2017; 32: 1243-1250 INTRODUCTION Brainstem stroke, traumatic brain injury, and neurodegenera - tive disorders can result in locked-in syndrome, characterized  by near-total paralysis despite intact cognitive function.",Non-OADS,/arxiv_data1/oa_pdf/e7/2a/jkms-32-1243.PMC5494321.pdf
"• Saccadic Directions Can Be Predicted Using Epidural ECoG Signal 1244  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1243ber of studies have shown that various movement parameters  can be decoded using ECoG (10,11).",OADS,/arxiv_data1/oa_pdf/e7/2a/jkms-32-1243.PMC5494321.pdf
• Saccadic Directions Can Be Predicted Using Epidural ECoG Signal http://jkms.org   1245 https://doi.org/10.3346/jkms.2017.32.8.1243to analysis.,OADS,/arxiv_data1/oa_pdf/e7/2a/jkms-32-1243.PMC5494321.pdf
"• Saccadic Directions Can Be Predicted Using Epidural ECoG Signal 1246  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1243Classification We decoded the brain signal with 3 different comparison types:  4 for each direction (4d), left vs. right (LR, left: 135°+225°, right:  45°+315°) and top vs. bottom (TB, top: 45°+135°, bottom: 225°+  315°).",Non-OADS,/arxiv_data1/oa_pdf/e7/2a/jkms-32-1243.PMC5494321.pdf
• Saccadic Directions Can Be Predicted Using Epidural ECoG Signal http://jkms.org   1247 https://doi.org/10.3346/jkms.2017.32.8.1243band ‘freq’ and the temporal contribution Wt(time) of each time  bin ‘time’ (Equations 2 and 3) were also calculated in the same  way as the spatial contribution.,OADS,/arxiv_data1/oa_pdf/e7/2a/jkms-32-1243.PMC5494321.pdf
"• Saccadic Directions Can Be Predicted Using Epidural ECoG Signal 1248  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1243DISCUSSION In the present study, we developed a BCI paradigm using eECoG  signals related to eye movement and successfully decoded sac - cadic directions before saccade execution time.",Non-OADS,/arxiv_data1/oa_pdf/e7/2a/jkms-32-1243.PMC5494321.pdf
"• Saccadic Directions Can Be Predicted Using Epidural ECoG Signal http://jkms.org   1249 https://doi.org/10.3346/jkms.2017.32.8.1243frequency band is hypothesized source of variability in saccadic  response latency and control oscillations (28,29).",OADS,/arxiv_data1/oa_pdf/e7/2a/jkms-32-1243.PMC5494321.pdf
ORCID Jeyeon Lee https://orcid.org/0000-0003-2709-7642 Hoseok Choi https://orcid.org/0000-0001-5930-3688 Seho Lee https://orcid.org/0000-0001-7125-6271 Baek Hwan Cho https://orcid.org/0000-0002-4106-9042 Kyoung-ha Ahn https://orcid.org/0000-0003-3415-5492 In Young Kim https://orcid.org/0000-0002-4007-8465 Kyoung-Min Lee https://orcid.org/0000-0002-6168-8385 Dong-Pyo Jang https://orcid.org/0000-0002-2832-2576 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e7/2a/jkms-32-1243.PMC5494321.pdf
"• Saccadic Directions Can Be Predicted Using Epidural ECoG Signal 1250  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1243terface: current status, limitations and future directions.",Non-OADS,/arxiv_data1/oa_pdf/e7/2a/jkms-32-1243.PMC5494321.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Occupational Risk of Latent Tuberculosis Infection in Health  Workers of 14 Military Hospitals Tuberculosis (TB) is a known occupational risk to health workers.",Non-OADS,/arxiv_data1/oa_pdf/07/bc/jkms-32-1251.PMC5494322.pdf
2013-MDG-0497).https://doi.org/10.3346/jkms.2017.32.8.1251  • J Korean Med Sci 2017; 32: 1251-1257 INTRODUCTION Tuberculosis (TB) causes a serious disease burden with an esti - mated 1.4 million deaths worldwide in 2015 (1).,Non-OADS,/arxiv_data1/oa_pdf/07/bc/jkms-32-1251.PMC5494322.pdf
• Occupational Tuberculosis in Military Health Workers 1252  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1251Screening for the detection of LTBI cases LTBI is defined as a state that shows a persistent immune re - sponse to stimulation by Mycobacterium tuberculosis  antigens  with no evidence of clinically manifested active TB (14).,Non-OADS,/arxiv_data1/oa_pdf/07/bc/jkms-32-1251.PMC5494322.pdf
• Occupational Tuberculosis in Military Health Workers http://jkms.org   1253 https://doi.org/10.3346/jkms.2017.32.8.1251Ethics statement The protocol of this study was reviewed and approved by the  Institutional Review Board of the Korean Institute of Tubercu - losis (2014-KIT-IRB-01).,Non-OADS,/arxiv_data1/oa_pdf/07/bc/jkms-32-1251.PMC5494322.pdf
• Occupational Tuberculosis in Military Health Workers 1254  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1251Table 2.,Non-OADS,/arxiv_data1/oa_pdf/07/bc/jkms-32-1251.PMC5494322.pdf
• Occupational Tuberculosis in Military Health Workers http://jkms.org   1255 https://doi.org/10.3346/jkms.2017.32.8.1251DISCUSSION This study sought to identify LTBI cases in military health work - ers with TST and IGRA.,Non-OADS,/arxiv_data1/oa_pdf/07/bc/jkms-32-1251.PMC5494322.pdf
• Occupational Tuberculosis in Military Health Workers 1256  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1251tings.,Non-OADS,/arxiv_data1/oa_pdf/07/bc/jkms-32-1251.PMC5494322.pdf
ORCID Chang-gyo Yoon https://orcid.org/0000-0002-1543-4659 Soo Yon Oh https://orcid.org/0000-0003-4371-0793 Jin Beom Lee https://orcid.org/0000-0002-4495-3116 Mi-Hyun Kim https://orcid.org/0000-0003-1905-1759 Younsuk Seo https://orcid.org/0000-0002-3595-5064 Juyoun Yang https://orcid.org/0000-0003-1771-0642 Kyu-jung Bae https://orcid.org/0000-0002-5061-5893 Seoyean Hong https://orcid.org/0000-0002-9813-655X Eun-Suk Yang https://orcid.org/0000-0002-6700-6154 Hee Jin Kim https://orcid.org/0000-0002-0128-2789  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/07/bc/jkms-32-1251.PMC5494322.pdf
• Occupational Tuberculosis in Military Health Workers http://jkms.org   1257 https://doi.org/10.3346/jkms.2017.32.8.1251tions of interferon-gamma release assays for the diagnosis of latent tuber - culosis infection.,Non-OADS,/arxiv_data1/oa_pdf/07/bc/jkms-32-1251.PMC5494322.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Clinical Impacts of Donor Types of Living vs. Deceased Donors:  Predictors of One-Year Mortality in Patients with Liver  Transplantation Transplantation studies about the clinical differences according to the type of donors are  mostly conducted in western countries with rare reports from Asians.",Non-OADS,/arxiv_data1/oa_pdf/15/55/jkms-32-1258.PMC5494323.pdf
"Keywords:  Liver Transplantation; Mortality; Living Donor; BNP; Infection Eun Jung Kim,1,2 Seungjin Lim,1,2   Chong Woo Chu,3 Je Ho Ryu,3   Kwangho Yang,3 Young Mok Park,3   Byung Hyun Choi,3 Tae Beom Lee,3   and Su Jin Lee1,2 1Department of Internal Medicine, Pusan National  University School of Medicine, Yangsan, Korea; 2Research Institute for Convergence of Biomedical  Science and Technology, Pusan National University  Yangsan Hospital, Yangsan, Korea; 3Department of  Surgery, Pusan National University Yangsan  Hospital, Yangsan, Korea Received: 20 March 2017 Accepted: 20 May 2017 Address for Correspondence: Su Jin Lee, MD Department of Internal Medicine, Pusan National University  Yangsan Hospital, Pusan National University School of Medicine,  20 Geumo-ro, Mulgeum-eup, Yangsan 50612, Republic of Korea E-mail: beauty192@hanmail.net Funding:  This research was supported by Research Institute for  Convergence of Biomedical Science and Technology, Pusan  National University Yangsan Hospital.https://doi.org/10.3346/jkms.2017.32.8.1258  • J Korean Med Sci 2017; 32: 1258-1262 INTRODUCTION Living donor liver transplantation (LDLT) has been used to in - crease the donor pool and significantly reduce the waiting list  mortality of patients in need of liver transplantation (LT) (1).",Non-OADS,/arxiv_data1/oa_pdf/15/55/jkms-32-1258.PMC5494323.pdf
• Impacts of Type of Donor and Mortality in Liver Transplantation http://jkms.org   1259 https://doi.org/10.3346/jkms.2017.32.8.1258pital.,Non-OADS,/arxiv_data1/oa_pdf/15/55/jkms-32-1258.PMC5494323.pdf
"• Impacts of Type of Donor and Mortality in Liver Transplantation 1260  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1258Child-Pugh score (mean ± SD, 3.6 ± 3.2 vs. 6.1 ± 3.9, respective - ly; P< 0.001).",Non-OADS,/arxiv_data1/oa_pdf/15/55/jkms-32-1258.PMC5494323.pdf
• Impacts of Type of Donor and Mortality in Liver Transplantation http://jkms.org   1261 https://doi.org/10.3346/jkms.2017.32.8.1258tween the survivors and the non-survivors.,Non-OADS,/arxiv_data1/oa_pdf/15/55/jkms-32-1258.PMC5494323.pdf
ORCID Eun Jung Kim https://orcid.org/0000-0003-3302-7827 Seungjin Lim https://orcid.org/0000-0001-7939-9744 Chong Woo Chu https://orcid.org/0000-0003-4909-1815 Je Ho Ryu https://orcid.org/0000-0002-9377-3074 Kwangho Yang https://orcid.org/0000-0003-1489-6787,Non-OADS,/arxiv_data1/oa_pdf/15/55/jkms-32-1258.PMC5494323.pdf
• Impacts of Type of Donor and Mortality in Liver Transplantation 1262  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1258Young Mok Park https://orcid.org/0000-0002-4165-3054 Byung Hyun Choi https://orcid.org/0000-0002-9245-5066 Tae Beom Lee https://orcid.org/0000-0001-6700-3255 Su Jin Lee https://orcid.org/0000-0003-1907-9102 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/15/55/jkms-32-1258.PMC5494323.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Recovery Rates of Non-Tuberculous Mycobacteria from Clinical  Specimens Are Increasing in Korean Tertiary-Care Hospitals Non-tuberculous mycobacteria (NTM) are being recognized increasingly as the causative  agents of opportunistic infections in humans.",Non-OADS,/arxiv_data1/oa_pdf/4d/46/jkms-32-1263.PMC5494324.pdf
"Keywords:  Mycobacterium tuberculosis ; Non-tuberculous Mycobacteria; Mycobacterium  intracellulare ; Mycobacterium aviumNamhee Kim,1,2 Jongyoun Yi,1,2   and Chulhun L. Chang3 1Department of Laboratory Medicine, Pusan  National University Hospital, Busan, Korea; 2Biomedical Research Institute, Pusan National  University Hospital, Busan, Korea; 3Department of Laboratory Medicine, Pusan  National University Yangsan Hospital, Yangsan,  Korea Received: 13 January 2017 Accepted: 12 May 2017 Address for Correspondence: Chulhun L. Chang, MD Department of Laboratory Medicine, Pusan National University  Yangsan Hospital, 20 Geumo-ro, Mulgeum-eup, Yangsan 50612,  Republic of Korea E-mail: cchl@pusan.ac.kr Funding:  This work was supported by the annual clinical  research grant from Pusan National University Yangsan Hospital.https://doi.org/10.3346/jkms.2017.32.8.1263  • J Korean Med Sci 2017; 32: 1263-1267 INTRODUCTION Non-tuberculous mycobacteria (NTM) are a diverse group of  species that are widespread in the environment.",Non-OADS,/arxiv_data1/oa_pdf/4d/46/jkms-32-1263.PMC5494324.pdf
"• Increasing NTM Recovery Rate in Korea 1264  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1263cavity opacities on chest radiography, or multifocal bronchiec - tasis with or without multiple small nodules on high-resolution  computed tomography; and 3) 2 positive sputum cultures or a  single positive bronchial washing fluid culture.",Non-OADS,/arxiv_data1/oa_pdf/4d/46/jkms-32-1263.PMC5494324.pdf
• Increasing NTM Recovery Rate in Korea http://jkms.org   1265 https://doi.org/10.3346/jkms.2017.32.8.1263Table 1.,Non-OADS,/arxiv_data1/oa_pdf/4d/46/jkms-32-1263.PMC5494324.pdf
• Increasing NTM Recovery Rate in Korea 1266  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1263Koh et al.,Non-OADS,/arxiv_data1/oa_pdf/4d/46/jkms-32-1263.PMC5494324.pdf
• Increasing NTM Recovery Rate in Korea http://jkms.org   1267 https://doi.org/10.3346/jkms.2017.32.8.1263underestimated the significance of NTM diseases.,Non-OADS,/arxiv_data1/oa_pdf/4d/46/jkms-32-1263.PMC5494324.pdf
ORCID Namhee Kim https://orcid.org/0000-0003-0844-5058 Jongyoun Yi https://orcid.org/0000-0001-9098-3765 Chulhun L. Chang https://orcid.org/0000-0001-9117-4919 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4d/46/jkms-32-1263.PMC5494324.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Metabolic Complications among Korean Patients with HIV  Infection: The Korea HIV/AIDS Cohort Study Currently, metabolic complications are the most common problem among human  immunodeficiency virus (HIV)-infected patients, with a high incidence.",Non-OADS,/arxiv_data1/oa_pdf/d3/e6/jkms-32-1268.PMC5494325.pdf
"Keywords:  HIV Infection; Metabolic Complication; Dyslipidemia; Protease InhibitorDong Hyun Oh,1 Jin Young Ahn,1   Sang Il Kim,2 Min Ja Kim,3   Jun Hee Woo,4 Woo Joo Kim,3   Ji Hyeon Baek,5 Shin-Woo Kim,6   Bo Youl Choi,7,8 Mi Hwa Lee,7   Ju-yeon Choi,9 Myung Guk Han,9   Chun Kang,9 June Myung Kim,10   Jun Yong Choi,10 and Korea HIV/AIDS  Cohort Study 1Department of Internal Medicine, Seoul Medical  Center, Seoul, Korea; 2Division of Infectious Disease,  Department of Internal Medicine, Seoul St. Mary’s  Hospital, The Catholic University of Korea College of  Medicine, Seoul, Korea; 3Division of Infectious  Diseases, Department of Internal Medicine, Korea  University College of Medicine, Seoul, Korea; 4Department of Infectious Diseases, University of  Ulsan College of Medicine, Asan Medical Center,  Seoul, Korea; 5Department of Internal Medicine,  Inha University School of Medicine, Incheon, Korea; 6Department of Internal Medicine, Kyungpook  National University School of Medicine, Daegu,  Korea; 7Institute for Health and Society, Hanyang  University, Seoul, Korea; 8Department of Preventive  Medicine, Hanyang University College of Medicine,  Seoul, Korea; 9Division of AIDS, Korea Centers for  Disease Control and Prevention, Osong, Korea; 10Department of Internal Medicine, Yonsei University  College of Medicine, Seoul, Korea Received: 22 March 2017 Accepted: 28 May 2017 Address for Correspondence: Jun Yong Choi, MD, PhD Department of Internal Medicine, Yonsei University College of  Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea E-mail: seran@yuhs.ac Funding:  This work was supported by the Research Program  funded by the Korea Centers for Disease Control and Prevention  (4800-4859-304, 2016-E51003-00).https://doi.org/10.3346/jkms.2017.32.8.1268  • J Korean Med Sci 2017; 32: 1268-1274 INTRODUCTION The introduction of highly active antiretroviral therapy (HAART) for the treatment of  human immunodeficiency virus (HIV) infection changed the characteristics of HIV in - fection, from a fatal disease to a chronic manageable infectious disease (1).",Non-OADS,/arxiv_data1/oa_pdf/d3/e6/jkms-32-1268.PMC5494325.pdf
• Metabolic Complications and HIV Infection http://jkms.org   1269 https://doi.org/10.3346/jkms.2017.32.8.1268an incidence of metabolic complications of 20.3%.,Non-OADS,/arxiv_data1/oa_pdf/d3/e6/jkms-32-1268.PMC5494325.pdf
"• Metabolic Complications and HIV Infection 1270  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1268ratio ≥ 1 in men, ≥ 0.85 in women), hyperglycemia, hypercho - lesterolemia, hypoalphalipoproteinemia, hyper LDL-cholester - olemia, and hypertriglyceridemia were 16.4%, 19.0%, 10.4%, 6.0%,  44.2%, 5.5%, and 32.1%, respectively (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/d3/e6/jkms-32-1268.PMC5494325.pdf
• Metabolic Complications and HIV Infection http://jkms.org   1271 https://doi.org/10.3346/jkms.2017.32.8.1268Table 2.,Non-OADS,/arxiv_data1/oa_pdf/d3/e6/jkms-32-1268.PMC5494325.pdf
"• Metabolic Complications and HIV Infection 1272  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1268median total cholesterol, HDL-cholesterol, and triglyceride lev - els were high among patients who received antiretroviral thera - py.",Non-OADS,/arxiv_data1/oa_pdf/d3/e6/jkms-32-1268.PMC5494325.pdf
• Metabolic Complications and HIV Infection http://jkms.org   1273 https://doi.org/10.3346/jkms.2017.32.8.1268in the appearance of fat accumulation between treatment with  PIs and other classes of antiretroviral drugs (26).,Non-OADS,/arxiv_data1/oa_pdf/d3/e6/jkms-32-1268.PMC5494325.pdf
ORCID Dong Hyun Oh https://orcid.org/0000-0002-9990-6042 Jin Young Ahn https://orcid.org/0000-0002-3740-2826 Sang Il Kim https://orcid.org/0000-0001-9361-7381 Min Ja Kim https://orcid.org/0000-0002-2125-7521 Jun Hee Woo https://orcid.org/0000-0003-4512-5352 Woo Joo Kim https://orcid.org/0000-0002-4546-3880 Ji Hyeon Baek https://orcid.org/0000-0002-1783-6950 Shin-Woo Kim https://orcid.org/0000-0002-3755-8249 Bo Youl Choi https://orcid.org/0000-0003-0115-5736 Mi Hwa Lee https://orcid.org/0000-0002-9048-5552 Ju-yeon Choi https://orcid.org/0000-0003-3477-8569 Myung Guk Han https://orcid.org/0000-0002-3543-1826 Chun Kang https://orcid.org/0000-0003-4318-5247 June Myung Kim https://orcid.org/0000-0002-0337-8573 Jun Yong Choi https://orcid.org/0000-0002-2775-3315 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d3/e6/jkms-32-1268.PMC5494325.pdf
• Metabolic Complications and HIV Infection 1274  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.12687.,Non-OADS,/arxiv_data1/oa_pdf/d3/e6/jkms-32-1268.PMC5494325.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Uric Acid Level Has a U-shaped Association with Clinical  Outcomes in Patients with Vasospastic Angina No data are available on the association of serum uric acid and vasospastic angina (VSA)  which has endothelial dysfunction as a possible pathophysiologic mechanism.",Non-OADS,/arxiv_data1/oa_pdf/2b/f5/jkms-32-1275.PMC5494326.pdf
"Received: 7 March 2017 Accepted: 20 May 2017 Address for Correspondence: Seung-Hyuk Choi, MD, PhD Division of Cardiology, Department of Medicine, Samsung  Medical Center, Sungkyunkwan University School of Medicine,  81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea E-mail: cardiochoi@skku.eduhttps://doi.org/10.3346/jkms.2017.32.8.1275  • J Korean Med Sci 2017; 32: 1275-1280 INTRODUCTION Increased serum uric acid level is proposed to be associated  with adverse cardiovascular (CV) events in patients with risk  factors such as hypertension, diabetes, heart failure, or meta - bolic syndrome (1-4).",Non-OADS,/arxiv_data1/oa_pdf/2b/f5/jkms-32-1275.PMC5494326.pdf
• Uric Acid and Vasospastic Angina 1276  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1275Fig.,Non-OADS,/arxiv_data1/oa_pdf/2b/f5/jkms-32-1275.PMC5494326.pdf
• Uric Acid and Vasospastic Angina http://jkms.org   1277 https://doi.org/10.3346/jkms.2017.32.8.1275among uric acid groups and to determine prognostic factors for  clinical outcomes.,Non-OADS,/arxiv_data1/oa_pdf/2b/f5/jkms-32-1275.PMC5494326.pdf
• Uric Acid and Vasospastic Angina 1278  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1275free survival was also compared according to use of nitrates by  uric acid groups (Fig.,OADS,/arxiv_data1/oa_pdf/2b/f5/jkms-32-1275.PMC5494326.pdf
"• Uric Acid and Vasospastic Angina http://jkms.org   1279 https://doi.org/10.3346/jkms.2017.32.8.1275DISCUSSION In the present study, we investigated the association of serum  uric acid levels and clinical outcomes in VSA patients with or  without significant coronary artery stenosis confirmed by spasm- provocation test.",Non-OADS,/arxiv_data1/oa_pdf/2b/f5/jkms-32-1275.PMC5494326.pdf
"• Uric Acid and Vasospastic Angina 1280  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1275AUTHOR CONTRIBUTION Conceptualization: Gwon HC, Choi SH.",Non-OADS,/arxiv_data1/oa_pdf/2b/f5/jkms-32-1275.PMC5494326.pdf
ORCID Hye Bin Gwag https://orcid.org/0000-0001-5610-2872 Jeong Hoon Yang https://orcid.org/0000-0001-8138-1367 Taek Kyu Park https://orcid.org/0000-0003-1440-3583 Young Bin Song https://orcid.org/0000-0002-2581-8891 Joo-Yong Hahn https://orcid.org/0000-0002-4412-377X Jin-Ho Choi https://orcid.org/0000-0002-5421-793X Sang Hoon Lee https://orcid.org/0000-0003-1202-917X Hyeon-Cheol Gwon https://orcid.org/0000-0002-8967-4305 Seung-Hyuk Choi https://orcid.org/0000-0002-0304-6317   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/2b/f5/jkms-32-1275.PMC5494326.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Is Colonoscopic Screening Necessary for Patients Younger than  50 Years with Gastric Adenoma or Cancer?",Non-OADS,/arxiv_data1/oa_pdf/68/16/jkms-32-1281.PMC5494327.pdf
"Keywords:  Colorectal Neoplasm; Gastric Neoplasm; Colonoscopy; YoungNam Hee Kim,1 Jung Ho Park,2   Dong Il Park,2 Chong Il Sohn,2   and Yoon Suk Jung2 1Preventive Healthcare Center, Kangbuk Samsung  Hospital, Sungkyunkwan University School of  Medicine, Seoul, Korea; 2Division of  Gastroenterology, Department of Internal Medicine,  Kangbuk Samsung Hospital, Sungkyunkwan  University School of Medicine, Seoul, Korea Received: 7 April 2017 Accepted: 20 May 2017 Address for Correspondence: Yoon Suk Jung, MD, PhD Division of Gastroenterology, Department of Internal Medicine,  Kangbuk Samsung Hospital, Sungkyunkwan University School  of Medicine, 29 Saemunan-ro, Jongno-gu, Seoul 03181, Korea E-mail: ys810.jung@samsung.comhttps://doi.org/10.3346/jkms.2017.32.8.1281  • J Korean Med Sci 2017; 32: 1281-1287 INTRODUCTION Patients with gastric cancer have been reported to be at risk of  synchronous second cancers in other organs (1,2).",Non-OADS,/arxiv_data1/oa_pdf/68/16/jkms-32-1281.PMC5494327.pdf
• Colonoscopy in Young Patients with Gastric Neoplasm 1282  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1281established cohort.,Non-OADS,/arxiv_data1/oa_pdf/68/16/jkms-32-1281.PMC5494327.pdf
• Colonoscopy in Young Patients with Gastric Neoplasm http://jkms.org   1283 https://doi.org/10.3346/jkms.2017.32.8.1281Statistical analysis Data are expressed as mean ± standard deviation or frequency  (%).,Non-OADS,/arxiv_data1/oa_pdf/68/16/jkms-32-1281.PMC5494327.pdf
"• Colonoscopy in Young Patients with Gastric Neoplasm 1284  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1281Subjects aged ≥ 50 with gastric neoplasm had a significantly  higher proportion of any adenoma (47.3% vs. 31.5%, P< 0.001),  advanced adenoma (11.6% vs. 4.3%, P< 0.001), high-risk ade - noma (17.0% vs. 7.3%, P< 0.001), overall CRN (48.2% vs. 31.7%,  P< 0.001), ACRN (12.5% vs. 4.5%, P< 0.001), and non-ACRN  (35.7% vs. 27.2%, P= 0.044), compared with those without gas - tric neoplasm.",Non-OADS,/arxiv_data1/oa_pdf/68/16/jkms-32-1281.PMC5494327.pdf
"• Colonoscopy in Young Patients with Gastric Neoplasm http://jkms.org   1285 https://doi.org/10.3346/jkms.2017.32.8.1281ras, deleted in colorectal cancer (DCC), and p53 (15,21-26,29- 31).",Non-OADS,/arxiv_data1/oa_pdf/68/16/jkms-32-1281.PMC5494327.pdf
ORCID Nam Hee Kim https://orcid.org/0000-0002-2686-9754 Jung Ho Park https://orcid.org/0000-0002-8367-4371 Dong Il Park https://orcid.org/0000-0003-2307-8575  Chong Il Sohn https://orcid.org/0000-0002-9748-8537 Yoon Suk Jung https://orcid.org/0000-0002-1963-7170 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/68/16/jkms-32-1281.PMC5494327.pdf
"• Colonoscopy in Young Patients with Gastric Neoplasm 1286  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1281Raszeja-Wyszomirska J, Białek A, Karpi ńska-Kaczmarczyk K, Starzy ńska  T. Synchronous and metachronous neoplasms in gastric cancer patients:  a 23-year study.",Non-OADS,/arxiv_data1/oa_pdf/68/16/jkms-32-1281.PMC5494327.pdf
• Colonoscopy in Young Patients with Gastric Neoplasm http://jkms.org   1287 https://doi.org/10.3346/jkms.2017.32.8.1281nous prevalence of colorectal neoplasms in patients with stomach can - cer.,Non-OADS,/arxiv_data1/oa_pdf/68/16/jkms-32-1281.PMC5494327.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Prophylactic versus Early Rescue Surfactant Treatment in  Preterm Infants Born at Less than 30 Weeks Gestation or with  Birth Weight Less than or Equal 1,250 Grams Prophylactic surfactant is known to be effective to reduce chronic lung disease in preterm  infants compared with rescue surfactant treatment.",Non-OADS,/arxiv_data1/oa_pdf/77/60/jkms-32-1288.PMC5494328.pdf
"Received: 18 January 2017 Accepted: 24 April 2017 Address for Correspondence: Won Soon Park, MD, PhD Department of Pediatrics, Samsung Medical Center,  Sungkyunkwan University School of Medicine, 81 Irwon-ro,  Gangnam-gu, Seoul 06351, Korea E-mail: wonspark@skku.edu, ws123.park@samsung.com Funding:  This study was supported by grants from Yuhan  Corporation (PHO1125565) and from the 20 by 20 Project   (Best #3, GFO1150091) of Samsung Medical Center.https://doi.org/10.3346/jkms.2017.32.8.1288  • J Korean Med Sci 2017; 32: 1288-1294 INTRODUCTION Respiratory distress syndrome (RDS), a clinical condition of  pulmonary insufficiency due to lack of surfactant, is the most  important factor in mortality and morbidity of preterm infants.",Non-OADS,/arxiv_data1/oa_pdf/77/60/jkms-32-1288.PMC5494328.pdf
"• Prophylactic Surfactant in Preterm Infants http://jkms.org   1289 https://doi.org/10.3346/jkms.2017.32.8.1288and early stabilization on continuous positive airway pressure  (CPAP) in the delivery room, an updated meta-analysis report - ed that the benefit of prophylactic surfactant administration is  no longer clear (9).",Non-OADS,/arxiv_data1/oa_pdf/77/60/jkms-32-1288.PMC5494328.pdf
• Prophylactic Surfactant in Preterm Infants 1290  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1288Ethics statement The present study protocol was reviewed and approved by the  IRB of Samsung Medical Center (IRB No.,Non-OADS,/arxiv_data1/oa_pdf/77/60/jkms-32-1288.PMC5494328.pdf
• Prophylactic Surfactant in Preterm Infants http://jkms.org   1291 https://doi.org/10.3346/jkms.2017.32.8.1288vs.,Non-OADS,/arxiv_data1/oa_pdf/77/60/jkms-32-1288.PMC5494328.pdf
• Prophylactic Surfactant in Preterm Infants 1292  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1288the length of CPAP was significantly shorter in period 2 than pe - riod 1 ( P= 0.009).,Non-OADS,/arxiv_data1/oa_pdf/77/60/jkms-32-1288.PMC5494328.pdf
• Prophylactic Surfactant in Preterm Infants http://jkms.org   1293 https://doi.org/10.3346/jkms.2017.32.8.1288changes in ventilator management that could have affected the  rate of pneumothorax.,Non-OADS,/arxiv_data1/oa_pdf/77/60/jkms-32-1288.PMC5494328.pdf
ORCID Jiyoung Chun https://orcid.org/0000-0003-3509-6391 Se In Sung https://orcid.org/0000-0002-8717-6142 Yo Han Ho https://orcid.org/0000-0001-7517-955X Jisook Kim https://orcid.org/0000-0002-0100-5845 Ga Young Park https://orcid.org/0000-0002-9095-6457 Shin Ae Yoon https://orcid.org/0000-0001-7892-5853 So Yoon Ahn https://orcid.org/0000-0002-1821-3173 Yun Sil Chang https://orcid.org/0000-0001-9201-2938 Won Soon Park https://orcid.org/0000-0002-8245-4692 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/77/60/jkms-32-1288.PMC5494328.pdf
• Prophylactic Surfactant in Preterm Infants 1294  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1288term and term neonate.,Non-OADS,/arxiv_data1/oa_pdf/77/60/jkms-32-1288.PMC5494328.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Comparison of Follow-up Courses after Discharge from Neonatal  Intensive Care Unit between Very Low Birth Weight Infants with  and without Home Oxygen In order to investigate the clinical impact of home oxygen use for care of premature  infants, we compared the follow-up courses after neonatal intensive care unit (NICU)  discharge between very low birth weight infants (VLBWIs) with and without home oxygen.",Non-OADS,/arxiv_data1/oa_pdf/00/9b/jkms-32-1295.PMC5494329.pdf
"Received: 13 February 2017 Accepted: 30 April 2017 Address for Correspondence: Yun Sil Chang, MD, PhD Department of Pediatrics, Samsung Medical Center,  Sungkyunkwan University School of Medicine,  81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea  E-mail: yschang@skku.edu Funding:  This study was supported by a grant (PHO1115545)  from the Committee on Data Collection and Statistical Analysis  of the Korean Society of Neonatology.https://doi.org/10.3346/jkms.2017.32.8.1295  • J Korean Med Sci 2017; 32: 1295-1303 INTRODUCTION Recently advanced neonatal intensive care markedly improved  the survival rates of very low birth weight infants (VLBWIs) wei- ghing less than 1,500 g at birth (1).",Non-OADS,/arxiv_data1/oa_pdf/00/9b/jkms-32-1295.PMC5494329.pdf
"• Home Oxygen Use in Very Low Birth Weight Infants   1296  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1295admission, and death following NICU discharge by comparison  between those of VLBWI with and without home oxygen at NICU  discharge.",Non-OADS,/arxiv_data1/oa_pdf/00/9b/jkms-32-1295.PMC5494329.pdf
• Home Oxygen Use in Very Low Birth Weight Infants   http://jkms.org   1297 https://doi.org/10.3346/jkms.2017.32.8.1295Table 1.,Non-OADS,/arxiv_data1/oa_pdf/00/9b/jkms-32-1295.PMC5494329.pdf
• Home Oxygen Use in Very Low Birth Weight Infants   1298  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1295was longer than that of in the ≥ 29w GA subgroup.,Non-OADS,/arxiv_data1/oa_pdf/00/9b/jkms-32-1295.PMC5494329.pdf
"• Home Oxygen Use in Very Low Birth Weight Infants   http://jkms.org   1299 https://doi.org/10.3346/jkms.2017.32.8.129539.5% in the 26–28w GA, and 48.5% in the ≥ 29w GA subgroup;  30.6% of the CON infants readmitted in total, 41.0%, 33.4%, and  27.1% in each GA subgroup, respectively.",Non-OADS,/arxiv_data1/oa_pdf/00/9b/jkms-32-1295.PMC5494329.pdf
• Home Oxygen Use in Very Low Birth Weight Infants   1300  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1295home oxygen showing significant institutional variations in Ko - rea.,Non-OADS,/arxiv_data1/oa_pdf/00/9b/jkms-32-1295.PMC5494329.pdf
"• Home Oxygen Use in Very Low Birth Weight Infants   http://jkms.org   1301 https://doi.org/10.3346/jkms.2017.32.8.1295the use of medical equipment at home, and home care of the  infant may increase the risks of various aspects such as vulner - able lung function (22-24), which necessitate careful monitor - ing and follow-up plan.",Non-OADS,/arxiv_data1/oa_pdf/00/9b/jkms-32-1295.PMC5494329.pdf
• Home Oxygen Use in Very Low Birth Weight Infants   1302  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1295institutions that participated in this study.,Non-OADS,/arxiv_data1/oa_pdf/00/9b/jkms-32-1295.PMC5494329.pdf
ORCID Ji Sook Kim https://orcid.org/0000-0002-0100-5845 Jae Won Shim https://orcid.org/0000-0003-0101-3076 Jang Hoon Lee https://orcid.org/0000-0003-4765-9948 Yun Sil Chang https://orcid.org/0000-0001-9201-2938   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/00/9b/jkms-32-1295.PMC5494329.pdf
• Home Oxygen Use in Very Low Birth Weight Infants   http://jkms.org   1303 https://doi.org/10.3346/jkms.2017.32.8.129520.,Non-OADS,/arxiv_data1/oa_pdf/00/9b/jkms-32-1295.PMC5494329.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Different Clinical Aspects of Pediatric Primary Airway  Tumors in the Larynx, Trachea, and Bronchi Primary airway tumors are rare in children and no literature reviewed their characteristics  each location.",Non-OADS,/arxiv_data1/oa_pdf/93/06/jkms-32-1304.PMC5494330.pdf
"Keywords:  Neoplasms; Larynx; Trachea; Bronchi; PediatricsHyun-Ju Cho,1 Jisun Yoon,1 Eun Lee,2  Yoon Se Lee,3 Sang Yoon Kim,3   Jong Lyel Roh,3 Dong Kwan Kim,4   Se Hoon Choi,4 Seung-Il Park,4   Yong-Hee Kim,4 Kyung-Nam Koh,5   Ho Joon Im,5 Jong Jin Seo,5   Soo-Jong Hong,1 and Jinho Yu1 1Division of Pediatric Allergy and Respiratory,  Department of Pediatrics, Childhood Asthma Atopy  Center, University of Ulsan College of Medicine,  Asan Medical Center, Seoul, Korea; 2Department of  Pediatrics, Chonnam National University Hospital,  Gwangju, Korea; 3Department of Otolaryngology,  University of Ulsan College of Medicine, Asan  Medical Center, Seoul, Korea; 4Department of  Thoracic and Cardiovascular Surgery, University of  Ulsan College of Medicine, Asan Medical Center,  Seoul, Korea; 5Division of Pediatric Hematology and  Oncology, Department of Pediatrics, University of  Ulsan College of Medicine, Asan Medical Center  Children’s Hospital, Seoul, Korea Received: 28 February 2017 Accepted: 18 May 2017 Address for Correspondence: Jinho Yu, MD Division of Pediatric Allergy and Respiratory, Department of  Pediatrics, Childhood Asthma Atopy Center, University of Ulsan  College of Medicine, Asan Medical Center, 88 Olympic-ro 43-gil,  Songpa-gu, Seoul 05505, Korea E-mail: jyu3922@gmail.com Funding:  This research was supported by the Asan Institute for  Life Science, University of Ulsan College of Medicine, Asan  Medical Center, Seoul, Korea (grant number: 2016-644).https://doi.org/10.3346/jkms.2017.32.8.1304  • J Korean Med Sci 2017; 32: 1304-1311 INTRODUCTION Primary airway tumors originating from the larynx, trachea, and bronchi are rare in the  pediatric and adult populations.",Non-OADS,/arxiv_data1/oa_pdf/93/06/jkms-32-1304.PMC5494330.pdf
"• Difference in Pediatric Primary Airway Tumor http://jkms.org   1305 https://doi.org/10.3346/jkms.2017.32.8.1304and prognosis based on the location from larynx to bronchi, in  Korean children with primary airway tumor.",Non-OADS,/arxiv_data1/oa_pdf/93/06/jkms-32-1304.PMC5494330.pdf
"• Difference in Pediatric Primary Airway Tumor 1306  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1304The median age at onset was 2 months (interquartile range [IQR],  0.9–22 months) and age at diagnosis was 4 months (IQR, 2.5–26  months).",Non-OADS,/arxiv_data1/oa_pdf/93/06/jkms-32-1304.PMC5494330.pdf
• Difference in Pediatric Primary Airway Tumor http://jkms.org   1307 https://doi.org/10.3346/jkms.2017.32.8.1304Table 3.,Non-OADS,/arxiv_data1/oa_pdf/93/06/jkms-32-1304.PMC5494330.pdf
• Difference in Pediatric Primary Airway Tumor 1308  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1304ogy revealed a benign pleomorphic adenoma (Fig.,Non-OADS,/arxiv_data1/oa_pdf/93/06/jkms-32-1304.PMC5494330.pdf
"• Difference in Pediatric Primary Airway Tumor http://jkms.org   1309 https://doi.org/10.3346/jkms.2017.32.8.13044.0 months; IQR, 2.5–26 months) were diagnosed earlier ( P=  0.004) than both tracheal (154 months) and bronchial tumors  (median age, 138 months; IQR, 36–160 months).",Non-OADS,/arxiv_data1/oa_pdf/93/06/jkms-32-1304.PMC5494330.pdf
"• Difference in Pediatric Primary Airway Tumor 1310  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1304nancy, previous data showed that carcinoid tumors accounted  for about 50% of primary malignant lung tumors in patients un - der the age of 19 years and MEC consisted of < 10% of these tu - mors (30).",Non-OADS,/arxiv_data1/oa_pdf/93/06/jkms-32-1304.PMC5494330.pdf
"Writing - review &  editing: Hong SJ, Yu J. ORCID Hyun-Ju Cho https://orcid.org/0000-0003-4282-4000 Jisun Yoon https://orcid.org/0000-0002-4904-9118 Eun Lee https://orcid.org/0000-0002-7462-0144 Yoon Se Lee https://orcid.org/0000-0001-6534-5753 Sang Yoon Kim https://orcid.org/0000-0002-1991-0165 Jong Lyel Roh https://orcid.org/0000-0002-1537-1977 Dong Kwan Kim https://orcid.org/0000-0003-1984-0352 Se Hoon Choi https://orcid.org/0000-0002-9961-9289 Seung-Il Park https://orcid.org/0000-0002-8729-0498 Yong-Hee Kim https://orcid.org/0000-0003-2177-4876 Kyung-Nam Koh https://orcid.org/0000-0002-6376-672X Ho Joon Im https://orcid.org/0000-0001-8799-4068 Jong Jin Seo https://orcid.org/0000-0002-0191-7836 Soo-Jong Hong https://orcid.org/0000-0003-1409-2113 Jinho Yu https://orcid.org/0000-0002-1226-8077 REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/93/06/jkms-32-1304.PMC5494330.pdf
• Difference in Pediatric Primary Airway Tumor http://jkms.org   1311 https://doi.org/10.3346/jkms.2017.32.8.13049.,Non-OADS,/arxiv_data1/oa_pdf/93/06/jkms-32-1304.PMC5494330.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Comparison of the Birth Statistics between Multi-cultural and  Korean Families in Korea (2015) Since 2002, the number of marriages, births, and family members among multi-cultural  families (MCFs) has increased.",Non-OADS,/arxiv_data1/oa_pdf/6f/23/jkms-32-1312.PMC5494331.pdf
"Keywords:  Korea; Multi-cultural Society; Birth Outcomes; Birth Weight; Gestational Age;  Health DisparitiesSung-Hoon Chung and Chong-Woo Bae Department of Pediatrics, Kyung Hee University  Hospital at Gangdong, Kyung Hee University School  of Medicine, Seoul, Korea Received: 4 April 2017 Accepted: 28 May 2017 Address for Correspondence: Chong-Woo Bae, MD Department of Pediatrics, Kyung Hee University Hospital at  Gangdong, Kyung Hee University School of Medicine, 892  Dongnam-ro, Gangdong-gu, Seoul 05278, Korea  E-mail: baecw@khnmc.or.krhttps://doi.org/10.3346/jkms.2017.32.8.1312  • J Korean Med Sci 2017; 32: 1312-1318 INTRODUCTION According to the Korean ‘Multicultural Family Support Act’ 2012,  the definitions of multi-cultural family (MCF) are: 1) marriage- based immigrants under the Basic Act on the Treatment of For - eigners, 2) men acquiring Korean nationality after marriage ac - cording to the Nationality Act, and 3) all members getting Kore - an nationality for other reasons.",Non-OADS,/arxiv_data1/oa_pdf/6f/23/jkms-32-1312.PMC5494331.pdf
"• Birth Statistics of Multi-cultural Families in Korea http://jkms.org   1313 https://doi.org/10.3346/jkms.2017.32.8.13122012 (5), and the second MCF supporting policy for 2013 to 2017  (6) from the ministry of Gender Equality and Family is currently  operational.",Non-OADS,/arxiv_data1/oa_pdf/6f/23/jkms-32-1312.PMC5494331.pdf
• Birth Statistics of Multi-cultural Families in Korea 1314  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1312Table 3.,Non-OADS,/arxiv_data1/oa_pdf/6f/23/jkms-32-1312.PMC5494331.pdf
"• Birth Statistics of Multi-cultural Families in Korea http://jkms.org   1315 https://doi.org/10.3346/jkms.2017.32.8.1312ble 4): 5,720 in Gyeonggi-do, 5,007 in Seoul, and 1,240 in Gyeong- sangnam-do.",Non-OADS,/arxiv_data1/oa_pdf/6f/23/jkms-32-1312.PMC5494331.pdf
• Birth Statistics of Multi-cultural Families in Korea 1316  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1312 The distribution of births by birth order in MCF and KF is  shown in Table 7.,OADS,/arxiv_data1/oa_pdf/6f/23/jkms-32-1312.PMC5494331.pdf
"• Birth Statistics of Multi-cultural Families in Korea http://jkms.org   1317 https://doi.org/10.3346/jkms.2017.32.8.1312resources and allocation, etc.",Non-OADS,/arxiv_data1/oa_pdf/6f/23/jkms-32-1312.PMC5494331.pdf
"• Birth Statistics of Multi-cultural Families in Korea 1318  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1312and decreased to 197,550 persons in 2015 (2).",Non-OADS,/arxiv_data1/oa_pdf/6f/23/jkms-32-1312.PMC5494331.pdf
ORCID Sung-Hoon Chung https://orcid.org/0000-0002-0352-9722 Chong-Woo Bae https://orcid.org/0000-0002-0965-5674REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/6f/23/jkms-32-1312.PMC5494331.pdf
Available at http://kostat.go.kr/portal/korea/kor_nw/2/2/1/in - dex.board?bmode=read&aSeq=357476&pageNo=&rowNum=10&amSe q=&sTarget=&sTxt [accessed on 20 March 2017].,Non-OADS,/arxiv_data1/oa_pdf/6f/23/jkms-32-1312.PMC5494331.pdf
Available at http://kosis.kr/ [accessed on 20 March 2017].,Non-OADS,/arxiv_data1/oa_pdf/6f/23/jkms-32-1312.PMC5494331.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Trends in Fetal and Perinatal Mortality in Korea (2009–2014):  Comparison with Japan and the United States Fetal death is an important indicator of national health care.",Non-OADS,/arxiv_data1/oa_pdf/50/9a/jkms-32-1319.PMC5494332.pdf
"Keywords:  Fetal Death; Fetal Mortality; Stillbirth; Perinatal Mortality; Newborn; Infant  MortalityYoung Hwa Song,1 Gyung-Min Lee,1   Jung Min Yoon,1 Eun Jung Cheon,1   Sung Ki Lee,2 Sung-Hoon Chung,3   and Jae Woo Lim1 1Department of Pediatrics, Konyang University  College of Medicine, Daejeon, Korea;  2Department of Obstetrics and Gynecology, Konyang  University College of Medicine, Daejeon, Korea;  3Department of Pediatrics, Kyung Hee University  School of Medicine, Seoul, Korea Received: 7 April 2017 Accepted: 20 May 2017 Address for Correspondence: Jae Woo Lim, MD Department of Pediatrics, Konyang University College of  Medicine, 158 Gwanjeodong-ro, Seo-gu, Daejeon 35365,  Republic of Korea E-mail: limsoa@hanmail.nethttps://doi.org/10.3346/jkms.2017.32.8.1319  • J Korean Med Sci 2017; 32: 1319-1326 INTRODUCTION Most countries around the world are interested in statistics re - lated to births, but there is less interest in fetal death statistics.",Non-OADS,/arxiv_data1/oa_pdf/50/9a/jkms-32-1319.PMC5494332.pdf
• Trends in Fetal and Perinatal Mortality in Korea 1320  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1319Fig.,Non-OADS,/arxiv_data1/oa_pdf/50/9a/jkms-32-1319.PMC5494332.pdf
"• Trends in Fetal and Perinatal Mortality in Korea http://jkms.org   1321 https://doi.org/10.3346/jkms.2017.32.8.1319The fetal mortality rate, the fetal mortality rate per gestation, the  male and female ratio of fetal deaths, the number of fetal deaths,  and the yearly trends of fetal mortality rate were confirmed.",OADS,/arxiv_data1/oa_pdf/50/9a/jkms-32-1319.PMC5494332.pdf
• Trends in Fetal and Perinatal Mortality in Korea 1322  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1319Table 2.,Non-OADS,/arxiv_data1/oa_pdf/50/9a/jkms-32-1319.PMC5494332.pdf
• Trends in Fetal and Perinatal Mortality in Korea http://jkms.org   1323 https://doi.org/10.3346/jkms.2017.32.8.1319Table 4.,Non-OADS,/arxiv_data1/oa_pdf/50/9a/jkms-32-1319.PMC5494332.pdf
"• Trends in Fetal and Perinatal Mortality in Korea 1324  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1319ture infants less than 37 weeks increased by 15% from 25,374  persons to 29,086 persons.",Non-OADS,/arxiv_data1/oa_pdf/50/9a/jkms-32-1319.PMC5494332.pdf
"• Trends in Fetal and Perinatal Mortality in Korea http://jkms.org   1325 https://doi.org/10.3346/jkms.2017.32.8.1319The fetal mortality rates at 20–23 weeks of gestation were signif - icantly higher in Korea and Japan, with 937 fetal deaths and 909  fetal deaths, respectively, per 1,000 births and fetal deaths, than  the 509 fetal deaths in the United States.",Non-OADS,/arxiv_data1/oa_pdf/50/9a/jkms-32-1319.PMC5494332.pdf
ORCID Young Hwa Song https://orcid.org/0000-0002-6837-0599 Gyung-Min Lee https://orcid.org/0000-0003-2209-9542 Jung Min Yoon https://orcid.org/0000-0003-3496-0061 Eun Jung Cheon https://orcid.org/0000-0003-3844-0864 Sung Ki Lee https://orcid.org/0000-0002-6941-192X Sung-Hoon Chung https://orcid.org/0000-0002-0352-9722 Jae Woo Lim https://orcid.org/0000-0003-2001-0727 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/50/9a/jkms-32-1319.PMC5494332.pdf
Available at http://apps.who.int/ iris/bitstream/10665/43444/1/9241563206_eng.pdf [accessed on 26 March  2017].,OADS,/arxiv_data1/oa_pdf/50/9a/jkms-32-1319.PMC5494332.pdf
• Trends in Fetal and Perinatal Mortality in Korea 1326  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1319congenital anomalies.,Non-OADS,/arxiv_data1/oa_pdf/50/9a/jkms-32-1319.PMC5494332.pdf
Available at http://www.e-stat.go.jp/SG1/estat/NewListE.,OADS,/arxiv_data1/oa_pdf/50/9a/jkms-32-1319.PMC5494332.pdf
Available at https://mdis.kostat.go.kr/index.do [acce- ssed on 31 March 2017].,Non-OADS,/arxiv_data1/oa_pdf/50/9a/jkms-32-1319.PMC5494332.pdf
Available at https://mdis.kostat.go.kr/index.do [accessed on  31 March 2017].,Non-OADS,/arxiv_data1/oa_pdf/50/9a/jkms-32-1319.PMC5494332.pdf
Available at http://www.e-stat.go.jp/SG1/estat/NewListE.do?tid= 000001028897 [accessed on 31 March 2017].,OADS,/arxiv_data1/oa_pdf/50/9a/jkms-32-1319.PMC5494332.pdf
Available at https://www.cdc.gov/nchs/  data_access/vitalstatsonline.htm [accessed on 31 March 2017].,OADS,/arxiv_data1/oa_pdf/50/9a/jkms-32-1319.PMC5494332.pdf
Available at https://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/50/9a/jkms-32-1319.PMC5494332.pdf
Available at http://opendata.hira.or.kr/op/opc/olap4th Ds- Info.do [accessed on 31 March 2017].,Non-OADS,/arxiv_data1/oa_pdf/50/9a/jkms-32-1319.PMC5494332.pdf
Available at http://www.so - cialservice.or.kr/upload/etc/2017_3000.pdf [accessed on 31 March 2017].,Non-OADS,/arxiv_data1/oa_pdf/50/9a/jkms-32-1319.PMC5494332.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Identification of Downstream Genes of the mTOR Pathway that  Predict Recurrence and Progression in Non-Muscle Invasive  High-Grade Urothelial Carcinoma of the Bladder Microarray analysis was used to investigate the lack of identified mammalian target of  rapamycin (mTOR) pathway downstream genes to overcome cross-talk at non-muscle  invasive high-grade (HG)-urothelial carcinoma (UC) of the bladder, gene expression  patterns, gene ontology, and gene clustering by triple ( p70S6K, S6K,  and eIF4E) small  interfering RNAs (siRNAs) or rapamycin in 5637 and T24 cell lines.",Non-OADS,/arxiv_data1/oa_pdf/ea/3f/jkms-32-1327.PMC5494333.pdf
"Received: 18 March 2017 Accepted: 13 May 2017 Address for Correspondence: Tae-Jin Lee, MD Department of Pathology, Chung-Ang University College of  Medicine, Chung-Ang University Hospital, 102 Heukseok-ro,  Dongjak-gu, Seoul, 06973, Korea E-mail: taejlee@cau.ac.kr Funding:  This research was supported by the Basic Science  Research Program through the National Research Foundation of  Korea (NRF) funded by the Ministry of Education, Science and  Technology, Republic of Korea (2015R1A2A1A15054364), and  also by the Chung-Ang University Research Scholarship Grants  in 2016.https://doi.org/10.3346/jkms.2017.32.8.1327  • J Korean Med Sci 2017; 32: 1327-1336 INTRODUCTION Mammalian target of rapamycin (mTOR) inhibitors are potent - ly active against a wide variety of cancers.",Non-OADS,/arxiv_data1/oa_pdf/ea/3f/jkms-32-1327.PMC5494333.pdf
"• Downstream Genes of the mTOR Pathway to Predict Recurrence and Progression of Bladder Cancer 1328  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1327MATERIALS AND METHODS Cell cultures and reagents Human HG-UC cell lines 5637 and T24 were purchased from  the American Type Culture Collection (Manassas, VA, USA).",Non-OADS,/arxiv_data1/oa_pdf/ea/3f/jkms-32-1327.PMC5494333.pdf
"• Downstream Genes of the mTOR Pathway to Predict Recurrence and Progression of Bladder Cancer http://jkms.org   1329 https://doi.org/10.3346/jkms.2017.32.8.1327from 8,976 to 234.",Non-OADS,/arxiv_data1/oa_pdf/ea/3f/jkms-32-1327.PMC5494333.pdf
• Downstream Genes of the mTOR Pathway to Predict Recurrence and Progression of Bladder Cancer 1330  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1327and 2 rapamycin up-regulated genes ( PLXND1 and ADAMTS5 )  were filtered from both the 5637 and T24 cell lines.,Non-OADS,/arxiv_data1/oa_pdf/ea/3f/jkms-32-1327.PMC5494333.pdf
• Downstream Genes of the mTOR Pathway to Predict Recurrence and Progression of Bladder Cancer http://jkms.org   1331 https://doi.org/10.3346/jkms.2017.32.8.1327pressor genes.,Non-OADS,/arxiv_data1/oa_pdf/ea/3f/jkms-32-1327.PMC5494333.pdf
• Downstream Genes of the mTOR Pathway to Predict Recurrence and Progression of Bladder Cancer 1332  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1327mentary Table 2.,Non-OADS,/arxiv_data1/oa_pdf/ea/3f/jkms-32-1327.PMC5494333.pdf
• Downstream Genes of the mTOR Pathway to Predict Recurrence and Progression of Bladder Cancer http://jkms.org   1333 https://doi.org/10.3346/jkms.2017.32.8.1327Table 2.,Non-OADS,/arxiv_data1/oa_pdf/ea/3f/jkms-32-1327.PMC5494333.pdf
"• Downstream Genes of the mTOR Pathway to Predict Recurrence and Progression of Bladder Cancer 1334  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1327tors predicting recurrence and strong ATP7A  gene expression  (HR, 5.866; P= 0.038) was an independent factor predicting pro - gression (Table 2).",OADS,/arxiv_data1/oa_pdf/ea/3f/jkms-32-1327.PMC5494333.pdf
"• Downstream Genes of the mTOR Pathway to Predict Recurrence and Progression of Bladder Cancer http://jkms.org   1335 https://doi.org/10.3346/jkms.2017.32.8.1327cell proliferation, migration, and invasion inhibition effect of  rapamycin.",Non-OADS,/arxiv_data1/oa_pdf/ea/3f/jkms-32-1327.PMC5494333.pdf
ORCID Subin Jin https://orcid.org/0000-0002-0779-8348 In Ho Chang https://orcid.org/0000-0003-0240-1310 Jin Wook Kim https://orcid.org/0000-0003-4157-9365 Young Mi Whang https://orcid.org/0000-0003-0437-204X Ha Jeong Kim https://orcid.org/0000-0001-7353-575X Soon Auck Hong https://orcid.org/0000-0002-7902-4608 Tae-Jin Lee https://orcid.org/0000-0002-0026-5936 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ea/3f/jkms-32-1327.PMC5494333.pdf
• Downstream Genes of the mTOR Pathway to Predict Recurrence and Progression of Bladder Cancer 1336  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.132712.,Non-OADS,/arxiv_data1/oa_pdf/ea/3f/jkms-32-1327.PMC5494333.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Feasibility and Safety of Mild Therapeutic Hypothermia in Poor- Grade Subarachnoid Hemorrhage: Prospective Pilot Study Therapeutic hypothermia (TH) improves the neurological outcome in patients after cardiac  arrest and neonatal hypoxic brain injury.",Non-OADS,/arxiv_data1/oa_pdf/56/2f/jkms-32-1337.PMC5494334.pdf
"15-05).https://doi.org/10.3346/jkms.2017.32.8.1337  • J Korean Med Sci 2017; 32: 1337-1344 INTRODUCTION Subarachnoid hemorrhage (SAH) is a devastating, although  uncommon, type of stroke with high morbidity and mortality  rates (1).",Non-OADS,/arxiv_data1/oa_pdf/56/2f/jkms-32-1337.PMC5494334.pdf
"• Mild Hypothermia in Subarachnoid Hemorrhage 1338  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1337tient characteristics at admission, including demographic data,  neurological and neuroradiological data, risk factors for delayed  cerebral ischemia (DCI), laboratory findings, in-hospital com - plications, and mortality (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/56/2f/jkms-32-1337.PMC5494334.pdf
• Mild Hypothermia in Subarachnoid Hemorrhage http://jkms.org   1339 https://doi.org/10.3346/jkms.2017.32.8.1337by a neuroradiologist blinded to the laboratory and clinical data.,Non-OADS,/arxiv_data1/oa_pdf/56/2f/jkms-32-1337.PMC5494334.pdf
• Mild Hypothermia in Subarachnoid Hemorrhage 1340  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1337pacetamol intravenously.,Non-OADS,/arxiv_data1/oa_pdf/56/2f/jkms-32-1337.PMC5494334.pdf
• Mild Hypothermia in Subarachnoid Hemorrhage http://jkms.org   1341 https://doi.org/10.3346/jkms.2017.32.8.1337receiving TH.,Non-OADS,/arxiv_data1/oa_pdf/56/2f/jkms-32-1337.PMC5494334.pdf
• Mild Hypothermia in Subarachnoid Hemorrhage 1342  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1337spasm and DCI rather than an acute major treatment strategy  (21-23).,Non-OADS,/arxiv_data1/oa_pdf/56/2f/jkms-32-1337.PMC5494334.pdf
• Mild Hypothermia in Subarachnoid Hemorrhage http://jkms.org   1343 https://doi.org/10.3346/jkms.2017.32.8.1337blinded.,Non-OADS,/arxiv_data1/oa_pdf/56/2f/jkms-32-1337.PMC5494334.pdf
ORCID Wookjin Choi https://orcid.org/0000-0001-8779-0081 Soon Chan Kwon https://orcid.org/0000-0003-4885-1456 Won Joo Lee https://orcid.org/0000-0003-4892-4045 Young Cheol Weon https://orcid.org/0000-0002-7311-7352 Byungho Choi https://orcid.org/0000-0002-4816-822X Hyeji Lee https://orcid.org/0000-0002-6584-1471 Eun Suk Park https://orcid.org/0000-0002-5090-5284 Ryeok Ahn https://orcid.org/0000-0003-2787-5133 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/56/2f/jkms-32-1337.PMC5494334.pdf
Available at http://www.cdc.gov/nhsn/pdfs/pscmanual/6psc - vapcurrent.pdf [accessed on 20 September 2016].,Non-OADS,/arxiv_data1/oa_pdf/56/2f/jkms-32-1337.PMC5494334.pdf
• Mild Hypothermia in Subarachnoid Hemorrhage 1344  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1337line for healthcare professionals from the American Heart Association/ American Stroke Association.,Non-OADS,/arxiv_data1/oa_pdf/56/2f/jkms-32-1337.PMC5494334.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Relationship between Physical Activity Intensity and Mental  Health Status in Patients with Breast Cancer The aim of this study was to investigate the correlation between physical activity (PA) level  and mental health status in a population-based sample of Korean female patients with  breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/c1/b5/jkms-32-1345.PMC5494335.pdf
"Keywords:  Physical Activity Intensity; Mental Health Status; Breast CancerKyoung Doo Kang,1 Sujin Bae,2   Hee-Jun Kim,3 In Gyu Hwang,3   Sun Mi Kim,3 and Doug Hyun Han3 1Department of Medicine, Chung-Ang University  College of Medicine, Seoul, Korea; 2Department of Industry Academic Cooperation  Foundation, Chung-Ang University, Seoul, Korea; 3Department of Psychiatry, Chung-Ang University  Hospital, Seoul, Korea Received: 29 November 2016 Accepted: 13 May 2017 Address for Correspondence: Doug Hyun Han, MD, PhD Department of Psychiatry, Chung-Ang University Hospital,   102 Heukseok-ro, Dongjak-gu, Seoul 06973, Korea E-mail: hduk@yahoo.com Funding:  This study was supported by a grant from the Korea  Creative Content Agency (R2014040055).https://doi.org/10.3346/jkms.2017.32.8.1345  • J Korean Med Sci 2017; 32: 1345-1350 INTRODUCTION Breast cancer is one of the most common cancers in women  worldwide, accounting for 25% of all new cancers (1).",Non-OADS,/arxiv_data1/oa_pdf/c1/b5/jkms-32-1345.PMC5494335.pdf
• Physical Activity and Breast Cancer 1346  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1345of PA reduces the risk of death from breast cancer (19).,Non-OADS,/arxiv_data1/oa_pdf/c1/b5/jkms-32-1345.PMC5494335.pdf
• Physical Activity and Breast Cancer http://jkms.org   1347 https://doi.org/10.3346/jkms.2017.32.8.1345tions (29).,Non-OADS,/arxiv_data1/oa_pdf/c1/b5/jkms-32-1345.PMC5494335.pdf
• Physical Activity and Breast Cancer 1348  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1345tients was significantly higher than that in healthy control par - ticipants (t = 2.85; P= 0.005).,Non-OADS,/arxiv_data1/oa_pdf/c1/b5/jkms-32-1345.PMC5494335.pdf
ORCID Kyoung Doo Kang https://orcid.org/0000-0003-4379-6435 Sujin Bae https://orcid.org/0000-0002-9671-4627,Non-OADS,/arxiv_data1/oa_pdf/c1/b5/jkms-32-1345.PMC5494335.pdf
• Physical Activity and Breast Cancer http://jkms.org   1349 https://doi.org/10.3346/jkms.2017.32.8.1345Hee-Jun Kim https://orcid.org/0000-0002-2388-0552 In Gyu Hwang https://orcid.org/0000-0002-7461-0333 Sun Mi Kim https://orcid.org/0000-0003-4131-0542 Doug Hyun Han https://orcid.org/0000-0002-8314-0767 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c1/b5/jkms-32-1345.PMC5494335.pdf
• Physical Activity and Breast Cancer 1350  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1345cer patients taking chemotherapy.,Non-OADS,/arxiv_data1/oa_pdf/c1/b5/jkms-32-1345.PMC5494335.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Sebaceous Carcinoma: Clinicopathologic Analysis of 29 Cases in  a Tertiary Hospital in Korea Sebaceous carcinoma (SC) is a neoplasm derived from the adnexal epithelium of the  sebaceous glands, and most studies on this neoplasm have been conducted in Caucasians.",Non-OADS,/arxiv_data1/oa_pdf/9d/48/jkms-32-1351.PMC5494336.pdf
"Keywords:  Clinical; Extraocular; Ocular; Pathology; Sebaceous CarcinomaSu-Kyung Park,1 Jin Park,1,2   Han-Uk Kim,1,2 and Seok-Kweon Yun1,2 1Department of Dermatology, Chonbuk National  University Hospital, Jeonju, Korea; 2Research  Institute of Clinical Medicine of Chonbuk National  University, Biomedical Research Institute of  Chonbuk National University Hospital, Jeonju, Korea Received: 7 February 2017 Accepted: 13 May 2017 Address for Correspondence: Seok-Kweon Yun, MD, PhD Department of Dermatology, Chonbuk National University  Hospital, 20 Geonji-ro, Deokjin-gu, Jeonju 54907,   Republic of Korea E-mail: dermayun@jbnu.ac.krhttps://doi.org/10.3346/jkms.2017.32.8.1351  • J Korean Med Sci 2017; 32: 1351-1359 INTRODUCTION Sebaceous carcinoma (SC) is a rare malignant neoplasm that  arises from the adnexal epithelium of sebaceous glands (1).",Non-OADS,/arxiv_data1/oa_pdf/9d/48/jkms-32-1351.PMC5494336.pdf
"• Clinicopathologic Analysis of Sebaceous Carcinoma Cases 1352  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1351The infiltrative cell type was categorized into epidermoid, basa - loid, basosquamous, and others.",Non-OADS,/arxiv_data1/oa_pdf/9d/48/jkms-32-1351.PMC5494336.pdf
"• Clinicopathologic Analysis of Sebaceous Carcinoma Cases http://jkms.org   1353 https://doi.org/10.3346/jkms.2017.32.8.135118.75%) and temple (2/16, 12.50%).",Non-OADS,/arxiv_data1/oa_pdf/9d/48/jkms-32-1351.PMC5494336.pdf
• Clinicopathologic Analysis of Sebaceous Carcinoma Cases 1354  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1351lobular (Fig.,Non-OADS,/arxiv_data1/oa_pdf/9d/48/jkms-32-1351.PMC5494336.pdf
"• Clinicopathologic Analysis of Sebaceous Carcinoma Cases http://jkms.org   1355 https://doi.org/10.3346/jkms.2017.32.8.1351DISCUSSION SC is very rarely diagnosed in clinical settings because its pre - sentation is similar to that of other benign and malignant lesions,  and making a histological diagnosis is not easy because of its  rarity and the difficulty in determining the sebaceous differen - tiation of tumor cells (4).",Non-OADS,/arxiv_data1/oa_pdf/9d/48/jkms-32-1351.PMC5494336.pdf
• Clinicopathologic Analysis of Sebaceous Carcinoma Cases 1356  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1351Fig.,Non-OADS,/arxiv_data1/oa_pdf/9d/48/jkms-32-1351.PMC5494336.pdf
• Clinicopathologic Analysis of Sebaceous Carcinoma Cases http://jkms.org   1357 https://doi.org/10.3346/jkms.2017.32.8.1351 G IH J Fig.,Non-OADS,/arxiv_data1/oa_pdf/9d/48/jkms-32-1351.PMC5494336.pdf
"• Clinicopathologic Analysis of Sebaceous Carcinoma Cases 1358  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1351assumptions, SC might not be aggressive in most cases.",Non-OADS,/arxiv_data1/oa_pdf/9d/48/jkms-32-1351.PMC5494336.pdf
ORCID Su-Kyung Park https://orcid.org/0000-0003-4697-4639 Jin Park https://orcid.org/0000-0002-8830-5479 Han-Uk Kim https://orcid.org/0000-0002-7173-7937 Seok-Kweon Yun https://orcid.org/0000-0002-1498-3701 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9d/48/jkms-32-1351.PMC5494336.pdf
"• Clinicopathologic Analysis of Sebaceous Carcinoma Cases http://jkms.org   1359 https://doi.org/10.3346/jkms.2017.32.8.1351NY, McGraw-Hill, 2012, p1341-2.",Non-OADS,/arxiv_data1/oa_pdf/9d/48/jkms-32-1351.PMC5494336.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Clinical Features of Atopic Dermatitis in Adults Are Different  according to Onset Few studies of atopic dermatitis (AD) in adult patients have evaluated differences in clinical  features of AD according to onset age.",Non-OADS,/arxiv_data1/oa_pdf/95/e8/jkms-32-1360.PMC5494337.pdf
"This  research was also supported by a grant of the Korea Health  Technology R&D Project through the Korea Health Industry  Development Institute (KHIDI), funded by the Ministry of Health  & Welfare, Republic of Korea (grant number : HI17C0597).https://doi.org/10.3346/jkms.2017.32.8.1360  • J Korean Med Sci 2017; 32: 1360-1366 INTRODUCTION Atopic dermatitis (AD) is a common pruritic, chronic, relaps - ing, inflammatory skin disease occurring primarily in childhood  (1-4).",Non-OADS,/arxiv_data1/oa_pdf/95/e8/jkms-32-1360.PMC5494337.pdf
"• Atopic Dermatitis Phenotypes by Onset Age http://jkms.org   1361 https://doi.org/10.3346/jkms.2017.32.8.1360AD between birth and 18th year of life, and the adult-onset AD  subgroup, including the 18th year of life and after (3,18,19).",Non-OADS,/arxiv_data1/oa_pdf/95/e8/jkms-32-1360.PMC5494337.pdf
"• Atopic Dermatitis Phenotypes by Onset Age 1362  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1360adult patients with AD, 48 (17.14%) had adult-onset ( ≥ 18 years  of age) history of AD and 232 (82.86%) had pre-adult-onset ( < 18  years of age).",Non-OADS,/arxiv_data1/oa_pdf/95/e8/jkms-32-1360.PMC5494337.pdf
• Atopic Dermatitis Phenotypes by Onset Age http://jkms.org   1363 https://doi.org/10.3346/jkms.2017.32.8.1360were not (BMI < 25) obese.,Non-OADS,/arxiv_data1/oa_pdf/95/e8/jkms-32-1360.PMC5494337.pdf
"• Atopic Dermatitis Phenotypes by Onset Age 1364  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1360 In our research, 17.14% of adult AD patients had a history of  late-onset.",Non-OADS,/arxiv_data1/oa_pdf/95/e8/jkms-32-1360.PMC5494337.pdf
• Atopic Dermatitis Phenotypes by Onset Age http://jkms.org   1365 https://doi.org/10.3346/jkms.2017.32.8.1360obesity and the weight change in each patient.,Non-OADS,/arxiv_data1/oa_pdf/95/e8/jkms-32-1360.PMC5494337.pdf
ORCID Jee Hee Son https://orcid.org/0000-0002-7816-1942 Bo Young Chung https://orcid.org/0000-0002-2795-0140 Hye One Kim https://orcid.org/0000-0001-5846-0008 Chun Wook Park https://orcid.org/0000-0003-4512-8668 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/95/e8/jkms-32-1360.PMC5494337.pdf
• Atopic Dermatitis Phenotypes by Onset Age 1366  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1360matol 2000; 41: 225-8.,Non-OADS,/arxiv_data1/oa_pdf/95/e8/jkms-32-1360.PMC5494337.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Rapid Health Needs Assessment after Typhoons Bolaven and  Tembin Using the Public Health Assessment for Emergency  Response Toolkit in Paju and Jeju, Korea 2012 Following natural disasters, rapid health needs assessments are required to quickly assess  health status and help decision making during the recovery phase.",Non-OADS,/arxiv_data1/oa_pdf/19/a0/jkms-32-1367.PMC5494338.pdf
"Keywords:  Disaster; Needs Assessment; Typhoon; Mental Health ServicesKi Jeong Hong,1 Kyoung Jun Song,2   Sang Do Shin,2 Sung Wook Song,3   Young Sun Ro,4 Joo Jeong,5   Tae Han Kim,2 Yu Jin Lee,6   Minsook Kim,7 Soo-Nam Jo,8   and Min Young Kim9 1Department of Emergency Medicine, Seoul  Metropolitan Government-Seoul National University  Boramae Medical Center, Seoul, Korea; 2Department  of Emergency Medicine, Seoul National University  College of Medicine and Hospital, Seoul, Korea;  3Department of Emergency Medicine, Jeju National  University School of Medicine, Jeju, Korea;  4Laboratory of Emergency Medical Services, Seoul  National University Hospital Biomedical Research  Institute, Seoul, Korea; 5Department of Emergency  Medicine, Seoul National University Bundang  Hospital, Seongnam, Korea; 6Department of  Emergency Medicine, National Medical Center,  Seoul, Korea; 7Gangbuk-gu Community Health  Center, Seoul, Korea; 8Gyeonggi Infectious Disease  Control Center, Seongnam, Korea; 9Jeju National  University College of Nursing, Jeju, Korea Received: 19 March 2017 Accepted: 28 May 2017 Address for Correspondence: Kyoung Jun Song, MD, PhD Department of Emergency Medicine, Seoul National University  College of Medicine and Hospital, 101 Daehak-ro, Jongno-gu,  Seoul 03080, Korea E-mail: skciva@gmail.comhttps://doi.org/10.3346/jkms.2017.32.8.1367  • J Korean Med Sci 2017; 32: 1367-1373 INTRODUCTION Tropical storms including hurricanes, typhoons and cyclones significantly impact hu - man populations and result in public health consequence including storm related  mortality, injury and psychosocial effects (1).",Non-OADS,/arxiv_data1/oa_pdf/19/a0/jkms-32-1367.PMC5494338.pdf
• Rapid Health Needs Assessment Using Newly Developed Toolkit in Korea 1368  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1367the disaster response system of Korea.,Non-OADS,/arxiv_data1/oa_pdf/19/a0/jkms-32-1367.PMC5494338.pdf
• Rapid Health Needs Assessment Using Newly Developed Toolkit in Korea http://jkms.org   1369 https://doi.org/10.3346/jkms.2017.32.8.1367ter) and accessibility of medical services after typhoon.,Non-OADS,/arxiv_data1/oa_pdf/19/a0/jkms-32-1367.PMC5494338.pdf
• Rapid Health Needs Assessment Using Newly Developed Toolkit in Korea 1370  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1367Table 3.,Non-OADS,/arxiv_data1/oa_pdf/19/a0/jkms-32-1367.PMC5494338.pdf
"• Rapid Health Needs Assessment Using Newly Developed Toolkit in Korea http://jkms.org   1371 https://doi.org/10.3346/jkms.2017.32.8.1367households (95% CI, 1,276–4,334) required electrical power.",Non-OADS,/arxiv_data1/oa_pdf/19/a0/jkms-32-1367.PMC5494338.pdf
• Rapid Health Needs Assessment Using Newly Developed Toolkit in Korea 1372  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1367unit data was managed by the Statistics Korea to take a census.,OADS,/arxiv_data1/oa_pdf/19/a0/jkms-32-1367.PMC5494338.pdf
ORCID Ki Jeong Hong https://orcid.org/0000-0003-3334-817X Kyoung Jun Song https://orcid.org/0000-0002-0027-6352 Sang Do Shin https://orcid.org/0000-0003-4953-2916 Sung Wook Song https://orcid.org/0000-0002-7056-6179 Young Sun Ro https://orcid.org/0000-0003-3634-9573 Joo Jeong https://orcid.org/0000-0002-7747-3987 Tae Han Kim https://orcid.org/0000-0003-3855-081X Yu Jin Lee https://orcid.org/0000-0002-6301-1175 Minsook Kim https://orcid.org/0000-0001-8539-0682 Soo-Nam Jo https://orcid.org/0000-0003-1797-7152 Min Young Kim https://orcid.org/0000-0001-6024-1111  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/19/a0/jkms-32-1367.PMC5494338.pdf
• Rapid Health Needs Assessment Using Newly Developed Toolkit in Korea http://jkms.org   1373 https://doi.org/10.3346/jkms.2017.32.8.136712.,Non-OADS,/arxiv_data1/oa_pdf/19/a0/jkms-32-1367.PMC5494338.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Congenital Syphilis Presenting with Only Nephrotic Syndrome:  Reemergence of a Forgotten Disease Syphilis infection has re-emerged after years of declining incidence.",Non-OADS,/arxiv_data1/oa_pdf/9b/a2/jkms-32-1374.PMC5494339.pdf
"Keywords:  Syphilis; Nephrotic Syndrome; CongenitalYun Hee Kim, Ji Ho Song, Chan Jong Kim,  and Eun Mi Yang Department of Pediatrics, Chonnam National  University Hospital, Chonnam National University  Medical School, Gwangju, Korea Received: 16 December 2015 Accepted: 21 April 2016 Address for Correspondence: Eun Mi Yang, MD Department of Pediatrics, Chonnam National University  Hospital, 42 Jebong-ro, Dong-gu, Gwangju 61469,   Republic of Korea  E-mail: emyang@chonnam.ac.krhttps://doi.org/10.3346/jkms.2017.32.8.1374  • J Korean Med Sci 2017; 32: 1374-1376 INTRODUCTION Syphilis is generally considered to be largely eradicated in many  countries; however, its incidence remains high in the develop - ing world and is increasing in developed countries (1,2).",Non-OADS,/arxiv_data1/oa_pdf/9b/a2/jkms-32-1374.PMC5494339.pdf
• Congenital Syphilis Presenting with Nephrotic Syndrome http://jkms.org   1375 https://doi.org/10.3346/jkms.2017.32.8.1374Congenital nephrotic syndrome (CNS) was diagnosed and cause  of CNS include congenital infection was evaluated at the first  day of admission.,Non-OADS,/arxiv_data1/oa_pdf/9b/a2/jkms-32-1374.PMC5494339.pdf
"• Congenital Syphilis Presenting with Nephrotic Syndrome 1376  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1374mothers could be related to failure of prenatal care delivery sys - tems (9,16,17).",Non-OADS,/arxiv_data1/oa_pdf/9b/a2/jkms-32-1374.PMC5494339.pdf
ORCID Yun Hee Kim https://orcid.org/0000-0002-1992-3337 Ji Ho Song https://orcid.org/0000-0002-4675-9237 Chan Jong Kim https://orcid.org/0000-0001-6519-2427 Eun Mi Yang https://orcid.org/0000-0001-9410-5855 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9b/a2/jkms-32-1374.PMC5494339.pdf
Available at  http://www.who.int/reproductivehealth/publications/rtis/9789241563 475/en [accessed on 10 October 2015].,Non-OADS,/arxiv_data1/oa_pdf/9b/a2/jkms-32-1374.PMC5494339.pdf
Available at http://is.cdc.go.kr/dstat/index.jsp [ac - cessed on 10 October 2015].,OADS,/arxiv_data1/oa_pdf/9b/a2/jkms-32-1374.PMC5494339.pdf
Available at http://www.cdc.gov/ std/stats14/ [accessed on 27 March 2016].,OADS,/arxiv_data1/oa_pdf/9b/a2/jkms-32-1374.PMC5494339.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357https://doi.org/10.3346/jkms.2017.32.8.1377  • J Korean Med Sci 2017; 32: 1377-1378 Letter to the Editor:  Plagiarism in Scientific Writings:   Is There Any Way Out?",Non-OADS,/arxiv_data1/oa_pdf/f5/f4/jkms-32-1377.PMC5494340.pdf
ORCID Jyotindu Debnath https://orcid.org/0000-0002-5466-8896 REFERENCE 1.,Non-OADS,/arxiv_data1/oa_pdf/f5/f4/jkms-32-1377.PMC5494340.pdf
"Debnath J • Plagiarism in Scientific Writings 1378  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1377Address for Correspondence: Jyotindu Debnath, MD Department of Radiology, Armed Forces Medical College, Southern Command, Near Race Course, Solapur Road, Wanowrie,Pune, Maharashtra 411040, India E-mail: jyotindu_debnath@rediffmail.com Received: 3 April 2017 / Accepted: 30 April 2017",Non-OADS,/arxiv_data1/oa_pdf/f5/f4/jkms-32-1377.PMC5494340.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357https://doi.org/10.3346/jkms.2017.32.8.1379  • J Korean Med Sci 2017; 32: 1379-1380 Letter to the Editor:  Appropriate Statistical Analysis and  Research Reporting We read with interest the article on presenting results of statisti - cal analysis by Farrokh Habibzadeh (1), the Past President of  the World Association of Medical Editors and one of the leading  eastern Mediterranean editors.",Non-OADS,/arxiv_data1/oa_pdf/bb/0c/jkms-32-1379.PMC5494341.pdf
"Writing - review & editing: Wakhlu A, Sharma A, Negi VS. ORCID Durga Prasanna Misra https://orcid.org/0000-0002-5035-7396CORRESPONDENCE1/ 1 CROSSMARK_logo_3_Test 2017-03-16 https://crossmar k-cdn.crossref.org/widget/v2.0/logos /CROSSMARK_Color_square.sv g",Non-OADS,/arxiv_data1/oa_pdf/bb/0c/jkms-32-1379.PMC5494341.pdf
• Appropriate Statistical Analysis 1380  http://jkms.org https://doi.org/10.3346/jkms.2017.32.8.1379Anupam Wakhlu https://orcid.org/0000-0003-4342-9547 Vikas Agarwal https://orcid.org/0000-0002-4508-1233 Aman Sharma https://orcid.org/0000-0003-0813-1243 Vir Singh Negi https://orcid.org/0000-0003-1518-6031 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/bb/0c/jkms-32-1379.PMC5494341.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357https://doi.org/10.3346/jkms.2017.32.8.1381  • J Korean Med Sci 2017; 32: 1381 Letter to the Editor:  Sharing Image Data from Clinical   Trials Dear Editor:  The International Committee of Medical Journal Editors (IC ­ MJE) recently published data sharing statements for clinical tri ­ als (1).",Non-OADS,/arxiv_data1/oa_pdf/75/6f/jkms-32-1381.PMC5494342.pdf
ORCID Yousun Ko https://orcid.org/0000­0002­2181­9555 Kyung Won Kim https://orcid.org/0000­0003­0871­6858 Kyong Joon Lee https://orcid.org/0000­0002­0658­433X Kyoung Ho Lee https://orcid.org/0000­0001­6045­765X REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/75/6f/jkms-32-1381.PMC5494342.pdf
Available at https://www.acrin.org/RE - SEARCHERS/POLICIES.aspx [accessed on 23 June 2017].,Non-OADS,/arxiv_data1/oa_pdf/75/6f/jkms-32-1381.PMC5494342.pdf
Serum levels may increase slightly  after a DRE but the performance of cystoscopy or prostate  biopsy may increase PSA levels as much as tenfold for up to  www.icurology.orgInvestig Clin Urol 2017;58:217-219. https://doi.org/10.4111/icu.2017.58.4.217pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/3f/9d/icu-58-217.PMC5494343.pdf
218 www.icurology.orgEastham https://doi.org/10.4111/icu.2017.58.4.217 10 weeks.,Non-OADS,/arxiv_data1/oa_pdf/3f/9d/icu-58-217.PMC5494343.pdf
"Keywords: Immune checkpoint inhibitors; Immunotherapy; Renal cell carcinoma; Vaccines This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review Article Received: 27 March, 2017  •  Accepted: 24 April, 2017 Corresponding Author: Eu Chang Hwang Department of Urology, Chonnam National University Hwasun Hospital, 160 Baekseo-ro, Dong-gu, Gwangju 61469, KoreaTEL: +82-61-379-7745, FAX: +82-61-379-7750, E-mail: urohwang@gmail.com ⓒ The Korean Urological Association, 2017use of cytokines after showing improved clinical benefit  and survival, with a median survival to approximately 40  months and a progression-free survival of  up to 27 months  in randomized prospective clinical trials [6-8] .",Non-OADS,/arxiv_data1/oa_pdf/b7/df/icu-58-220.PMC5494344.pdf
www.icurology.orgInvestig Clin Urol 2017;58:220-227. https://doi.org/10.4111/icu.2017.58.4.220pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/b7/df/icu-58-220.PMC5494344.pdf
"222 www.icurology.orgCho et al https://doi.org/10.4111/icu.2017.58.4.220 adult tissues but is expressed at high levels by the placenta  and by a range of  human carcinomas including kidney,  colorectal, prostate, ovary, and breast.",Non-OADS,/arxiv_data1/oa_pdf/b7/df/icu-58-220.PMC5494344.pdf
"Ongoing clinical trials involving PD-1 and PD-L1 inhibitor use for treatment of metastatic renal cell carcinoma (phase II or III trials) Drug Line NCT numberaStudy name PD-1 inhibitor    Nivolumab (OPDIVO ®) 2nd NCT02596035 A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma    Nivolumab (OPDIVO ®) 1st NCT02446860 A Study of Anti-PD1 (Nivolumab) Therapy as Pre- and Post-operative Therapy in Metastatic Renal Cell Cancer (ADAPTeR)    Nivolumab (OPDIVO ®) + Ipilimuab (YERVOY ®) 1st NCT02231749 Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell  Carcinoma (CheckMate 214)    Pembrolizumab (KEYTRUDA ®) 1st NCT02014636 Safety and Efficacy Study of Pazopanib and MK 3475 in Advanced Renal Cell Carcinoma (RCC; KEYNOTE-018)    Pembrolizumab (KEYTRUDA ®) 1st/2nd NCT02348008 Phase Ib and Phase II Studies of Anti-PD-1 Antibody MK-3475 in Combination With Bevacizumab for the Treatment of  Metastatic Renal Cell Carcinoma: Big Ten Cancer Research Consortium GU14-003    Pembrolizumab (KEYTRUDA ®) 1st/2nd NCT02619253 A Phase I/Ib, Open Label, Dose Finding Study to Evaluate Safety, Pharmacodynamics and Efficacy of Pembrolizumab  (MK-3475) in Combination With Vorinostat in Patients With Advanced Renal or Urothelial Cell Carcinoma PDL-1 inhibitor   Atezolizumab (TECENTRIQ ®) 1st NCT02420821 A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced  Renal Cell Carcinoma [IMmotion151]    Atezolizumab (TECENTRIQ ®) 1st NCT01984242 A Phase II, Randomized Study of Atezolizumab (Anti PD-L1 Antibody) Administered as Monotherapy or in Combina- tion With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma    Avelumab 1st NCT02684006 A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101) PD-1, programmed cell death-1; PD-L1, programmed cell death protein ligand 1. a:https://clinicaltrials.gov/.",Non-OADS,/arxiv_data1/oa_pdf/b7/df/icu-58-220.PMC5494344.pdf
"224 www.icurology.orgCho et al https://doi.org/10.4111/icu.2017.58.4.220 Other PD-1 inhibitors, such as pembrolizumab (KEYT - RUDA, IgG4 monoclonal antibody) and pidilizumab (IgG1  monoclonal antibody), are currently undergoing clinical  trials, the majority of which are combination trials.",Non-OADS,/arxiv_data1/oa_pdf/b7/df/icu-58-220.PMC5494344.pdf
Available from: https://clinicaltrials.gov/ct2/show/ NCT01582672  20.,Non-OADS,/arxiv_data1/oa_pdf/b7/df/icu-58-220.PMC5494344.pdf
226 www.icurology.orgCho et al https://doi.org/10.4111/icu.2017.58.4.220 Med 2009;7:2.,Non-OADS,/arxiv_data1/oa_pdf/b7/df/icu-58-220.PMC5494344.pdf
"Keywords: Glomerular filtration rate; Nephrectomy; Renal cell carcinoma; Renal insufficiency This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Urological Oncology Received: 9 January, 2017  •  Accepted: 1 April, 2017 Corresponding Author: Shuichi Shimada Department of Urology, Tohoku University Graduate School of Medicine, 1-1 Seiryomachi, Aoba-ku, Sendai, 980-8574, JapanTEL: +81-22-717-7276, FAX: +81-22-717-7283, E-mail: Shimapp@uro.med.tohoku.ac.jp ⓒ The Korean Urological Association, 2017CKD immediately after radical nephrectomy (RN) for the  treatment of renal cell carcinoma (RCC), and the prevalence  of  CKD increases steadily thereafter [1,2].",Non-OADS,/arxiv_data1/oa_pdf/bd/90/icu-58-228.PMC5494345.pdf
"Although RN has  long been the standard treatment for renal cell tumors,  partial nephrectomy (PN) is now the appropriate treatment  option based on its provision of equivalent cancer control  www.icurology.orgInvestig Clin Urol 2017;58:228-234.https://doi.org/10.4111/icu.2017.58.4.228pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/bd/90/icu-58-228.PMC5494345.pdf
230 www.icurology.orgShimada et al https://doi.org/10.4111/icu.2017.58.4.228 RESUL TS The rate of change in eGFR before and 1 year after RN  is shown in Table 1 .,OADS,/arxiv_data1/oa_pdf/bd/90/icu-58-228.PMC5494345.pdf
"232 www.icurology.orgShimada et al https://doi.org/10.4111/icu.2017.58.4.228 renal function after RN in both males and females, whereas  smaller tumor size and higher BMI are significant predictors  only in males.",Non-OADS,/arxiv_data1/oa_pdf/bd/90/icu-58-228.PMC5494345.pdf
234 www.icurology.orgShimada et al https://doi.org/10.4111/icu.2017.58.4.228 7.,Non-OADS,/arxiv_data1/oa_pdf/bd/90/icu-58-228.PMC5494345.pdf
Available from: http://www.health-net.,Non-OADS,/arxiv_data1/oa_pdf/bd/90/icu-58-228.PMC5494345.pdf
"Keywords: Angiomyolipoma; Decision support techniques; Nephrectomy; Renal cell carcinoma This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Robotics/Laparoscopy Received: 9 January, 2017  •  Accepted: 15 February, 2017 Corresponding Author: R. Sherburne Figenshau Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine, 4960 Children’s Place, Campus Box 8242, St. Louis, MO 63110, USATEL: +1-314-454-2235, FAX: +1-314-367-5016, E-mail: figenshaur@wudosis.wustl.edu ⓒ The Korean Urological Association, 2017to the widespread use of abdominal imaging modalities [2].",Non-OADS,/arxiv_data1/oa_pdf/f4/a7/icu-58-235.PMC5494346.pdf
"Imaging moda­ lities are highly useful for stratifying patients at risk for  renal malignancy; however, upwards of 30% of excised  www.icurology.orgInvestig Clin Urol 2017;58:235-240.https://doi.org/10.4111/icu.2017.58.4.235pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/f4/a7/icu-58-235.PMC5494346.pdf
236 www.icurology.orgBauman et al https://doi.org/10.4111/icu.2017.58.4.235 lesions ultimately show benign pathology [5] .,Non-OADS,/arxiv_data1/oa_pdf/f4/a7/icu-58-235.PMC5494346.pdf
238 www.icurology.orgBauman et al https://doi.org/10.4111/icu.2017.58.4.235 in these studies.,Non-OADS,/arxiv_data1/oa_pdf/f4/a7/icu-58-235.PMC5494346.pdf
"SUPPLEMENTARY MATERIALS Scan this QR code to see the supplementary Tables, or  visit http://icurology.org/src/sm/icu ­58­235­s001.pdf .",Non-OADS,/arxiv_data1/oa_pdf/f4/a7/icu-58-235.PMC5494346.pdf
240 www.icurology.orgBauman et al https://doi.org/10.4111/icu.2017.58.4.235 Value of the diffusion-weighted MRI in the differential diag- nostics of malignant and benign kidney neoplasms - our clini- cal experience.,OADS,/arxiv_data1/oa_pdf/f4/a7/icu-58-235.PMC5494346.pdf
"Keywords: Artificial urinary sphincter; Male; Urinary bladder; Urinary incontinence This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Lower Urinary Tract Dysfunction Received: 20 February, 2017  •  Accepted: 3 April, 2017 Corresponding Author: Daniel S. Elliott Department of Urology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USATEL: +1-507-284-3983, FAX: +1-507-284-4951, E-mail: Elliott.Daniel@mayo.edu ⓒ The Korean Urological Association, 2017predictor of postoperative complications is scarce [2,5-7] .",Non-OADS,/arxiv_data1/oa_pdf/4e/69/icu-58-241.PMC5494347.pdf
"Moreover, data evaluating outcomes in other  etiologic groups such as benign prostatic resection, or  www.icurology.orgInvestig Clin Urol 2017;58:241-246.https://doi.org/10.4111/icu.2017.58.4.241pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/4e/69/icu-58-241.PMC5494347.pdf
242 www.icurology.orgMiller et al https://doi.org/10.4111/icu.2017.58.4.241 cryotherapy are lacking.,Non-OADS,/arxiv_data1/oa_pdf/4e/69/icu-58-241.PMC5494347.pdf
"244 www.icurology.orgMiller et al https://doi.org/10.4111/icu.2017.58.4.241 patient populations, there is no comparison of  AUS outcomes  amongst these groups provided [13, 16- 19] .",OADS,/arxiv_data1/oa_pdf/4e/69/icu-58-241.PMC5494347.pdf
246 www.icurology.orgMiller et al https://doi.org/10.4111/icu.2017.58.4.241 8.,Non-OADS,/arxiv_data1/oa_pdf/4e/69/icu-58-241.PMC5494347.pdf
"Keywords: Detrusor underactivity; Diagnosis; Urodynamics This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Lower Urinary Tract Dysfunction Received: 23 March, 2017  •  Accepted: 9 June, 2017 Corresponding Author: Seung-June Oh Department of Urology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, KoreaTEL: +82-2-2072-2406, FAX: +82-2-742-4665, E-mail: sjo@snu.ac.kr ⓒ The Korean Urological Association, 2017and benign prostatic hyperplasia in men.",Non-OADS,/arxiv_data1/oa_pdf/02/93/icu-58-247.PMC5494348.pdf
www.icurology.orgInvestig Clin Urol 2017;58:247-254. https://doi.org/10.4111/icu.2017.58.4.247pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/02/93/icu-58-247.PMC5494348.pdf
"248 www.icurology.orgJeong et al https://doi.org/10.4111/icu.2017.58.4.247 DU is defined as a contraction of reduced strength and/ or duration, resulting in prolonged bladder emptying and/ or a failure to achieve complete bladder emptying within a  normal time span by the International Continence Society  (ICS) in 2003 [3].",Non-OADS,/arxiv_data1/oa_pdf/02/93/icu-58-247.PMC5494348.pdf
250 www.icurology.orgJeong et al https://doi.org/10.4111/icu.2017.58.4.247 analyses were conducted with IBM SPSS Statistics ver.,OADS,/arxiv_data1/oa_pdf/02/93/icu-58-247.PMC5494348.pdf
"252 www.icurology.orgJeong et al https://doi.org/10.4111/icu.2017.58.4.247 [1,2,4-8], although it has received little scientific attention.",Non-OADS,/arxiv_data1/oa_pdf/02/93/icu-58-247.PMC5494348.pdf
254 www.icurology.orgJeong et al https://doi.org/10.4111/icu.2017.58.4.247 we did not classify the clinical symptoms regarding LUTS.,Non-OADS,/arxiv_data1/oa_pdf/02/93/icu-58-247.PMC5494348.pdf
"Keywords: Magnetic resonance imaging; Penis; Rupture This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Sexual Dysfunction/Infertility Received: 22 December, 2016  •  Accepted: 2 March, 2017 Corresponding Author: Erkin Saglam Dr. Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi Denizer Cad., Cevizli/Istanbul 34500, TurkeyTEL: +90-216-3068265, FAX: +90-216-3833193, E-mail: erkinsaglam@hotmail.com ⓒ The Korean Urological Association, 2017diagnosis in most cases, and additional imaging methods  are usually not necessary.",Non-OADS,/arxiv_data1/oa_pdf/f5/5f/icu-58-255.PMC5494349.pdf
"As a differential diagnosis, rupture of the  www.icurology.orgInvestig Clin Urol 2017;58:255-260.https://doi.org/10.4111/icu.2017.58.4.255pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/f5/5f/icu-58-255.PMC5494349.pdf
256 www.icurology.orgSaglam et al https://doi.org/10.4111/icu.2017.58.4.255 penile superficial dorsal vein can be treated conservatively  [2].,Non-OADS,/arxiv_data1/oa_pdf/f5/5f/icu-58-255.PMC5494349.pdf
"258 www.icurology.orgSaglam et al https://doi.org/10.4111/icu.2017.58.4.255 those in the literature, with sexual intercourse (30%) and  manual bending of the erect penis (27%) as common causes.",Non-OADS,/arxiv_data1/oa_pdf/f5/5f/icu-58-255.PMC5494349.pdf
260 www.icurology.orgSaglam et al https://doi.org/10.4111/icu.2017.58.4.255 et al.,OADS,/arxiv_data1/oa_pdf/f5/5f/icu-58-255.PMC5494349.pdf
"Keywords: Antimuscarinics; Mirabegron; Overactive urinary bladder This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Female Urology Received: 17 March, 2017  •  Accepted: 10 April, 2017 Corresponding Author: Myung-Soo Choo Department of Urology, Asan Medical Center, Ulsan University College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, KoreaTEL: +82-2-3010-3735, FAX: +82-2-477-8928, E-mail: mschoo@amc.seoul.kr ⓒ The Korean Urological Association, 2017frequency and nocturia, with or without urinary urgency  incontinence (UUI), in the absence of urinary tract  infection or other pathological conditions [1].",Non-OADS,/arxiv_data1/oa_pdf/b8/56/icu-58-261.PMC5494350.pdf
"Among the  OAB symptoms, UUI—noted in approximately one-third  www.icurology.orgInvestig Clin Urol 2017;58:261-266. https://doi.org/10.4111/icu.2017.58.4.261pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/b8/56/icu-58-261.PMC5494350.pdf
262 www.icurology.orgShin et al https://doi.org/10.4111/icu.2017.58.4.261 of  OAB cases—leads to the most discomfort [2].,Non-OADS,/arxiv_data1/oa_pdf/b8/56/icu-58-261.PMC5494350.pdf
264 www.icurology.orgShin et al https://doi.org/10.4111/icu.2017.58.4.261 3.,Non-OADS,/arxiv_data1/oa_pdf/b8/56/icu-58-261.PMC5494350.pdf
"266 www.icurology.orgShin et al https://doi.org/10.4111/icu.2017.58.4.261 voiding parameters, including urinary frequency, number  of urgency episodes, and number of urgency incontinence  episodes, improved after add-on therapy.",Non-OADS,/arxiv_data1/oa_pdf/b8/56/icu-58-261.PMC5494350.pdf
"Keywords: Adolescent; Pelvic pain; Prostatitis This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Infection/Inflammation Received: 29 November, 2016  •  Accepted: 28 February, 2017 Corresponding Author: In-Rae Cho Department of Urology, Inje University Ilsan Paik Hospital, Inje University School of Medicine, 170 Juhwa-ro, Ilsanseo-gu, Goyang 10380, KoreaTEL: +82-31-910-7230, FAX: +82-31-910-7239, E-mail: ircho@paik.ac.kr ⓒ The Korean Urological Association, 2017Numerous studies exist regarding CP/CPPS in adult  patients; however, reports on adolescent CP/CPPS are rare,  possibly due to the low incidence of CP/CPPS in adolescence.",Non-OADS,/arxiv_data1/oa_pdf/aa/b1/icu-58-267.PMC5494351.pdf
Community prevalence is different from that seen in  www.icurology.orgInvestig Clin Urol 2017;58:267-270. https://doi.org/10.4111/icu.2017.58.4.267pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/aa/b1/icu-58-267.PMC5494351.pdf
268 www.icurology.orgLee and Cho https://doi.org/10.4111/icu.2017.58.4.267 urology department patients; CP-like symptoms could include  many other disorders besides CP/CPPS.,Non-OADS,/arxiv_data1/oa_pdf/aa/b1/icu-58-267.PMC5494351.pdf
270 www.icurology.orgLee and Cho https://doi.org/10.4111/icu.2017.58.4.267 be due to the specific issues seen in adolescence as well as  unawareness or misunderstandings regarding CP/CPPS.,Non-OADS,/arxiv_data1/oa_pdf/aa/b1/icu-58-267.PMC5494351.pdf
"Keywords: Drug resistance; Infection; Prostatitis This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Infection/Inflammation Received: 26 January, 2017  •  Accepted: 8 March, 2017 Corresponding Author: Konstantinos Stamatiou Department of Urology, Tzaneio General Hospital of Piraeus, 2 Salepoula str., 18536 Piraeus, GreeceTEL: +30-2104592387, FAX: +30-2104592311, E-mail: stamatiouk@gmail.com ⓒ The Korean Urological Association, 2017unknown and include host, bacterial, and treatment- related factors.",Non-OADS,/arxiv_data1/oa_pdf/c9/ae/icu-58-271.PMC5494352.pdf
"Of note, a combination of  www.icurology.orgInvestig Clin Urol 2017;58:271-280. https://doi.org/10.4111/icu.2017.58.4.271pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/c9/ae/icu-58-271.PMC5494352.pdf
272 www.icurology.orgStamatiou and Pierris https://doi.org/10.4111/icu.2017.58.4.271 the above that includes incomplete bacterial eradication  associated with treatment duration issues and alteration of  drug resistance patterns of responsible bacteria has been  proposed to contribute the most to risk of  CBP recurrence [2].,Non-OADS,/arxiv_data1/oa_pdf/c9/ae/icu-58-271.PMC5494352.pdf
274 www.icurology.orgStamatiou and Pierris https://doi.org/10.4111/icu.2017.58.4.271 was greater in monomicrobial cultures of group B (relapses)  than in those of group A (first-time CBP presenters) (Table 3).,OADS,/arxiv_data1/oa_pdf/c9/ae/icu-58-271.PMC5494352.pdf
276 www.icurology.orgStamatiou and Pierris https://doi.org/10.4111/icu.2017.58.4.271 in this study are largely consistent with those of our  previous study [5].,Non-OADS,/arxiv_data1/oa_pdf/c9/ae/icu-58-271.PMC5494352.pdf
278 www.icurology.orgStamatiou and Pierris https://doi.org/10.4111/icu.2017.58.4.271 than a patient who has not recently taken an antibiotic [1 1] .,Non-OADS,/arxiv_data1/oa_pdf/c9/ae/icu-58-271.PMC5494352.pdf
280 www.icurology.orgStamatiou and Pierris https://doi.org/10.4111/icu.2017.58.4.271 sitivity in naturally-occurring gonococci.,Non-OADS,/arxiv_data1/oa_pdf/c9/ae/icu-58-271.PMC5494352.pdf
"Keywords: Cohort studies; Health services for the aged; Physicians’ practice patterns; Propensity score; Urologic diseases This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Geriatric Urology Received: 6 December, 2016  •  Accepted: 15 March, 2017 Corresponding Author: Chang Wook Jeong Department of Urology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, KoreaTEL: +82-2-2072-3899, FAX: +82-2-742-4665, E-mail: drboss@gmail.com*These authors contributed equally to this study and should be considered co-first authors.",Non-OADS,/arxiv_data1/oa_pdf/c6/a5/icu-58-281.PMC5494353.pdf
"Based on the ratio of the elderly (65 years and over) to the entire population,  www.icurology.orgInvestig Clin Urol 2017;58:281-288. https://doi.org/10.4111/icu.2017.58.4.281pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/c6/a5/icu-58-281.PMC5494353.pdf
282 www.icurology.orgSuh et al https://doi.org/10.4111/icu.2017.58.4.281 Korea joined the list of  aging societies (7%–14%) in 2000 and  is expected to become an aged society (14%–20%) in 2018 [2].,Non-OADS,/arxiv_data1/oa_pdf/c6/a5/icu-58-281.PMC5494353.pdf
"284 www.icurology.orgSuh et al https://doi.org/10.4111/icu.2017.58.4.281 95% CI, 1.673–1.877) for BPH, OAB, and neurogenic bladder,  respectively.",OADS,/arxiv_data1/oa_pdf/c6/a5/icu-58-281.PMC5494353.pdf
286 www.icurology.orgSuh et al https://doi.org/10.4111/icu.2017.58.4.281 DISCUSSION In this population-based study we wish to know preva - lence and management status in geriatric hospitals in South  Korea.,Non-OADS,/arxiv_data1/oa_pdf/c6/a5/icu-58-281.PMC5494353.pdf
"SUPPLEMENTARY MATERIALS Scan this QR code to see the supplementary Tables, or  visit http://icurology.org/src/sm/icu-58-281-s001.pdf.",Non-OADS,/arxiv_data1/oa_pdf/c6/a5/icu-58-281.PMC5494353.pdf
Available  from: http://www.un.org/en/development/desa/population/ publications/pdf/ageing/WPA2015_Report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c6/a5/icu-58-281.PMC5494353.pdf
288 www.icurology.orgSuh et al https://doi.org/10.4111/icu.2017.58.4.281 2.,Non-OADS,/arxiv_data1/oa_pdf/c6/a5/icu-58-281.PMC5494353.pdf
Available from: http://kosis.kr/statHtml/statH- tml.do?orgId=354&tblId=DT_HIRA4K&vw_cd=&list_ id=&scrId=&seqNo=&lang_mode=ko&obj_var_id=&itm_id=&conn_path=K1&path=#.,OADS,/arxiv_data1/oa_pdf/c6/a5/icu-58-281.PMC5494353.pdf
July 2017. https://doi.org/10.4111/icu.2017.58.4 .281   Supplementary Table 1.,Non-OADS,/arxiv_data1/oa_pdf/c6/a5/icu-58-281.PMC5494353.pdf
"Keywords: Comet assay; Ischemia reperfusion injury; Mannitol; Ngal protein; Udenafil This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Basic and Translational Research Received: 6 February, 2017  •  Accepted: 14 March, 2017 Corresponding Author: Yusuf Özlülerden Denizli State Hospital, Urology Clinic, Denizli 20100, TurkeyTEL: +90-506-9680184, FAX: +90-258-2619206,  E-mail: yusufozlu35@hotmail.com ⓒ The Korean Urological Association, 2017these patients will need renal transplantation [3] .",Non-OADS,/arxiv_data1/oa_pdf/50/6b/icu-58-289.PMC5494354.pdf
"In partial nephrectomy, renal arteries are clamped before  tumor removal and during this time I/R injury leads to  www.icurology.orgInvestig Clin Urol 2017;58:289-295. https://doi.org/10.4111/icu.2017.58.4.289pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/50/6b/icu-58-289.PMC5494354.pdf
290 www.icurology.orgÖzlülerden et al https://doi.org/10.4111/icu.2017.58.4.289 functional renal tissue damage [7].,Non-OADS,/arxiv_data1/oa_pdf/50/6b/icu-58-289.PMC5494354.pdf
292 www.icurology.orgÖzlülerden et al https://doi.org/10.4111/icu.2017.58.4.289 higher in the I/R group.,Non-OADS,/arxiv_data1/oa_pdf/50/6b/icu-58-289.PMC5494354.pdf
"294 www.icurology.orgÖzlülerden et al https://doi.org/10.4111/icu.2017.58.4.289 CONCLUSIONS This study showed that udenafil improves renal func - tions, decreases lipid peroxidation and reduces histological  and DNA damage in the renal I/R injury models.",Non-OADS,/arxiv_data1/oa_pdf/50/6b/icu-58-289.PMC5494354.pdf
"There is no consistently successful treatment, but oral steroids, topical dovonex, extracorporeal photopheresis, and plasmapheresis have been tried [http://www.icnfdr.org/ Last accessed: 1/6/2017].",Non-OADS,/arxiv_data1/oa_pdf/14/2f/CCR3-5-1184.PMC5494376.pdf
"It was predict- ed that this variant would not be tolerated based on SIFT (http://sift.jvci.org), and probably damaging using Polymorphism Phenotyping v2 (PolyPhen2) (http://gene- tics.bwh.",Non-OADS,/arxiv_data1/oa_pdf/e8/5c/pr-9-2-6810.PMC5494441.pdf
Available from URL: https://www.nccn.org/professionals/physician_gls/pdf/hepatobiliary.pdf.,Non-OADS,/arxiv_data1/oa_pdf/32/82/TCA-8-365.PMC5494450.pdf
Available from URL: https://www.nccn.org/professionals/ physician_gls/pdf/kidney.pdf.,Non-OADS,/arxiv_data1/oa_pdf/32/82/TCA-8-365.PMC5494450.pdf
Asian J Surg 2016; https://doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/32/82/TCA-8-365.PMC5494450.pdf
"NEK2 was a direct target of miR-128 in SK- MES-1 cells To explore the underlying mechanism for the function of miR-128 in SK-MES-1 cells, we used the public database TargetScan (http://www.targetscan.org/) to predict the potential targets of miR-128.",OADS,/arxiv_data1/oa_pdf/c3/ab/TCA-8-304.PMC5494458.pdf
"Clin Respir J 2016. https://doi.org/10.1111/crj.12605 14 Galdiero MR, Garlanda C, Jaillon S, Marone G, Mantovani A. Tumor associated macrophages and neutrophils in tumorprogression.",OADS,/arxiv_data1/oa_pdf/80/a6/TCA-8-350.PMC5494473.pdf
"Breast Dis 2016. https://doi.org/10.3233/BD- 160251 17 Chen F, Lin L, Yan L, Qiu Y, Cai L, He B. Preoperative neutrophil-to-lymphocyte ratio predicts the prognosis of oral squamous cell carcinoma: A large-sample prospective study.",Non-OADS,/arxiv_data1/oa_pdf/80/a6/TCA-8-350.PMC5494473.pdf
"1061Copyright © 2017 by Asian-Australasian Journal of Animal Sciences  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.www.ajas.infoAsian-Australas J Anim Sci   Vol.",Non-OADS,/arxiv_data1/oa_pdf/11/14/ajas-30-8-1061.PMC5494477.pdf
"8:1061-1065 August 2017 https://doi.org/10.5713/ajas.16.0562 pISSN 1011-2367 eISSN 1976-5517 Genome scan linkage analysis identifies a major quantitative trait  loci for fatty acid composition in longissimus dorsi  muscle in an  F2 intercross between Landrace and Korean native pigs Hee-Bok Park1,a, Sang-Hyun Han2,a, Chae-Kyoung Yoo3, Jae-Bong Lee4, Ji-Hyang Kim1, Kwang-Soo Baek1,  Jun-Kyu Son1, Sang-Min Shin1, Hyun-Tae Lim3,5,*, and In-Cheol Cho1,* Objective:  This study was conducted to locate quantitative trait loci (QTL) influencing fatty  acid (FA) composition in a large F2 intercross between Landrace and Korean native pigs.",Non-OADS,/arxiv_data1/oa_pdf/11/14/ajas-30-8-1061.PMC5494477.pdf
Statistical and quantitative trait loci analyses We used a web­based GridQTL program to conduct QTL analysis  (http://www.gridqtl.org.uk/).,OADS,/arxiv_data1/oa_pdf/11/14/ajas-30-8-1061.PMC5494477.pdf
The verifications of novel QTL were done by  comparing the flanking markers of previously reported QTL in  the pig QTLdb (http://www.animalgenome.org/QTLdb/pig) with  those of newly detected QTL in this study.RESULTS AND DISCUSSION Basic statistics on the phenotypic measurements of the FA traits  have been described in our previous report [8].,Non-OADS,/arxiv_data1/oa_pdf/11/14/ajas-30-8-1061.PMC5494477.pdf
"1066Copyright © 2017 by Asian-Australasian Journal of Animal Sciences  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.www.ajas.infoAsian-Australas J Anim Sci   Vol.",Non-OADS,/arxiv_data1/oa_pdf/a3/02/ajas-30-8-1066.PMC5494478.pdf
"8:1066-1073 August 2017 https://doi.org/10.5713/ajas.16.0679 pISSN 1011-2367 eISSN 1976-5517 Genome-wide association study identifies 22 new loci for body  dimension and body weight traits in a White Duroc×Erhualian   F2 intercross population Jiuxiu Ji1, Lisheng Zhou1, Yuanmei Guo1, Lusheng Huang1, and Junwu Ma1,* Objective:  Growth-related traits are important economic traits in the swine industry.",Non-OADS,/arxiv_data1/oa_pdf/a3/02/ajas-30-8-1066.PMC5494478.pdf
"To date, 1,424 QTLs  for production traits have been deposited in the PigQTLdb (http://www.genome.iastate.edu/cgi-*  Corresponding Author:  Junwu Ma Tel: +86-791-83813080, Fax: +86-791-83813080,  E-mail:  ma_junwu@hotmail.com  1  National Key Laboratory for Pig Genetic Improvement  and Production Technology, Jiangxi Agricultural  University, Nanchang 330045, China Submitted Sept 5, 2016; Revised Nov 9, 2016;   Accepted Jan 8, 2017Open Access",Non-OADS,/arxiv_data1/oa_pdf/a3/02/ajas-30-8-1066.PMC5494478.pdf
Bioinformatics analyses SNP positions on chromosomes and the closest genes to tag (sig- nificant and suggestive) SNPs associated with traits were obtained  by using Sscrofa 10.2 genome assembly from Ensembl website  (http://www.ensembl.org/Sus_scrofa/Info/Index).,OADS,/arxiv_data1/oa_pdf/a3/02/ajas-30-8-1066.PMC5494478.pdf
The overlap  between our GW AS data and previously mapped QTL data were  assessed using the PigQTLdb (http://www.animalgenome.org/ cgi-bin/QTLdb/SS/index).,OADS,/arxiv_data1/oa_pdf/a3/02/ajas-30-8-1066.PMC5494478.pdf
"1074Copyright © 2017 by Asian-Australasian Journal of Animal Sciences  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.www.ajas.infoAsian-Australas J Anim Sci   Vol.",Non-OADS,/arxiv_data1/oa_pdf/9c/a8/ajas-30-8-1074.PMC5494479.pdf
"8:1074-1080 August 2017 https://doi.org/10.5713/ajas.16.0692 pISSN 1011-2367 eISSN 1976-5517 Genetic correlation between live body measurements and beef  cutability traits in Hanwoo steers Yun Ho Choy1,*, Jae Goo Lee1, Alam Mahboob1, Tae Jeong Choi1, and Seung Hee Rho2 Objective:  The growth, carcass and retail cut yield records on 1,428 Hanwoo steers obtained  through progeny testing were analyzed in this study, and their heritability and genetic relation­ ships among the traits were estimated using animal models.",OADS,/arxiv_data1/oa_pdf/9c/a8/ajas-30-8-1074.PMC5494479.pdf
Available from http://nce.ads.uga.edu/~ignacy  12.,Non-OADS,/arxiv_data1/oa_pdf/9c/a8/ajas-30-8-1074.PMC5494479.pdf
"1081Copyright © 2017 by Asian-Australasian Journal of Animal Sciences  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.www.ajas.infoAsian-Australas J Anim Sci   Vol.",Non-OADS,/arxiv_data1/oa_pdf/0c/2e/ajas-30-8-1081.PMC5494480.pdf
"8:1081-1085 August 2017 https://doi.org/10.5713/ajas.16.0414 pISSN 1011-2367 eISSN 1976-5517 Association of a missense mutation in the positional candidate  gene glutamate receptor-interacting protein 1 with backfat  thickness traits in pigs Jae-Bong Lee1,a, Hee-Bok Park2,a, Chae-Kyoung Yoo3, Hee-Sung Kim4, In-Cheol Cho2, and Hyun-Tae Lim3,4,* Objective:  Previously, we reported quantitative trait loci (QTLs) affecting backfat thickness  (BFT) traits on pig chromosome 5 ( SW1482–SW963 ) in an F2 intercross population between  Landrace and Korean native pigs.",Non-OADS,/arxiv_data1/oa_pdf/0c/2e/ajas-30-8-1081.PMC5494480.pdf
"1086Copyright © 2017 by Asian-Australasian Journal of Animal Sciences  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.www.ajas.infoAsian-Australas J Anim Sci   Vol.",Non-OADS,/arxiv_data1/oa_pdf/6f/bc/ajas-30-8-1086.PMC5494481.pdf
"8:1086-1092 August 2017 https://doi.org/10.5713/ajas.17.0143 pISSN 1011-2367 eISSN 1976-5517 Polymorphism in the intron 20 of porcine   O-linked N-acetylglucosamine transferase Jong Gug Kim1,*, Dan Nonneman2, Doo-Wan Kim3, Sangsu Shin4, and Gary A. Rohrer2 Objective:  O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT) catalyzes the addition  of O-GlcNAc and GlcNAcylation has extensive crosstalk with phosphorylation to regulate signal- ing and transcription.",Non-OADS,/arxiv_data1/oa_pdf/6f/bc/ajas-30-8-1086.PMC5494481.pdf
DQ400859) [15]  and the OGT  gene sequence in the Genome Browser for pig  (http://genome.ucsc.edu/).,OADS,/arxiv_data1/oa_pdf/6f/bc/ajas-30-8-1086.PMC5494481.pdf
The expected size of the  PCR amplicon across intron 20 was 825 bp based on the gene  sequence in the Genome Browser for pig (http://genome.ucsc.,OADS,/arxiv_data1/oa_pdf/6f/bc/ajas-30-8-1086.PMC5494481.pdf
"1088  www.ajas.infoKim et al  (2017) Asian-Australas J Anim Sci 30:1086-1092 Browser for pig (NM_001039748.2, http://genome.ucsc.edu/).",OADS,/arxiv_data1/oa_pdf/6f/bc/ajas-30-8-1086.PMC5494481.pdf
"The 514-bp intron 20, including the inserted 276-bp element  of OGT from the WC pigs, was analyzed by BLAT in the pig  genome (http://genome.ucsc.edu/cgi-bin/hgBlat).",OADS,/arxiv_data1/oa_pdf/6f/bc/ajas-30-8-1086.PMC5494481.pdf
"Twenty-six SINE and 16 long inter - spersed nuclear elements (LINE) are scattered within the introns  of OGT  in European pigs (http://genome.ucsc.edu/), while the  numbers of SINE and LINE elements were not reported in  Chinese pigs.",Non-OADS,/arxiv_data1/oa_pdf/6f/bc/ajas-30-8-1086.PMC5494481.pdf
"On the other hand, insertion of the SINE element sequence  may affect gene expression or insert a putative constitutive accep - tor at chrX:64993713 and alternatively splicing the mRNA before  the constitutive acceptor at chrX:64993880, and therefore altering  the mRNA sequence with the premature stop codon (Alternative  Splice Site Predictor: http://wangcomputing.com/assp/) [18].",Non-OADS,/arxiv_data1/oa_pdf/6f/bc/ajas-30-8-1086.PMC5494481.pdf
"OGT  intron 20 from human and cattle were 240 and 243 bp  (http://genome.ucsc.edu/), respectively.",OADS,/arxiv_data1/oa_pdf/6f/bc/ajas-30-8-1086.PMC5494481.pdf
"1093Copyright © 2017 by Asian-Australasian Journal of Animal Sciences  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.www.ajas.infoAsian-Australas J Anim Sci   Vol.",Non-OADS,/arxiv_data1/oa_pdf/75/35/ajas-30-8-1093.PMC5494482.pdf
"8:1093-1098 August 2017 https://doi.org/10.5713/ajas.16.0882 pISSN 1011-2367 eISSN 1976-5517 The effect of lactation number, stage, length, and milking  frequency on milk yield in Korean Holstein dairy cows using  automatic milking system Mayakrishnan Vijayakumar1,a, Ji Hoo Park1,a, Kwang Seok Ki1, Dong Hyun Lim1, Sang Bum Kim1,   Seong Min Park1, Ha Yeon Jeong1, Beom Young Park1, and Tae Il Kim1,* Objective:  The aim of the current study was to describe the relationship between milk yield and  lactation number, stage, length and milking frequency in Korean Holstein dairy cows using an  automatic milking system (AMS).",Non-OADS,/arxiv_data1/oa_pdf/75/35/ajas-30-8-1093.PMC5494482.pdf
"1099Copyright © 2017 by Asian-Australasian Journal of Animal Sciences  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.www.ajas.infoAsian-Australas J Anim Sci   Vol.",Non-OADS,/arxiv_data1/oa_pdf/4c/e7/ajas-30-8-1099.PMC5494483.pdf
"8:1099-1104 August 2017 https://doi.org/10.5713/ajas.16.0708 pISSN 1011-2367 eISSN 1976-5517 Effect of alcohol dehydrogenase 1C (ADH1C) genotype on   vitamin A restriction and marbling in Korean native steers Dong Qiao Peng1,2, U Suk Jung1, Jae Sung Lee1,2, Won Seob Kim1,2, Yong Ho Jo1,2, Min Jeong Kim1,   Young Kun Oh3, Youl Chang Baek3, Seong Gu Hwang4, and Hong Gu Lee1,2,* Objective:  This work was to find the correlation of alcohol dehydrogenase 1C (ADH1C) geno­ type with vitamin A reduction and carcass traits during the vitamin A restriction period.",OADS,/arxiv_data1/oa_pdf/4c/e7/ajas-30-8-1099.PMC5494483.pdf
"1105Copyright © 2017 by Asian-Australasian Journal of Animal Sciences  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.www.ajas.infoAsian-Australas J Anim Sci   Vol.",Non-OADS,/arxiv_data1/oa_pdf/b3/70/ajas-30-8-1105.PMC5494484.pdf
"8:1105-1116 August 2017 https://doi.org/10.5713/ajas.16.0611 pISSN 1011-2367 eISSN 1976-5517 Production responses of Holstein dairy cows when fed supplemental  fat containing saturated free fatty acids: a meta-analysis Wenping Hu1,*, Jacquelyn P. Boerman1, and James M. Aldrich1 Objective:  A meta-analysis was conducted to evaluate the effects of supplemental fat containing  saturated free fatty acids (FA) on milk performance of Holstein dairy cows.",Non-OADS,/arxiv_data1/oa_pdf/b3/70/ajas-30-8-1105.PMC5494484.pdf
"Version  3.1.3, 2015; Available from: https://www.r-project.org 34.",Non-OADS,/arxiv_data1/oa_pdf/b3/70/ajas-30-8-1105.PMC5494484.pdf
"1117Copyright © 2017 by Asian-Australasian Journal of Animal Sciences  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.www.ajas.infoAsian-Australas J Anim Sci   Vol.",Non-OADS,/arxiv_data1/oa_pdf/2a/05/ajas-30-8-1117.PMC5494485.pdf
"8:1117-1123 August 2017 https://doi.org/10.5713/ajas.17.0166 pISSN 1011-2367 eISSN 1976-5517 Effects of feeding system on growth performance, plasma  biochemical components and hormones, and carcass  characteristics in Hanwoo steers Chan Sung Chung1,a, Woong Ki Cho2,a, In Seok Jang3, Sung Sill Lee2, and Yea Hwang Moon3,* Objective:  This study was conducted to compare growth performance, blood components and  carcass traits by two feeding systems (concentrate with roughage separately [CON] vs total mixed  ration [TMR]) in Hanwoo steers, and to learn the relationship between blood components  during fattening or finishing phases and carcass traits in Hanwoo steers.",Non-OADS,/arxiv_data1/oa_pdf/2a/05/ajas-30-8-1117.PMC5494485.pdf
"1124Copyright © 2017 by Asian-Australasian Journal of Animal Sciences  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.www.ajas.infoAsian-Australas J Anim Sci   Vol.",Non-OADS,/arxiv_data1/oa_pdf/f3/61/ajas-30-8-1124.PMC5494486.pdf
8:1124-1134 August 2017 https://doi.org/10.5713/ajas.16.0677 pISSN 1011-2367 eISSN 1976-5517 Physico-chemical properties of late-incubation egg amniotic fluid  and a potential in ovo feed supplement A.,Non-OADS,/arxiv_data1/oa_pdf/f3/61/ajas-30-8-1124.PMC5494486.pdf
"1135Copyright © 2017 by Asian-Australasian Journal of Animal Sciences  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.www.ajas.infoAsian-Australas J Anim Sci   Vol.",Non-OADS,/arxiv_data1/oa_pdf/d2/d3/ajas-30-8-1135.PMC5494487.pdf
"8:1135-1142 August 2017 https://doi.org/10.5713/ajas.16.0683 pISSN 1011-2367 eISSN 1976-5517 An evaluation of heat on protein oxidation of soy protein isolate  or soy protein isolate mixed with soybean oil in vitro  and its  consequences on redox status of broilers at early age Xianglun Zhang1, Peng Lu1, Wenyue Xue1, Dawei Wu1, Chao Wen1, and Yanmin Zhou1,* Objective:  The objective of this study was to evaluate effects of heat treatment and soybean oil  inclusion on protein oxidation of soy protein isolate (SPI) and of oxidized protein on redox  status of broilers at an early age.",Non-OADS,/arxiv_data1/oa_pdf/d2/d3/ajas-30-8-1135.PMC5494487.pdf
"1143Copyright © 2017 by Asian-Australasian Journal of Animal Sciences  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.www.ajas.infoAsian-Australas J Anim Sci   Vol.",Non-OADS,/arxiv_data1/oa_pdf/e3/1a/ajas-30-8-1143.PMC5494488.pdf
"8:1143-1149 August 2017 https://doi.org/10.5713/ajas.16.0847 pISSN 1011-2367 eISSN 1976-5517 Evaluation of mango saponin in broilers: effects on growth  performance, carcass characteristics, meat quality and plasma  biochemical indices Y. N. Zhang1, J. Wang1, B. Qi1, S. G. Wu1, H. R. Chen2, H. Y. Luo2, D. J. Yin3, F. J. Lü3, H. J. Zhang1,*, and G. H. Qi1,* Objective:  The objective of the present study was to determine whether mango saponin (MS)  could be used as a feed additive in broiler chicks by evaluating growth performance, carcass  characteristics, meat quality, and plasma biochemical indices.",Non-OADS,/arxiv_data1/oa_pdf/e3/1a/ajas-30-8-1143.PMC5494488.pdf
"1150Copyright © 2017 by Asian-Australasian Journal of Animal Sciences  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.www.ajas.infoAsian-Australas J Anim Sci   Vol.",Non-OADS,/arxiv_data1/oa_pdf/bd/aa/ajas-30-8-1150.PMC5494489.pdf
"8:1150-1159 August 2017 https://doi.org/10.5713/ajas.16.0838 pISSN 1011-2367 eISSN 1976-5517 Effects of wheat supplementation levels on growth performance,  blood profiles, nutrient digestibility, and pork quality in   growing-finishing pigs Tae Hee Han1, Jin Su Hong1, Lin Hu Fang1, Sung Ho Do1, Byung Ock Kim1, and Yoo Yong Kim1,* Objective:  This study was conducted to evaluate various wheat supplementation levels on  growth performance, blood profiles, nutrient digestibility, and pork quality in growing-finishing  pigs.",Non-OADS,/arxiv_data1/oa_pdf/bd/aa/ajas-30-8-1150.PMC5494489.pdf
Available from: http://www.fao.org/worldfoodsituation/  csdb/en/  9.,Non-OADS,/arxiv_data1/oa_pdf/bd/aa/ajas-30-8-1150.PMC5494489.pdf
"1160Copyright © 2017 by Asian-Australasian Journal of Animal Sciences  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.www.ajas.infoAsian-Australas J Anim Sci   Vol.",Non-OADS,/arxiv_data1/oa_pdf/e0/a7/ajas-30-8-1160.PMC5494490.pdf
"8:1160-1167 August 2017 https://doi.org/10.5713/ajas.16.0867 pISSN 1011-2367 eISSN 1976-5517 Effects of proteinate complex zinc on growth performance,  hepatic and splenic trace elements concentrations, antioxidative  function and immune functions in weaned piglets Yue She1, Qiang Huang1, Defa Li1, and Xiangshu Piao1,* Objective:  To assess the effects of proteinate complex zinc (PC-Zn) on growth performance,  antioxidative function, trace element concentrations and immune function in weaned piglets.",Non-OADS,/arxiv_data1/oa_pdf/e0/a7/ajas-30-8-1160.PMC5494490.pdf
"1168Copyright © 2017 by Asian-Australasian Journal of Animal Sciences  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.www.ajas.infoAsian-Australas J Anim Sci   Vol.",Non-OADS,/arxiv_data1/oa_pdf/60/3d/ajas-30-8-1168.PMC5494491.pdf
"8:1168-1174 August 2017 https://doi.org/10.5713/ajas.16.0512 pISSN 1011-2367 eISSN 1976-5517 Volatile compounds and some physico-chemical properties of  pastırma produced with different nitrate levels Ahmet Akköse1, Nazen Ünal1, Barı ş Yalınkılıç2, Güzin Kaban1,*, and Mükerrem Kaya1 Objective:  The aim of the study was to evaluate the effects of different nitrate levels (150, 300,  450, and 600 ppm KNO3) on the volatile compounds and some other properties of pastırma.",OADS,/arxiv_data1/oa_pdf/60/3d/ajas-30-8-1168.PMC5494491.pdf
"1175Copyright © 2017 by Asian-Australasian Journal of Animal Sciences  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.www.ajas.infoAsian-Australas J Anim Sci   Vol.",Non-OADS,/arxiv_data1/oa_pdf/d1/25/ajas-30-8-1175.PMC5494492.pdf
"8:1175-1182 August 2017 https://doi.org/10.5713/ajas.16.0697 pISSN 1011-2367 eISSN 1976-5517 Human lactoferrin efficiently targeted into caprine beta-lactoglobulin  locus with transcription activator-like effector nucleases Yu-Guo Yuan1,2,a, Shao-Zheng Song1,a, Meng-Ming Zhu1, Zheng-Yi He1, Rui Lu1, Ting Zhang1, Fei Mi1,   Jin-Yu Wang1,*, and Yong Cheng1,2,* Objective:  To create genetically modified goat as a biopharming source of recombinant human  lacotoferrin (hLF) with transcription activator-like effector nucleases.",Non-OADS,/arxiv_data1/oa_pdf/d1/25/ajas-30-8-1175.PMC5494492.pdf
"1183Copyright © 2017 by Asian-Australasian Journal of Animal Sciences  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.www.ajas.infoAsian-Australas J Anim Sci   Vol.",Non-OADS,/arxiv_data1/oa_pdf/26/75/ajas-30-8-1183.PMC5494493.pdf
"8:1183-1189 August 2017 https://doi.org/10.5713/ajas.16.0865 pISSN 1011-2367 eISSN 1976-5517 Functional analysis of SH3 domain containing ring finger 2  during the myogenic differentiation of quail myoblast cells Si Won Kim1,a, Jeong Hyo Lee1,a, and Tae Sub Park1,* Objective:  Owing to the public availability of complete genome sequences, including avian  species, massive bioinformatics analyses may be conducted for computational gene prediction  and the identification of gene regulatory networks through various informatics tools.",Non-OADS,/arxiv_data1/oa_pdf/26/75/ajas-30-8-1183.PMC5494493.pdf
"To define known transcriptomic regions, we used Trinotate (http://trinotate.github.io) applying the default  settings.",OADS,/arxiv_data1/oa_pdf/26/75/ajas-30-8-1183.PMC5494493.pdf
"1190Copyright © 2017 by Asian-Australasian Journal of Animal Sciences  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.www.ajas.infoAsian-Australas J Anim Sci   Vol.",Non-OADS,/arxiv_data1/oa_pdf/33/c5/ajas-30-8-1190.PMC5494494.pdf
"8:1190-1197 August 2017 https://doi.org/10.5713/ajas.17.0006 pISSN 1011-2367 eISSN 1976-5517 Adiponectin induced AMP-activated protein kinase impairment  mediates insulin resistance in Bama mini-pig fed high-fat and  high-sucrose diet Miaomiao Niu1,a, Lei Xiang1,a, Yaqian Liu1, Yuqiong Zhao1, Jifang Yuan1, Xin Dai1, and Hua Chen1,2,* Objective:  Adipose tissue is no longer considered as an inert storage organ for lipid, but  instead is thought to play an active role in regulating insulin effects via secretion adipokines.",Non-OADS,/arxiv_data1/oa_pdf/33/c5/ajas-30-8-1190.PMC5494494.pdf
"1198Copyright © 2017 by Asian-Australasian Journal of Animal Sciences  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.www.ajas.infoAsian-Australas J Anim Sci   Vol.",Non-OADS,/arxiv_data1/oa_pdf/29/e3/ajas-30-8-1198.PMC5494495.pdf
"8:1198-1205 August 2017 https://doi.org/10.5713/ajas.16.0830 pISSN 1011-2367 eISSN 1976-5517 Isolation and characterization of new Methanosarcina mazei strains  KOR-3, -4, -5, and -6 from an anaerobic digester using pig slurry Urantulkhuur Battumur1,2, Youngman Yoon3, Gui Sek Bae4, and Chang-Hyun Kim3,5,* Objective:  An experiment was conducted to isolate and identify new methanogens in Korea  from an anaerobic digester that uses pig slurry.",Non-OADS,/arxiv_data1/oa_pdf/29/e3/ajas-30-8-1198.PMC5494495.pdf
"Although Ubc is expressed in multiple tissues in mice (http://biogps.org/) [58], ithas only been shown to oscillate in the murine heart [52] and(skeletal) muscle [14] (JTK, P=3.32E-6 and P=5.97E-7, respec- tively; Fig 5C).",Non-OADS,/arxiv_data1/oa_pdf/0d/57/EMBR-18-1199.PMC5494509.pdf
"Among the putative UBC interacting partners, several genes were known oscillators in the murine heartaccording to the CircaDB database (http://circadb.hogeneschlab.org/) [11,14,59].",OADS,/arxiv_data1/oa_pdf/0d/57/EMBR-18-1199.PMC5494509.pdf
"Data were obtained from CircaDB (http://circadb.hogeneschlab.org/, deducted from [ 14,83]).",OADS,/arxiv_data1/oa_pdf/0d/57/EMBR-18-1199.PMC5494509.pdf
"CircaDB gene expression website The circadian expression database (CircaDB, http://circadb.hogene schlab.org/) is an open access online platform [59] compiling circa-dian gene expression profiles from microarrays and RNA sequencingexperiments [11,14,18,82 –88].",OADS,/arxiv_data1/oa_pdf/0d/57/EMBR-18-1199.PMC5494509.pdf
"The gene expression profile data  of GSE14407 ( 10) and GSE29220 ( 11) were obtained from  the Gene Expression Omnibus (GEO, http://www.ncbi.nlm   .nih.gov/geo/ ) database, which was based on the platform of  the GPL570 [HG -U133_Plus_2] Affymetrix Human Genome  U133 Plus 2.0 Array (Affymetrix, Inc., Santa Clara, CA, USA).",OADS,/arxiv_data1/oa_pdf/50/51/ol-14-01-0725.PMC5494615.pdf
Genes that differed significantly in their  expression in EOC samples were identified by the Linear  Models for Microarray Data package (version 3.30.13; http://www.bioconductor.org/packages/release/bioc/html/ limma.html ) (15).,OADS,/arxiv_data1/oa_pdf/50/51/ol-14-01-0725.PMC5494615.pdf
PPI networks of  upregulated and downregulated DEGs were then visualized  by Cytoscape (version 3.4.0; http://cytoscape.org/ ) (20).,OADS,/arxiv_data1/oa_pdf/50/51/ol-14-01-0725.PMC5494615.pdf
The University of California  Santa Cruz database ( http://genome.ucsc.edu/ ) (24) was used  to obtain information on the associations between DEGs and  related TFs.,OADS,/arxiv_data1/oa_pdf/50/51/ol-14-01-0725.PMC5494615.pdf
"The integrated regulatory networks containing  TFs with the 5 highest degrees and their corresponding  upregulated or downregulated DEGs were then respectively  visualized by Cytoscape (version 3.4.0, http://cytoscape.org/ ).",OADS,/arxiv_data1/oa_pdf/50/51/ol-14-01-0725.PMC5494615.pdf
"The common miRNAs predicted to be expressed by the  databases of miRecords (http://c1.accurascience.com/miRe - cords/)  (25), TarBase (http://diana.imis.athena -innovation.gr/ DianaTools/index.php?r=tarbase/index)  (26) and TargetScan  (http://www.targetscan.org/) ( 27) were selected for the  DEGs.",OADS,/arxiv_data1/oa_pdf/50/51/ol-14-01-0725.PMC5494615.pdf
"Subsequently, the upregulated and downregulated  miRNA -DEG regulatory networks were respectively visual - ized using Cytoscape (version 3.4.0, http://cytoscape.org/).",OADS,/arxiv_data1/oa_pdf/50/51/ol-14-01-0725.PMC5494615.pdf
"ClinicalTrials.gov ClinicalTrials.gov Identifier: NCT00003594:  Combination Chemotherapy in Treating Patients With Advanced  Colorectal Cancer, http://clinicaltrials.gov/show/NCT00003594.",Non-OADS,/arxiv_data1/oa_pdf/81/b3/ol-14-01-0639.PMC5494646.pdf
http://clinicaltrials.gov/show/NCT02500043.,Non-OADS,/arxiv_data1/oa_pdf/81/b3/ol-14-01-0639.PMC5494646.pdf
http://www.uptodate.com/contents/overview-of-sentinel-lymph- node-biopsy-in-breast-cancer.,Non-OADS,/arxiv_data1/oa_pdf/38/6d/ol-14-01-0758.PMC5494671.pdf
http://www.r-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/2c/d1/ol-14-01-0743.PMC5494676.pdf
"All primers were designed using the Primer  Premier version 5.0 software (Premier Biosoft International,  Palo Alto, CA, USA), with their specificity confirmed by the  Basic Local Alignment Search Tool on the National Center  for Biotechnology Information website (http://blast.ncbi.nlm.",OADS,/arxiv_data1/oa_pdf/40/64/ol-14-01-0561.PMC5494688.pdf
All adverse  events were recorded and followed up according to the National  Cancer Institute Common Terminology Criteria for Adverse  Events (NCI -CTCAE4.0; version 4.03; http://evs.nci.nih.,Non-OADS,/arxiv_data1/oa_pdf/d5/d1/ol-14-01-0579.PMC5494698.pdf
"Survival  data (survival rates) in the reported survival curves at specific  time points were extracted using DigitizeIt (version 2.0; Braun - schweig, Germany; http://www.digitizeit.de /) (10).",OADS,/arxiv_data1/oa_pdf/ce/dd/ol-14-01-0655.PMC5494762.pdf
http://ecog.dfci.harvard.edu/general/common_tox.,Non-OADS,/arxiv_data1/oa_pdf/89/c2/ol-14-01-0501.PMC5494764.pdf
Available from URL: http://esophagus.jp  2.,Non-OADS,/arxiv_data1/oa_pdf/07/6f/ol-14-01-0737.PMC5494775.pdf
http://groups.eortc.be/qol/why-do-we-need- modules.,Non-OADS,/arxiv_data1/oa_pdf/7a/c8/ol-14-01-0185.PMC5494809.pdf
"ONCOLOGY LETTERS  14:  55-62,  2017 59 RB1 probes for chromosome 13 labeled in red spectrums,  provided by An Biping Pharmaceutical Co., Ltd. (Guangzhou,  China, http://www.gzlbp.com/).",Non-OADS,/arxiv_data1/oa_pdf/f3/c9/ol-14-01-0055.PMC5494830.pdf
National Comprehensive Cancer Network: Head and Neck  Cancers Version 1. https://www.nccn.org/professionals/physi - cian_gls/pdf/head- and-neck.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fc/9e/ol-14-01-0257.PMC5494837.pdf
"222  Ultrasonography 36(3), July 2017 e-ultrasonography.orgUltrasonography of pediatric urogenital  emergencies: review of classic and new techniques Masahiro Kitami Department of Diagnostic Radiology, Tohoku University Graduate School of Medicine,  Sendai, Japanhttps://doi.org/10.14366/usg.17011 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2017;36:222-238 Urogenital emergencies are fairly common in the pediatric population, and a timely and  correct diagnosis is necessary to avoid possible future infertility.",Non-OADS,/arxiv_data1/oa_pdf/54/1b/usg-17011.PMC5494863.pdf
"ac.jpREVIEW ARTICLE This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/54/1b/usg-17011.PMC5494863.pdf
ORCID: Masahiro Kitami: http://orcid.org/0000-0003-3116-5441   Conflict of Interest No potential conflict of interest relevant to this article was reported.,Non-OADS,/arxiv_data1/oa_pdf/54/1b/usg-17011.PMC5494863.pdf
"260  Ultrasonography 36(3), July 2017 e-ultrasonography.orgDifferential diagnosis between intraductal  papillary mucinous neoplasm with an associated invasive carcinoma and pancreatic ductal adenocarcinoma on ultrasonography: the utility of echo intensity and contrast enhancement Masato Saito1, Naoki Hirokawa2, Yoko Usami2, Masanori Someya2, Koh-ichi Sakata2 1Department of Radiology, Sapporo Teishinkai Hospital, Sapporo; 2Department of Radiology,  Sapporo Medical University School of Medicine, Sapporo, Japanhttps://doi.org/10.14366/usg.16039 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2017;36:260-269 Purpose: The aim of this study was to investigate the utility of echo intensity and contrast  enhancement in the differential diagnosis between intraductal papillary mucinous neoplasm with  an associated invasive carcinoma (IPMN-IC) and pancreatic ductal adenocarcinoma (PDAC) on ultrasonography.",OADS,/arxiv_data1/oa_pdf/87/4b/usg-16039.PMC5494864.pdf
"+81-11-751-0239 E-mail: ma_saito@teishinkai.jpORIGINAL ARTICLE This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/87/4b/usg-16039.PMC5494864.pdf
ORCID: Masato Saito: http://orcid.org/0000-0002-2567-6272; Naoki Hirokawa:  http://orcid.org/0000-0002-7346-889X; Yoko Usami: http://orcid.org/0000-0003-2230-5457; Masanori Someya: http://orcid.org/0000-0001-8821-7754; Koh-ichi Sakata: http://orcid.org/0000-0002-9900-9632 Conflict of Interest No potential conflict of interest relevant to this article was reported.,Non-OADS,/arxiv_data1/oa_pdf/87/4b/usg-16039.PMC5494864.pdf
"270  Ultrasonography 36(3), July 2017 e-ultrasonography.orgComparison of the severity of lower  extremity arterial disease in smokers and patients with diabetes using a novel duplex Doppler scoring system Rudresh Hiremath, Goutham Gowda, Jebin Ibrahim, Harish T Reddy , Haritha Chodiboina,  Rushit Shah Department of Radiodiagnosis and Imaging, KVG Medical College and Hospital, Sullia, Indiahttps://doi.org/10.14366/usg.16049  pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2017;36:270-277 Purpose: The aim of this study was to validate the diagnostic feasibility of a novel scoring system  of peripheral arterial disease (PAD) in smokers and patients with diabetes depending on duplex  Doppler sonographic features.Methods: Patients presenting with the symptomatology of PAD were divided into three  groups: diabetes only, smoking only, and smokers with diabetes.",Non-OADS,/arxiv_data1/oa_pdf/5e/c7/usg-16049.PMC5494865.pdf
"+91-8257-233408 E-mail: drrudresh76@yahoo.co.inORIGINAL ARTICLE This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/c7/usg-16049.PMC5494865.pdf
ORCID: Rudresh Hiremath: http://orcid.org/0000-0003-0387-9359; Goutham  Gowda: http://orcid.org/0000-0001-8390-5056; Jebin Ibrahim: http://orcid.org/0000-0002-8541-8929; Harish T Reddy: http://orcid.org/0000-0001-9873-8692; Haritha Chodiboina: http://orcid.org/0000-0002-0916-201X; Rushit Shah: http://orcid.org/0000-0001-7953-8628 Conflict of Interest No potential conflict of interest relevant to this article was reported.,Non-OADS,/arxiv_data1/oa_pdf/5e/c7/usg-16049.PMC5494865.pdf
"198  Ultrasonography 36(3), July 2017 e-ultrasonography.orgMedical auditing of whole-breast  screening ultrasonography Min Jung Kim Department of Radiology, Research Institute of Radiological Science, Severance Hospital,  Yonsei University College of Medicine, Seoul, Korea https://doi.org/10.14366/usg.17005 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2017;36:198-203 Since breast ultrasonography (US) has been used as an adjunctive screening modality in women  with dense breasts, the need has arisen to evaluate and monitor its possible harm and benefits in comparison with other screening modalities such as mammography.",Non-OADS,/arxiv_data1/oa_pdf/5e/d4/usg-17005.PMC5494866.pdf
"+82-2-361-3035 E-mail: mines@yuhs.acREVIEW ARTICLE This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/d4/usg-17005.PMC5494866.pdf
ORCID: Min Jung Kim: http://orcid.org/0000-0003-4949-1237 Conflict of Interest No potential conflict of interest relevant to this article was reported.,Non-OADS,/arxiv_data1/oa_pdf/5e/d4/usg-17005.PMC5494866.pdf
Available from:  http://www.fda.gov/radiation-emittingproducts/mammographyqualitystandardsactandprogram/regulations/ucm110906.htm.,Non-OADS,/arxiv_data1/oa_pdf/5e/d4/usg-17005.PMC5494866.pdf
"252  Ultrasonography 36(3), July 2017 e-ultrasonography.orgMetastatic renal cell carcinoma in the  thyroid gland: ultrasonographic features and the diagnostic role of core needle biopsy Ok Kyu Song1, Ja Seung Koo2, Jin Young Kwak1, Hee Jung Moon1, Jung Hyun Yoon1,  Eun-Kyung Kim1 1Department of Radiology and Research Institute of Radiological Science, Severance  Hospital, Yonsei University College of Medicine, Seoul; 2Department of Pathology, Severance  Hospital, Yonsei University College of Medicine, Seoul, Koreahttps://doi.org/10.14366/usg.16037 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2017;36:252-259 Purpose: The aims of this study were to present the ultrasonographic (US) features of metastatic  renal cell carcinoma (RCC) in the thyroid gland and to evaluate the diagnostic utility of fine- needle aspiration (FNA) and core needle biopsy (CNB).Methods: Eight patients with nine metastatic RCC nodules in the thyroid glands who were  treated from January 2002 to March 2015 in a single tertiary hospital were consecutively selected and retrospectively reviewed.",Non-OADS,/arxiv_data1/oa_pdf/45/39/usg-16037.PMC5494867.pdf
"+82-2-393-3035  E-mail: ekkim@yuhs.acORIGINAL ARTICLE This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/45/39/usg-16037.PMC5494867.pdf
ORCID: Ok Kyu Song: http://orcid.org/0000-0002-3914-9203; Ja Seung Koo:  http://orcid.org/0000-0003-4546-4709; Jin Young Kwak: http://orcid.org/0000-0002- 6212-1495;  Hee Jung Moon: http://orcid.org/0000-0002-5643-5885; Jung Hyun  Yoon: http://orcid.org/0000-0002-2100-3513; Eun-Kyung Kim: http://orcid.org/0000-0002-3368-5013 Conflict of Interest No potential conflict of interest relevant to this article was reported.,Non-OADS,/arxiv_data1/oa_pdf/45/39/usg-16037.PMC5494867.pdf
"204  Ultrasonography 36(3), July 2017 e-ultrasonography.orgEmergency ultrasonography of the  gastrointestinal tract of children Jae-Yeon Hwang1,2 1Department of Radiology, 2Research Institute for Convergence of Biomedical Science and  Technology, Pusan National University Yangsan Hospital, Yangsan, Korea https://doi.org/10.14366/usg.16052 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2017;36:204-221Ultrasonography (US) is widely used to evaluate most body parts in pediatric patients because  it is simple, noninvasive, easy to use, and applicable in a wide variety of clinical situations.",Non-OADS,/arxiv_data1/oa_pdf/98/db/usg-16052.PMC5494868.pdf
"+82-55-360-1848 E-mail: jyhwang79@gmail.comREVIEW ARTICLE This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/98/db/usg-16052.PMC5494868.pdf
ORCID: Jae-Yeon Hwang: http://orcid.org/0000-0003-2777-3444 Conflict of Interest No potential conflict of interest relevant to this article was reported.,Non-OADS,/arxiv_data1/oa_pdf/98/db/usg-16052.PMC5494868.pdf
A movie clip shows graded compression technique of the abdomen (https://doi.org/10.14366/usg.16052.v001).,Non-OADS,/arxiv_data1/oa_pdf/98/db/usg-16052.PMC5494868.pdf
A movie clip shows graded compression technique of  the upper abdomen (https://doi.org/10.14366/usg.16052.v002).,Non-OADS,/arxiv_data1/oa_pdf/98/db/usg-16052.PMC5494868.pdf
Movie clip shows typical course of the sigmoid colon  (https://doi.org/10.14366/usg.16052.v003).Video clip 4.,Non-OADS,/arxiv_data1/oa_pdf/98/db/usg-16052.PMC5494868.pdf
A movie clip shows normal retroperitoneal course of the duodenal third portion (https://doi.org/10.14366/usg.16052.v004).,Non-OADS,/arxiv_data1/oa_pdf/98/db/usg-16052.PMC5494868.pdf
"A movie clip shows ""whirlpool"" sign in a patient with  midgut volvulus (https://doi.org/10.14366/usg.16052.v005).",Non-OADS,/arxiv_data1/oa_pdf/98/db/usg-16052.PMC5494868.pdf
A movie clip shows abnormal location of the superior  mesenteric artery and vein due to off-center scanning (https://doi.org/10.14366/usg.16052.v006).,Non-OADS,/arxiv_data1/oa_pdf/98/db/usg-16052.PMC5494868.pdf
A movie clip shows normal couterclockwise rotation of  the superior mesenteric vein (https://doi.org/10.14366/usg.16052.v007).,Non-OADS,/arxiv_data1/oa_pdf/98/db/usg-16052.PMC5494868.pdf
A movie clip shows normal position and appearance of  pylorus (https://doi.org/10.14366/usg.16052.v008).,Non-OADS,/arxiv_data1/oa_pdf/98/db/usg-16052.PMC5494868.pdf
A movie clip shows passage of fluid through the  pylorus in a normal patient (https://doi.org/10.14366/usg.16052.v009).,Non-OADS,/arxiv_data1/oa_pdf/98/db/usg-16052.PMC5494868.pdf
"A movie clip shows normal location of the ileocecal  valve, terminal ileum, and appendix (https://doi.org/10.14366/usg.16052.v010).",Non-OADS,/arxiv_data1/oa_pdf/98/db/usg-16052.PMC5494868.pdf
"Jae-Yeon Hwang220  Ultrasonography 36(3), July 2017 e-ultrasonography.orgof pelvic brim type appendix (https://doi.org/10.14366/usg.16052.",Non-OADS,/arxiv_data1/oa_pdf/98/db/usg-16052.PMC5494868.pdf
A movie clip shows posterior compression technique  (https://doi.org/10.14366/usg.16052.v012).,Non-OADS,/arxiv_data1/oa_pdf/98/db/usg-16052.PMC5494868.pdf
A movie clip shows acute calculous appendicitis  (https://doi.org/10.14366/usg.16052.v013).,Non-OADS,/arxiv_data1/oa_pdf/98/db/usg-16052.PMC5494868.pdf
A movie clip shows acute appendicitis limited to the  tip of the appendix (https://doi.org/10.14366/usg.16052.v014).,Non-OADS,/arxiv_data1/oa_pdf/98/db/usg-16052.PMC5494868.pdf
"278  Ultrasonography 36(3), July 2017 e-ultrasonography.orgPrenatal diagnosis of aberrant right  subclavian artery in an unselected population Mi Jin Song1, Byoung Hee Han1, Young-Hwa Kim1, So Young Yoon2, Yoo Mi Lee1,  Hye Su Jeon1, Bo Kyung Park1 Departments of 1Radiology and 2Pediatrics, Cheil General Hospital and Women’s Healthcare  Center, Dankook University College of Medicine, Seoul, Koreahttps://doi.org/10.14366/usg.16046 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2017;36:278-283 Purpose: The purpose of this study was to determine the frequency of aberrant right subclavian  artery (ARSA) among unselected fetuses and to evaluate its association with chromosomal  abnormalities and other congenital anomalies.Methods: In all, 7,547 fetuses (gestational age, 20 to 34 weeks) were examined using routine  antenatal sonography at our institution between April 2014 and September 2015.",Non-OADS,/arxiv_data1/oa_pdf/ac/1f/usg-16046.PMC5494869.pdf
"+82-2-2000-7369 E-mail: ubf2931@msn.comORIGINAL ARTICLE This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/1f/usg-16046.PMC5494869.pdf
ORCID: Mi Jin Song: http://orcid.org/0000-0003-4853-3167; Byoung Hee Han: http:// orcid.org/0000-0001-5449-7014; Young-Hwa Kim: http://orcid.org/0000-0003-0517-9559; So Young Yoon: http://orcid.org/0000-0002-0705-5712; Yoo Mi Lee: http://orcid.org/0000-0001-5171-0182; Hye Su Jeon: http://orcid.org/0000-0002-6620-8846; Bo Kyung Park: http://orcid.org/0000-0002-2413-6899 Conflict of Interest No potential conflict of interest relevant to this article was reported.,Non-OADS,/arxiv_data1/oa_pdf/ac/1f/usg-16046.PMC5494869.pdf
"e-ultrasonography.org Ultrasonography 36(3), July 2017185Current status of musculoskeletal  application of shear wave elastography JeongAh Ryu1, Woo Kyoung Jeong2 1Department of Radiology, Hanyang University Guri Hospital, Hanyang University School of  Medicine, Guri; 2Department of Radiology and Center for Imaging Science, Samsung Medical  Center, Sungkyunkwan University School of Medicine, Seoul, Korea https://doi.org/10.14366/usg.16053 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2017;36:185-197 Ultrasonography (US) is a very powerful diagnostic modality for the musculoskeletal system  due to the ability to perform real-time dynamic high-resolution examinations with the Doppler technique.",Non-OADS,/arxiv_data1/oa_pdf/8e/f6/usg-16053.PMC5494870.pdf
"+82-31-560-2551 E-mail: ryuja@hanyang.ac.krREVIEW ARTICLE This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/f6/usg-16053.PMC5494870.pdf
ORCID: JeongAh Ryu: http://orcid.org/0000-0002-4474-180X; Woo Kyoung Jeong:  http://orcid.org/0000-0002-0676-2116 Conflict of Interest No potential conflict of interest relevant to this article was reported.,Non-OADS,/arxiv_data1/oa_pdf/8e/f6/usg-16053.PMC5494870.pdf
Available from:  http://www.aium.org/cme/testsWebinar.aspx.,Non-OADS,/arxiv_data1/oa_pdf/8e/f6/usg-16053.PMC5494870.pdf
Available from: http://qibawiki.rsna.org/images/3/3a/US_ SWS_Poster2016.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8e/f6/usg-16053.PMC5494870.pdf
"e-ultrasonography.org Ultrasonography 36(3), July 2017171Ultrasound-guided drug delivery in cancer Sayan Mullick Chowdhury, Taehwa Lee, Jürgen K. Willmann  Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA https://doi.org/10.14366/usg.17021 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2017;36:171-184Recent advancements in ultrasound and microbubble (USMB) mediated drug delivery technology  has shown that this approach can improve spatially confined delivery of drugs and genes to target tissues while reducing systemic dose and toxicity.",Non-OADS,/arxiv_data1/oa_pdf/08/a3/usg-17021.PMC5494871.pdf
"+1-650-723-1909 E-mail: willmann@stanford.eduREVIEW ARTICLE This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/08/a3/usg-17021.PMC5494871.pdf
ORCID: Sayan Mullick Chowdhury: http://orcid.org/0000-0002-0502-7531; Taehwa  Lee: http://orcid.org/0000-0001-6813-7669; Jürgen K. Willmann: http://orcid.org/0000-0002-9517-4657 Conflict of Interest No potential conflict of interest relevant to this article was reported.,Non-OADS,/arxiv_data1/oa_pdf/08/a3/usg-17021.PMC5494871.pdf
https://doi.org/10.1200/JCO.2016.70.8594.,Non-OADS,/arxiv_data1/oa_pdf/08/a3/usg-17021.PMC5494871.pdf
"284  Ultrasonography 36(3), July 2017 e-ultrasonography.orgUse of transcatheter contrast-enhanced  ultrasound with vessel navigation to reduce the contrast requirement during transarterial chemoembolization in patients with renal impairment Uei Pua1,2  1Department of Diagnostic Radiology, Tan Tock Seng Hospital, 2Yong Loo Lin School of  Medicine, National University of Singapore, Singaporehttps://doi.org/10.14366/usg.17006 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2017;36:284-285 Received: January 30, 2017 Revised: March 5, 2017Accepted: March 13, 2017 Correspondence to: Uei Pua, MBBS, MMed, FRCR, FAMS, Department of Diagnostic Radiology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 309199, Singapore  Tel.",Non-OADS,/arxiv_data1/oa_pdf/3d/7c/usg-17006.PMC5494872.pdf
"+65-67599940 E-mail: druei@yahoo.comLETTER This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/7c/usg-17006.PMC5494872.pdf
ORCID: Uei Pua: http://orcid.org/0000-0001-8896-5648 Conflict of Interest No potential conflict of interest relevant to this article was reported.,Non-OADS,/arxiv_data1/oa_pdf/3d/7c/usg-17006.PMC5494872.pdf
Embolization was performed from this catheter position based on these findings (https://doi.org/10.14366/usg.17006.v001).,OADS,/arxiv_data1/oa_pdf/3d/7c/usg-17006.PMC5494872.pdf
"e-ultrasonography.org Ultrasonography 36(3), July 2017239Ultrasonography of the pediatric hip  and spine Yeo Ryang Kang, Joonbum Koo Department of Radiology, Dongguk University Ilsan Hospital, Dongguk University College of  Medicine, Goyang, Korea https://doi.org/10.14366/usg.16051 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2017;36:239-251Ultrasonography (US) is a useful screening method for the diagnosis of developmental dysplasia  of the hip (DDH) and congenital spinal anomalies in infants.",Non-OADS,/arxiv_data1/oa_pdf/54/b6/usg-16051.PMC5494873.pdf
"+82-31-961-7851 E-mail: drkoo1@daum.netREVIEW ARTICLE This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/54/b6/usg-16051.PMC5494873.pdf
ORCID: Yeo Ryang Kang: http://orcid.org/0000-0003-1161-8415; Joonbum Koo:  http://orcid.org/0000-0002-1884-7758 Conflict of Interest No potential conflict of interest relevant to this article was reported.,Non-OADS,/arxiv_data1/oa_pdf/54/b6/usg-16051.PMC5494873.pdf
Longitudinal lumbar sonogram of a 3-week-old boy  with a linear 5-12 MHz probe shows normal anatomy (https://doi.org/10.14366/usg.16051.v001).,Non-OADS,/arxiv_data1/oa_pdf/54/b6/usg-16051.PMC5494873.pdf
"Copyright © 2017 The Korean Society of Environmental Health and Toxicology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 7 http://e-eht.org/ INTRODUCTION Zinc oxide nanoparticles (ZnO NPs) and titanium dioxide  nanoparticles (TiO 2 NPs), well known as photoreactive nanopar - ticles (NPs), are increasingly found in personal care products  and distributed in the environment due to their easy biodegrad - ability [1,2].",Non-OADS,/arxiv_data1/oa_pdf/e3/1d/eht-32-e2017007.PMC5494877.pdf
"Particle size distributions of hydrodynamic di - ameters and zeta potential of 10 mg/L ZnO NPs and TiO 2 NPs  suspended in deionized water (DW) and M4 medium [7] were  measured using an electrophoretic light scattering spectropho -Accelerated ecotoxicity of photoreactive  nanoparticles on Moina macrocopa Sun-Hwa Nam, Yu-Jin Shin, Y oun-Joo An Department of Environmental Health Science, Konkuk University, Seoul, Korea• Brief ReportOpen Access Environmental Health and Toxicology Volume: 32, Article ID: e2017007, 7 pages https://doi.org/10.5620/eht.e2017007 eISSN: 2233-6567  Zinc oxide nanoparticles (ZnO NPs) and titanium dioxide nanoparticles (TiO2 NPs) are  well known as photoreactive nanoparticles (NPs).",OADS,/arxiv_data1/oa_pdf/e3/1d/eht-32-e2017007.PMC5494877.pdf
"Keywords : Moina macrocopa , Phototoxicity, Titanium dioxide nanoparticles, Ultraviolet,  Zinc oxide nanoparticles Correspondence:   Youn-Joo An  Department of Environmental Health  Science, Konkuk University, 120  Neungdong-ro, Gwangjin-gu, Seoul 05029,  Korea  E-mail: anyjoo@konkuk.ac.kr Received:  December 6, 2016 Accepted:  February 10, 2017 Published:  March 22, 2017 This article is available from: http://e-eht.org/",Non-OADS,/arxiv_data1/oa_pdf/e3/1d/eht-32-e2017007.PMC5494877.pdf
"http://e-eht.org/ Page 2 of 7Environmental Health and Toxicology    2017;32:e2017007 tometer (ELS-8000, Otsuka Electronics Co., Osaka, Japan).",Non-OADS,/arxiv_data1/oa_pdf/e3/1d/eht-32-e2017007.PMC5494877.pdf
"http://e-eht.org/ Page 3 of 7Sun-Hwa Nam, et al.",Non-OADS,/arxiv_data1/oa_pdf/e3/1d/eht-32-e2017007.PMC5494877.pdf
"http://e-eht.org/ Page 4 of 7Environmental Health and Toxicology    2017;32:e2017007 hours-EC 50 presented in T able 1, the sensitivity of ZnO NPs for  M. macrocopa  was UVB > UVA > visible light irradiation.",Non-OADS,/arxiv_data1/oa_pdf/e3/1d/eht-32-e2017007.PMC5494877.pdf
ORCID  Sun-Hwa Nam http://orcid.org/0000-0003-4633-296X Y oun-Joo An http://orcid.org/0000-0002-0193-1929 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e3/1d/eht-32-e2017007.PMC5494877.pdf
"http://e-eht.org/ Page 5 of 7Sun-Hwa Nam, et al.",Non-OADS,/arxiv_data1/oa_pdf/e3/1d/eht-32-e2017007.PMC5494877.pdf
http://e-eht.org/ Page 6 of 7Environmental Health and Toxicology    2017;32:e2017007 Table S1.,Non-OADS,/arxiv_data1/oa_pdf/e3/1d/eht-32-e2017007.PMC5494877.pdf
"http://e-eht.org/ Page 7 of 7Sun-Hwa Nam, et al.",Non-OADS,/arxiv_data1/oa_pdf/e3/1d/eht-32-e2017007.PMC5494877.pdf
Clinical Trial Registration: http://www.clinicaltrials.gov; NCT02327585.,Non-OADS,/arxiv_data1/oa_pdf/c7/14/CMJ-130-1513.PMC5494912.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/b2/d6/CMJ-130-1521.PMC5494913.pdf
Gene sequence of HIF‑1α  was obtained from Ensembl  database (http://www.ensembl.org/index.html) and used  to design and construct the targeting vector.,OADS,/arxiv_data1/oa_pdf/f4/2d/CMJ-130-1570.PMC5494921.pdf
Available	 from:	 http://www.Heart.,Non-OADS,/arxiv_data1/oa_pdf/59/a2/IJNMR-22-184.PMC5494946.pdf
Available	from:	http://www.ncbi.nlm.nih.gov/ pubmed/20492044.,Non-OADS,/arxiv_data1/oa_pdf/2c/14/IJNMR-22-237.PMC5494955.pdf
Available	 from:	http://www.hindawi.,Non-OADS,/arxiv_data1/oa_pdf/2c/14/IJNMR-22-237.PMC5494955.pdf
"Increasing	 of	MS	prevalence	 in	 Iran	2012,	Available	 at	http://www.iranms.ir.",Non-OADS,/arxiv_data1/oa_pdf/50/80/IJNMR-22-243.PMC5494956.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/7f/f7/idr-10-167.PMC5495008.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/7f/f7/idr-10-167.PMC5495008.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Infection and Drug Resistance  2017:10 167–174Infection and Drug Resistance Dovepress submit your manuscript | www.dovepress.com Dovepress 167 ORIg Inal ReseaRch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S130203genotypic distribution of multidrug-resistant  and extensively drug-resistant tuberculosis in  northern Thailand Risara Jaksuwan1 Prasit Tharavichikul2 Jayanton Patumanond3 charoen chuchottaworn4 sakarin chanwong5 saijai smithtikarn6 Jongkolnee settakorn7 1clinical epidemiology Unit,   2Department of Microbiology, Faculty  of Medicine, chiang Mai University,   chiang Mai, 3Division of clinical  epidemiology, Faculty of Medicine,   Thammasat University, Pathum Thani,   4Division of Respiratory Medicine,   chest Disease Institute, nonthaburi,   5Office of Disease Prevention and  control Region 10, chiang Mai,   6Bureau of T uberculosis, Department  of Disease control, Ministry of Public  health, Bangkok, 7Department of  Pathology, Faculty of Medicine, chiang  Mai University, chiang Mai, ThailandBackground: Multidrug/extensively drug-resistant tuberculosis (M/XDR-TB) is a major  public health problem, and early detection is important for preventing its spread.",Non-OADS,/arxiv_data1/oa_pdf/7f/f7/idr-10-167.PMC5495008.pdf
"2 Approximately 9.5% of MDR-TB correspondence: Jongkolnee settakorn Department of Pathology, Faculty of Medicine, chiang Mai University, Inthavaroros Road, sriphum sub-district, Mueang chiang Mai District, chiang Mai Province 50200, ThailandTel +66 53 94 5442–4Fax +66 53 21 7144email jsettakorn@gmail.comJournal name: Infection and Drug Resistance  Article Designation: Original ResearchY ear: 2017V olume: 10Running head verso: Jaksuwan et alRunning head recto: Genetypic distribution of MDR-TB and XDR-TB in ThailandDOI: http://dx.doi.org/10.2147/IDR.S130203",Non-OADS,/arxiv_data1/oa_pdf/7f/f7/idr-10-167.PMC5495008.pdf
Available from: http://apps.who.int/iris/bitstr eam/10665/44597/1/9789241501583_eng.pdf.,OADS,/arxiv_data1/oa_pdf/7f/f7/idr-10-167.PMC5495008.pdf
"Infection and Drug Resistance  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Infection and Drug Resistance  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/infection-and-drug-resistance-journalInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte-rial, fungal and viral) and the development and institution of preventive strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/7f/f7/idr-10-167.PMC5495008.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 174 Jaksuwan et al References  1.,Non-OADS,/arxiv_data1/oa_pdf/7f/f7/idr-10-167.PMC5495008.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/15/e3/idr-10-043.PMC5495009.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/15/e3/idr-10-043.PMC5495009.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Treatment patterns, resource utilization, and  outcomes among hospitalized patients with  methicillin-resistant Staphylococcus aureus   complicated skin and soft tissue infections in  Lebanon and Saudi Arabia Madonna J Matar1 Rima Moghnieh2 Adel F Alothman3 Abdulhakeem O Althaqafi4 Thamer H Alenazi3 Fayssal M Farahat4 Shelby Corman5 Caitlyn T Solem5 Nirvana Raghubir6 Cynthia Macahilig7 Seema Haider8 Jennifer M Stephens5 1Department of Infectious Diseases,   Notre Dame des Secours University  Hospital, Jbeil, Lebanon; 2Department  of Internal Medicine, Makassed General  Hospital, Beirut, Lebanon; 3College  of Medicine, King Saud bin Abdulaziz  University for Health Sciences, King  Abdullah International Medical Research  Center, Riyadh, Saudi Arabia; 4King  Abdullah International Medical Research  Center, Infection Prevention and  Control, King AbdulAziz Medical City,   King Saud bin AbdulAziz University for  Health Sciences, Jeddah, Saudi Arabia;   5Pharmerit International, Real-World  Evidence/Data Analytics, Bethesda, MD,   6Pfizer, New Y ork, NY, 7Medical Data  Analytics, Parsippany, NJ, 8Pfizer, Groton,   CT, USA Correspondence: Jennifer M Stephens   Pharmerit International, 4350 East West  Highway, Suite 430, Bethesda, MD 20814,  USA  T el +1 301 821 1290   Fax +1 301 821 1296   Email jstephens@pharmerit.co mObjectives:  To describe treatment patterns and medical resource use for methicillin-resistant  Staphylococcus aureus  (MRSA) complicated skin and soft tissue infections (cSSTI) in Saudi  Arabia and Lebanon in terms of drug selection against the infecting pathogen as well as hospital  resource utilization and clinical outcomes among patients with these infections.",Non-OADS,/arxiv_data1/oa_pdf/15/e3/idr-10-043.PMC5495009.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/15/e3/idr-10-043.PMC5495009.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/15/e3/idr-10-043.PMC5495009.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/05/omx034.PMC5495011.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ea/4c/omx035.PMC5495012.pdf
